FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Alkhammash, AM
   Alshehri, WA
   Alhozali, AM
   Bahieldin, A
AF Alkhammash, Alhanouf M.
   Alshehri, Wafa A.
   Alhozali, Amani M.
   Bahieldin, Ahmed
TI Link of Gut Microbiome with Risk of 2 Diabetes Mellitus
SO JOURNAL OF CONTEMPORARY MEDICAL SCIENCES
LA English
DT Article
DE Gastrointestinal microbiome; diabetes mellitus; type 2; microbial
   metabolites; epigenomics
ID CHAIN FATTY-ACIDS; RNA GENE DATABASE; DIETARY FIBER; OBESITY;
   INFLAMMATION; ENDOTOXEMIA; AXIS; PATHOGENESIS; METAGENOME; RECEPTORS
AB The gut microbiota presented in the human digestive system plays an active role in maintaining host health. Recent studies that rely on the use of high throughput metagenomic sequencing (MGS) revealed the association of dysbiosis in the intestinal microbial community and many chronic diseases, specifically type 2 diabetes (T2D). This disease is considered one of the most prevalent metabolic diseases worldwide comprising up to 90%. This article presents the most prominent research in this field and summarizes the method used to study the diversity of the gut microbiome through the use bioinformatics tools. We highlight the role of gut metabolic products in the development of T2D, as many studies have proven the influence of microbial metabolite products, such as LPS and SCFAs, on blood glucose levels through the microbial-host cross-talk. In addition, this article underlines the interaction of epigenetic mechanisms and the gut microbiome in regulating and developing T2D. The latter can be an appropriate preventative or therapeutic approach for several human metabolic diseases. Therefore, future research is required to build new type of T2D therapy based on epigenetic mechanisms, microbial composition, and microbial metabolites.
C1 [Alkhammash, Alhanouf M.; Bahieldin, Ahmed] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia.
   [Alshehri, Wafa A.] Univ Jeddah, Coll Sci, Dept Biol, Jeddah, Saudi Arabia.
   [Alhozali, Amani M.] King Abdulaziz Univ, Fac Med, Dept Med, Jeddah, Saudi Arabia.
C3 King Abdulaziz University; University of Jeddah; King Abdulaziz
   University
RP Alshehri, WA (corresponding author), Univ Jeddah, Coll Sci, Dept Biol, Jeddah, Saudi Arabia.
EM waalsheri@uj.edu.sa
CR Allin KH, 2015, EUR J ENDOCRINOL, V172, pR167, DOI 10.1530/EJE-14-0874
   Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Barengolts E, 2016, ENDOCR PRACT, V22, P1224, DOI 10.4158/EP151157.RA
   Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002
   Bu P., 2015, NAT COMMUN, V6, P1
   Burcelin R, 2011, ACTA DIABETOL, V48, P257, DOI 10.1007/s00592-011-0333-6
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Carabotti M, 2015, ANN GASTROENTEROL, V28, P203
   Chen X, 2013, PROTEIN CELL, V4, P403, DOI 10.1007/s13238-013-3017-x
   Chimerel C, 2014, CELL REP, V9, P1202, DOI 10.1016/j.celrep.2014.10.032
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160
   Delzenne NM, 2011, CURR DIABETES REP, V11, P154, DOI 10.1007/s11892-011-0191-1
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   Everard A, 2014, REV ENDOCR METAB DIS, V15, P189, DOI 10.1007/s11154-014-9288-6
   Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439
   Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611
   Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]
   Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253
   Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721
   Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377
   Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1
   Gotelli N. J., 2013, MEASURING ESTIMATING
   Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094
   Hagerty SL, 2019, PERSPECT PSYCHOL SCI, V14, P633, DOI 10.1177/1745691619827010
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Internation Diabetes Federation, 2019, MENA MEMB
   Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Khan MT, 2014, CELL METAB, V20, P753, DOI 10.1016/j.cmet.2014.07.006
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Langenberg C, 2018, LANCET, V391, P2463, DOI 10.1016/S0140-6736(18)31132-2
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]
   Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Martin AM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00428
   Mohammad S, 2016, DIABETES METAB SYND, V10, P171, DOI 10.1016/j.dsx.2016.01.017
   Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190
   Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Paul B, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0144-7
   Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646
   Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034
   Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309
   Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Radwan S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238764
   Rapin Alexis, 2017, Curr Protoc Mouse Biol, V7, P100, DOI 10.1002/cpmo.29
   Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14
   Reimann F, 2012, CELL METAB, V15, P421, DOI 10.1016/j.cmet.2011.12.019
   Remely M, 2014, BENEF MICROBES, V5, P33, DOI 10.3920/BM2013.006
   Romano KA, 2018, LAB ANIMAL, V47, P240, DOI 10.1038/s41684-018-0129-1
   Ruchat SM, 2009, ACTA DIABETOL, V46, P217, DOI 10.1007/s00592-008-0080-5
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Sharma M, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01329
   Sharma Rohit, 2015, Ayu, V36, P10, DOI 10.4103/0974-8520.169014
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Sikalidis AK, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8010008
   Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Upadhyaya S, 2015, GUT MICROBES, V6, P85, DOI 10.1080/19490976.2015.1024918
   Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158
   VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088
   Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108
   Zhao LJ, 2019, ENDOCRINE, V66, P526, DOI 10.1007/s12020-019-02103-8
NR 83
TC 0
Z9 0
U1 2
U2 2
PU NABA AL-HAYAT FOUNDATION MEDICAL SCIENCES & HEALTH CARE
PI NAJAF
PA PO BOX 494, NAJAF, 00000, IRAQ
SN 2413-0516
J9 J CONTEMP MED SCI
JI J. Contemp. Med. Sci.
PD NOV-DEC
PY 2022
VL 8
IS 6
BP 363
EP 369
DI 10.22317/jcms.v8i6.1305
PG 7
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA C4WO4
UT WOS:000961937800001
OA gold
DA 2023-09-14
ER

PT J
AU Koo, SH
   Deng, J
   Ang, DSW
   Hsiang, JC
   Lee, LS
   Aazmi, S
   Mohamed, EHM
   Yang, H
   Yap, SY
   Teh, LK
   Salleh, MZ
   Lee, EJD
   Ang, TL
AF Koo, Seok Hwee
   Deng, Jing
   Ang, Daphne Shih Wen
   Hsiang, John Chen
   Lee, Lian Shien
   Aazmi, Shafiq
   Mohamed, Elsa Haniffah Mejia
   Yang, Hong
   Yap, Siew Yoon
   Teh, Lay Kek
   Salleh, Mohd Zaki
   Lee, Edmund Jon Deoon
   Ang, Tiing Leong
TI Effects of proton pump inhibitor on the human gut microbiome profile in
   multi-ethnic groups in Singapore
SO SINGAPORE MEDICAL JOURNAL
LA English
DT Article
DE gastroesophageal reflux disease; gastrointestinal microbiome; omeprazole
ID CLOSTRIDIUM-DIFFICILE INFECTION; DIVERSITY; BACTERIA; BUTYRATE;
   DIARRHEA; ALTER; RISK; AGE
AB INTRODUCTION The objectives of this study were to examine the effects of ethnicity, gender and a proton pump inhibitor (PPI), omeprazole, on the human gut microbiome. PPIs are commonly used for the treatment of acid-related disorders. We hypothesised that PPI therapy might perturb microbial communities and alter the gut microbiome.
   METHODS Healthy subjects of Chinese (n = 12), Malay (n = 12) and Indian (n = 10) ancestry, aged 21-37 years, were enrolled. They provided a baseline stool sample (Day 1) and were then given a course of omeprazole at therapeutic dose (20 mg daily) for seven days. Stool samples were collected again on Day 7 and 14 (one week after stopping omeprazole). Microbial DNA was extracted from the stool samples, followed by polymerase chain reaction, library construction, 16S rRNA sequencing using Illumina MiSeq, and statistical and bioinformatics analyses.
   RESULTS The findings showed an increase in species richness (p = 0.018) after omeprazole consumption on Day 7, which reverted to baseline on Day 14. There were significant increases in the relative abundance of Streptococcus vestibularis (p = 0.0001) and Veillonella dispar (p = 0.0001) on Day 7, which diminished on Day 14. Faecalibacterium prausnitzii, Sutterella stercoricanis and Bacteroides denticanum were characteristic of Chinese, Malays and Indians, respectively. Lactobacillaceae and Bacteroides xylanisolvens were the signature taxa of male and female subjects, respectively.
   CONCLUSION The study demonstrated alterations in the gut microbiome following omeprazole treatment. This may explain the underlying pathology of increased risk of Clostridium difficile infections associated with omeprazole therapy.
C1 [Koo, Seok Hwee; Deng, Jing; Yap, Siew Yoon; Lee, Edmund Jon Deoon] Natl Univ Singapore, Changi Gen Hosp, Clin Trials & Res Unit, Singapore, Singapore.
   [Koo, Seok Hwee; Deng, Jing; Mohamed, Elsa Haniffah Mejia; Lee, Edmund Jon Deoon] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore.
   [Ang, Daphne Shih Wen; Hsiang, John Chen; Ang, Tiing Leong] Changi Gen Hosp, Dept Gastroenterol & Hepatol, 2 Simei St 3, Singapore 329889, Singapore.
   [Lee, Lian Shien; Aazmi, Shafiq; Teh, Lay Kek; Salleh, Mohd Zaki] Univ Teknol MARA, Integrat Pharmacogen Inst iPROMISE, Selangor Campus, Selangor, Malaysia.
   [Mohamed, Elsa Haniffah Mejia] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia.
   [Yang, Hong] Temasek Polytech, Sch Appl Sci, Singapore, Singapore.
C3 Changi General Hospital; National University of Singapore; National
   University of Singapore; Changi General Hospital; Universiti Teknologi
   MARA; Universiti Malaya
RP Ang, TL (corresponding author), Changi Gen Hosp, Dept Gastroenterol & Hepatol, 2 Simei St 3, Singapore 329889, Singapore.
EM ang.tiing.leong@singhealth.com.sg
RI Teh, Lay Kek/ABH-6209-2020; aazmi, shafiq/HPH-3472-2023; Teh, Lay
   Kek/AAV-2790-2020; Salleh, Mohd Zaki/ABD-4784-2020; MOHAMED, ELSA
   HANIFFAH MEJIA/B-8451-2010; AAZMI, MOHD SHAFIQ/AAL-1763-2020
OI aazmi, shafiq/0000-0003-4942-8457; MOHAMED, ELSA HANIFFAH
   MEJIA/0000-0001-5091-2970; AAZMI, MOHD SHAFIQ/0000-0003-4942-8457;
   Hsiang, John Chen/0000-0002-7124-6396; Teh, Lay Kek/0000-0002-2830-4263
FU Changi General Hospital, Singapore [CHF2014.03-P]
FX The study was financially supported by a research grant (CHF2014.03-P)
   from Changi General Hospital, Singapore, awarded to Ang TL. We would
   like to thank all staff of the Clinical Trials and Research Unit for
   their assistance in conducting the trial.
CR Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005
   Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13
   Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chen J, 2016, PEERJ, V4, DOI 10.7717/peerj.1514
   Clooney AG, 2016, ALIMENT PHARM THER, V43, P974, DOI 10.1111/apt.13568
   de Carcer DA, 2011, ISME J, V5, P801, DOI 10.1038/ismej.2010.177
   Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599
   Freedberg DE, 2015, GASTROENTEROLOGY, V149, P883, DOI 10.1053/j.gastro.2015.06.043
   Guo Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20602
   Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376
   Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861
   Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5
   Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x
   Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x
   Magalhaes PP, 2005, COMP BIOCHEM PHYS B, V140, P589, DOI 10.1016/j.cbpc.2004.12.007
   Mao EJ, 2015, ANTIMICROB AGENTS CH, V59, P6283, DOI 10.1128/AAC.00795-15
   Mashima I, 2011, CURR MICROBIOL, V63, P403, DOI 10.1007/s00284-011-9993-2
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006
   Pilotto A, 2008, AM J GASTROENTEROL, V103, P2816, DOI 10.1111/j.1572-0241.2008.02107.x
   Rigsbee L, 2012, AM J GASTROENTEROL, V107, P1740, DOI 10.1038/ajg.2012.287
   SACHS G, 1995, ANNU REV PHARMACOL, V35, P277, DOI 10.1146/annurev.pharmtox.35.1.277
   Sanz Y, 2014, ADV EXP MED BIOL, V817, P291, DOI 10.1007/978-1-4939-0897-4_14
   Simsek AD, 2008, CLIN KIDNEY J, V1, P276, DOI 10.1093/ndtplus/sfn071
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x
   Ulsemer P, 2012, BENEF MICROBES, V3, P99, DOI 10.3920/BM2011.0051
   Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553
   Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11
NR 34
TC 10
Z9 10
U1 0
U2 2
PU SINGAPORE MEDICAL ASSOC
PI SINGAPORE
PA 2985 JALAN BUKIT MERAH, #02-2C, SMF BUILDING, SINGAPORE, SINGAPORE
SN 0037-5675
J9 SINGAP MED J
JI Singap. Med. J.
PD OCT
PY 2019
VL 60
IS 10
BP 512
EP 521
DI 10.11622/smedj.2018152
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA JI2PB
UT WOS:000493305300006
PM 30488079
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Mori, H
   Kato, T
   Ozawa, H
   Sakamoto, M
   Murakami, T
   Taylor, TD
   Toyoda, A
   Ohkuma, M
   Kurokawa, K
   Ohno, H
AF Mori, Hiroshi
   Kato, Tamotsu
   Ozawa, Hiroaki
   Sakamoto, Mitsuo
   Murakami, Takumi
   Taylor, Todd D.
   Toyoda, Atsushi
   Ohkuma, Moriya
   Kurokawa, Ken
   Ohno, Hiroshi
TI Assessment of metagenomic workflows using a newly constructed human gut
   microbiome mock community
SO DNA RESEARCH
LA English
DT Article
DE human gut microbiome; bacterial mock community; metagenomics; 16S rRNA
   gene sequencing
ID GENOMES; QUALITY; TOOLS
AB To quantify the biases introduced during human gut microbiome studies, analyzing an artificial mock community as the reference microbiome is indispensable. However, there are still limited resources for a mock community which well represents the human gut microbiome. Here, we constructed a novel mock community comprising the type strains of 18 major bacterial species in the human gut and assessed the influence of experimental and bioinformatics procedures on the 16S rRNA gene and shotgun metagenomic sequencing. We found that DNA extraction methods greatly affected the DNA yields and taxonomic composition of sequenced reads, and that some of the commonly used primers for 16S rRNA genes were prone to underestimate the abundance of some gut commensal taxa such as Erysipelotrichia, Verrucomicrobiota and Methanobacteriota. Binning of the assembled contigs of shotgun metagenomic sequences by MetaBAT2 produced phylogenetically consistent, less-contaminated bins with varied completeness. The ensemble approach of multiple binning tools by MetaWRAP can improve completeness but sometimes increases the contamination rate. Our benchmark study provides an important foundation for the interpretation of human gut microbiome data by providing means for standardization among gut microbiome data obtained with different methodologies and will facilitate further development of analytical methods.
C1 [Mori, Hiroshi; Murakami, Takumi; Toyoda, Atsushi; Kurokawa, Ken] Natl Inst Genet, Adv Genom Ctr, 1111 Yata, Mishima, Shizuoka 4118540, Japan.
   [Mori, Hiroshi; Murakami, Takumi] Natl Inst Genet, Dept Informat, 1111 Yata, Mishima, Shizuoka 4118540, Japan.
   [Kato, Tamotsu; Ozawa, Hiroaki; Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci, Lab Intestinal Ecosyst, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [Kato, Tamotsu; Ozawa, Hiroaki; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, 1-7-29 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [Sakamoto, Mitsuo; Ohkuma, Moriya] RIKEN BioResource Res Ctr, Microbe Div, Japan Collect Microorganisms, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.
   [Taylor, Todd D.; Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci, Lab Microbiome Sci, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
   [Toyoda, Atsushi] Natl Inst Genet, Dept Genom & Evolutionary Biol, 1111 Yata, Mishima, Shizuoka 4118540, Japan.
C3 Research Organization of Information & Systems (ROIS); National
   Institute of Genetics (NIG) - Japan; Research Organization of
   Information & Systems (ROIS); National Institute of Genetics (NIG) -
   Japan; RIKEN; Yokohama City University; RIKEN; RIKEN; Research
   Organization of Information & Systems (ROIS); National Institute of
   Genetics (NIG) - Japan
RP Mori, H (corresponding author), Natl Inst Genet, Adv Genom Ctr, 1111 Yata, Mishima, Shizuoka 4118540, Japan.; Mori, H (corresponding author), Natl Inst Genet, Dept Informat, 1111 Yata, Mishima, Shizuoka 4118540, Japan.; Ohno, H (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Intestinal Ecosyst, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.; Ohno, H (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, 1-7-29 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.; Ohno, H (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Microbiome Sci, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.
EM hmori@nig.ac.jp; hiroshi.ohno@riken.jp
RI Ohno, Hiroshi/L-7899-2014; Sakamoto, Mitsuo/C-3612-2017
OI Ohno, Hiroshi/0000-0001-8776-9661; Sakamoto, Mitsuo/0000-0002-3622-4642
CR Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   [Anonymous], 16S MET SEQ LIB PREP
   Bokulich NA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00062-16
   Browne PD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa008
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038
   Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960
   Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Gaspar JM, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2579-2
   Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517
   Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4
   Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110
   Hang J, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-31
   Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429
   Kang DWD, 2019, PEERJ, V7, DOI 10.7717/peerj.7359
   Kato H, 2015, DNA RES, V22, P413, DOI 10.1093/dnares/dsv023
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863
   Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033
   Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Mori H, 2014, DNA RES, V21, P217, DOI 10.1093/dnares/dst052
   Nicholls SM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz043
   Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Orellana LH, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw900
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109
   Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10
   Rodrigues JFM, 2017, BIOINFORMATICS, V33, P3808, DOI 10.1093/bioinformatics/btx517
   Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104
   Sato MP, 2019, DNA RES, V26, P391, DOI 10.1093/dnares/dsz017
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]
   Singer E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.81
   Sinha R, 2017, NAT BIOTECHNOL, V35, P1077, DOI 10.1038/nbt.3981
   Tourlousse D.M., 2022, MICROBIOL SPECTR, V10, pe0191521
   Tourlousse DM, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01048-3
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Uritskiy GV, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0541-1
   Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x
   Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3
   Weissbrod O, 2018, CURR OPIN MICROBIOL, V44, P9, DOI 10.1016/j.mib.2018.05.003
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638
NR 51
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1340-2838
EI 1756-1663
J9 DNA RES
JI DNA Res.
PD JUN 1
PY 2023
VL 30
IS 3
AR dsad010
DI 10.1093/dnares/dsad010
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA I0VV8
UT WOS:001000049000005
PM 37253538
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Yu, HN
   Fang, CJ
   Li, P
   Wu, MM
   Shen, SR
AF Yu, Haining
   Fang, Chengjie
   Li, Peng
   Wu, Manman
   Shen, Shengrong
TI The relevance of DHA with modulating of host-gut microbiome signatures
   alterations and repairing of lipids metabolism shifts
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Gut microbiome; Lipids metabolism; DHA; Bile acids; Fatty acids
AB Huge of previous reports recommended that gut microbiome have a crucial role in the human health and its change was profound impact for the metabolic improvements associated with lipids metabolism. In order to explore the relevance of a direct dysbiosis effect of gut microbiome on lipids metabolism shifts and repaired position of DHA, we built the animal model for the study with gut microbiome dysbiosis administrated by i.g. with CRO and intervened by DHA in the present work. Gut microbiome was analyzed by high throughput sequencing and bioinformatics analyses of bacteria. The composition of fatty acids and short chain fatty acids (SCFAs) were determined by gas chromatography. Blood lipids and bile acids were assayed by kit and UPLC-MS/MS, respectively. The expressions of enzymes of long chain fatty acid metabolism were analyzed by qRT-PCR. The results showed that gut microbiome dysbiosis caused lipid metabolism abnormal, and DHA was able to repair the lipids metabolism shifts resulted from gut microbiome dysbiosis. DHA could modulate host-gut microbiome signatures, improve concentrations of SCFAs, regulate fatty acids metabolism but modify bile acid profiles. In conclusion, we considered that DHA repaired lipid metabolism by modulating gut microbiome and regulating fatty acids metabolism pathway.
C1 [Yu, Haining; Fang, Chengjie; Wu, Manman] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310014, Peoples R China.
   [Li, Peng] Third Peoples Hosp Hangzhou, Dept Geratoloy, Hangzhou, Peoples R China.
   [Shen, Shengrong] Zhejiang Univ, Hangzhou, Peoples R China.
C3 Zhejiang University of Technology; Zhejiang University
RP Yu, HN (corresponding author), Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310014, Peoples R China.
EM yuhaining@zjut.edu.cn
RI Yu, Haining/HHC-0235-2022
FU Zhejiang Natural Science Foundation, China [LY19C200012]
FX Financial support from Zhejiang Natural Science Foundation, China (No.
   LY19C200012) is gratefully acknowledged.
CR Alam C, 2011, DIABETOLOGIA, V54, P1398, DOI 10.1007/s00125-011-2097-5
   Andersen AD, 2011, J PEDIATR GASTR NUTR, V53, P303, DOI 10.1097/MPG.0b013e31821d298f
   Beaugerie L, 2004, BEST PRACT RES CL GA, V18, P337, DOI 10.1016/j.bpg.2003.10.002
   Behr C, 2018, TOXICOL LETT, V296, P139, DOI 10.1016/j.toxlet.2018.08.002
   Cao WX, 2019, FOOD FUNCT, V10, P277, DOI 10.1039/c8fo01404c
   Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400
   Costantini L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122645
   Do MH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060761
   Ghaffarzadegan T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40272-8
   Granado-Serrano AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38874-3
   Hantsoo L, 2019, BRAIN BEHAV IMMUN, V75, P240, DOI 10.1016/j.bbi.2018.11.005
   Hereu M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112606
   Horigome A, 2019, BENEF MICROBES, V10, P751, DOI 10.3920/BM2019.0034
   Huang SM, 2019, FOOD FUNCT, V10, P3224, DOI [10.1039/C9FO00263D, 10.1039/c9fo00263d]
   Huang W, 2015, BIOFACTORS, V41, P453, DOI 10.1002/biof.1246
   Jin YX, 2016, TOXICOL SCI, V154, P140, DOI 10.1093/toxsci/kfw150
   Kok DEG, 2018, J NUTR BIOCHEM, V56, P152, DOI 10.1016/j.jnutbio.2018.01.001
   Li K, 2019, FOOD FUNCT, V10, P1915, DOI 10.1039/c8fo02265h
   Liu HL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091298
   Liu Q, 2017, ENVIRON POLLUT, V226, P268, DOI 10.1016/j.envpol.2017.03.068
   Marra F, 2018, J HEPATOL, V68, P280, DOI 10.1016/j.jhep.2017.11.014
   Menni C, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-10382-2, 10.1038/s41598-017-13722-4]
   Metherel AH, 2019, PROG LIPID RES, V76, DOI 10.1016/j.plipres.2019.101008
   Miyamoto J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11978-0
   Molinaro A, 2018, TRENDS ENDOCRIN MET, V29, P31, DOI 10.1016/j.tem.2017.11.002
   Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200
   Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857
   Patterson E, 2014, BRIT J NUTR, V111, P1905, DOI 10.1017/S0007114514000117
   Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151
   Peng WJ, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.03141
   Ramos-Romero S, 2017, FOOD RES INT, V97, P364, DOI 10.1016/j.foodres.2017.04.024
   Salazar N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01809
   Song JJ, 2017, BRIT J NUTR, V118, P481, DOI [10.1017/S0007114517002380, 10.1017/s0007114517002380]
   Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wan JC, 2017, FOOD FUNCT, V8, P1793, DOI 10.1039/c7fo00094d
   Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536
   Xu WT, 2016, FUTURE MICROBIOL, V11, P825, DOI 10.2217/fmb-2015-0024
   Yang YH, 2019, FOOD FUNCT, V10, P5952, DOI [10.1039/C9FO00766K, 10.1039/c9fo00766k]
   Yu HN, 2019, BIOFACTORS, V45, P439, DOI 10.1002/biof.1495
   Zhang CC, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900248
   Zhang LM, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00070-16
   Zheng XJ, 2018, FASEB J, V32, P4878, DOI 10.1096/fj.201700614R
   Zhou SM, 2017, J AGR FOOD CHEM, V65, P6599, DOI 10.1021/acs.jafc.7b01803
NR 44
TC 5
Z9 5
U1 5
U2 20
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD MAR 15
PY 2021
VL 895
AR 173885
DI 10.1016/j.ejphar.2021.173885
EA JAN 2021
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA QH8TA
UT WOS:000618544200019
PM 33482183
DA 2023-09-14
ER

PT J
AU Bikel, S
   Gallardo-Becerra, L
   Cornejo-Granados, F
   Ochoa-Leyva, A
AF Bikel, Shirley
   Gallardo-Becerra, Luigui
   Cornejo-Granados, Fernanda
   Ochoa-Leyva, Adrian
TI Protocol for the isolation, sequencing, and analysis of the gut phageome
   from human fecal samples
SO STAR PROTOCOLS
LA English
DT Article
ID READ ALIGNMENT; VIRUSES
AB The phage-bacteria interactions in the gut microbiome are critical for health and disease, but viruses of the human gut microbiome are poorly understood. Here, we present a simple and cost-efficient protocol for collecting viral-like particles (VLPs) from human fecal samples. We describe VLPs quantification using epifluorescence and TEM microscopy, followed by DNA sequencing and bioinformatics analysis. This protocol characterizes the gut phageome in normal-weight and obese children with metabolic syndrome. It is also suitable to conduct high-throughput studies for other diseases. For complete details on the use and execution of this profile, please refer to Bikel et al. (2021).
C1 [Bikel, Shirley; Gallardo-Becerra, Luigui; Cornejo-Granados, Fernanda; Ochoa-Leyva, Adrian] Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.
C3 Universidad Nacional Autonoma de Mexico
RP Ochoa-Leyva, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.
EM adrian.ochoa@ibt.unam.mx
RI ; Ochoa-Leyva, Adrian/E-5540-2013
OI Cornejo-Granados, Fernanda/0000-0002-8860-0996; Ochoa-Leyva,
   Adrian/0000-0002-4701-2303
FU Biotechnology Institute at UNAM; CONACyT [CVU: 778192, CVU: 443238];
   DGAPA PAPIIT UNAM [IN215520]; CONACYT grant Ciencia-Frontera from Mexico
   [2019-263986]; program Actividades de Intercambio Academico 2019
   CIC-UNAM-CIAD
FX We thank Juan Manuel Hurtado Ramirez for the informatics technical
   support. We thank the National Laboratory of Advanced Microscopy for
   helping us with epifluorescence microscopy and Dr. Guadalupe Trinidad
   Zavala Padilla for her help with TEM microscopy, both in the
   Biotechnology Institute at UNAM. S.B. thanks the Master's and Doctoral
   Program in Medical, Dental and Health Sciences, in the field of
   knowledge: Experimental Clinical Research in Health, disciplinary field:
   Clinical Biochemistry, at UNAM. Doctoral fellowship: F.C.G. (CVU:
   443238) and L.G.B. (CVU: 778192) acknowledge the support of CONACyT as
   postgraduate fellows. We also thank the Unidad de Secuenciacion Masiva
   from INMEGEN for sequencing technical support. We thank Abigail
   Hernandez and Filiberto Sanchez for the technical support in VLPs
   isolation and visualization. There is no conflict of interest for
   authors. The DGAPA PAPIIT UNAM funded this research (IN215520) , and
   CONACYT grant Ciencia-Frontera-2019-263986 from Mexico to A.O.-L. We
   also acknowledge the support of program Actividades de Intercambio
   Academico 2019 CIC-UNAM-CIAD.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Bikel S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102900
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Gallardo-Becerra L, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01319-y
   Guo JR, 2021, MICROBIOME, V9, DOI 10.1186/s40168-020-00990-y
   Hoyles L, 2014, RES MICROBIOL, V165, P803, DOI 10.1016/j.resmic.2014.10.006
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Huson DH, 2018, BIOL DIRECT, V13, DOI 10.1186/s13062-018-0208-7
   Jepson CD, 2004, VACCINE, V22, P2413, DOI 10.1016/j.vaccine.2003.11.065
   Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8
   Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11
   Kristensen DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mullan W.M.A., 2001, ISOLATION PURIFICATI
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Shkoporov AN, 2019, CELL HOST MICROBE, V26, P527, DOI 10.1016/j.chom.2019.09.009
NR 21
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2666-1667
J9 STAR PROTOC
JI STAR Protoc.
PD MAR 18
PY 2022
VL 3
IS 1
AR 101170
DI 10.1016/j.xpro.2022.101170
PG 21
WC Biochemical Research Methods
WE Emerging Sources Citation Index (ESCI)
SC Biochemistry & Molecular Biology
GA Q1LY6
UT WOS:001055214800008
PM 35199035
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Mas-Lloret, J
   Obon-Santacana, M
   Ibanez-Sanz, G
   Guino, E
   Pato, ML
   Rodriguez-Moranta, F
   Mata, A
   Garcia-Rodriguez, A
   Moreno, V
   Pimenoff, VN
AF Mas-Lloret, Joan
   Obon-Santacana, Mireia
   Ibanez-Sanz, Gemma
   Guino, Elisabet
   Pato, Miguel L.
   Rodriguez-Moranta, Francisco
   Mata, Alfredo
   Garcia-Rodriguez, Ana
   Moreno, Victor
   Pimenoff, Ville Nikolai
TI Gut microbiome diversity detected by high-coverage 16S and shotgun
   sequencing of paired stool and colon sample
SO SCIENTIFIC DATA
LA English
DT Article; Data Paper
ID METAGENOMICS; IMPACT
AB The gut microbiome has a fundamental role in human health and disease. However, studying the complex structure and function of the gut microbiome using next generation sequencing is challenging and prone to reproducibility problems. Here, we obtained cross-sectional colon biopsies and faecal samples from nine participants in our COLSCREEN study and sequenced them in high coverage using Illumina pair-end shotgun (for faecal samples) and IonTorrent 16S (for paired feces and colon biopsies) technologies. The metagenomes consisted of between 47 and 92 million reads per sample and the targeted sequencing covered more than 300 k reads per sample across seven hypervariable regions of the 16S gene. Our data is freely available and coupled with code for the presented metagenomic analysis using up-to-date bioinformatics algorithms. These results will add up to the informed insights into designing comprehensive microbiome analysis and also provide data for further testing for unambiguous gut microbiome analysis.
C1 [Mas-Lloret, Joan; Obon-Santacana, Mireia; Ibanez-Sanz, Gemma; Guino, Elisabet; Moreno, Victor; Pimenoff, Ville Nikolai] Catalan Inst Oncol ICO, Oncol Data Analyt Program, Barcelona, Spain.
   [Mas-Lloret, Joan; Obon-Santacana, Mireia; Ibanez-Sanz, Gemma; Guino, Elisabet; Moreno, Victor; Pimenoff, Ville Nikolai] Bellvitge Inst Biomed Res IDIBELL, Colorectal Canc Grp, ONCOBELL Program, Barcelona, Spain.
   [Mas-Lloret, Joan; Obon-Santacana, Mireia; Ibanez-Sanz, Gemma; Guino, Elisabet; Moreno, Victor; Pimenoff, Ville Nikolai] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Barcelona, Spain.
   [Ibanez-Sanz, Gemma; Rodriguez-Moranta, Francisco] Bellvitge Univ Hosp IDIBELL, Gastroenterol Dept, Barcelona, Spain.
   [Pato, Miguel L.] Bellvitge Biomed Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Catalonia, Spain.
   [Mata, Alfredo] Moises Broggi Hosp, Digest Syst Serv, St Joan Despi, Spain.
   [Garcia-Rodriguez, Ana] Viladecans Hosp IDIBELL, Digest Syst Serv, Endoscopy Unit, Viladecans, Spain.
   [Moreno, Victor] Univ Barcelona, Dept Clin Sci, Fac Med, Barcelona, Spain.
   [Pimenoff, Ville Nikolai] Natl Canc Ctr Finland FICAN MID, Stockholm, Sweden.
   [Pimenoff, Ville Nikolai] Karolinska Inst, Stockholm, Sweden.
C3 Institut Catala d'Oncologia; Institut d'Investigacio Biomedica de
   Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red;
   CIBERESP; University of Barcelona; Institut d'Investigacio Biomedica de
   Bellvitge (IDIBELL); Bellvitge University Hospital; Institut
   d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio
   Biomedica de Bellvitge (IDIBELL); Hospital Valdecans; University of
   Barcelona; Karolinska Institutet
RP Moreno, V; Pimenoff, VN (corresponding author), Catalan Inst Oncol ICO, Oncol Data Analyt Program, Barcelona, Spain.; Moreno, V; Pimenoff, VN (corresponding author), Bellvitge Inst Biomed Res IDIBELL, Colorectal Canc Grp, ONCOBELL Program, Barcelona, Spain.; Moreno, V; Pimenoff, VN (corresponding author), Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Barcelona, Spain.; Moreno, V (corresponding author), Univ Barcelona, Dept Clin Sci, Fac Med, Barcelona, Spain.; Pimenoff, VN (corresponding author), Natl Canc Ctr Finland FICAN MID, Stockholm, Sweden.; Pimenoff, VN (corresponding author), Karolinska Inst, Stockholm, Sweden.
EM v.moreno@iconcologia.net; ville.pimenoff@ki.se
RI Pimenoff, Ville/H-9865-2019; Moreno, Victor/A-1697-2010; Pato, Miguel
   L./AGZ-3097-2022; RODRIGUEZ MORANTA, FRANCISCO/H-9333-2015
OI Pimenoff, Ville/0000-0002-0813-7031; Moreno, Victor/0000-0002-2818-5487;
   Pato, Miguel L./0000-0001-8840-7259; Obon-Santacana,
   Mireia/0000-0003-4646-3513; Ibanez Sanz, Gemma/0000-0001-6071-7343; Mas
   Lloret, Joan/0000-0001-6484-3937; RODRIGUEZ MORANTA,
   FRANCISCO/0000-0003-4025-5510
FU Ministry of Science, Innovation and Universities, Government of Spain
   [FPU17/05474]; Ministry of Health, Government of Catalonia
   [SLT002/16/00496, SLT002/16/00398]; Spanish Ministry for Economy and
   Competitivity, Instituto de Salud Carlos III; FEDER funds -a way to
   build Europe [FIS PI17/00092]; Agency for Management of University and
   Research Grants (AGAUR) of the Catalan Government [2017SGR723];
   Karolinska Institute
FX We appreciate the collaboration of all participants who provided
   epidemiological data and biological samples. We thank all the personnel
   that were involved in the recruitment process, specially our
   documentalist Carmen Atencia and our laboratory technician Susana Lopez.
   This research was financially supported by the Ministry of Science,
   Innovation and Universities, Government of Spain (grant FPU17/05474).
   Ministry of Health, Government of Catalonia (grants SLT002/16/00496 and
   SLT002/16/00398), Spanish Ministry for Economy and Competitivity,
   Instituto de Salud Carlos III, co-funded by FEDER funds -a way to build
   Europe- (FIS PI17/00092), Agency for Management of University and
   Research Grants (AGAUR) of the Catalan Government (grant 2017SGR723).
   Mireia Obon-Santacana received a post-doctoral fellow from "Fundacion
   Cientifica de la Asociacion Espanola Contra el Cancer (AECC)". We thank
   CERCA Program, Generalitat de Catalunya for institutional support. None
   of these agencies had any role in the interpretation of the results or
   the preparation of this manuscript. Open access funding provided by
   Karolinska Institute.
CR Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1
   [Anonymous], 2019, MANAGEMENT
   [Anonymous], 2018, FASTQC
   Atkin WS, 2012, ENDOSCOPY, V44, pSE151, DOI 10.1055/s-0032-1309821
   Barb JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148047
   Binefa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19532
   Breitwieser FP, 2019, BRIEF BIOINFORM, V20, P1125, DOI 10.1093/bib/bbx120
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028
   D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9
   Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116
   Edgar RC, 2018, BIOINFORMATICS, V34, P2371, DOI 10.1093/bioinformatics/bty113
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224
   Goodrich JK, 2017, ANNU REV GENET, V51, P413, DOI 10.1146/annurev-genet-110711-155532
   Hillmann B, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00069-18
   Joint Genome Institute, 2018, BBTOOLS VERS 38 26
   Jones RB., 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Kang DWD, 2019, PEERJ, V7, DOI 10.7717/peerj.7359
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Laudadio I, 2018, OMICS, V22, P248, DOI 10.1089/omi.2018.0013
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lindgreen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19233
   Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104
   Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979
   Maier L, 2017, CURR OPIN MICROBIOL, V39, P128, DOI 10.1016/j.mib.2017.11.001
   Martinez-Porchas M, 2017, PEERJ, V5, DOI 10.7717/peerj.3036
   McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7
   Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257
   Murali A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0521-5
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019
   Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001
   Peris M, 2007, J MED SCREEN, V14, P81, DOI 10.1258/096914107781261936
   Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304
   Tessler M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06665-3
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   van der Walt AJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3918-9
   Vincent AT, 2017, J MICROBIOL METH, V138, P60, DOI 10.1016/j.mimet.2016.02.016
   Walsh AM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0437-0
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y
   Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330
NR 49
TC 24
Z9 24
U1 3
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2052-4463
J9 SCI DATA
JI Sci. Data
PD MAR 16
PY 2020
VL 7
IS 1
AR 92
DI 10.1038/s41597-020-0427-5
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KU8QE
UT WOS:000519976000001
PM 32179734
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Ortiz, JMP
   Read, MN
   McClure, DD
   Holmes, A
   Dehghani, F
   Shanahan, ER
AF Molina Ortiz, Juan P.
   Read, Mark Norman
   McClure, Dale David
   Holmes, Andrew
   Dehghani, Fariba
   Shanahan, Erin Rose
TI High throughput genome scale modeling predicts microbial vitamin
   requirements contribute to gut microbiome community structure
SO GUT MICROBES
LA English
DT Article
DE Gut microbiome; genome scale modeling; computational biology; networks;
   interactions; cofactors; vitamins; enterotypes
ID GLUCOSE-METABOLISM; DIET; ENTEROTYPES; OBESITY
AB Human gut microbiome structure and emergent metabolic outputs impact health outcomes. However, what drives such community characteristics remains underexplored. Here, we rely on high throughput genomic reconstruction modeling, to infer the metabolic attributes and nutritional requirements of 816 gut strains, via a framework termed GEMNAST. This has been performed in terms of a group of human vitamins to examine the role vitamin exchanges have at different levels of community organization. We find that only 91 strains can satisfy their vitamin requirements (prototrophs) while the rest show various degrees of auxotrophy/specialization, highlighting their dependence on external sources, such as other members of the microbial community. Further, 79% of the strains in our sample were mapped to 11 distinct vitamin requirement profiles with low phylogenetic consistency. Yet, we find that human gut microbial community enterotype indicators display marked metabolic differences. Prevotella strains display a metabolic profile that can be complemented by strains from other genera often associated with the Prevotella enterotype and agrarian diets, while Bacteroides strains occupy a prototrophic profile. Finally, we identify pre-defined interaction modules (IMs) of gut species from human and mice predicted to be driven by, or highly independent of vitamin exchanges. Our analysis provides mechanistic grounding to gut microbiome stability and to co-abundance-based observations, a fundamental step toward understanding emergent processes that influence health outcomes. Further, our work opens a path to future explorations in the field through applications of GEMNAST to additional nutritional dimensions.
C1 [Molina Ortiz, Juan P.; McClure, Dale David; Dehghani, Fariba] Univ Sydney, Sch Chem & Biomol Engn, Sydney, Australia.
   [Molina Ortiz, Juan P.; Read, Mark Norman; McClure, Dale David; Holmes, Andrew; Dehghani, Fariba] Univ Sydney, Ctr Adv Food Engn, Sydney, Australia.
   [Read, Mark Norman] Univ Sydney, Sch Comp Sci, Fac Engn, Sydney, Australia.
   [Read, Mark Norman; Holmes, Andrew; Shanahan, Erin Rose] Univ Sydney, Charles Perkins Ctr, Sydney, Australia.
   [McClure, Dale David] Brunel Univ, Coll Engn Design & Phys Sci, Dept Chem Engn, London, England.
   [Holmes, Andrew; Shanahan, Erin Rose] Univ Sydney, Sch Life & Environm Sci, Fac Sci, Sydney, Australia.
C3 University of Sydney; University of Sydney; University of Sydney;
   University of Sydney; Brunel University; University of Sydney
RP Ortiz, JMP (corresponding author), Univ Sydney, Sch Chem & Biomol Engn, Sydney, Australia.; Ortiz, JMP (corresponding author), Univ Sydney, Ctr Adv Food Engn, Sydney, Australia.; Shanahan, ER (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, Australia.; Shanahan, ER (corresponding author), Univ Sydney, Sch Life & Environm Sci, Fac Sci, Sydney, Australia.
EM juan.molina@sydney.edu.au; erin.shanahan@sydney.edu.au
RI Shanahan, Erin R/H-1852-2015
OI Shanahan, Erin R/0000-0003-4637-0851; Molina Ortiz, Juan
   Pablo/0000-0003-4432-6689
FU University of Sydney's Centre for Advanced Food Engineering; Faculty of
   Engineering at the University of Sydney; Beckett Cancer Research Trust
   (University of Sydney Fellowship)
FX This work was supported by the University of Sydney's Centre for
   Advanced Food Engineering. JM acknowledges a PhD scholarship from the
   Faculty of Engineering at the University of Sydney. ES acknowledges
   financial support from the a Beckett Cancer Research Trust (University
   of Sydney Fellowship).
CR Abby SS, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148259
   Aden K, 2019, GASTROENTEROLOGY, V157, P1279, DOI 10.1053/j.gastro.2019.07.025
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   ALBERT MJ, 1980, NATURE, V283, P781, DOI 10.1038/283781a0
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Ashniev GA, 2022, MICROORGANISMS, V10, DOI 10.3390/microorganisms10040740
   Asnicar F, 2021, GUT, V70, P1665, DOI 10.1136/gutjnl-2020-323877
   Babaei P, 2018, NAT BIOTECHNOL, V36, P682, DOI 10.1038/nbt.4213
   Belzer C, 2017, MBIO, V8, DOI [10.1128/mBio.00770-17, 10.1128/mbio.00770-17]
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Carroll IM, 2011, AM J PHYSIOL-GASTR L, V301, pG799, DOI 10.1152/ajpgi.00154.2011
   Chen LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17840-y
   Combs Jr G.F., 2012, VITAMINS
   Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341
   D'Souza G, 2014, EVOLUTION, V68, P2559, DOI 10.1111/evo.12468
   Daisley BA, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110087
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Degnan PH, 2014, CELL METAB, V20, P769, DOI 10.1016/j.cmet.2014.10.002
   Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007
   Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74
   Fenn K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0380-5
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597
   Fritts RK, 2021, MICROBIOL MOL BIOL R, V85, DOI 10.1128/MMBR.00135-20
   Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005
   Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92
   Glick-Bauer M, 2014, NUTRIENTS, V6, P4822, DOI 10.3390/nu6114822
   Gruning NM, 2010, TRENDS BIOCHEM SCI, V35, P220, DOI 10.1016/j.tibs.2009.12.001
   Guillen MN, 2021, CELL SYST, V12, P1064, DOI 10.1016/j.cels.2021.08.002
   LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005
   Heinken A., 2019, BIORXIV
   Heinken A, 2021, NPJ SYST BIOL APPL, V7, DOI 10.1038/s41540-021-00178-6
   Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Magnusdottir S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00148
   Maloy S., 2013, BRENNERS ENCY GENETI
   McKinney W., 2010, P 9 PYTHON SCI C, P56, DOI [DOI 10.25080/MAJORA-92BF1922-00A, 10.25080/Majora-92bf1922-00a]
   Menni C, 2017, INT J OBESITY, V41, P1099, DOI 10.1038/ijo.2017.66
   Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Noronha A, 2019, NUCLEIC ACIDS RES, V47, pD614, DOI 10.1093/nar/gky992
   Ortiz JPM, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1965698
   Pham VT, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1875774
   Putnam EE, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008208
   Roager HM, 2014, APPL ENVIRON MICROB, V80, P1142, DOI 10.1128/AEM.03549-13
   Schoch CL, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa062
   Sharma V, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01485
   Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104
   Sokolovskaya OM, 2020, SCIENCE, V369, P48, DOI 10.1126/science.aba0165
   Soto-Martin EC, 2020, MBIO, V11, DOI 10.1128/mBio.00886-20
   Tomova A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00047
   VAREL VH, 1974, APPL MICROBIOL, V28, P251, DOI 10.1128/AEM.28.2.251-257.1974
   Vieira-Silva S, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.88, 10.1038/nmicrobiol.2016.88]
   Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2
   Wang HP, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0118-0
   Wang JJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00887
   Waskom M., 2021, J OPEN SOURCE SOFTW, V6, P3021, DOI DOI 10.21105/JOSS.03021
   Webb E, 1998, J BIOL CHEM, V273, P8946, DOI 10.1074/jbc.273.15.8946
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Zengler K, 2018, NAT REV MICROBIOL, V16, P383, DOI 10.1038/s41579-018-0004-5
   Zhang CH, 2015, EBIOMEDICINE, V2, P968, DOI 10.1016/j.ebiom.2015.07.007
NR 63
TC 5
Z9 5
U1 4
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-0976
EI 1949-0984
J9 GUT MICROBES
JI Gut Microbes
PD DEC 31
PY 2022
VL 14
IS 1
AR 2118831
DI 10.1080/19490976.2022.2118831
PG 21
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA 4K6JF
UT WOS:000852052700001
PM 36081364
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Dubey, AK
   Uppadhyaya, N
   Nilawe, P
   Chauhan, N
   Kumar, S
   Gupta, UA
   Bhaduri, A
AF Dubey, Ashok Kumar
   Uppadhyaya, Niyati
   Nilawe, Pravin
   Chauhan, Neeraj
   Kumar, Santosh
   Gupta, Urmila Anurag
   Bhaduri, Anirban
TI Data Descriptor: LogMPIE, pan-India profiling of the human gut
   microbiome using 16S rRNA sequencing
SO SCIENTIFIC DATA
LA English
DT Article; Data Paper
ID INFLAMMATORY-BOWEL-DISEASE; COMMUNITY; BACTERIA; DIVERSITY; CATALOG;
   PROJECT; HEALTH; ASSOCIATION; ENTEROTYPES; PREVENTION
AB The "Landscape Of Gut Microbiome - Pan-India Exploration", or LogMPIE study, is the first large-scale, nationwide record of the Indian gut microbiome. The primary objective of the study was to identify and map the Indian gut microbiome baseline. This observational study was conducted across 14 geographical locations in India. Enrolled subjects were uniformly distributed across geographies (north, east, west and south) and body mass index (obese and non-obese). Furthermore, factors influencing the microbiome, such as age and physical activity, were also considered in the study design. The LogMPIE study recorded data from 1004 eligible subjects and reported 993 unique microorganisms across the Indian microbiome diaspora. The data not only map the Indian gut microbiome baseline but also function as a useful resource to study, analyse and identify signatures characterizing the physiological dispositions of the subjects. Furthermore, they provide insight into the unique features describing the Indian microbiome. The data are open and may be accessed from the European Nucleotide Archive (ENA) portal of the European Bioinformatics Institute (https://www.ebi.ac.uk/ena/data/view/PRJEB25642).
C1 [Dubey, Ashok Kumar; Uppadhyaya, Niyati; Bhaduri, Anirban] Tata Chem Ltd, Innovat Ctr, Pune 412111, Maharashtra, India.
   [Nilawe, Pravin] Invitrogen BioServ India Pvt Ltd, Thermo Fisher Sci, Bombay 400076, Maharashtra, India.
   [Chauhan, Neeraj] Thermo Fisher Sci, Life Sci Solut, Gurgaon 122016, Haryana, India.
   [Kumar, Santosh] JSS Med Res India Pvt Ltd, Faridabad 121003, Haryana, India.
   [Gupta, Urmila Anurag] JSS Med Res India Pvt Ltd, Bombay 400086, Maharashtra, India.
C3 Tata Sons; Tata Chemicals Limited; Thermo Fisher Scientific; Thermo
   Fisher Scientific
RP Dubey, AK; Bhaduri, A (corresponding author), Tata Chem Ltd, Innovat Ctr, Pune 412111, Maharashtra, India.
EM adubey@tatachemicals.com; abhaduri@-tatachemicals.com
CR Abrahamson M, 2017, CONT CLIN TRIAL COMM, V7, P158, DOI 10.1016/j.conctc.2017.07.002
   Al-Hebshi NN, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.28934
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Bacci Giovanni, 2015, J Genomics, V3, P36, DOI 10.7150/jgen.9204
   Bhute SS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00214
   Brunkwall L, 2017, DIABETOLOGIA, V60, P943, DOI 10.1007/s00125-017-4278-3
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chauhan NS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00118
   Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669
   Das A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15510-6
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Del Savio L, 2017, GENET MED, V19, P959, DOI 10.1038/gim.2016.208
   Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162
   Hedin CR, 2017, GUT MICROBES, V8, P359, DOI 10.1080/19490976.2017.1284733
   Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937
   Hullar MAJ, 2014, CANCER J, V20, P170, DOI 10.1097/PPO.0000000000000053
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847
   Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2
   Kasselman LJ, 2018, ATHEROSCLEROSIS, V271, P203, DOI 10.1016/j.atherosclerosis.2018.02.036
   Korpela K, 2018, GENOME RES, V28, P561, DOI 10.1101/gr.233940.117
   Kumbhare SV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11215-y
   Kundu P, 2017, CELL, V171, P1481, DOI 10.1016/j.cell.2017.11.024
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Liang DC, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0230-4
   Liang QY, 2017, CLIN CANCER RES, V23, P2061, DOI 10.1158/1078-0432.CCR-16-1599
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   Meijnikman AS, 2018, ENDOCR REV, V39, P133, DOI 10.1210/er.2017-00192
   Michail S, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu002
   Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739
   Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322
   Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011
   Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397
   Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109
   Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605
   Nhlbi Overweight and Obesity in Adults Expert Panel, 2013, MANAGING OVERWEIGHT
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Pfeiffer S, 2014, ENVIRON MICROBIOL, V16, P2389, DOI 10.1111/1462-2920.12350
   Prosberg M, 2016, SCAND J GASTROENTERO, V51, P1407, DOI 10.1080/00365521.2016.1216587
   Pyky R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2495-6
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044
   Schnorr S. L., 2014, NAT COMMUN, V15, P5
   Shi N, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-017-0122-9
   Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532
   Siegwald L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169563
   Sinha R, 2017, NAT BIOTECHNOL, V35, P1077, DOI 10.1038/nbt.3981
   Statovci D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00838
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Wang DD, 2018, LANCET DIABETES ENDO, V6, P416, DOI 10.1016/S2213-8587(18)30037-8
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yadav D, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0099-z
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
NR 58
TC 17
Z9 17
U1 2
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2052-4463
J9 SCI DATA
JI Sci. Data
PD OCT 30
PY 2018
VL 5
AR 180232
DI 10.1038/sdata.2018.232
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GY7BW
UT WOS:000448759000001
PM 30375992
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Osman, AEG
   Luke, JJ
AF Osman, Afaf E. G.
   Luke, Jason J.
TI The Impact of the Fecal Microbiome on Cancer Immunotherapy
SO BIODRUGS
LA English
DT Article
ID INTESTINAL MICROBIOTA; MORTALITY; DISEASE
AB Recent advances in culture-free methods of studying the human microbiome, coupled with strong bioinformatics tools, have provided new insights on the role of the human microbiome in health and disease. The human gut, in particular, houses a vast number and diverse variety of microbes. A plethora of evidence has demonstrated the significant effects of the gut microbiome on local and systemic immunity. Studies in hematopoietic stem cell transplantation recipients provided early evidence of the involvement of the gut microbiome in the development of graft-versus-host disease and its related mortality. Cancer immunotherapy and checkpoint inhibitors, in particular, harness the power of the host's immune system to fight a range of malignancies. Resistance to immunotherapy and fatal immune-related adverse events both continue to be challenges in the field. The role of the human gut microbiome in affecting the response to immunotherapy was recently uncovered through a series of preclinical and clinical studies. The evidence presented in these studies provides tremendous potential for gut microbes to be used for biomarker development and therapeutic intervention trials.
C1 [Osman, Afaf E. G.; Luke, Jason J.] Univ Chicago, Dept Med, 5841 S Maryland Ave MC2115, Chicago, IL 60637 USA.
C3 University of Chicago
RP Luke, JJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave MC2115, Chicago, IL 60637 USA.
EM jluke@medicine.bsd.uchicago.edu
RI Luke, Jason John/AAB-9724-2022
OI Luke, Jason John/0000-0002-1182-4908; Osman, Afaf/0000-0002-3688-4683
FU Department of Defense Career Development Award [W81XWH-17-1-0265];
   Arthur J Schreiner Family Melanoma Research Fund; J. Edward Mahoney
   Foundation Research Fund; Brush Family Immunotherapy Research Fund;
   Buffet Fund for Cancer Immunotherapy
FX Jason J. Luke has received the following funding: Department of Defense
   Career Development Award (W81XWH-17-1-0265), the Arthur J Schreiner
   Family Melanoma Research Fund, the J. Edward Mahoney Foundation Research
   Fund, Brush Family Immunotherapy Research Fund, and Buffet Fund for
   Cancer Immunotherapy.
CR Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275
   Chang LS, 2018, APPL IMMUNOHISTO M M, V26, pE15, DOI 10.1097/PAI.0000000000000575
   Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108
   Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572
   Derosa L, 2018, ANN ONCOL, V29, P1437, DOI 10.1093/annonc/mdy103
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5
   Goncalves P, 2018, INFLAMM BOWEL DIS, V24, P558, DOI 10.1093/ibd/izx029
   Guthrie L, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0034-1
   Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016
   JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066
   Kim D, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.24
   Lee ACW, 2011, HEMATOL REP, V3, P32, DOI 10.4081/hr.2011.e11
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Shanahan ER, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0531-3
   Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725
   Thomsen M, 2018, BENEF MICROBES, V9, P899, DOI [10.3920/BM2017.0172, 10.3920/bm2017.0172]
   Troy EB, 2010, FRONT BIOSCI-LANDMRK, V15, P25, DOI 10.2741/3603
   VANBEKKU.DW, 1974, J NATL CANCER I, V52, P401, DOI 10.1093/jnci/52.2.401
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Vossen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105706
NR 30
TC 5
Z9 5
U1 0
U2 19
PU ADIS INT LTD
PI NORTHCOTE
PA 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND
SN 1173-8804
EI 1179-190X
J9 BIODRUGS
JI Biodrugs
PD FEB
PY 2019
VL 33
IS 1
BP 1
EP 7
DI 10.1007/s40259-018-0328-8
PG 7
WC Oncology; Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Immunology; Pharmacology & Pharmacy
GA HL7QF
UT WOS:000458935400001
PM 30604388
DA 2023-09-14
ER

PT J
AU Lai, JJ
   Zhuo, XL
   Yin, K
   Jiang, FX
   Liu, L
   Xu, XY
   Liu, HJ
   Wang, JL
   Zhao, J
   Xu, W
   Yang, SP
   Guo, HL
   Yuan, XT
   Lin, XY
   Qi, FH
   Fu, GB
AF Lai, Jingjiang
   Zhuo, Xiaoli
   Yin, Ke
   Jiang, Fengxian
   Liu, Lei
   Xu, Xiaoying
   Liu, Hongjing
   Wang, Jingliang
   Zhao, Jing
   Xu, Wei
   Yang, Shuping
   Guo, Honglin
   Yuan, Xiaotian
   Lin, Xiaoyan
   Qi, Fanghua
   Fu, Guobin
TI Potential mechanism of pyrotinib-induced diarrhea was explored by gut
   microbiome and ileum metabolomics
SO ANTI-CANCER DRUGS
LA English
DT Article
DE bioinformatics analysis; gut microbiome; metabolomics; pyrotinib
   maleate; pyrotinib-induced diarrhea
ID TYROSINE KINASE INHIBITOR; PHASE-I; LAPATINIB; CANCER; METABOLISM
AB Pyrotinib is a novel epidermal growth factor receptor/human epidermal growth factor receptor-2 (HER2) tyrosine kinase inhibitor that exhibited clinical efficacy in patients with HER2-positive breast cancer and HER2-mutant/amplified lung cancer. However, severe diarrhea adverse responses preclude its practical use. At present, the mechanism of pyrotinib-induced diarrhea is unknown and needs further study. First, to develop a suitable and reproducible animal model, we compared the effects of different doses of pyrotinib (20, 40, 60 and 80 mg/kg) in Wistar rats. Second, we used this model to examine the intestinal toxicity of pyrotinib. Finally, the mechanism underlying pyrotinib-induced diarrhea was fully studied using gut microbiome and host intestinal tissue metabolomics profiling. Reproducible diarrhea occurred in rats when they were given an 80 mg/kg daily dose of pyrotinib. Using the pyrotinib-induced model, we observed that Lachnospiraceae and Acidaminococcaceae decreased in the pyrotinib groups, whereas Enterobacteriaceae, Helicobacteraceae and Clostridiaceae increased at the family level by 16S rRNA gene sequence. Multiple bioinformatics methods revealed that glycocholic acid, ursodeoxycholic acid and cyclic AMP increased in the pyrotinib groups, whereas kynurenic acid decreased, which may be related to the pathogenesis of pyrotinib-induced diarrhea. Additionally, pyrotinib-induced diarrhea may be associated with a number of metabolic changes mediated by the gut microbiome, such as Primary bile acid biosynthesis. We reported the establishment of a reproducible pyrotinib-induced animal model for the first time. Furthermore, we concluded from this experiment that gut microbiome imbalance and changes in related metabolites are significant contributors to pyrotinib-induced diarrhea.
C1 [Lai, Jingjiang; Zhuo, Xiaoli; Jiang, Fengxian; Liu, Lei; Wang, Jingliang; Zhao, Jing; Yang, Shuping; Fu, Guobin] Shandong First Med Univ, Dept Oncol, Shandong Prov Hosp, Jinan, Peoples R China.
   [Lai, Jingjiang; Jiang, Fengxian; Liu, Hongjing; Wang, Jingliang] Shandong Univ Tradit Chinese Med, Clin Med Coll 2, Jinan, Peoples R China.
   [Zhuo, Xiaoli; Liu, Lei; Zhao, Jing] Shandong First Med Univ, Shandong Acad Med, Clin Med Coll, Jinan, Peoples R China.
   [Yin, Ke; Xu, Xiaoying; Lin, Xiaoyan] Shandong Prov Hosp, Cheeloo Coll Med, Dept Pathol, Jinan, Peoples R China.
   [Xu, Wei; Fu, Guobin] Shandong Prov Hosp, Dept Oncol, Jinan, Peoples R China.
   [Guo, Honglin] Shandong Prov Hosp, Dept Cent Lab, Jinan, Peoples R China.
   [Guo, Honglin] Shandong Univ, Cheeloo Coll Med, Sch Publ Hlth, Dept Biostat, Jinan, Peoples R China.
   [Yuan, Xiaotian] Shandong First Med Univ, Lab Anim Ctr, Shandong Prov Hosp, Jinan, Peoples R China.
   [Lin, Xiaoyan] Shandong First Med Univ, Dept Pathol, Shandong Prov Hosp, Jinan, Peoples R China.
   [Qi, Fanghua] Shandong First Med Univ, Tradit Chinese Med, Shandong Prov Hosp, Jinan, Peoples R China.
   [Fu, Guobin] Shandong First Med Univ, Dept Oncol, Shandong Prov Hosp, 324 Jingwuweiqi Rd, Jinan, Shandong, Peoples R China.
C3 Shandong First Medical University & Shandong Academy of Medical
   Sciences; Shandong University of Traditional Chinese Medicine; Shandong
   First Medical University & Shandong Academy of Medical Sciences;
   Shandong First Medical University & Shandong Academy of Medical
   Sciences; Shandong First Medical University & Shandong Academy of
   Medical Sciences; Shandong First Medical University & Shandong Academy
   of Medical Sciences; Shandong University; Shandong First Medical
   University & Shandong Academy of Medical Sciences; Shandong First
   Medical University & Shandong Academy of Medical Sciences; Shandong
   First Medical University & Shandong Academy of Medical Sciences;
   Shandong First Medical University & Shandong Academy of Medical Sciences
RP Fu, GB (corresponding author), Shandong Prov Hosp, Dept Oncol, Jinan, Peoples R China.; Fu, GB (corresponding author), Shandong First Med Univ, Dept Oncol, Shandong Prov Hosp, 324 Jingwuweiqi Rd, Jinan, Shandong, Peoples R China.
EM fgbs@sina.com
OI Fu, Guobin/0000-0003-0893-7714
FU National Natural Science Foundation of China [81802284]; Taishan Scholar
   Foundation of Shandong Province [tsqn202103179]; Clinical Research Fund
   of Shandong Provincial Medical Association [YXH2022ZX02176]
FX The authors thank the fund supported by the National Natural Science
   Foundation of China (No. 81802284), Taishan Scholar Foundation of
   Shandong Province (No. tsqn202103179), Clinical Research Fund of
   Shandong Provincial Medical Association (No. YXH2022ZX02176).This work
   was supported by the National Natural Science Foundation of China (No.
   81802284), Taishan Scholar Foundation of Shandong Province (No.
   tsqn202103179), Clinical Research Fund of Shandong Provincial Medical
   Association (No. YXH2022ZX02176).
CR Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003
   Ai XH, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08759-8
   Alexeev EE, 2018, AM J PATHOL, V188, P1183, DOI 10.1016/j.ajpath.2018.01.011
   Barrett KE, 2017, J PHYSIOL-LONDON, V595, P423, DOI 10.1113/JP272227
   BouSaba J, 2022, CLIN GASTROENTEROL H, V20, P2083, DOI 10.1016/j.cgh.2021.11.035
   Bowen JM, 2007, CANCER BIOL THER, V6, P1449, DOI 10.4161/cbt.6.9.4622
   Bowen JM, 2014, CANCER CHEMOTH PHARM, V74, P617, DOI 10.1007/s00280-014-2519-4
   Bowen JM, 2013, CURR OPIN SUPPORT PA, V7, P162, DOI 10.1097/SPC.0b013e32835ec861
   Bowen JM, 2012, CANCER BIOL THER, V13, P1269, DOI 10.4161/cbt.21783
   Cameron D, 2008, BREAST CANCER RES TR, V112, P533, DOI 10.1007/s10549-007-9885-0
   Cheng L, 2020, NUCLEIC ACIDS RES, V48, P7603, DOI 10.1093/nar/gkaa511
   Darsigny M, 2010, INFLAMM BOWEL DIS, V16, P1739, DOI 10.1002/ibd.21274
   Duan TY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126444
   Huang QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32518
   Hwang TC, 2018, J GEN PHYSIOL, V150, P539, DOI 10.1085/jgp.201711946
   Inatomi T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02931-7
   Janjigian YY, 2016, J CLIN ONCOL, V34, P401, DOI 10.1200/JCO.2015.64.2892
   Kelly DL, 2016, CANCER NURS, V39, pE56, DOI 10.1097/NCC.0000000000000286
   Kim Y, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14490
   Kolho KL, 2017, J CROHNS COLITIS, V11, P321, DOI 10.1093/ecco-jcc/jjw158
   Krautkramer KA, 2021, NAT REV MICROBIOL, V19, P77, DOI 10.1038/s41579-020-0438-4
   Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Li Q, 2019, CLIN CANCER RES, V25, P5212, DOI 10.1158/1078-0432.CCR-18-4173
   Loriot Y, 2008, NAT CLIN PRACT ONCOL, V5, P268, DOI 10.1038/ncponc1087
   Ma F, 2019, J CLIN ONCOL, V37, P2610, DOI 10.1200/JCO.19.00108
   Ma F, 2017, J CLIN ONCOL, V35, P3105, DOI 10.1200/JCO.2016.69.6179
   Mahtani Reshma, 2019, J Adv Pract Oncol, V10, P136
   Maier L, 2017, CURR OPIN MICROBIOL, V39, P128, DOI 10.1016/j.mib.2017.11.001
   Mayo BJ, 2020, CANCER CHEMOTH PHARM, V85, P793, DOI 10.1007/s00280-020-04040-0
   MOLINO G, 1986, EUR J CLIN INVEST, V16, P397, DOI 10.1111/j.1365-2362.1986.tb01015.x
   Natividad JM, 2018, CELL METAB, V28, P737, DOI 10.1016/j.cmet.2018.07.001
   Negoro S, 2014, J INFECT CHEMOTHER, V20, P682, DOI 10.1016/j.jiac.2014.07.007
   Pal SK, 2015, CLIN CANCER RES, V21, P5286, DOI 10.1158/1078-0432.CCR-15-0724
   Pang ZQ, 2021, NUCLEIC ACIDS RES, V49, pW388, DOI 10.1093/nar/gkab382
   Platten M, 2019, NAT REV DRUG DISCOV, V18, P379, DOI 10.1038/s41573-019-0016-5
   Ramlau R, 2015, CLIN LUNG CANCER, V16, P348, DOI 10.1016/j.cllc.2015.01.004
   Secombe KR, 2021, BREAST CANCER-TOKYO, V28, P99, DOI 10.1007/s12282-020-01133-9
   Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011
   Song G H, 2020, Beijing Da Xue Xue Bao Yi Xue Ban, V52, P254
   Sun Y, 2022, EUR RESPIR J, V60, DOI 10.1183/13993003.00260-2022
   Wang Y, 2019, ANN ONCOL, V30, P447, DOI 10.1093/annonc/mdy542
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Wu SC, 2020, NUCLEIC ACIDS RES, V48, pD545, DOI 10.1093/nar/gkz764
   Xu BH, 2021, LANCET ONCOL, V22, P351, DOI 10.1016/S1470-2045(20)30702-6
   Xuhong JC, 2019, AM J CANCER RES, V9, P2103
   Yang G., 2021, J NATL CANC CTR, V1, P139, DOI DOI 10.1016/J.JNCC.2021.08.001
   Yang M, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.515614
   Zeng J., 2021, J NAT CANC CTR, V1, P58, DOI [DOI 10.1016/J.JNCC.2021.04.001, 10.1016/j.jncc.2021.04.001]
   Zhou CC, 2020, J CLIN ONCOL, V38, P2753, DOI 10.1200/JCO.20.00297
NR 51
TC 0
Z9 0
U1 2
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0959-4973
EI 1473-5741
J9 ANTI-CANCER DRUG
JI Anti-Cancer Drugs
PD JUL
PY 2023
VL 34
IS 6
BP 747
EP 762
DI 10.1097/CAD.0000000000001440
PG 16
WC Oncology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pharmacology & Pharmacy
GA G0NW4
UT WOS:000986236000005
PM 36378136
OA Bronze
DA 2023-09-14
ER

PT J
AU Leino, L
   Tall, T
   Helander, M
   Saloniemi, I
   Saikkonen, K
   Ruuskanen, S
   Puigbo, P
AF Leino, Lyydia
   Tall, Tuomas
   Helander, Marjo
   Saloniemi, Irma
   Saikkonen, Kari
   Ruuskanen, Suvi
   Puigbo, Pere
TI Classification of the glyphosate target enzyme
   (5-enolpyruvylshikimate-3-phosphate synthase) for assessing sensitivity
   of organisms to the herbicide
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Shikimate pathway; Epsps enzyme; Glyphosate; Herbicide; Resistance;
   Microbiome; Bioinformatics resource; Biomarkers; Sensitivity
ID RESISTANCE
AB Glyphosate is the most common broad-spectrum herbicide. It targets the key enzyme of the shikimate pathway, 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), which synthesizes three essential aromatic amino acids (phenylalanine, tyrosine and tryptophan) in plants. Because the shikimate pathway is also found in many prokaryotes and fungi, the widespread use of glyphosate may have unsuspected impacts on the diversity and composition of microbial communities, including the human gut microbiome. Here, we introduce the first bioinformatics method to assess the potential sensitivity of organisms to glyphosate based on the type of EPSPS enzyme. We have precomputed a dataset of EPSPS sequences from thousands of species that will be an invaluable resource to advancing the research field. This novel methodology can classify sequences from nearly 90% of eukaryotes and >80% of prokaryotes. A conservative estimate from our results shows that 54% of species in the core human gut microbiome are sensitive to glyphosate.
C1 [Leino, Lyydia; Tall, Tuomas; Helander, Marjo; Saloniemi, Irma; Ruuskanen, Suvi; Puigbo, Pere] Univ Turku, Dept Biol, Turku, Finland.
   [Saikkonen, Kari] Univ Turku, Biodivers Unit, Turku, Finland.
   [Puigbo, Pere] Eurecat Technol Ctr Catalonia, Nutr & Hlth Unit, Reus, Catalonia, Spain.
   [Puigbo, Pere] Rovira & Virgili Univ, Dept Biochem & Biotechnol, Tarragona, Catalonia, Spain.
C3 University of Turku; University of Turku; Universitat Rovira i Virgili
RP Puigbo, P (corresponding author), Univ Turku, Dept Biol, Turku, Finland.
EM pepuav@utu.fi
RI Ruuskanen, Suvi/A-1790-2013; Puigbo, Pere/AAL-5286-2021
OI Ruuskanen, Suvi/0000-0001-5582-9455; Saikkonen,
   Kari/0000-0001-5203-9984; Puigbo, Pere/0000-0002-0072-8726; Leino,
   Lyydia/0000-0002-3423-0811; Helander, Marjo/0000-0002-9759-4321
FU Turku Collegium for Science and Medicine; Academy of Finland [311077];
   Academy of Finland (AKA) [311077, 311077] Funding Source: Academy of
   Finland (AKA)
FX This research is supported by funds from the Turku Collegium for Science
   and Medicine (PP, TT) and by the Academy of Finland (MH, grant no.
   311077). We thank the three reviewers for their insightful comments and
   careful review.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI [10.1093/nar/gkh131, 10.1093/nar/gkw1099]
   Barry G.F., 1997, US5627061A-Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases, Patent No. [US5627061A, 5627061]
   Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkt1030, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkp1024, 10.1093/nar/gkn723, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202]
   BENTLEY R, 1990, NUCLEIC ACIDS RES, V25, P307
   BRAGA RM, 2016, NUCLEIC ACIDS RES, V47, P86, DOI DOI 10.1016/J.BJM.2016.10.005
   Burchfield SL, 2019, ENVIRON TOXICOL PHAR, V66, P36, DOI 10.1016/j.etap.2018.12.019
   Burley SK, 2017, METHODS MOL BIOL, V1606, P627, DOI 10.1007/978-1-4939-7000-1_26
   Carozzi N., 2006, Patent No. [US20060253921A1, 20060253921]
   CASTRESANA J, 2000, CRIT REV BIOCHEM MOL, V17, P540, DOI DOI 10.1093/10.1093
   DUKE SO, 2017, MOL BIOL EVOL, V73, P7, DOI DOI 10.1002/PS.4466
   DUKE SO, 2018, BRAZ J MICROBIOL, V74, P1027, DOI DOI 10.1002/PS.4652
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   FIRDOUS S, 2018, NUCLEIC ACIDS RES, V74, P1184, DOI DOI 10.1002/PS.4624
   Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103
   Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200
   Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223
   GILBERT JA, 2018, PEST MANAG SCI, V24, P392, DOI DOI 10.1038/NM.4517
   GOMES MP, 2016, NUCLEIC ACIDS RES, V218, P402, DOI DOI 10.1016/J.ENVPOL.2016.07.019
   Gomez-Gallego C, 2020, FEMS MICROBIOL LETT, V367, DOI 10.1093/femsle/fnaa050
   Heap I., INT SURVEY HERBICIDE
   HEAP I, 2018, NAT MED, V74, P1040, DOI DOI 10.1002/PS.4760
   HELANDER M, 2012, PEST MANAG SCI, V17, P569, DOI DOI 10.1016/J.TPLANTS.2012.05.008
   HELANDER M, 2018, ENVIRON POLLUT, V642, P285, DOI DOI 10.1016/J.SCITOTENV.2018.05.377
   JUTURU V, 2018, SCI TOTAL ENVIRON, V36, P2187, DOI DOI 10.1016/J.BIOTECHADV.2018.10.007
   KURENBACH B, 2018, TRENDS PLANT SCI, V6, pE5801, DOI DOI 10.7717/PEERJ.5801
   Kurenbach B, 2015, MBIO, V6, DOI 10.1128/mBio.00009-15
   Light SH, 2016, BIOCHEMISTRY-US, V55, P1239, DOI 10.1021/acs.biochem.5b00553
   Lira J.M., 2013, US20130217577A1-Novel class of glyphosate resistance genes, Patent No. [US20130217577A1, 20130217577]
   MORJAN WE, 2002, PEERJ, V31, P1206, DOI DOI 10.1603/0046-225X-31.6.1206
   MOTTA EVS, 2018, BIOCHEMISTRY-US, V115, P10305, DOI DOI 10.1073/PNAS.1803880115
   Myers JP, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0117-0
   Nandula VK., 2010, GLYPHOSATE RESISTANC, DOI [10.1002/9780470634394, DOI 10.1002/9780470634394]
   Nerozzi C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67538-w
   POLLEGIONI L, 2011, SCI REP-UK, V278, P2753, DOI DOI 10.1111/J.1742-4658.2011.08214.X
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Priestman MA, 2005, FEBS LETT, V579, P728, DOI 10.1016/j.febslet.2004.12.057
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Richards TA, 2006, EUKARYOT CELL, V5, P1517, DOI 10.1128/EC.00106-06
   SAMMONS RD, 2014, NATURE, V70, P1367
   Shehata AA, 2013, CURR MICROBIOL, V66, P350, DOI 10.1007/s00284-012-0277-2
   STEINRUCKEN HC, 1980, EUKARYOT CELL, V94, P1207, DOI DOI 10.1016/0006-291X(80)90547-1
   TATUSOV RL, 1997, PEST MANAG SCI, V278, P631, DOI DOI 10.1126/SCIENCE.278.5338.631
   VANOVERBEEK LS, 2016, ENVIRON HEALTH-GLOB, V21, P230, DOI DOI 10.1016/J.TPLANTS.2016.01.003
   WANG B, 2017, SCIENCE, V3, P71, DOI DOI 10.1016/J.ENG.2017.01.008
NR 47
TC 41
Z9 42
U1 3
U2 26
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD APR 15
PY 2021
VL 408
AR 124556
DI 10.1016/j.jhazmat.2020.124556
EA FEB 2021
PG 8
WC Engineering, Environmental; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Environmental Sciences & Ecology
GA QK4UJ
UT WOS:000620381800005
PM 33243645
OA hybrid, Green Published
DA 2023-09-14
ER

PT J
AU Sadeghi, A
   Ebrahimi, M
   Kharazmi, MS
   Jafari, SM
AF Sadeghi, Alireza
   Ebrahimi, Maryam
   Kharazmi, Mohammad Saeed
   Jafari, Seid Mahdi
TI Effects of microbial-derived biotics (meta/pharma/post-biotics) on the
   modulation of gut microbiome and metabolome; general aspects and
   emerging trends
SO FOOD CHEMISTRY
LA English
DT Article
DE Meta; pharma; post-biotics; Gut microbiome; Bioinformatics;
   Metabolomics; Human health
ID LACTIC-ACID BACTERIA; CHAIN FATTY-ACIDS; EXOPOLYSACCHARIDE;
   LACTOBACILLUS; GABA; MECHANISMS; DATABASE; TARGET; METAPROTEOMICS;
   POSTBIOTICS
AB Potential effects of metabiotics (probiotics effector molecules or signaling factors), pharmabiotics (pro-functional metabolites produced by gut microbiota (GMB)) and postbiotics (multifunctional metabolites and structural compounds of food-grade microorganisms) on GMB have been rarely reviewed. These multifunctional compo-nents have several promising capabilities for prevention, alleviation and treatment of some diseases or disorders. Correlations between these essential biotics and GMB are also very interesting and important in human health and nutrition. Furthermore, these natural bioactives are involved in modulation of the immune function, control of metabolic dysbiosis and regulation of the signaling pathways. This review discusses the potential of meta/ pharma/post-biotics as new classes of pharmaceutical agents and their effective mechanisms associated with GMB-host cell to cell communications with therapeutic benefits which are important in balance and the integrity of the host microbiome. In addition, cutting-edge findings about bioinformatics /metabolomics analyses related to GMB and these essential biotics are reviewed.
C1 [Sadeghi, Alireza] Gorgan Univ Agr Sci & Nat Resources, Dept Food Sci & Technol, Gorgan, Iran.
   [Ebrahimi, Maryam] Golestan Univ Med Sci, Food Drug & Nat Prod Hlth Res Ctr, Gorgan, Iran.
   [Kharazmi, Mohammad Saeed] Univ Calif Riverside, Fac Med, Riverside, CA USA.
   [Jafari, Seid Mahdi] Gorgan Univ Agr Sci & Nat Resources, Dept Food Mat & Proc Design Engn, Gorgan, Iran.
   [Jafari, Seid Mahdi] Univ Vigo, Fac Sci, Dept Analyt Chem & Food Sci, Nutr & Bromatol Grp, E-32004 Orense, Spain.
   [Jafari, Seid Mahdi] Hebei Agr Univ, Coll Food Sci & Technol, Baoding 071001, Peoples R China.
   [Sadeghi, Alireza; Jafari, Seid Mahdi] Gorgan Univ Agr Sci & Nat Resources, Fac Food Sci & Technol, Gorgan, Iran.
C3 Golestan University of Medical Sciences; University of California
   System; University of California Riverside; Universidade de Vigo; Hebei
   Agricultural University
RP Sadeghi, A; Jafari, SM (corresponding author), Gorgan Univ Agr Sci & Nat Resources, Fac Food Sci & Technol, Gorgan, Iran.
EM sadeghi.gau@gmail.com; smjafari@gau.ac.ir
CR Aarti Singh, 2018, Advances in Bioscience and Biotechnology, V9, P147, DOI 10.4236/abb.2018.94012
   Aguilar-Toala JE, 2018, TRENDS FOOD SCI TECH, V75, P105, DOI 10.1016/j.tifs.2018.03.009
   Al Kassaa I, 2019, INT J ANTIMICROB AG, V54, P771, DOI 10.1016/j.ijantimicag.2019.07.012
   Amjadi M, 2020, MICROCHIM ACTA, V187, DOI 10.1007/s00604-020-4168-0
   Andlid TA, 2018, BIFIDOBACTERIA AND RELATED ORGANISMS: BIOLOGY, TAXONOMY, APPLICATIONS, P195, DOI 10.1016/B978-0-12-805060-6.00011-9
   [Anonymous], 2008, MODERN TECHNIQUES FO
   Ashraf S. A., 2020, ANAL CHEM
   Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x
   Bence KK, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101143
   Birch J, 2019, CARBOHYD POLYM, V205, P565, DOI 10.1016/j.carbpol.2018.10.063
   Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108
   Cai Z., 2014, APPL MALDI TOF SPECT, V331
   Capponi M, 2022, J CLIN MED, V11, DOI 10.3390/jcm11175154
   Chakrabarti A, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0033-0
   Chambers Edward S, 2018, Curr Nutr Rep, V7, P198, DOI 10.1007/s13668-018-0248-8
   Chatterjee G, 2022, SCI TOTAL ENVIRON, V838, DOI 10.1016/j.scitotenv.2022.155915
   Chen DF, 2020, CANCER LETT, V469, P456, DOI 10.1016/j.canlet.2019.11.019
   Cheng L, 2022, NUCLEIC ACIDS RES, V50, pD795, DOI 10.1093/nar/gkab786
   Cheng L, 2020, NUCLEIC ACIDS RES, V48, pD554, DOI 10.1093/nar/gkz843
   Chichlowski M., 2022, EXPLORATION MED, V3, P331
   Choyam S., 2019, ACCESS MICROBIOLOGY, V1
   Cosola C, 2018, PHARMACOL RES, V130, P132, DOI 10.1016/j.phrs.2018.03.003
   Coyne MJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11494-1
   Cuevas-Gonzalez PF, 2020, FOOD RES INT, V136, DOI 10.1016/j.foodres.2020.109502
   Dai D, 2022, NUCLEIC ACIDS RES, V50, pD777, DOI 10.1093/nar/gkab1019
   Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3
   Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002
   Dicks LMT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02297
   Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104
   Dordevic D, 2021, J ADV RES, V27, P55, DOI 10.1016/j.jare.2020.03.003
   Drider D, 2021, PROBIOTICS ANTIMICRO, V13, P1759, DOI 10.1007/s12602-021-09843-y
   Drissi F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00441
   Druart C, 2013, BRIT J NUTR, V110, P998, DOI 10.1017/S0007114513000123
   Duranti S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70986-z
   Fanning S, 2012, GUT MICROBES, V3, P420, DOI 10.4161/gmic.20630
   Feng YL, 2019, CELL MOL LIFE SCI, V76, P4961, DOI 10.1007/s00018-019-03155-9
   Garcia-Gutierrez E, 2019, GUT MICROBES, V10, P1, DOI 10.1080/19490976.2018.1455790
   Gilbert M. S., 2018, AM J PHYSIOL-GASTR L
   Gui DD, 2021, EUR J PHARMACOL, V896, DOI 10.1016/j.ejphar.2021.173916
   Guinane CM, 2016, ANAEROBE, V40, P41, DOI 10.1016/j.anaerobe.2016.05.001
   Gulati M., 2021, PROBIOTIC RES THERAP, P95
   Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22
   Hao HP, 2017, CELL METAB, V25, P856, DOI 10.1016/j.cmet.2017.03.007
   Heinken A., 2020, BIORXIV
   Hiseni P, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01114-w
   Do MH, 2021, CRIT REV FOOD SCI, V61, P1212, DOI 10.1080/10408398.2020.1755949
   Janssens Y, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1197-5
   Jian TY, 2022, J AGR FOOD CHEM, V70, P13279, DOI 10.1021/acs.jafc.2c04900
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kim Chang H, 2014, Immune Netw, V14, P277, DOI 10.4110/in.2014.14.6.277
   Kok DE, 2020, CRIT REV FOOD SCI, V60, P244, DOI 10.1080/10408398.2018.1522499
   Kolmeder CA, 2014, J PROTEOMICS, V97, P3, DOI 10.1016/j.jprot.2013.05.018
   Kuang JH, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104212
   Kumariya R, 2019, MICROB PATHOGENESIS, V128, P171, DOI 10.1016/j.micpath.2019.01.002
   Kunisawa J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00189
   Laroute V, 2022, ELIFE, V11, DOI 10.7554/eLife.77100
   Lazar V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01830
   Lemfack MC, 2018, NUCLEIC ACIDS RES, V46, pD1261, DOI 10.1093/nar/gkx1016
   Li BY, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.634204
   Li BY, 2020, INT J BIOL MACROMOL, V150, P991, DOI 10.1016/j.ijbiomac.2019.10.186
   Li J., 2022, FRONT PHARMACOL, P3102
   Li LZ, 2017, DRUG DES DEV THER, V11, P3531, DOI 10.2147/DDDT.S150825
   Li L, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.697059
   Liu GY, 2019, APPL MICROBIOL BIOT, V103, P1693, DOI 10.1007/s00253-018-9572-6
   Liu MM, 2022, FOODS, V11, DOI 10.3390/foods11020234
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lynch KM, 2018, FOOD RES INT, V110, P52, DOI 10.1016/j.foodres.2017.03.012
   Magnusdottir S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00148
   Malinowska AM, 2022, FOOD RES INT, V156, DOI 10.1016/j.foodres.2022.111290
   Mallick H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10927-1
   Martin G., 1989, NMR-BASIC PRINC PROG, P1
   Martin-Gallausiaux C, 2021, P NUTR SOC, V80, P37, DOI 10.1017/S0029665120006916
   Mayorgas A, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000188
   Millette M, 2008, APPL ENVIRON MICROB, V74, P1997, DOI 10.1128/AEM.02150-07
   Molzer C, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/9998200
   Moradi M, 2021, ENZYME MICROB TECH, V143, DOI 10.1016/j.enzmictec.2020.109722
   Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082
   Motta JP, 2015, INFLAMM BOWEL DIS, V21, P1006, DOI 10.1097/MIB.0000000000000345
   Muninathan C, 2022, INT J FOOD SCI TECH, V57, P27, DOI 10.1111/ijfs.15334
   Murros KE, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11060978
   Nagpal R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30114-4
   Oerlemans MMP, 2021, J FUNCT FOODS, V76, DOI 10.1016/j.jff.2020.104289
   Padilla C, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/6747190
   Pan L, 2020, J FUNCT FOODS, V67, DOI 10.1016/j.jff.2020.103853
   Patterson E, 2014, P NUTR SOC, V73, P477, DOI 10.1017/S0029665114001426
   Peluzio MDG, 2021, TRENDS FOOD SCI TECH, V108, P11, DOI 10.1016/j.tifs.2020.12.004
   Pileggi M., 2022, FRONT GENET, P2069
   Pique N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102534
   Pokusaeva K, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12904
   Pourjafar H, 2022, CRIT REV FOOD SCI, DOI 10.1080/10408398.2022.2047883
   Quereda JJ, 2016, P NATL ACAD SCI USA, V113, P5706, DOI 10.1073/pnas.1523899113
   Rajakovich LJ, 2019, NAT PROD REP, V36, P593, DOI 10.1039/c8np00074c
   Rashmi D, 2018, STUD NAT PROD CHEM, V57, P413, DOI 10.1016/B978-0-444-64057-4.00013-2
   Rea MC, 2013, J MED MICROBIOL, V62, P1369, DOI 10.1099/jmm.0.058933-0
   Ren WK, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00685
   Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113
   Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Rodriguez-Morato J, 2020, CURR ATHEROSCLER REP, V22, DOI 10.1007/s11883-020-00863-7
   Rolhion N, 2019, CELL HOST MICROBE, V26, P691, DOI 10.1016/j.chom.2019.10.016
   Rooijers K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-6
   Rosario D, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108807
   Ross RP, 2010, INT DAIRY J, V20, P269, DOI 10.1016/j.idairyj.2009.12.003
   Rui Y, 2019, LWT-FOOD SCI TECHNOL, V116, DOI 10.1016/j.lwt.2019.108508
   Saha S, 2016, DRUG DISCOV TODAY, V21, P692, DOI 10.1016/j.drudis.2016.02.009
   Salazar N, 2016, CRIT REV FOOD SCI, V56, P1440, DOI 10.1080/10408398.2013.770728
   Sanmiguel C, 2015, CURR OBES REP, V4, P250, DOI 10.1007/s13679-015-0152-0
   Santovito E, 2018, FOODBORNE PATHOG DIS, V15, P531, DOI 10.1089/fpd.2018.2430
   Sarasa SB, 2020, CURR MICROBIOL, V77, P534, DOI 10.1007/s00284-019-01839-w
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Sharma M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01940
   Sharpton SR, 2019, HEPATOL COMMUN, V3, P29, DOI 10.1002/hep4.1284
   Shenderov Boris A., 2013, Microbial Ecology in Health and Disease, V24, P20399, DOI 10.3402/mehd.v24i0.20399
   Silva YP, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00025
   Sitkin S I, 2016, Eksp Klin Gastroenterol, V12, P6
   Smirnov KS, 2016, INT J MED MICROBIOL, V306, P266, DOI 10.1016/j.ijmm.2016.03.006
   Strandwitz P, 2019, NAT MICROBIOL, V4, P396, DOI 10.1038/s41564-018-0307-3
   Theriot CM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00045-15
   Thorakkattu P, 2022, FOODS, V11, DOI 10.3390/foods11193094
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   Tian JJ, 2021, INT J BIOL MACROMOL, V188, P833, DOI 10.1016/j.ijbiomac.2021.08.052
   Ticho Alexander L, 2019, Liver Res, V3, P31, DOI 10.1016/j.livres.2019.01.001
   Uebanso T, 2020, MOL NUTR FOOD RES, DOI 10.1002/mnfr.202000426
   Umu Ozgun C. O., 2017, Microbial Ecology in Health and Disease, V28, P1348886, DOI 10.1080/16512235.2017.1348886
   Umu OCO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164036
   Utpott M, 2022, FOOD CHEM, V366, DOI 10.1016/j.foodchem.2021.130685
   van Heel AJ, 2018, NUCLEIC ACIDS RES, V46, pW278, DOI 10.1093/nar/gky383
   Vernocchi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01144
   Walsh CJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0515-4
   Wang G, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010049
   Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278
   Wang HL, 2020, FOOD FUNCT, V11, P10386, DOI [10.1039/D0FO02224A, 10.1039/d0fo02224a]
   Wang Q, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21911-y
   Wang QQ, 2020, J BIOMED INFORM, V109, DOI 10.1016/j.jbi.2020.103524
   Whon TW, 2021, J MICROBIOL, V59, P292, DOI 10.1007/s12275-021-1004-0
   Wu CH, 2022, METABOLITES, V12, DOI 10.3390/metabo12090775
   Xiong WL, 2015, PROTEOMICS, V15, P3424, DOI 10.1002/pmic.201400571
   Xu RH, 2019, J AGR FOOD CHEM, V67, P11627, DOI 10.1021/acs.jafc.9b04323
   Yan S, 2019, FOOD FUNCT, V10, P1595, DOI 10.1039/c9fo00014c
   Yang B, 2018, J FUNCT FOODS, V49, P61, DOI 10.1016/j.jff.2018.08.014
   Yu G., 2022, IMETA, V1, pe10, DOI [10.1002/imt2.10, DOI 10.1002/IMT2.10]
   Yunes RA, 2016, ANAEROBE, V42, P197, DOI 10.1016/j.anaerobe.2016.10.011
   Zarei I., 2022, SCI REP-UK, V12, P1
   Zhang J, 2020, FOOD FUNCT, V11, P6308, DOI [10.1039/d0fo00480d, 10.1039/D0FO00480D]
   Zhang J, 2017, J DAIRY SCI, V100, P6025, DOI 10.3168/jds.2016-12480
   Zhen W., 2021, FRONT MICROBIOL, V12
   Zhu YZ, 2021, LWT-FOOD SCI TECHNOL, V139, DOI 10.1016/j.lwt.2020.110524
NR 148
TC 4
Z9 4
U1 19
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD JUN 15
PY 2023
VL 411
AR 135478
DI 10.1016/j.foodchem.2023.135478
EA JAN 2023
PG 15
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA C6XQ1
UT WOS:000963327200001
PM 36696721
DA 2023-09-14
ER

PT J
AU Das, P
   Marcisauskas, S
   Ji, BY
   Nielsen, J
AF Das, Promi
   Marcisauskas, Simonas
   Ji, Boyang
   Nielsen, Jens
TI Metagenomic analysis of bile salt biotransformation in the human gut
   microbiome
SO BMC GENOMICS
LA English
DT Article
DE Secondary bile acids; Gut microbiota; IBD; Bioinformatics; Metagenomics;
   Metabolomics; And bile salt biotransformation genes
ID INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; HYDROLASE ACTIVITY;
   URSODEOXYCHOLIC ACID; CLOSTRIDIUM-SCINDENS; HELICOBACTER-PYLORI;
   CROHNS-DISEASE; DOUBLE-BLIND; METABOLOMICS; ANNOTATION
AB BackgroundIn the biochemical milieu of human colon, bile acids act as signaling mediators between the host and its gut microbiota. Biotransformation of primary to secondary bile acids have been known to be involved in the immune regulation of human physiology. Several 16S amplicon-based studies with inflammatory bowel disease (IBD) subjects were found to have an association with the level of fecal bile acids. However, a detailed investigation of all the bile salt biotransformation genes in the gut microbiome of healthy and IBD subjects has not been performed.ResultsHere, we report a comprehensive analysis of the bile salt biotransformation genes and their distribution at the phyla level. Based on the analysis of shotgun metagenomes, we found that the IBD subjects harbored a significantly lower abundance of these genes compared to the healthy controls. Majority of these genes originated from Firmicutes in comparison to other phyla. From metabolomics data, we found that the IBD subjects were measured with a significantly low level of secondary bile acids and high levels of primary bile acids compared to that of the healthy controls.ConclusionsOur bioinformatics-driven approach of identifying bile salt biotransformation genes predicts the bile salt biotransformation potential in the gut microbiota of IBD subjects. The functional level of dysbiosis likely contributes to the variation in the bile acid pool. This study sets the stage to envisage potential solutions to modulate the gut microbiome with the objective to restore the bile acid pool in the gut.
C1 [Das, Promi; Marcisauskas, Simonas; Ji, Boyang; Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, SE-41296 Gothenburg, Sweden.
   [Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2800 Lyngby, Denmark.
C3 Chalmers University of Technology; Novo Nordisk Foundation; Technical
   University of Denmark
RP Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, SE-41296 Gothenburg, Sweden.; Nielsen, J (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2800 Lyngby, Denmark.
EM promi@chalmers.se; nielsenj@chalmers.se
RI Ji, Boyang/HMV-6662-2023; Nielsen, Jens Bo/C-7632-2015; Nielsen,
   Jens/Q-1347-2017
OI Ji, Boyang/0000-0002-7269-4342; Nielsen, Jens Bo/0000-0001-5568-2916;
   Nielsen, Jens/0000-0002-9955-6003; Das, Promi/0000-0001-6733-2059
FU European Commission FP7 project METACARDIS [HEALTH-F4-2012-305312]
FX This study was supported by a grant from the European Commission FP7
   project METACARDIS with the grant agreement HEALTH-F4-2012-305312. The
   funding body did not have any role in the study design, data collection,
   analysis and interpretation, the writing of the manuscript, or any
   influence on the content of the manuscript.
CR Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x
   [Anonymous], 2016, GGPLOT2 USE R, DOI DOI 10.1007/978-3-319-24277-4_9
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI [10.1093/nar/gkh131, 10.1093/nar/gkw1099]
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Baars Annemarie, 2015, Microorganisms, V3, P641, DOI 10.3390/microorganisms3040641
   Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
   Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049
   Becker C, 2015, ILAR J, V56, P192, DOI 10.1093/ilar/ilv030
   Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006
   Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003
   Bjerrum JT, 2015, METABOLOMICS, V11, P122, DOI 10.1007/s11306-014-0677-3
   Bustos AY, 2018, FOOD RES INT, V112, P250, DOI 10.1016/j.foodres.2018.06.035
   Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578
   Feng HY, 2016, WORLD J GASTROENTERO, V22, P7463, DOI 10.3748/wjg.v22.i33.7463
   Finegold SM., 1996, ANAEROBIC GRAM NEGAT
   Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344
   Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4
   Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444
   Ghouri YA, 2014, CLIN EXP GASTROENTER, V7, P473, DOI 10.2147/CEG.S27530
   Gillespie S.H., 2006, PRINCIPLES PRACTICE
   GILLILAND SE, 1977, APPL ENVIRON MICROB, V33, P15, DOI 10.1128/AEM.33.1.15-18.1977
   Gothe F, 2014, J CROHNS COLITIS, V8, P1072, DOI 10.1016/j.crohns.2014.02.027
   Han SW, 1996, AM J GASTROENTEROL, V91, P1135
   Harris SC, 2018, GUT MICROBES, V9, P523, DOI 10.1080/19490976.2018.1458180
   HIRANO S, 1981, APPL ENVIRON MICROB, V42, P912, DOI 10.1128/AEM.42.5.912-915.1981
   HOFMANN AF, 1989, AM J SURG, V158, P198, DOI 10.1016/0002-9610(89)90252-3
   Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192
   Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013
   Itoh M, 1999, J GASTROENTEROL, V34, P571, DOI 10.1007/s005350050374
   Jacobs JP, 2016, CELL MOL GASTROENTER, V2, P750, DOI 10.1016/j.jcmgh.2016.06.004
   Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386
   Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Joyce SA, 2014, GUT MICROBES, V5, P669, DOI 10.4161/19490976.2014.969986
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008
   Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171
   Kim JE, 2016, INT J MOL SCI, V17, pE1234, DOI DOI 10.1186/s12859-016-1278-0
   Labbe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115175
   Lambert JM, 2008, MICROBIOL-SGM, V154, P2492, DOI 10.1099/mic.0.2008/016808-0
   Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598
   Leuschner U, RECENTI PROG MED, V83, P392
   Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656
   Long SL, 2017, MOL ASPECTS MED, V56, P54, DOI 10.1016/j.mam.2017.06.002
   LUNDEEN SG, 1992, FEMS MICROBIOL LETT, V94, P121, DOI 10.1111/j.1574-6968.1992.tb05300.x
   Mallonee DH, 1996, J BACTERIOL, V178, P7053, DOI 10.1128/jb.178.24.7053-7058.1996
   MALLONEE DH, 1990, J BACTERIOL, V172, P7011, DOI 10.1128/jb.172.12.7011-7019.1990
   Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89
   Martin G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01153
   Martinot E, 2017, MOL ASPECTS MED, V56, P2, DOI 10.1016/j.mam.2017.01.006
   Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4
   Mullish BH, 2019, GUT, V68, P1791, DOI 10.1136/gutjnl-2018-317842
   Ochsenkuhn T, 1999, CANCER, V85, P1664, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1664::AID-CNCR4>3.3.CO;2-F
   Ocvirk Soren, 2017, Curr Nutr Rep, V6, P315, DOI 10.1007/s13668-017-0219-5
   Panigrahi P, 2014, MICROBIOL-SGM, V160, P1162, DOI 10.1099/mic.0.077586-0
   Payne CM, 2008, CLIN EXP GASTROENTER, V1, P19
   Pereira SP, 1997, DIGEST DIS SCI, V42, P1775, DOI 10.1023/A:1018834103873
   Pols TWH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176715
   Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   R Core Team, 2017, R LANG ENV STAT COMP
   Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483
   Ridlon JM, 2013, GUT MICROBES, V4, P382, DOI 10.4161/gmic.25723
   Ridlon JM, 2012, J LIPID RES, V53, P66, DOI 10.1194/jlr.M020313
   Ruiz L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00396
   Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z
   SHAH HN, 1995, INT J SYST BACTERIOL, V45, P586, DOI 10.1099/00207713-45-3-586
   Sjoqvist U, 2004, ANTICANCER RES, V24, P3121
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122
   Nguyen TT, 2018, WORLD J CLIN CASES, V6, P577, DOI 10.12998/wjcc.v6.i13.577
   Travers MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01453
   Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218
   Tyner S.C., 2017, R J
   Uchiyama K, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/7270486
   Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013
   Van den Bossche L, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02766-16
   Vaughn BP, 2019, CLIN EXP GASTROENTER, V12, P9, DOI 10.2147/CEG.S186097
   Wahlstrom A, 2017, DIGEST DIS, V35, P246, DOI 10.1159/000450982
   Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Ward JBJ, 2017, AM J PHYSIOL-GASTR L, V312, pG550, DOI 10.1152/ajpgi.00256.2016
   Watanabe K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202083
   Yokota A, 2012, GUT MICROBES, V3, P455, DOI 10.4161/gmic.21216
NR 86
TC 37
Z9 38
U1 3
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD JUN 25
PY 2019
VL 20
AR 517
DI 10.1186/s12864-019-5899-3
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA IF1RU
UT WOS:000472856500001
PM 31234773
OA Green Published, gold, Green Submitted
DA 2023-09-14
ER

PT J
AU Parad, JE
   Liao, W
AF Parad, Jason E.
   Liao, Wilson
TI Bioinformatic applications in psoriasis: genetics, transcriptomics, and
   microbiomics
SO SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
LA English
DT Article
ID LINKAGE ANALYSIS; RNA-SEQ; GUT MICROBIOME; HUMAN SKIN; EXPRESSION; CELL;
   CHARACTERIZES; EXACERBATION; MUTATIONS; INSIGHTS
AB Bioinformatics uses computationally intensive approaches to make sense of complex biological data sets. Here we review the role of bioinformatics in 3 areas of biology: genetics, transcriptomics, and microbiomics. Examples of bioinformatics in each area are given with respect to psoriasis and psoriatic arthritis, related inflammatory disorders at the forefront of bioinformatic research in dermatology. While bioinformatic technologies and analyses have traditionally been developed and deployed in siloes, the field of integrative omics is on the horizon. Powered by the advent of machine learning, bioinformatic integration of large data sets has the potential to dramatically revolutionize our knowledge of pathogenetic mechanisms and therapeutic targets. (C) 2019 Frontline Medical Communications
C1 [Parad, Jason E.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
   [Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco
RP Parad, JE (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.
EM jason.parad@ucsf.edu
CR Ahluwalia V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26800
   Ahn R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29472-w
   Ahn R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3188-y
   Ahn RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01468-y
   Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31
   Amar J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054461
   Bailey-Wilson JE, 2011, HUM HERED, V72, P228, DOI 10.1159/000334381
   Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313
   Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793
   Chang HW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0533-1
   Chavan SS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S4
   Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024
   Chen YJ, 2018, EXP DERMATOL, V27, P1336, DOI 10.1111/exd.13786
   Chow M, 2016, J DRUGS DERMATOL, V15, P988
   Codoner FM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22125-y
   Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152
   Das S, 2015, EUR J HUM GENET, V23, P844, DOI 10.1038/ejhg.2014.172
   Dolcino M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01533
   Dolcino M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128262
   Eppinga H, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0407-2
   Fahlen A, 2012, ARCH DERMATOL RES, V304, P15, DOI 10.1007/s00403-011-1189-x
   Fan X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000038
   Farooq M, 2013, HUM MUTAT, V34, P176, DOI 10.1002/humu.22203
   Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606
   Foulkes AC, 2019, J INVEST DERMATOL, V139, P100, DOI 10.1016/j.jid.2018.04.041
   Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719
   Gomez-Moyano E, 2014, J MYCOL MED, V24, P87, DOI 10.1016/j.mycmed.2013.10.007
   Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037
   Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537
   Gudjonsson JE, 2003, BRIT J DERMATOL, V149, P530, DOI 10.1046/j.1365-2133.2003.05552.x
   Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173
   Gupta R, 2016, J INVEST DERMATOL, V136, P603, DOI 10.1016/j.jid.2015.12.009
   Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157
   Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103
   Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564
   Jabbari A, 2012, J INVEST DERMATOL, V132, P246, DOI 10.1038/jid.2011.267
   Johnston A, 2017, J INVEST DERMATOL, V137, pE87, DOI 10.1016/j.jid.2016.02.817
   Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012
   Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331
   Julia A, 2012, HUM MOL GENET, V21, P4549, DOI 10.1093/hmg/dds295
   Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322
   Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344
   Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954
   Kruglyak L, 1996, AM J HUM GENET, V58, P1347
   Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129
   Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28
   Li JQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18705-z
   Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041
   LOBER CW, 1982, ARCH DERMATOL, V118, P322, DOI 10.1001/archderm.118.5.322
   Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371
   Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x
   Manzoni C, 2018, BRIEF BIOINFORM, V19, P286, DOI 10.1093/bib/bbw114
   Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796
   Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068
   Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016
   Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21
   Munz OH, 2010, ARCH DERMATOL RES, V302, P495, DOI 10.1007/s00403-010-1065-0
   Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821
   Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349
   Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8
   Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049
   NORRLIND R, 1950, Acta Derm Venereol, V30, P64
   Oestreicher J. L., 2001, Pharmacogenomics Journal, V1, P272
   Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022
   Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908
   Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06
   Ritchlin CT, 2017, NEW ENGL J MED, V376, P957, DOI 10.1056/NEJMra1505557
   Saliba AE, 2014, NUCLEIC ACIDS RES, V42, P8845, DOI 10.1093/nar/gku555
   Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Spain SL, 2015, HUM MOL GENET, V24, pR111, DOI 10.1093/hmg/ddv260
   Statnikov A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02620
   Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833
   Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911
   Swindell WR, 2014, PHYSIOL GENOMICS, V46, P533, DOI 10.1152/physiolgenomics.00022.2014
   t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705
   Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]
   TELFER NR, 1992, ARCH DERMATOL, V128, P39, DOI 10.1001/archderm.128.1.39
   Tett A, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0022-5
   TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173
   Tsoi LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15382
   Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136
   Williamson JC, 2013, J PROTEOMICS, V94, P176, DOI 10.1016/j.jprot.2013.09.010
   Yan D, 2017, J CLIN TRANSL SCI S1, V1, P15, DOI [10.1017/cts.2017.68, DOI 10.1017/CTS.2017.68]
   Yan D, 2017, CURR DERMATOL REP, V6, P94, DOI 10.1007/s13671-017-0178-5
   Yan D, 2017, PSORIASIS-TARGETS TH, V7, P1, DOI 10.2147/PTT.S118348
   Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y
   Yin XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7916
   Zakostelska Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159539
   Zhang XY, 2018, EUR J HUM GENET, V26, P1369, DOI 10.1038/s41431-018-0168-5
   Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002
NR 96
TC 5
Z9 5
U1 1
U2 20
PU FRONTLINE MEDICAL COMMUNICATIONS
PI THE WOODLANDS
PA WRIGHTS MEDIA, 2407 TIMBERLOCH PLACE, SUITE B, THE WOODLANDS, TX 77386
   USA
SN 1085-5629
EI 1558-0768
J9 SEMIN CUTAN MED SURG
JI Semin. Cutan. Med. Surg.
PD MAR
PY 2019
VL 38
IS 1
BP E3
EP E11
DI 10.12788/j.sder.2019.003
PG 9
WC Dermatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Dermatology; Surgery
GA JL2LV
UT WOS:000495364500002
PM 31051017
DA 2023-09-14
ER

PT J
AU Alili, R
   Belda, E
   Le, P
   Wirth, T
   Zucker, JD
   Prifti, E
   Clement, K
AF Alili, Rohia
   Belda, Eugeni
   Le, Phuong
   Wirth, Thierry
   Zucker, Jean-Daniel
   Prifti, Edi
   Clement, Karine
TI Exploring Semi-Quantitative Metagenomic Studies Using Oxford Nanopore
   Sequencing: A Computational and Experimental Protocol
SO GENES
LA English
DT Article
DE semi-quantitative metagenomics; microbiome; obesity; gut microbiota;
   microbial DNA extraction; sequencing; simulation; Oxford Nanopore
   Technologies; MinION
ID HUMAN GUT MICROBIOME; CATALOG; SAMPLES; GENES; KEGG
AB The gut microbiome plays a major role in chronic diseases, of which several are characterized by an altered composition and diversity of bacterial communities. Large-scale sequencing projects allowed for characterizing the perturbations of these communities. However, translating these discoveries into clinical applications remains a challenge. To facilitate routine implementation of microbiome profiling in clinical settings, portable, real-time, and low-cost sequencing technologies are needed. Here, we propose a computational and experimental protocol for whole-genome semi-quantitative metagenomic studies of human gut microbiome with Oxford Nanopore sequencing technology (ONT) that could be applied to other microbial ecosystems. We developed a bioinformatics protocol to analyze ONT sequences taxonomically and functionally and optimized preanalytic protocols, including stool collection and DNA extraction methods to maximize read length. This is a critical parameter for the sequence alignment and classification. Our protocol was evaluated using simulations of metagenomic communities, which reflect naturally occurring compositional variations. Next, we validated both protocols using stool samples from a bariatric surgery cohort, sequenced with ONT, Illumina, and SOLiD technologies. Results revealed similar diversity and microbial composition profiles. This protocol can be implemented in a clinical or research setting, bringing rapid personalized whole-genome profiling of target microbiome species.</p>
C1 [Alili, Rohia; Wirth, Thierry; Clement, Karine] PSL Univ, Ecole Prat Hautes Etud, Patios Saint Jacques, 4-14 Rue Ferrus, F-75014 Paris, France.
   [Alili, Rohia] Hop La Pitie Salpetriere, AP HP, CRNH, Dept Nutr, F-75013 Paris, France.
   [Alili, Rohia; Le, Phuong; Zucker, Jean-Daniel; Prifti, Edi; Clement, Karine] Sorbonne Univ, INSERM, Nutr & Obes Syst Approaches NutriOm, F-75013 Paris, France.
   [Belda, Eugeni] Unit Insect Vector Genet & Gen, Integrat Phen, 8 Rue Pirogues Bercy, F-75012 Paris, France.
   [Wirth, Thierry] UMR CNRS, ISYEB, Dept Systemat & Evolut, 16 Rue Buffon, F-75231 Paris, France.
   [Zucker, Jean-Daniel; Prifti, Edi] Sorbonne Univ, Inst Res Dev IRD, Unite Modelisat Mathemat & Informat Syst Complexe, F-93143 Bondy, France.
C3 UDICE-French Research Universities; Universite PSL; Ecole Pratique des
   Hautes Etudes (EPHE); UDICE-French Research Universities; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Armand-Trousseau - APHP; Universite Paris Cite; Hopital
   Universitaire Saint-Louis - APHP; Hopital Universitaire Hotel-Dieu -
   APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Hopital
   Universitaire Paul-Brousse - APHP; Hopital Universitaire Charles-Foix -
   APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research
   Universities; Sorbonne Universite; Institut National de la Sante et de
   la Recherche Medicale (Inserm); UDICE-French Research Universities;
   Sorbonne Universite; Centre National de la Recherche Scientifique
   (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French
   Research Universities; Sorbonne Universite; Institut de Recherche pour
   le Developpement (IRD)
RP Belda, E (corresponding author), Unit Insect Vector Genet & Gen, Integrat Phen, 8 Rue Pirogues Bercy, F-75012 Paris, France.
EM rohia.alili@aphp.fr; e.belda@integrative-phenomics.com;
   phuongleee@gmail.com; thierry.wirth@mnhn.fr; jdzucker@gmail.com;
   edi.prifti@ird.fr; karine.clement@inserm.fr
RI Wirth, Thierry/B-4915-2008; Le, Phuong/E-5622-2019; ZUCKER,
   Jean-Daniel/K-3008-2016; Prifti, Edi/F-3967-2019
OI Wirth, Thierry/0000-0002-7371-0172; Le, Phuong/0000-0002-8738-6705;
   ZUCKER, Jean-Daniel/0000-0002-5597-7922; Prifti, Edi/0000-0001-8861-1305
FU European Union FP7 MetaCardis [HEALTH-F4-2012-305312]; European Union
   H2020 EPoS [H2020-PHC-2014-634413]; European Union Innovative Medicines
   Initiative 2 (IMI-2) Joint Undertaking [777377]; European Union's
   Horizon 2020 research and innovation program; EFPIA; Transatlantic
   Networks of Excellence Award from the Leducq Foundation [17CVD01]; JPI
   (a healthy diet for a healthy life) [2017-01996_3]; Assistance Publique
   Hopitaux de Paris
FX This study was supported by the European Union FP7 MetaCardis (grant
   agreement HEALTH-F4-2012-305312), H2020 EPoS (H2020-PHC-2014-634413),
   and Innovative Medicines Initiative 2 (IMI-2) Joint Undertaking under
   grant agreement no. 777377. This joint undertaking receives support from
   the European Union's Horizon 2020 research and innovation program and
   EFPIA. This study was also supported by a Transatlantic Networks of
   Excellence Award from the Leducq Foundation (17CVD01) and JPI (a healthy
   diet for a healthy life; 2017-01996_3). The clinical study (Microbaria)
   was sponsored by Assistance Publique Hopitaux de Paris.
CR Ammer-Herrmenau C, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00750-21
   Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23
   Aron-Wisnewsky J, 2013, CLIN MICROBIOL INFEC, V19, P338, DOI 10.1111/1469-0691.12140
   Aron-Wisnewsky J, 2020, NAT REV GASTRO HEPAT, V17, P279, DOI 10.1038/s41575-020-0269-9
   Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]
   Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645
   Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158
   Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1
   Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   Cranmer K, 2020, P NATL ACAD SCI USA, V117, P30055, DOI 10.1073/pnas.1912789117
   Deng XD, 2020, NAT MICROBIOL, V5, P443, DOI 10.1038/s41564-019-0637-9
   Fox Edward J, 2014, Next Gener Seq Appl, V1
   Fritz A, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0633-6
   Harstad H., 2018, NANOPORE BASED DNA S, DOI [10.1101/382580, DOI 10.1101/382580]
   Hillmann B, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00069-18
   James@cancer, 2012, COREGENOMICS DO SPRI
   Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Lee S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1597-8
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Maghini DG, 2021, NAT PROTOC, V16, P458, DOI 10.1038/s41596-020-00424-x
   Marcelino VR, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02014-2
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0
   Moss EL, 2020, NAT BIOTECHNOL, V38, P701, DOI 10.1038/s41587-020-0422-6
   Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Oksanen J., 2020, VEGAN COMMUNITY ECOL
   Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012
   Prifti E, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa010
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Sanderson ND, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5094-y
   Tedersoo L, 2019, MOL ECOL RESOUR, V19, P47, DOI 10.1111/1755-0998.12959
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Urban L, 2021, ELIFE, V10, DOI 10.7554/eLife.61504
   Vieira-Silva S, 2020, NATURE, V581, P310, DOI 10.1038/s41586-020-2269-x
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
NR 50
TC 7
Z9 7
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD OCT
PY 2021
VL 12
IS 10
AR 1496
DI 10.3390/genes12101496
PG 21
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA WP0IC
UT WOS:000712825300001
PM 34680891
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Xu, CM
   Zhou, M
   Xie, ZJ
   Li, M
   Zhu, X
   Zhu, HQ
AF Xu, Congmin
   Zhou, Man
   Xie, Zhongjie
   Li, Mo
   Zhu, Xi
   Zhu, Huaiqiu
TI LightCUD: a program for diagnosing IBD based on human gut microbiome
   data
SO BIODATA MINING
LA English
DT Article
DE Machine learning algorithm; Human gut microbiome; IBD; Biomarker
ID INFLAMMATORY-BOWEL-DISEASE
AB Background The diagnosis of inflammatory bowel disease (IBD) and discrimination between the types of IBD are clinically important. IBD is associated with marked changes in the intestinal microbiota. Advances in next-generation sequencing (NGS) technology and the improved hospital bioinformatics analysis ability motivated us to develop a diagnostic method based on the gut microbiome. Results Using a set of whole-genome sequencing (WGS) data from 349 human gut microbiota samples with two types of IBD and healthy controls, we assembled and aligned WGS short reads to obtain feature profiles of strains and genera. The genus and strain profiles were used for the 16S-based and WGS-based diagnostic modules construction respectively. We designed a novel feature selection procedure to select those case-specific features. With these features, we built discrimination models using different machine learning algorithms. The machine learning algorithm LightGBM outperformed other algorithms in this study and thus was chosen as the core algorithm. Specially, we identified two small sets of biomarkers (strains) separately for the WGS-based health vs IBD module and ulcerative colitis vs Crohn's disease module, which contributed to the optimization of model performance during pre-training. We released LightCUD as an IBD diagnostic program built with LightGBM. The high performance has been validated through five-fold cross-validation and using an independent test data set. LightCUD was implemented in Python and packaged free for installation with customized databases. With WGS data or 16S rRNA sequencing data of gut microbiome samples as the input, LightCUD can discriminate IBD from healthy controls with high accuracy and further identify the specific type of IBD. The executable program LightCUD was released in open source with instructions at the webpage . The identified strain biomarkers could be used to study the critical factors for disease development and recommend treatments regarding changes in the gut microbial community. Conclusions As the first released human gut microbiome-based IBD diagnostic tool, LightCUD demonstrates a high-performance for both WGS and 16S sequencing data. The strains that either identify healthy controls from IBD patients or distinguish the specific type of IBD are expected to be clinically important to serve as biomarkers.
C1 [Xu, Congmin; Zhou, Man; Xie, Zhongjie; Li, Mo; Zhu, Huaiqiu] Peking Univ, Coll Engn, Dept Biomed Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Xu, Congmin; Zhou, Man; Zhu, Huaiqiu] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China.
   [Zhu, Xi] Peking Univ Third Hosp, Dept Crit Care Med, Beijing 100191, Peoples R China.
C3 Peking University; Peking University
RP Zhu, HQ (corresponding author), Peking Univ, Coll Engn, Dept Biomed Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.; Zhu, HQ (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China.; Zhu, X (corresponding author), Peking Univ Third Hosp, Dept Crit Care Med, Beijing 100191, Peoples R China.
EM xizhuccm@163.com; hqznu@pku.edu.cn
RI xu, congmin/GYJ-5547-2022
FU National Key Research and Development Program of China [2017YFC1200205];
   National Natural Science Foundation of China [31671366, 32070667];
   Special Research Project of `Clinical Medicine + X' by Peking University
   [PKU2017LCX14]
FX This work was supported by the National Key Research and Development
   Program of China (2017YFC1200205), the National Natural Science
   Foundation of China (31671366, 32070667), and the Special Research
   Project of `Clinical Medicine + X' by Peking University (PKU2017LCX14).
CR Baumgart DC, 2009, DTSCH ARZTEBL INT, V106, P123, DOI 10.3238/arztebl.2009.0123
   Bennur T, 2015, MICROBIOL RES, V174, P33, DOI 10.1016/j.micres.2015.03.010
   Benson DA., 2012, GENBANK NUCL ACIDS R, V41, DOI [10.1093/nar/gks1195 1:CAS:528:DC%2BC38XhvV2ksbjJ, DOI 10.1093/NAR/GKS1195]
   Bishop C. M., 2006, INFORM SCI STAT PATT, V4, P738
   Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]
   BROUQUI P, 1991, VET MICROBIOL, V26, P103, DOI 10.1016/0378-1135(91)90046-I
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3
   Ewaschuk JB, 2006, WORLD J GASTROENTERO, V12, P5941, DOI 10.3748/wjg.v12.i37.5941
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Guo FD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076185, 10.1371/journal.pone.0071714]
   Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582
   Ke GL, 2017, ADV NEUR IN, V30
   Kugathasan Subra, 2007, Semin Pediatr Surg, V16, P146, DOI 10.1053/j.sempedsurg.2007.04.002
   Lai BB, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0686-x
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058
   Lu ZQJ, 2010, J R STAT SOC A STAT, V173, P693
   Nagy-Szakal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056685
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   Qin OY, 2006, J GASTROEN HEPATOL, V21, P1772, DOI 10.1111/j.1440-1746.2006.04674.x
   Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d
   Shalev-Shwartz S, 2013, UNDERSTANDING MACHIN, DOI [DOI 10.1017/CBO9781107298019, 10.1017/CBO9781107298019]
   Sizaire V, 2006, LANCET INFECT DIS, V6, P288, DOI 10.1016/S1473-3099(06)70464-9
   Stoyanova M, 2007, BIOTECHNOL BIOTEC EQ, V21, P306, DOI 10.1080/13102818.2007.10817465
   Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506
   WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269
   Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049
NR 31
TC 4
Z9 4
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-0381
J9 BIODATA MIN
JI BioData Min.
PD JAN 19
PY 2021
VL 14
IS 1
AR 2
DI 10.1186/s13040-021-00241-2
PG 13
WC Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Mathematical & Computational Biology
GA PU0FN
UT WOS:000608983500001
PM 33468221
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Sandoval-Vargas, D
   Concha-Rubio, ND
   Navarrete, P
   Castro, M
   Medina, DA
AF Sandoval-Vargas, Diego
   Concha-Rubio, Nataly D.
   Navarrete, Paola
   Castro, Matias
   Medina, Daniel A.
TI Short Communication: Obesity Intervention Resulting in Significant
   Changes in the Human Gut Viral Composition
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE obesity; human gut microbiome; human gut virome; viral changes
ID Y GASTRIC BYPASS; MICROBIOME; VIROME
AB Obesity is a health problem of global concern that negatively impacts quality of life. Various studies have implicated obesity in the disruption of the normal microbiome composition. The virome consists of a collection of all the viruses that inhabit a particular niche. However, the study of such viruses that compose the human gut microbiome in the context of obesity has been paid little attention. One interesting aspect of virome study is the description of phages that can specifically interact with the bacterial component of the microbiota and modulate the microbiome's dynamics. Previous work showed that the microbiota composition changes after obesity treatment and that these changes are country specific. In this work, we perform a quick gut viral composition of the gut microbiota of patients from Denmark, Italy, and Chile before and after obesity intervention using metagenomic sequences previously published and bioinformatics tools. Our results showed that obesity treatment results in significant changes in the human gut viral composition. These results conclude that the virome composition changes after obesity intervention by suggesting that changes can be related to the microbiota rearrangements reported in other works and may be involved in microbial dynamics after treatment.
C1 [Sandoval-Vargas, Diego] Univ Chile, Ctr Biotechnol & Engn CeBiB, Dept Chem Engn Biotechnol & Mat, Santiago 8320000, Chile.
   [Concha-Rubio, Nataly D.; Medina, Daniel A.] Univ San Sebastian, Lab Anal Datos Biol, Puerto Montt 5480000, Chile.
   [Navarrete, Paola] Univ Chile, Inst Nutr & Food Technol INTA, Lab Microbiol & Probiot, Santiago 7830490, Chile.
   [Navarrete, Paola; Castro, Matias; Medina, Daniel A.] Millennium Nucleus Biol Intestinal Microbiota, Santiago 7510689, Chile.
   [Castro, Matias] Inst Milenio Oceanog, Concepcion 4070386, Chile.
   [Medina, Daniel A.] Univ San Sebastian, Fac Med Vet, Lab Biotecnol Aplicada, Puerto Montt 5480000, Chile.
C3 Universidad de Chile; Universidad San Sebastian; Universidad de Chile;
   Universidad San Sebastian
RP Medina, DA (corresponding author), Univ San Sebastian, Lab Anal Datos Biol, Puerto Montt 5480000, Chile.; Medina, DA (corresponding author), Millennium Nucleus Biol Intestinal Microbiota, Santiago 7510689, Chile.; Medina, DA (corresponding author), Univ San Sebastian, Fac Med Vet, Lab Biotecnol Aplicada, Puerto Montt 5480000, Chile.
EM diego.esv@gmail.com; nconchar@correo.uss.cl; pnavarre@inta.uchile.cl;
   matiascastrog@gmail.com; daniel.medina@uss.cl
RI navarrete, paola/B-5371-2014; Sandoval Vargas, Diego/HIR-7208-2022
OI navarrete, paola/0000-0003-0692-2324; Medina,
   Daniel/0000-0002-8183-0043; Concha Rubio, Nataly de Los
   Angeles/0000-0002-1421-5606
FU CONICYT-Chile through the FONDECYT [3160525]; National Agency for
   Research and Development (ANID) grant FONDECYT [1181499]; CONICYT grant
   [21180560]
FX This work was supported by CONICYT-Chile through the FONDECYT (No.
   3160525) (D.A.M.) and by the National Agency for Research and
   Development (ANID) grant FONDECYT (No. 1181499) (P.N.) and CONICYT grant
   (No. 21180560) (D.S.-V.).
CR Andoh A, 2016, DIGESTION, V93, P176, DOI 10.1159/000444066
   Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110
   Carding SR, 2017, ALIMENT PHARM THER, V46, P800, DOI 10.1111/apt.14280
   Damms-Machado A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806248
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   Davis Cindy D, 2016, Nutr Today, V51, P167, DOI 10.1097/NT.0000000000000167
   Ellulu M, 2014, GLOBAL EPIDEMIC OBES, V2, P2, DOI [107243/2052-5966-2-2, DOI 10.7243/2052-5966-2-2]
   Farin W, 2020, SURG OBES RELAT DIS, V16, P852, DOI 10.1016/j.soard.2020.03.014
   Galtier M, 2017, J CROHNS COLITIS, V11, P840, DOI 10.1093/ecco-jcc/jjw224
   Ginestet C, 2011, J ROY STAT SOC A, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x
   Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787
   Jang HB, 2019, NAT BIOTECHNOL, V37, P632, DOI 10.1038/s41587-019-0100-8
   Kang JH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008632
   Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844
   Kho ZY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01835
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Leo L., 2017, TOOLS MICROBIOME ANA
   Liang GX, 2021, NAT REV MICROBIOL, V19, P514, DOI 10.1038/s41579-021-00536-5
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Medina DA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02346
   Nayfach S, 2021, NAT MICROBIOL, V6, P960, DOI 10.1038/s41564-021-00928-6
   Oksanen A.J., 2020, CRAN PACKAGE VEGAN V
   Palleja A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0312-1
   Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633
   Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   R Core Team, 2017, R LANG ENV STAT COMP
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shabana, 2018, FUTURE MICROBIOL, V13, P589, DOI 10.2217/fmb-2017-0179
   Shetty SA, 2017, FEMS MICROBIOL REV, V41, P182, DOI 10.1093/femsre/fuw045
   Siddell SG, 2019, ARCH VIROL, V164, P943, DOI 10.1007/s00705-018-04136-2
   Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177
   Tevis S, 2011, OBES SURG, V21, P1220, DOI 10.1007/s11695-011-0358-5
   Tithi SS, 2018, PEERJ, V6, DOI 10.7717/peerj.4227
   Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wolfe BM, 2016, CIRC RES, V118, P1844, DOI 10.1161/CIRCRESAHA.116.307591
   Yang KL, 2021, GASTROENTEROLOGY, V161, P1257, DOI 10.1053/j.gastro.2021.06.056
   Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003
   Zuo T, 2020, CELL HOST MICROBE, V28, P741, DOI 10.1016/j.chom.2020.08.005
NR 41
TC 2
Z9 2
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD NOV
PY 2021
VL 11
IS 21
AR 10039
DI 10.3390/app112110039
PG 8
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Engineering; Materials Science; Physics
GA WX0OJ
UT WOS:000718304200001
OA gold
DA 2023-09-14
ER

PT J
AU Andrade, BGN
   Goris, T
   Afli, H
   Coutinho, FH
   Davila, AMR
   Cuadrat, RRC
AF Andrade, Bruno G. N.
   Goris, Tobias
   Afli, Haithem
   Coutinho, Felipe H.
   Davila, Alberto M. R.
   Cuadrat, Rafael R. C.
TI Putative mobilized colistin resistance genes in the human gut microbiome
SO BMC MICROBIOLOGY
LA English
DT Article
DE Colistin; Human microbiome; MCR; Metagenomics; Antibiotic resistance
   genes
ID MULTIPLE SEQUENCE ALIGNMENT; ANTIBIOTIC-RESISTANCE; IDENTIFICATION;
   INFECTIONS; EPIDEMIOLOGY; PERFORMANCE; BACTERIA
AB Background The high incidence of bacterial genes that confer resistance to last-resort antibiotics, such as colistin, caused by mobilized colistin resistance (mcr) genes, poses an unprecedented threat to human health. Understanding the spread, evolution, and distribution of such genes among human populations will help in the development of strategies to diminish their occurrence. To tackle this problem, we investigated the distribution and prevalence of potential mcr genes in the human gut microbiome using a set of bioinformatics tools to screen the Unified Human Gastrointestinal Genome (UHGG) collection for the presence, synteny and phylogeny of putative mcr genes, and co-located antibiotic resistance genes. Results A total of 2079 antibiotic resistance genes (ARGs) were classified as mcr genes in 2046 metagenome assembled genomes (MAGs), distributed across 1596 individuals from 41 countries, of which 215 were identified in plasmidial contigs. The genera that presented the largest number of mcr-like genes were Suterella and Parasuterella. Other potential pathogens carrying mcr genes belonged to the genus Vibrio, Escherichia and Campylobacter. Finally, we identified a total of 22,746 ARGs belonging to 21 different classes in the same 2046 MAGs, suggesting multi-resistance potential in the corresponding bacterial strains, increasing the concern of ARGs impact in the clinical settings. Conclusion This study uncovers the diversity of mcr-like genes in the human gut microbiome. We demonstrated the cosmopolitan distribution of these genes in individuals worldwide and the co-presence of other antibiotic resistance genes, including Extended-spectrum Beta-Lactamases (ESBL). Also, we described mcr-like genes fused to a PAP2-like domain in S. wadsworthensis. These novel sequences increase our knowledge about the diversity and evolution of mcr-like genes. Future research should focus on activity, genetic mobility and a potential colistin resistance in the corresponding strains to experimentally validate those findings.
C1 [Andrade, Bruno G. N.; Afli, Haithem] Munster Technol Univ, Dept Comp Sci, MTU ADAPT, Cork, Ireland.
   [Goris, Tobias] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Toxicol, Res Grp Intestinal Microbiol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
   [Coutinho, Felipe H.] Univ Miguel Hernandez, Dept Prod Vegetal & Microbiol, Alicante, Spain.
   [Davila, Alberto M. R.] Fiocruz MS, Oswaldo Cruz Inst, Computat & Syst Biol Lab, Rio De Janeiro, RJ, Brazil.
   [Davila, Alberto M. R.] Fiocruz MS, Oswaldo Cruz Inst, Grad Program Biodivers & Hlth, Rio De Janeiro, RJ, Brazil.
   [Cuadrat, Rafael R. C.] Max Delbruck Ctr MDC, Berlin Inst Med Syst Biol BIMSB, Bioinformat & Omics Data Sci, Berlin, Germany.
   [Cuadrat, Rafael R. C.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
C3 Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE);
   Universidad Miguel Hernandez de Elche; Fundacao Oswaldo Cruz; Fundacao
   Oswaldo Cruz; Deutsches Institut fur Ernahrungsforschung
   Potsdam-Rehbrucke (DIfE)
RP Cuadrat, RRC (corresponding author), Max Delbruck Ctr MDC, Berlin Inst Med Syst Biol BIMSB, Bioinformat & Omics Data Sci, Berlin, Germany.; Cuadrat, RRC (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
EM Rafael.Cuadrat@mdc-berlin.de
RI Dávila, Alberto M. R./AAJ-4647-2021; Goris, Tobias/I-9370-2019;
   Nascimento Andrade, Bruno Gabriel/K-8158-2016
OI Dávila, Alberto M. R./0000-0002-6918-7673; Goris,
   Tobias/0000-0002-9977-5994; Nascimento Andrade, Bruno
   Gabriel/0000-0003-2481-401X; Afli, Haithem/0000-0002-7449-4707;
   Coutinho, Felipe/0000-0001-6430-7069; de Castro Cuadrat, Rafael
   Ricardo/0000-0001-8289-2599
FU European Union's Horizon 2020 research and innovation programme under
   the Marie Sklodowska-Curie grant [801522]; Science Foundation Ireland;
   European Regional Development Fund through the ADAPT Centre for Digital
   Content Technology [13/RC/2106]; Generalitat Valenciana
   [APOSTD/2018/186]; European Union's Horizon 2020 Research and Innovation
   Programme [814650]; Projekt DEAL
FX This research has received funding from the European Union's Horizon
   2020 research and innovation programme under the Marie Sklodowska-Curie
   grant agreement No. 801522, by Science Foundation Ireland and co-funded
   by the European Regional Development Fund through the ADAPT Centre for
   Digital Content Technology grant number 13/RC/2106. FHC was supported by
   APOSTD/2018/186 post-doctoral fellowships from Generalitat Valenciana.
   The work of Tobias Goris was supported by European Union's Horizon 2020
   Research and Innovation Programme under Grant Agreement no. 814650 for
   the project SynBio4Flav. The funding body provided funds for the salary
   of the authors but had no role in the design of the study and
   collection, analysis, and interpretation of data and writing of the
   manuscript. Open Access funding enabled and organized by Projekt DEAL.
CR AbuOun M, 2017, J ANTIMICROB CHEMOTH, V72, P2745, DOI 10.1093/jac/dkx286
   Allin KH, 2018, DIABETOLOGIA, V61, P810, DOI 10.1007/s00125-018-4550-1
   Almeida A, 2021, NAT BIOTECHNOL, V39, P105, DOI 10.1038/s41587-020-0603-3
   Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1
   [Anonymous], 2016, HHS PUBLIC ACCESS
   Arango-Argoty G, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0401-z
   Bengtsson-Palme J, 2015, ANTIMICROB AGENTS CH, V59, P6551, DOI 10.1128/AAC.00933-15
   Berglund B, 2019, INFECT MICROBE DIS, V1, P10, DOI 10.1097/IM9.0000000000000002
   Bitew A, 2020, J TROP MED-US, V2020, DOI 10.1155/2020/6167234
   Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004
   Borowiak M, 2017, J ANTIMICROB CHEMOTH, V72, P3317, DOI 10.1093/jac/dkx327
   Boto L, 2019, FEBS J, V286, P3959, DOI 10.1111/febs.15054
   Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110
   Capita R, 2013, CRIT REV FOOD SCI, V53, P11, DOI 10.1080/10408398.2010.519837
   Carattoli A, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.31.30589
   Carr VR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14422-w
   Carroll LM, 2019, MBIO, V10, DOI 10.1128/mBio.00853-19
   Cheng J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-113
   Choi Y, 2020, DIAGN MICR INFEC DIS, V97, DOI 10.1016/j.diagmicrobio.2020.114997
   Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210
   Cuadrat RRC, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa046
   Cytryn E, 2013, SOIL BIOL BIOCHEM, V63, P18, DOI 10.1016/j.soilbio.2013.03.017
   Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003
   Economou V, 2015, INFECT DRUG RESIST, V8, P49, DOI 10.2147/IDR.S55778
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Finegold SM, 1997, CLIN INFECT DIS, V25, pS88, DOI 10.1086/516237
   Gallardo A, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9090531
   Gerver SM, 2020, J HOSP INFECT, V106, P1, DOI 10.1016/j.jhin.2020.05.010
   Giamarellou H, 2016, INT J ANTIMICROB AG, V48, P614, DOI 10.1016/j.ijantimicag.2016.09.025
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hiippala K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01706
   Ho LKH, 2020, GUT PATHOG, V12, DOI 10.1186/s13099-020-0346-1
   Jean SS, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106016
   Ju TT, 2019, ISME J, V13, P1520, DOI 10.1038/s41396-019-0364-5
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Krawczyk PS, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1321
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Lei CW, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01191-20
   Lemoine F, 2019, NUCLEIC ACIDS RES, V47, pW260, DOI 10.1093/nar/gkz303
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lim SK, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa043
   Liu L, 2012, GENOMICS, V100, P265, DOI 10.1016/j.ygeno.2012.07.012
   Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7
   Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191
   Mukhopadhya I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027076
   Nadimpalli M, 2018, CLIN INFECT DIS, V66, P963, DOI 10.1093/cid/cix879
   Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x
   Martinez EP, 2020, J ANTIMICROB CHEMOTH, V75, P2314, DOI 10.1093/jac/dkaa165
   Partridge SR, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00088-17
   Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001
   Potter SC, 2018, NUCLEIC ACIDS RES, V46, pW200, DOI 10.1093/nar/gky448
   Rossi F, 2017, BRAZ J INFECT DIS, V21, P98, DOI 10.1016/j.bjid.2016.09.011
   Sophie AB, 2018, HUM MICROBIOME J, V10, P43, DOI DOI 10.1016/J.HUMIC.2018.08.005
   Stohr JJJM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233313
   Tan TY, 2006, J ANTIMICROB CHEMOTH, V58, P864, DOI 10.1093/jac/dkl330
   van Hecke O, 2017, CLIN INFECT DIS, V65, P371, DOI 10.1093/cid/cix233
   Wang CC, 2020, EMERG MICROBES INFEC, V9, P508, DOI 10.1080/22221751.2020.1732231
   Wang XM, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0124-z
   Warren YA, 2005, J CLIN MICROBIOL, V43, P4041, DOI 10.1128/JCM.43.8.4041-4045.2005
   Watts JEM, 2017, MAR DRUGS, V15, DOI 10.3390/md15060158
   Wei WH, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007389
   Xavier BB, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.27.30280
   Yang YQ, 2018, J ANTIMICROB CHEMOTH, V73, P1791, DOI 10.1093/jac/dky111
   Ye Z, 2020, GUT MICROBES, V11, P539, DOI 10.1080/19490976.2019.1700754
   Yin WJ, 2017, MBIO, V8, DOI 10.1128/mBio.00543-17
   Zafer MM, 2019, ANN CLIN MICROB ANTI, V18, DOI 10.1186/s12941-019-0339-4
   Zhang HM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0278-1
   Zhao RX, 2020, WATER RES, V186, DOI 10.1016/j.watres.2020.116318
   Zong ZY, 2021, TRENDS MICROBIOL, V29, P473, DOI 10.1016/j.tim.2020.12.009
   Zong ZY, 2020, TRENDS MICROBIOL, V28, P871, DOI 10.1016/j.tim.2020.09.007
NR 71
TC 4
Z9 4
U1 2
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD JUL 22
PY 2021
VL 21
IS 1
AR 220
DI 10.1186/s12866-021-02281-4
PG 10
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA TR3CV
UT WOS:000678847700001
PM 34294041
OA Green Published, Green Accepted, Green Submitted, gold
DA 2023-09-14
ER

PT J
AU Allaband, C
   Lingaraju, A
   Martino, C
   Russell, B
   Tripathi, A
   Poulsen, O
   Machado, ACD
   Zhou, D
   Xue, J
   Elijah, E
   Malhotra, A
   Dorrestein, PC
   Knight, R
   Haddad, GG
   Zarrinpar, A
AF Allaband, Celeste
   Lingaraju, Amulya
   Martino, Cameron
   Russell, Baylee
   Tripathi, Anupriya
   Poulsen, Orit
   Machado, Ana Carolina Dantas
   Zhou, Dan
   Xue, Jin
   Elijah, Emmanuel
   Malhotra, Atul
   Dorrestein, Pieter C.
   Knight, Rob
   Haddad, Gabriel G.
   Zarrinpar, Amir
TI Intermittent Hypoxia and Hypercapnia Alter Diurnal Rhythms of Luminal
   Gut Microbiome and Metabolome
SO MSYSTEMS
LA English
DT Article
DE circadian rhythm; metabolome; microbiome; animal models of human
   disease; atherosclerosis; computational biology
ID BILE-ACID METABOLISM; SLEEP-APNEA SYNDROME; INTESTINAL MICROBIOTA;
   CIRCADIAN VARIATION; MASS-SPECTROMETRY; BLOOD-PRESSURE; HEART-RATE;
   ATHEROSCLEROSIS; HOST; INFLAMMATION
AB Obstructive sleep apnea (OSA), characterized by intermittent hypoxia and hypercapnia (IHC), affects the composition of the gut microbiome and metabolome. The gut microbiome has diurnal oscillations that play a crucial role in regulating circadian and overall metabolic homeostasis. Thus, we hypothesized that IHC adversely alters the gut luminal dynamics of key microbial families and metabolites. The objective of this study was to determine the diurnal dynamics of the fecal microbiome and metabolome of Apoe(-/-) mice after a week of IHC exposure. Individually housed, 10-week-old Apoe(-/-) mice on an atherogenic diet were split into two groups. One group was exposed to daily IHC conditions for 10 h (Zeitgeber time 2 [ZT2] to ZT12), while the other was maintained in room air. Six days after the initiation of the IHC conditions, fecal samples were collected every 4 h for 24 h (6 time points). We performed 16S rRNA gene amplicon sequencing and untargeted liquid chromatography-mass spectrometry (LC-MS) to assess changes in the microbiome and metabolome. IHC induced global changes in the cyclical dynamics of the gut microbiome and metabolome. Ruminococcaceae, Lachnospiraceae, S24-7, and Verrucomicrobiaceae had the greatest shifts in their diurnal oscillations. In the metabolome, bile acids, glycerolipids (phosphocholines and phosphoethanolamines), and acylcarnitines were greatly affected. Multiomic analysis of these results demonstrated that Ruminococcaceae and tauro-beta-muricholic acid (T beta MCA) cooccur and are associated with IHC conditions and that Coriobacteriaceae and chenodeoxycholic acid (CDCA) cooccur and are associated with control conditions. IHC significantly change the diurnal dynamics of the fecal microbiome and metabolome, increasing members and metabolites that are proinflammatory and proatherogenic while decreasing protective ones.
   IMPORTANCE People with obstructive sleep apnea are at a higher risk of high blood pressure, type 2 diabetes, cardiac arrhythmias, stroke, and sudden cardiac death. We wanted to understand whether the gut microbiome changes induced by obstructive sleep apnea could potentially explain some of these medical problems. By collecting stool from a mouse model of this disease at multiple time points during the day, we studied how obstructive sleep apnea changed the day-night patterns of microbes and metabolites of the gut. Since the oscillations of the gut microbiome play a crucial role in regulating metabolism, changes in these oscillations can explain why these patients can develop so many metabolic problems. We found changes in microbial families and metabolites that regulate many metabolic pathways contributing to the increased risk for heart disease seen in patients with obstructive sleep apnea.
C1 [Allaband, Celeste; Lingaraju, Amulya; Russell, Baylee; Machado, Ana Carolina Dantas; Zarrinpar, Amir] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA.
   [Allaband, Celeste; Dorrestein, Pieter C.; Knight, Rob; Haddad, Gabriel G.; Zarrinpar, Amir] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA.
   [Allaband, Celeste; Martino, Cameron; Tripathi, Anupriya; Poulsen, Orit; Zhou, Dan; Xue, Jin; Knight, Rob; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
   [Martino, Cameron] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.
   [Tripathi, Anupriya; Elijah, Emmanuel; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm, Collaborat Mass Spectrometry Innovat Ctr, La Jolla, CA 92093 USA.
   [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.
   [Martino, Cameron; Dorrestein, Pieter C.; Knight, Rob; Haddad, Gabriel G.; Zarrinpar, Amir] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.
   [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.
   [Zarrinpar, Amir] Univ Calif San Diego, Inst Diabet & Metab Hlth, La Jolla, CA 92093 USA.
   [Malhotra, Atul; Zarrinpar, Amir] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA.
   [Zarrinpar, Amir] VA Hlth Sci San Diego, La Jolla, CA 92037 USA.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego
RP Zarrinpar, A (corresponding author), Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA.; Zarrinpar, A (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA.; Zarrinpar, A (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.; Zarrinpar, A (corresponding author), Univ Calif San Diego, Inst Diabet & Metab Hlth, La Jolla, CA 92093 USA.; Zarrinpar, A (corresponding author), Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA.; Zarrinpar, A (corresponding author), VA Hlth Sci San Diego, La Jolla, CA 92037 USA.
EM azarrinpar@ucsd.edu
RI Dorrestein, Pieter/D-5012-2012; Knight, Rob/D-1299-2010; Machado,
   Ana/HLV-9704-2023
OI Martino, Cameron/0000-0001-9334-1258; Knight, Rob/0000-0002-0975-9019;
   Allaband, Celeste/0000-0003-1832-4858
FU NIH [T32 OD017863, R01 HL14880102S1, R01 HL146530, R21 NS111270, K08
   DK102902, R03 DK114536, R21 MH117780, R01 HL148801, R01 HL085188, T32
   HL134632, R01 HL142114, R01 AG063925, R01 HL148436, K24 HL132105, P30
   DK120515, P30 DK063491, UL1 TR001442]
FX C.A. is supported by grant T32 OD017863. A.C.D.M. is funded by grant R01
   HL14880102S1. G.G.H. is supported by NIH grants R01 HL146530 and R21
   NS111270. A.Z. is supported by grants K08 DK102902, R03 DK114536, R21
   MH117780, and R01 HL148801. A.M. is funded by grants R01 HL085188, T32
   HL134632, R01 HL142114, R01 AG063925, R01 HL148436, and K24 HL132105.
   All authors receive institutional support from grants P30 DK120515, P30
   DK063491, and UL1 TR001442. The funders had no role in study design,
   data collection and interpretation, or the decision to submit the work
   for publication.
CR Allaband C, 2019, CLIN GASTROENTEROL H, V17, P218, DOI 10.1016/j.cgh.2018.09.017
   Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00191-16
   Anderson ML, 2014, AFTER PHRENOLOGY: NEURAL REUSE AND THE INTERACTIVE BRAIN, P1
   Bellentani S, 2005, EUR J GASTROEN HEPAT, V17, P137, DOI 10.1097/00042737-200502000-00001
   Berliner JA, 2001, TRENDS CARDIOVAS MED, V11, P142, DOI 10.1016/S1050-1738(01)00098-6
   Bisanz JE, 2019, CELL HOST MICROBE, V26, P265, DOI 10.1016/j.chom.2019.06.013
   Blair HC, 2016, VASC PHARMACOL, V78, P17, DOI 10.1016/j.vph.2015.06.012
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Chaix A, 2016, J CELL BIOL, V215, P15, DOI 10.1083/jcb.201603076
   Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699
   Chang Q, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-118
   Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006
   Chelakkot C, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.282
   Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Fedarko MW, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa023
   Frazier K, 2020, TRENDS ENDOCRIN MET, V31, P25, DOI 10.1016/j.tem.2019.08.013
   Goni FM, 1996, FEBS LETT, V390, P1, DOI 10.1016/0014-5793(96)00603-5
   Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9
   Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037
   Govindarajan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167319
   GUILLEMINAULT C, 1984, LANCET, V1, P126
   Hageman J, 2010, ARTERIOSCL THROM VAS, V30, P1519, DOI 10.1161/ATVBAHA.109.197897
   Hamoud AR, 2018, TRENDS ENDOCRIN MET, V29, P140, DOI 10.1016/j.tem.2018.01.002
   Hanniman EA, 2005, J LIPID RES, V46, P2595, DOI 10.1194/jlr.M500390-JLR200
   Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001
   Huynh K, 2019, CELL CHEM BIOL, V26, P71, DOI 10.1016/j.chembiol.2018.10.008
   Ikegami T, 2018, HEPATOL RES, V48, P15, DOI 10.1111/hepr.13001
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Kiouptsi K, 2019, MBIO, V10, DOI 10.1128/mBio.02298-19
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kurilshikov A, 2019, CIRC RES, V124, P1808, DOI 10.1161/CIRCRESAHA.118.314642
   LANCE GN, 1967, COMPUT J, V10, P271, DOI 10.1093/comjnl/10.3.271
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lemmer B, 2016, BLOOD PRESS MONIT, V21, P136, DOI 10.1097/MBP.0000000000000173
   Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006
   Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645
   Liang X, 2015, P NATL ACAD SCI USA, V112, P10479, DOI 10.1073/pnas.1501305112
   Liu BN, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0811-8
   Liu HJ, 2018, SURG OBES RELAT DIS, V14, P584, DOI 10.1016/j.soard.2018.01.012
   McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7
   Mencarelli A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013238
   Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685
   Morton JT, 2019, NAT METHODS, V16, P1306, DOI 10.1038/s41592-019-0616-3
   Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Mukherji A, 2019, J HEPATOL, V71, P200, DOI 10.1016/j.jhep.2019.03.020
   MULLER JE, 1987, J CARDIOVASC PHARM, V10, pS104, DOI 10.1097/00005344-198710011-00020
   Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]
   Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2
   Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200
   PANZA JA, 1991, NEW ENGL J MED, V325, P986, DOI 10.1056/NEJM199110033251402
   Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395
   Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8
   Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449
   Reitmeier S, 2020, CELL HOST MICROBE, V28, P258, DOI 10.1016/j.chom.2020.06.004
   Reutrakul S, 2014, ANN NY ACAD SCI, V1311, P151, DOI 10.1111/nyas.12355
   Roberts Amity L, 2010, BMC Res Notes, V3, P281, DOI 10.1186/1756-0500-3-281
   Ryan PM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0246-x
   Sansone SA, 2007, NAT BIOTECHNOL, V25, P844, DOI 10.1038/nbt0807-846b
   Saran AR, 2020, GASTROENTEROLOGY, V158, P1948, DOI 10.1053/j.gastro.2020.01.050
   Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003
   Scheubert K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01318-5
   Segers A, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13193
   Sehayek E, 2001, J LIPID RES, V42, P1250
   Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983
   Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008
   Singer JM, 2019, J BIOL RHYTHM, V34, P5, DOI 10.1177/0748730418813785
   Stenvers DJ, 2019, NAT REV ENDOCRINOL, V15, P75, DOI 10.1038/s41574-018-0122-1
   Strand E, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003620
   Summa KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067102
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003
   Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048
   Traub RJ, 2008, GASTROENTEROLOGY, V135, P2075, DOI 10.1053/j.gastro.2008.08.051
   Tripathi A, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00058-19
   Tripathi A, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00020-18
   Tuganbaev T, 2020, CELL, V182, P1441, DOI 10.1016/j.cell.2020.08.027
   van der Lugt B, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0145-z
   Vang Sheila, 2014, Glob Adv Health Med, V3, P58, DOI 10.7453/gahmj.2014.017
   Vital M, 2019, COMPUT STRUCT BIOTEC, V17, P1016, DOI 10.1016/j.csbj.2019.07.012
   Vorkas PA, 2015, J PROTEOME RES, V14, P1389, DOI 10.1021/pr5009898
   Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15
   Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597
   Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Warnow T, 2013, ENCY METAGENOMICS, P1
   Wilkinson MJ, 2020, CELL METAB, V31, P92, DOI 10.1016/j.cmet.2019.11.004
   Wilson A, 2016, CURR OPIN LIPIDOL, V27, P148, DOI 10.1097/MOL.0000000000000274
   Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008
   Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405
   Xu MQ, 2021, DIGEST DIS SCI, V66, P568, DOI 10.1007/s10620-020-06208-3
   Xue J, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.663950
   Xue J, 2017, AM J RESP CELL MOL, V57, P581, DOI 10.1165/rcmb.2017-0086OC
   Zarrinpar A, 2016, TRENDS ENDOCRIN MET, V27, P69, DOI 10.1016/j.tem.2015.11.007
   Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008
   Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683
   Zhao SN, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00536
   Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011
NR 103
TC 19
Z9 19
U1 1
U2 19
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD MAY
PY 2021
VL 6
IS 3
AR e00116-21
DI 10.1128/mSystems.00116-21
PG 17
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA WK6YI
UT WOS:000709870800007
PM 34184915
OA Green Published
DA 2023-09-14
ER

PT J
AU Ezzy, AC
   Hagstrom, AD
   George, C
   Hamlin, AS
   Pereg, L
   Murphy, AJ
   Winter, G
AF Ezzy, Alan C.
   Hagstrom, Amanda D.
   George, Chris
   Hamlin, Adam S.
   Pereg, Lily
   Murphy, Aron J.
   Winter, Gal
TI Storage and handling of human faecal samples affect the gut microbiome
   composition: A feasibility study
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE Intestinal microbiota; DNA extraction; Faecal sample storage; 16S rDNA;
   Gut microbiome; Gut microbiota
ID DNA EXTRACTION METHODS; DIVERSITY; BACTERIAL; RECOVERY
AB Human gut microbiome analysis through faecal sampling typically involves five stages: sample collection, storage, DNA extraction, next generation sequencing and bioinformatics analysis. Of these, the first three are considered irreversible. This feasibility study describes an assessment of methodologies used for faecal DNA extraction and sample handling, using the parameters DNA yield, purity and resultant microbial profile. Six DNA extraction techniques, including commercially available kits and manual protocols were compared on human faecal samples (n = 3). Different extraction techniques produced significant variance in DNA yield (range 2.7-164 ng/mg faeces) and microbial diversity profiles, with considerable variation in phyla dominance (Firmicutes (P < 0.001), Bacteroidetes (P = 0.003), Actinobacteria (P = 0.003), One-way ANOVA). The most effective method, with the highest DNA yield, was a simple and inexpensive extraction technique named MetaHIT. Using this method, DNA was extracted from separate faecal samples (n = 3) and had been aliquoted to seven storage conditions including three stabilizing buffers and three temperature conditions, for a period of 120-h, with storage at -80 degrees C as a control treatment. DNA yield and purity was not statistically different between the control and remaining treatments. 16S rDNA-based diversity profile was largely comparable across the treatments with only minor differences in genera between samples stored at room temperature in air and - 80 degrees C control. Overall these results suggest that the choice of DNA extraction method has a greater influence on the resultant microbial diversity profile than the short-term storage method.
C1 [Ezzy, Alan C.; George, Chris; Hamlin, Adam S.; Pereg, Lily; Murphy, Aron J.; Winter, Gal] Univ New England, Sch Sci & Technol, Armidale, NSW 2351, Australia.
   [Hagstrom, Amanda D.; Murphy, Aron J.] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia.
C3 University of New England; University of New South Wales Sydney
RP Winter, G (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW 2351, Australia.
EM gwinterz@une.edu.au
RI Hagstrom, Amanda/AAA-5781-2021; Hamlin, Adam S/C-8269-2009; Winter,
   Gal/B-9188-2012
OI Hagstrom, Amanda/0000-0002-8036-9216; Winter, Gal/0000-0003-3789-395X;
   Hamlin, Adam/0000-0003-0495-1973
CR Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158
   Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953
   Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]
   Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350
   Claassen S, 2013, J MICROBIOL METH, V94, P103, DOI 10.1016/j.mimet.2013.05.008
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Flores R, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0092-7
   Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355
   Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997
   Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802
   Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4
   Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192
   Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738
   Hsieh YH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01643
   Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015
   Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001
   Krishnamurthi S, 2009, INT J SYST EVOL MICR, V59, P1054, DOI 10.1099/ijs.0.65742-0
   Lee JH, 2010, YONSEI MED J, V51, P104, DOI 10.3349/ymj.2010.51.1.104
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Macfarlane G. T., 1995, P87
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808
   Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007
   Palleroni N. J., 2015, BERGEYS MANUAL SYSTE, DOI DOI 10.1002/9781118960608.GBM01210
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219
   Rintala Anniina, 2017, J Biomol Tech, V28, P19, DOI 10.7171/jbt.17-2801-003
   Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040
   Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007
   Scupham AJ, 2007, J APPL MICROBIOL, V102, P401, DOI 10.1111/j.1365-2672.2006.03094.x
   Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4
   Wickham H, 2017, TIDYVERSE EASILY INS
   Winter G, 2018, REV NEUROSCIENCE, V29, P629, DOI 10.1515/revneuro-2017-0072
   Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206
   Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212
NR 44
TC 11
Z9 11
U1 2
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD SEP
PY 2019
VL 164
AR 105668
DI 10.1016/j.mimet.2019.105668
PG 9
WC Biochemical Research Methods; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Microbiology
GA IZ6DK
UT WOS:000487171800003
PM 31302202
DA 2023-09-14
ER

PT J
AU Gaulke, CA
   Arnold, HK
   Humphreys, IR
   Kembel, SW
   O'Dwyer, JP
   Sharpton, TJ
AF Gaulke, Christopher A.
   Arnold, Holly K.
   Humphreys, Ian R.
   Kembel, Steven W.
   O'Dwyer, James P.
   Sharpton, Thomas J.
TI Ecophylogenetics Clarifies the Evolutionary Association between Mammals
   and Their Gut Microbiota
SO MBIO
LA English
DT Article
DE Gut microbiome; bioinformatics; ecology; evolution; phylogeny; taxonomy
ID FAECALIBACTERIUM-PRAUSNITZII; BACTERIA; BIOGEOGRAPHY; CONVERGENCE;
   COEVOLUTION; COMMUNITIES; PHYLOGENY; INSIGHTS; HEALTH; FAMILY
AB Our knowledge of how the gut microbiome relates to mammalian evolution benefits from the identification of gut microbial taxa that are unexpectedly prevalent or unexpectedly conserved across mammals. Such taxa enable experimental determination of the traits needed for such microbes to succeed as gut generalists, as well as those traits that impact mammalian fitness. However, the punctuated resolution of microbial taxonomy may limit our ability to detect conserved gut microbes, especially in cases in which broadly related microbial lineages possess shared traits that drive their apparent ubiquity across mammals. To advance the discovery of conserved mammalian gut microbes, we developed a novel ecophylogenetic approach to taxonomy that groups microbes into taxonomic units based on their shared ancestry and their common distribution across mammals. Applying this approach to previously generated gut microbiome data uncovered monophyletic clades of gut bacteria that are conserved across mammals. It also resolved microbial clades exclusive to and conserved among particular mammalian lineages. Conserved clades often manifest phylogenetic patterns, such as cophylogeny with their host, that indicate that they are subject to selective processes, such as host filtering. Moreover, this analysis identified variation in the rate at which mammals acquire or lose conserved microbial clades and resolved a human-accelerated loss of conserved clades. Collectively, the data from this study reveal mammalian gut microbiota that possess traits linked to mammalian phylogeny, point to the existence of a core set of microbes that comprise the mammalian gut microbiome, and clarify potential evolutionary or ecologic mechanisms driving the gut microbiome's diversification throughout mammalian evolution.
   IMPORTANCE Our understanding of mammalian evolution has become microbiome-aware. While emerging research links mammalian biodiversity and the gut microbiome, we lack insight into which microbes potentially impact mammalian evolution. Microbes common to diverse mammalian species may be strong candidates, as their absence in the gut may affect how the microbiome functionally contributes to mammalian physiology to adversely affect fitness. Identifying such conserved gut microbes is thus important to ultimately assessing the microbiome's potential role in mammalian evolution. To advance their discovery, we developed an approach that identifies ancestrally related groups of microbes that distribute across mammals in a way that indicates their collective conservation. These conserved clades are presumed to have evolved a trait in their ancestor that matters to their distribution across mammals and which has been retained among clade members. We found not only that such clades do exist among mammals but also that they appear to be subject to natural selection and characterize human evolution.
C1 [Gaulke, Christopher A.; Arnold, Holly K.; Humphreys, Ian R.; Sharpton, Thomas J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.
   [Arnold, Holly K.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA.
   [Kembel, Steven W.] Univ Quebec Montreal, Dept Sci biol, Montreal, PQ, Canada.
   [O'Dwyer, James P.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.
   [Sharpton, Thomas J.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.
C3 Oregon State University; Oregon State University; University of Quebec;
   University of Quebec Montreal; University of Illinois System; University
   of Illinois Urbana-Champaign; Oregon State University
RP Sharpton, TJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.; Sharpton, TJ (corresponding author), Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.
EM thomas.sharpton@oregonstate.edu
RI Humphreys, Ian R/E-6683-2010; Gaulke, Christopher/M-7308-2019
OI Gaulke, Christopher/0000-0001-7741-7822; Sharpton,
   Thomas/0000-0002-5996-7764; Kembel, Steven/0000-0001-5224-0952
FU National Science Foundation [1557192]; Division Of Environmental
   Biology; Direct For Biological Sciences [1557192] Funding Source:
   National Science Foundation
FX The National Science Foundation (grant 1557192) and institutional funds
   to T.J.S. supported this work.
CR Amend AS, 2016, ISME J, V10, P109, DOI 10.1038/ismej.2015.96
   [Anonymous], 2013, MICROSCI MED, DOI DOI 10.2478/MICSM-2013-0002
   Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251
   Backhed F, 2012, NUTR REV, V70, pS14, DOI 10.1111/j.1753-4887.2012.00496.x
   Barberan A, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00237-17
   Beaumont M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1052-7
   Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1
   Brooks AW, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000225
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Claus SP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.3
   Clavel T., 2014, PROKARYOTES ACTINOBA, P201, DOI [DOI 10.1007/978-3-642-30138-4_343, 10.1007/978-3-642-30138-4_343]
   Clayton JB, 2016, P NATL ACAD SCI USA, V113, P10376, DOI 10.1073/pnas.1521835113
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Duchene S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000094
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817
   Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017
   Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
   Groussin M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14319
   Heinken A, 2014, J BACTERIOL, V196, P3289, DOI 10.1128/JB.01780-14
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2
   Kohl KD, 2014, ECOL LETT, V17, P1238, DOI 10.1111/ele.12329
   Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35
   Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725
   Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133
   Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105
   Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002
   Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160
   Martiny JBH, 2015, SCIENCE, V350, DOI 10.1126/science.aac9323
   Matsen FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056859
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050
   Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003
   Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951
   Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111
   Moeller AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2159
   Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x
   Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719
   Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509
   Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115
   O'Dwyer JP, 2015, P NATL ACAD SCI USA, V112, P8356, DOI 10.1073/pnas.1419341112
   O'Dwyer JP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002832
   Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638
   Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Riesenfeld SJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-419
   Ronquist F, 1997, ZOOL SCR, V26, P313, DOI 10.1111/j.1463-6409.1997.tb00421.x
   Ruiz-Calderon JF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501061
   Schnorr SL, 2016, CURR OPIN GENET DEV, V41, P14, DOI 10.1016/j.gde.2016.07.003
   Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x
   Sharpton TJ, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00174-17
   Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061
   Solden LM, 2017, ISME J, V11, P691, DOI 10.1038/ismej.2016.150
   Stewart CS, 2004, FEMS MICROBIOL LETT, V230, P1, DOI 10.1016/S0378-1097(03)00864-4
   Vergin KL, 2013, ISME J, V7, P1322, DOI 10.1038/ismej.2013.32
   Washburne AD, 2017, PEERJ, V5, DOI 10.7717/peerj.2969
   Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
NR 60
TC 45
Z9 45
U1 6
U2 29
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2018
VL 9
IS 5
AR e01348-18
DI 10.1128/mBio.01348-18
PG 14
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA GZ5NY
UT WOS:000449472200012
PM 30206171
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Brabec, JL
   Wright, J
   Ly, T
   Wong, HT
   McClimans, CJ
   Tokarev, V
   Lamendella, R
   Sherchand, S
   Shrestha, D
   Uprety, S
   Dangol, B
   Tandukar, S
   Sherchand, JB
   Sherchan, SP
AF Brabec, Jeffrey L.
   Wright, Justin
   Ly, Truc
   Wong, Hoi Tong
   McClimans, Chris J.
   Tokarev, Vasily
   Lamendella, Regina
   Sherchand, Shardulendra
   Shrestha, Dipendra
   Uprety, Sital
   Dangol, Bipin
   Tandukar, Sarmila
   Sherchand, Jeevan B.
   Sherchan, Samendra P.
TI Arsenic disturbs the gut microbiome of individuals in a disadvantaged
   community in Nepal
SO HELIYON
LA English
DT Article
DE Microbiology; Public health; Gut microbiome; Arsenic; Well water; Nepal
ID COLONIC MICROBIOME; COLORECTAL-CANCER; GLUTATHIONE; INFECTION; EXPOSURE;
   HEALTHY; METABOLISM; SEQUENCES; BACTERIA; PROFILE
AB Arsenic is ubiquitous in nature, highly toxic, and is particularly abundant in Southern Asia. While many studies have focused on areas like Bangladesh and West Bengal, India, disadvantaged regions within Nepal have also suffered from arsenic contamination levels, with wells and other water sources possessing arsenic contamination over the recommended WHO and EPA limit of 10 mu g/L, some wells reporting levels as high as 500 mu g/L. Despite the region's pronounced arsenic concentrations within community water sources, few investigations have been conducted to understand the impact of arsenic contamination on host gut microbiota health. This study aims to examine differential arsenic exposure on the gut microbiome structure within two disadvantaged communities in southern Nepal. Fecal samples (n = 42) were collected from members of the Mahuawa (n = 20) and Ghanashyampur (n = 22) communities in southern Nepal. The 16S rRNA gene was amplified from fecal samples using Illumina-tag PCR and subject to high-throughput sequencing to generate the bacterial community structure of each sample. Bioinformatics analysis and multivariate statistics were conducted to identify if specific fecal bacterial assemblages and predicted functions were correlated with urine arsenic concentration. Our results revealed unique assemblages of arsenic volatilizing and pathogenic bacteria positively correlated with increased arsenic concentration in individuals within the two respective communities. Additionally, we observed that commensal gut bacteria negatively correlated with increased arsenic concentration in the two respective communities. Our study has revealed that arsenic poses a broader human health risk than was previously known. It is influential in shaping the gut microbiome through its enrichment of arsenic volatilizing and pathogenic bacteria and subsequent depletion of gut commensals. This aspect of arsenic has the potential to debilitate healthy humans by contributing to disorders like heart and liver cancers and diabetes, and it has already been shown to contribute to serious diseases and disorders, including skin lesions, gangrene and several types of skin, renal, lung, and liver cancers in disadvantaged areas of the world like Nepal.
C1 [Brabec, Jeffrey L.; Wright, Justin; Ly, Truc; Wong, Hoi Tong; McClimans, Chris J.; Tokarev, Vasily; Lamendella, Regina] Juniata Coll, Dept Biol, Huntingdon, PA 16652 USA.
   [Sherchand, Shardulendra] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA.
   [Shrestha, Dipendra] Natl Coll, Kathmandu, Nepal.
   [Uprety, Sital] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL USA.
   [Dangol, Bipin] Environm & Publ Hlth Org, Kathmandu, Nepal.
   [Tandukar, Sarmila; Sherchand, Jeevan B.] Tribhuvan Univ, Teaching Hosp, Publ Hlth Res Lab, Kathmandu 1524, Nepal.
   [Sherchan, Samendra P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Environm Hlth Sci, New Orleans, LA 70112 USA.
C3 Louisiana State University System; Louisiana State University Health
   Sciences Center New Orleans; University of Illinois System; University
   of Illinois Urbana-Champaign; Tribhuvan University; Institute of
   Medicine (IoM) - Nepal; Tulane University
RP Sherchan, SP (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Environm Hlth Sci, New Orleans, LA 70112 USA.
EM sshercha@tulane.edu
OI Brabec, Jeffrey/0000-0002-6740-4582
FU Tulane University
FX This work was partly supported by Tulane University Start-up award to
   Dr. Samendra Sherchan.
CR Akatsu S, 1917, J EXP MED, V25, P349, DOI 10.1084/jem.25.3.349
   Andres J, 2016, FEMS MICROBIOL REV, V40, P299, DOI 10.1093/femsre/fuv050
   [Anonymous], COMMUNITY ECOLOGY PA
   [Anonymous], GRID GRAPHICS
   [Anonymous], BACILLUSMEDICAL MICR
   [Anonymous], BIORXIV
   [Anonymous], 2010, WHO ARS MASS POIS UN
   [Anonymous], ARS CONT GROUNDW BAN
   [Anonymous], 3114B APHA AM WAT WO
   [Anonymous], CHEM CONT RUL
   [Anonymous], RSTUDIO DPLYR GRAMMA
   [Anonymous], RSTUDIO SCALE FUNCTI
   [Anonymous], 2015, R PACKAGE
   Blanco DR, 1997, EMERG INFECT DIS, V3, P11, DOI 10.3201/eid0301.970102
   BRAY TM, 1993, CAN J PHYSIOL PHARM, V71, P746, DOI 10.1139/y93-111
   Brikowski TH, 2014, J HYDROL, V518, P342, DOI 10.1016/j.jhydrol.2013.09.021
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   CARRILLO MC, 1989, MECH AGEING DEV, V47, P1, DOI 10.1016/0047-6374(89)90002-X
   Chen BW, 2018, TALANTA, V184, P446, DOI 10.1016/j.talanta.2018.03.021
   Choiniere J, 2016, ACTA PHARM SIN B, V6, P426, DOI 10.1016/j.apsb.2016.07.011
   Claus SP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.3
   Dahan D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01323
   de Theije CGM, 2014, BRAIN BEHAV IMMUN, V37, P197, DOI 10.1016/j.bbi.2013.12.005
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Dheer R, 2015, TOXICOL APPL PHARM, V289, P397, DOI 10.1016/j.taap.2015.10.020
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Feng Z, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0208-7
   Flanagan SV, 2012, B WORLD HEALTH ORGAN, V90, P839, DOI 10.2471/BLT.11.101253
   Grutzner N, 2015, VET J, V203, P320, DOI 10.1016/j.tvjl.2014.12.022
   Harrell FEJ, 2018, R PACKAGE VERSION, V4, P1
   Idrees M, 2020, ENVIRON TECHNOL, V41, P232, DOI 10.1080/09593330.2018.1494754
   Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]
   Kala SV, 2000, J BIOL CHEM, V275, P33404, DOI 10.1074/jbc.M007030200
   Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228
   Kuo CC, 2015, DIABETES CARE, V38, P620, DOI 10.2337/dc14-1641
   Liao VHC, 2011, J CONTAM HYDROL, V123, P20, DOI 10.1016/j.jconhyd.2010.12.003
   Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429
   Mateos LM, 2006, INT MICROBIOL, V9, P207
   Matsubayashi M, 2015, PARASITOL RES, V114, P3069, DOI 10.1007/s00436-015-4509-9
   McCarty Kathleen M., 2011, Reviews on Environmental Health, V26, P71, DOI 10.1515/REVEH.2011.010
   McMurdie PJ, 2015, BIOINFORMATICS, V31, P282, DOI 10.1093/bioinformatics/btu616
   Narrowe AB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0069-6
   Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903
   Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Resende TP, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0618-z
   RS Team, 2016, RSTUDIO INT DEV ENV
   Rubin SSCD, 2014, ENVIRON HEALTH PERSP, V122, P817, DOI 10.1289/ehp.1307759
   Scanlan PD, 2009, FEMS MICROBIOL ECOL, V69, P213, DOI 10.1111/j.1574-6941.2009.00709.x
   Sedighi M, 2017, MICROB PATHOGENESIS, V111, P362, DOI 10.1016/j.micpath.2017.08.038
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shankar S, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500419
   Shivani Y, 2015, SYST APPL MICROBIOL, V38, P110, DOI 10.1016/j.syapm.2014.11.002
   SUMMERS AO, 1993, ANTIMICROB AGENTS CH, V37, P825, DOI 10.1128/AAC.37.4.825
   Sze CW, 2012, INFECT IMMUN, V80, P2485, DOI 10.1128/IAI.00145-12
   SZINICZ L, 1988, ARCH TOXICOL, V61, P444, DOI 10.1007/BF00293690
   Tampa M, 2014, J Med Life, V7, P4
   Thakur JK, 2011, WATER-SUI, V3, P1, DOI 10.3390/w3010001
   VAHTER M, 1987, TOXICOL LETT, V37, P41, DOI 10.1016/0378-4274(87)90165-2
   Wei T, 2017, VISUALIZATION CORREL
   Whalen JG, 2007, ARCH DERMATOL, V143, P124, DOI 10.1001/archderm.143.1.124
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4
   Wickham H, 2007, J STAT SOFTW, V21, P1
   World Health Organization, 2010, FRAM ACT INT ED COLL, P1, DOI DOI 10.1111/J.1741-1130.2007.00144.X
   Wright J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02300
   Yazici C, 2015, GASTROENTEROLOGY, V148, pS100
   Yu HY, 2016, ENVIRON SCI TECHNOL, V50, P7189, DOI 10.1021/acs.est.6b01533
NR 69
TC 12
Z9 12
U1 3
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2405-8440
J9 HELIYON
JI Heliyon
PD JAN
PY 2020
VL 6
IS 1
AR e03313
DI 10.1016/j.heliyon.2020.e03313
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KH1BC
UT WOS:000510380200245
PM 32051876
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Costantini, MS
   Medeiros, MCI
   Crampton, LH
   Reed, FA
AF Costantini, Maria S.
   Medeiros, Matthew C. I.
   Crampton, Lisa H.
   Reed, Floyd A.
TI Wild gut microbiomes reveal individuals, species, and location as
   drivers of variation in two critically endangered Hawaiian honeycreepers
SO PEERJ
LA English
DT Article
DE Avian microbiome; Conservation; Microbial ecology; Molecular ecology;
   Island biology; Tropical birds
ID GASTROINTESTINAL MICROBIOTA; PASSERINES; AKIKIKI; LIFE
AB Background: The gut microbiome of animals is an important component that has strong influence on the health, fitness, and behavior of its host. Most research in the microbiome field has focused on human populations and commercially important species. However, researchers are now considering the link between endangered species conservation and the microbiome. In Hawaii., several threats (e.g., avian malaria and habitat loss) have caused widespread population declines of Hawaiian honeycreepers (subfamily: Carduelinae). These threats can have a significant effect on the avian gut microbiome and may even lead to disruption of microbial function. However, the gut microbiome of honeycreeper in the wild has yet to be explored.
   Methods: We collected 13 and 42 fecal samples, respectively, from two critically endangered honeycreeper species, the 'aldkiki (Oreomystis bairdi) and the `akeke`e (Loxops caeruleirostris). The 16S rRNA gene was sequenced and processed though a MOTHUR-based bioinformatics pipeline. Bacterial ASVs were identified using the DADA2 program and bacterial community analyses, including alpha and beta diversity measures, were conducted using R packages Phyloseq and vegan.
   Results: A total of 8,958 bacterial ASVs were identified from the fecal samples. Intraspecific differences in the gut microbiome among individual birds explained most of the variation present in the dataset, however differences between species did exist. Both species had distinct microbiomes with minimal overlap in beta diversity. 'Aldldld had a more diverse microbiome compared to 'akeke'e. Additionally, small but stastically significant differences in beta diversity also exist between sampling location and sexes in 'aldldki.
   Conclusion: 'Akikild and 'akeke'e are currently the focus of captive breeding efforts and plans to translocate the two species to other islands are underway. This baseline knowledge will help inform management decisions for these honeycreeper species in their native habitats, on other islands, and in captivity.
C1 [Costantini, Maria S.; Medeiros, Matthew C. I.; Reed, Floyd A.] Univ Hawaii Manoa, Sch Life Sci, Honolulu, HI 96822 USA.
   [Medeiros, Matthew C. I.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.
   [Crampton, Lisa H.] Hawai Div Forestry & Wildlife, Hanapepe, HI USA.
   [Crampton, Lisa H.] Univ Hawaii, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA.
C3 University of Hawaii System; University of Hawaii Manoa; University of
   Hawaii System; University of Hawaii Manoa; University of Hawaii System
RP Costantini, MS (corresponding author), Univ Hawaii Manoa, Sch Life Sci, Honolulu, HI 96822 USA.
EM mariacos@hawaii.edu
RI Reed, Floyd A/B-3586-2009
FU Hawai`i Audubon Society; Kaua`i Forest Bird Recovery Project; NIH COBRE
   [P20 GM125508]; Watson T. Yoshimoto Fellowship; C-MAIKI Fellowship
FX This work was funded by Hawai`i Audubon Society, Watson T. Yoshimoto
   Fellowship, C-MAIKI Fellowship, and the Kaua`i Forest Bird Recovery
   Project. Floyd A. Reed's work is supported by a grant from NIH COBRE P20
   GM125508. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16
   [Anonymous], 2011, PACKAGE CAR COMPANIO
   [Anonymous], 2007, COMMUN ECOL PACKAGE
   Arisdakessian Cedric, 2020, PEARC '20: Practice and Experience in Advanced Research Computing, P120, DOI 10.1145/3311790.3396664
   Barelli C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14862
   Behnke LAH, 2016, CONDOR, V118, P148, DOI 10.1650/CONDOR-15-80.1
   Bodawatta KH, 2022, TRENDS MICROBIOL, V30, P268, DOI 10.1016/j.tim.2021.07.003
   Bodawatta KH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01830
   Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Carthey AJR, 2020, FUNCT ECOL, V34, P764, DOI 10.1111/1365-2435.13504
   Chen CY, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00896-9
   Colston TJ, 2016, MOL ECOL, V25, P3776, DOI 10.1111/mec.13730
   Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
   Fortini LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144311
   Foster JT, 2000, BIRDS N AM
   Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1
   Grond K, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01788
   Grond K, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix142
   Grond K, 2014, J ORNITHOL, V155, P969, DOI 10.1007/s10336-014-1083-3
   Hird SM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00725
   Hird SM, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.01403, 10.3389/fmicb.2015.01403]
   Knutie SA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00119-0
   Kropackova L, 2017, MOL ECOL, V26, P5292, DOI 10.1111/mec.14144
   Lepson JK, 1997, BIRDS N AM, P295
   Lewis WB, 2017, AUK, V134, P137, DOI 10.1642/AUK-16-120.1
   Liu G, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.587873
   Lovette IJ, 2002, P ROY SOC B-BIOL SCI, V269, P37, DOI 10.1098/rspb.2001.1789
   McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Murray MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0220926
   Nieves-Ramirez ME, 2018, MSYSTEMS, V3, DOI [10.1128/mSystems.00007-18, 10.1128/msystems.00007-18]
   Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327
   Pascoe EL, 2017, ISME J, V11, P2644, DOI 10.1038/ismej.2017.133
   Paxton EH, 2018, CONDOR, V120, P557, DOI 10.1650/CONDOR-18-25.1
   Paxton EH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600029
   R Core Team, 2017, R LANG ENV STAT COMP
   Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584
   Rousk K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00150
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540
   Teyssier A, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2182
   Trevelline BK, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2448
   Trevelline BK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0225
   Videvall E, 2018, MOL ECOL RESOUR, V18, P424, DOI 10.1111/1755-0998.12744
   Werf EAV, 2008, WILSON J ORNITHOL, V120, P195, DOI 10.1676/07-022.1
   Youngblut ND, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10191-3
NR 47
TC 4
Z9 4
U1 5
U2 13
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD OCT 28
PY 2021
VL 9
AR e12291
DI 10.7717/peerj.12291
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA WQ7CX
UT WOS:000713971700001
PM 34760361
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Venugopal, G
   Khan, ZH
   Dash, R
   Tulsian, V
   Agrawal, S
   Rout, S
   Mahajan, P
   Ramadass, B
AF Venugopal, Giriprasad
   Khan, Zaiba Hasan
   Dash, Rishikesh
   Tulsian, Vinay
   Agrawal, Siwani
   Rout, Sudeshna
   Mahajan, Preetam
   Ramadass, Balamurugan
TI Predictive association of gut microbiome and NLR in anemic low
   middle-income population of Odisha- a cross-sectional study
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE anemia; gut microbiome; NLR; MCV; indicator species; MLPNN; iron
   supplementation
ID IRON FORTIFICATION; CHILDREN; FOODS; WOMEN
AB BackgroundIron is abundant on earth but not readily available for colonizing bacteria due to its low solubility in the human body. Hosts and microbiota compete fiercely for iron. <15% Supplemented Iron is absorbed in the small bowel, and the remaining iron is a source of dysbiosis. The gut microbiome signatures to the level of predicting anemia among low-middle-income populations are unknown. The present study was conducted to identify gut microbiome signatures that have predictive potential in association with Neutrophil to lymphocytes ratio (NLR) and Mean corpuscular volume (MCV) in anemia. MethodsOne hundred and four participants between 10 and 70 years were recruited from Odisha's Low Middle-Income (LMI) rural population. Hematological parameters such as Hemoglobin (HGB), NLR, and MCV were measured, and NLR was categorized using percentiles. The microbiome signatures were analyzed from 61 anemic and 43 non-anemic participants using 16 s rRNA sequencing, followed by the Bioinformatics analysis performed to identify the diversity, correlations, and indicator species. The Multi-Layered Perceptron Neural Network (MLPNN) model were applied to predict anemia. ResultsSignificant microbiome diversity among anemic participants was observed between the lower, middle, and upper Quartile NLR groups. For anemic participants with NLR in the lower quartile, alpha indices indicated bacterial overgrowth, and consistently, we identified R. faecis and B. uniformis were predominating. Using ROC analysis, R. faecis had better distinction (AUC = 0.803) to predict anemia with lower NLR. In contrast, E. biforme and H. parainfluenzae were indicators of the NLR in the middle and upper quartile, respectively. While in Non-anemic participants with low MCV, the bacterial alteration was inversely related to gender. Furthermore, our Multi-Layered Perceptron Neural Network (MLPNN) models also provided 89% accuracy in predicting Anemic or Non-Anemic from the top 20 OTUs, HGB level, NLR, MCV, and indicator species. ConclusionThese findings strongly associate anemic hematological parameters and microbiome. Such predictive association between the gut microbiome and NLR could be further evaluated and utilized to design precision nutrition models and to predict Iron supplementation and dietary intervention responses in both community and clinical settings.
C1 [Venugopal, Giriprasad; Khan, Zaiba Hasan; Dash, Rishikesh; Tulsian, Vinay; Ramadass, Balamurugan] All India Inst Med Sci AIIMS, Ctr Excellence Clin Microbiome Res CCMR, Bhubaneswar, Odisha, India.
   [Agrawal, Siwani; Rout, Sudeshna; Ramadass, Balamurugan] All India Inst Med Sci, Dept Biochem, Bhubaneswar, Odisha, India.
   [Mahajan, Preetam] All India Inst Med Sci AIIMS, Dept Community Med & Family Med, Bhubaneswar, Odisha, India.
   [Ramadass, Balamurugan] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia.
   [Mahajan, Preetam] JIPMER, Dept Community & Family Med, Karaikal, Puducherry, India.
C3 University of Adelaide; Jawaharlal Institute of Postgraduate Medical
   Education & Research
RP Ramadass, B (corresponding author), All India Inst Med Sci AIIMS, Ctr Excellence Clin Microbiome Res CCMR, Bhubaneswar, Odisha, India.; Ramadass, B (corresponding author), All India Inst Med Sci, Dept Biochem, Bhubaneswar, Odisha, India.; Ramadass, B (corresponding author), Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia.
EM balaramadass1@gmail.com
FU Institutional Intramural fund (IRC) from AIIMS, Bhubaneswar, India
   [IM-F/35/2018]
FX This work was supported by the Institutional Intramural fund (IRC ref.
   number: IM-F/35/2018) from AIIMS, Bhubaneswar, India.
CR Abdelmahmuod E, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8899
   Aly SS, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-0990-5
   [Anonymous], 2004, ACM SIGKDD EXPLORAT, DOI 10.1145/1007730.1007735
   Balamurugan R, 2010, BRIT J NUTR, V104, P931, DOI 10.1017/S0007114510001637
   Bang S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46249-x
   Behera S, 2016, ANEMIA, V2016, DOI 10.1155/2016/1729147
   Brzeniakiewicz-Janus K., 2020, RECENT POLISH HOSP S, V2020, P8874361, DOI [10.21203/rs.3.rs-21046/v1, DOI 10.21203/RS.3.RS-21046/V1]
   Cekmen N., 2019, HEART VESSELS TRANSP, V3, P109, DOI [10.24969/hvt.2019.133, DOI 10.24969/HVT.2019.133]
   Chaparro CM, 2019, ANN NY ACAD SCI, V1450, P15, DOI 10.1111/nyas.14092
   Del Chierico F, 2021, ACTA DIABETOL, V58, P1009, DOI 10.1007/s00592-020-01669-4
   Ditzler G, 2015, IEEE T NANOBIOSCI, V14, P608, DOI 10.1109/TNB.2015.2461219
   Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577
   Fritsch S., NEURALNET TRAINING N
   Gera T, 2012, AM J CLIN NUTR, V96, P309, DOI 10.3945/ajcn.111.031500
   Gibson RS, 2018, NUTR REV, V76, P793, DOI 10.1093/nutrit/nuy028
   Jaagura M, 2021, MICROBIOLOGYOPEN, V10, DOI 10.1002/mbo3.1194
   Kalipatnapu S, 2017, J GASTROEN HEPATOL, V32, P1475, DOI 10.1111/jgh.13725
   Kapil U, 2019, INDIAN J MED RES, V150, P239, DOI 10.4103/ijmr.IJMR_1782_18
   Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002
   Kumar Pradeep, 2021, Nutrition and Health (Bicester), V27, P191, DOI 10.1177/0260106020982348
   Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760
   Lee JY, 2022, KOREAN J INTERN MED, V37, P304, DOI 10.3904/kjim.2020.433
   Lopez-Almela I, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2020.1865706
   Magne F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051474
   Mahajan PB, 2018, J DRUG ASSESS, V7, P34, DOI 10.1080/21556660.2018.1487446
   Morgan MA, 2021, ANAEROBE, V69, DOI 10.1016/j.anaerobe.2021.102339
   Mueller NT, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120364
   Muleviciene A, 2018, ACTA MICROBIOL IMM H, V65, P551, DOI 10.1556/030.65.2018.045
   Paganini D, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080494
   Panigrahi MK, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-12431-x
   Paul VK., KEY FINDINGS NATL ST
   Qi Y, 2021, GENOMICS, V113, P664, DOI 10.1016/j.ygeno.2020.09.063
   Ramadass B, 2017, INDIAN J MED RES, V145, P236, DOI 10.4103/ijmr.IJMR_639_14
   Reiman D, 2017, IEEE ENG MED BIO, P4269, DOI 10.1109/EMBC.2017.8037799
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Seo IH, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10112697
   Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9
   Thomas MS, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00234
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Vangay P, 2018, CELL, V175, P962, DOI 10.1016/j.cell.2018.10.029
   Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002
   Yacoub MF, 2020, ANEMIA, V2020, DOI 10.1155/2020/3041738
   Yoon HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34398-4
   Zahorec R, 2021, BRATISL MED J, V122, P474, DOI 10.4149/BLL_2021_078
   Zhang J, 2019, COMPUT ASSIST SURG, V24, P62, DOI 10.1080/24699322.2019.1649074
   Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564
NR 46
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD JUL 13
PY 2023
VL 10
AR 1200688
DI 10.3389/fnut.2023.1200688
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA N9DC9
UT WOS:001039923400001
PM 37528994
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Hu, B
   Liu, C
   Jiang, WH
   Zhu, HK
   Zhang, H
   Qian, H
   Zhang, WG
AF Hu, Bin
   Liu, Chang
   Jiang, Wenhao
   Zhu, Hongkang
   Zhang, Hui
   Qian, He
   Zhang, Weiguo
TI Chronic in vitro fermentation and in vivo metabolism: Extracellular
   polysaccharides from Sporidiobolus pararoseus regulate the intestinal
   microbiome of humans and mice
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Sporidiobolus pararoseus polysaccharides; Gut microbiome; Fermentation
   in vitro; Short chain fatty acids; Amino acid metabolism; Bioinformatics
ID MECHANISM
AB The fungus Sporidiobolus pararoseus not only produces carotenoids, but also produces bioactive extracellular polysaccharides (SPP). However, the relationship between SPP and the metabolism of gut microbiome is unclear. The aim of this study was to investigate the mechanism of SPP regulating intestinal health in vivo and in vitro. Results showed that SPP are nondigestible polysaccharides after the digestion with simulated stomach and small intestinal juice in vitro. After SPP was cultured in an in vitro intestinal simulation system for seven days, the concentration of short-chain fatty acids (SCFAs) increased; the microbial diversity changed; the relative abundance of Bifidobacterium and Streptococcus increased; and that of Escherichia Shigella and Lachnospiraceae NK4A136 decreased. In addition, metabolism of SPP by the mice colonic microbiome showed SPP decreased the relative abundance of Firmicutes and Bacteroidota, while the relative abundance of Verrucomicrobiota, Desulfobacterota, and Actinobacteriota increased. Finally, predicted Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolism results also showed that SPP can enhance the metabolism of cofactors, vitamins, amino acids, starch, and sucrose. In conclusion, SPP can multiply the intestinal beneficial bacteria of humans and mice, promote the production of SCFAs and metabolism of amino acids, and promote intestinal health.
C1 [Hu, Bin; Zhang, Weiguo] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi 214122, Jiangsu, Peoples R China.
   [Liu, Chang; Jiang, Wenhao; Zhu, Hongkang; Qian, He] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
   [Liu, Chang; Jiang, Wenhao; Zhu, Hongkang; Qian, He] Jiangnan Univ, Int Joint Lab Food Safety, Wuxi 214122, Jiangsu, Peoples R China.
   [Zhang, Hui] China Certificat & Inspect Grp Shanghai Co Ltd, Shanghai 200120, Peoples R China.
C3 Jiangnan University; Jiangnan University; Jiangnan University
RP Zhang, WG (corresponding author), 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China.
EM zhangwg@jiangnan.edu.cn
CR Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007
   Lopez-Ortega MA, 2021, INT J BIOL MACROMOL, V177, P559, DOI 10.1016/j.ijbiomac.2021.02.101
   Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479
   Arasaradnam RP, 2009, MED HYPOTHESES, V73, P753, DOI 10.1016/j.mehy.2009.04.027
   Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128
   Cao WX, 2020, INT J FOOD SCI NUTR, V71, P453, DOI 10.1080/09637486.2019.1686608
   Chambers ES, 2019, GUT, V68, P1430, DOI 10.1136/gutjnl-2019-318424
   Cresci GA, 2017, J GASTROEN HEPATOL, V32, P1587, DOI 10.1111/jgh.13731
   Di T, 2018, J FUNCT FOODS, V40, P18, DOI 10.1016/j.jff.2017.10.040
   Engels C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00713
   Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463
   Han M, 2018, RSC ADV, V8, P3348, DOI 10.1039/c7ra12813d
   Huang F, 2019, INT J BIOL MACROMOL, V140, P965, DOI 10.1016/j.ijbiomac.2019.08.170
   Jones RB, 2019, GUT MICROBES, V10, P712, DOI 10.1080/19490976.2019.1592420
   Katuna-Czaplinska J, 2017, TRENDS FOOD SCI TECH, V70, P105, DOI 10.1016/j.tifs.2017.10.010
   Kelly S.S, 2015, J AGR FOOD CHEM, DOI [10.1021/acs.jafc.5b04618, DOI 10.1021/ACS.JAFC.5B04618]
   Kimura I, 2014, YAKUGAKU ZASSHI, V134, P1037, DOI 10.1248/yakushi.14-00169
   Liu C, 2021, CARBOHYD POLYM, V256, DOI 10.1016/j.carbpol.2020.117571
   Liu YY, 2019, J AGR FOOD CHEM, V67, P11665, DOI 10.1021/acs.jafc.9b04731
   Manichanh C, 2014, GUT, V63, P401, DOI 10.1136/gutjnl-2012-303013
   Marzorati M, 2016, J CLIN GASTROENTEROL, V50, pS124, DOI 10.1097/MCG.0000000000000711
   Mukherjee A, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1802866
   Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167
   Reichardt N, 2018, ISME J, V12, P610, DOI 10.1038/ismej.2017.196
   Ringseis R, 2020, ANNU REV ANIM BIOSCI, V8, P295, DOI 10.1146/annurev-animal-021419-083852
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Roca C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00288
   Saadat YR, 2019, CARBOHYD POLYM, V217, P79, DOI 10.1016/j.carbpol.2019.04.025
   Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Shanmugam M., 2019, J BIOL ACT PROD NAT, V9, P73, DOI [10.1080/22311866.2019.1571944, DOI 10.1080/22311866.2019.1571944]
   Song QQ, 2021, FOOD RES INT, V140, DOI 10.1016/j.foodres.2020.109858
   Thingholm LB, 2019, CELL HOST MICROBE, V26, P252, DOI 10.1016/j.chom.2019.07.004
   Toe LC, 2020, FEMS MICROBIOL ECOL, V96, DOI 10.1093/femsec/fiaa105
   Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460
   Wang HT, 2020, BIOPROC BIOSYST ENG, V43, P1403, DOI 10.1007/s00449-020-02335-3
   Wang MM, 2019, TRENDS FOOD SCI TECH, V88, P1, DOI 10.1016/j.tifs.2019.03.005
   Wu TR, 2019, GUT, V68, P248, DOI 10.1136/gutjnl-2017-315458
   Xiang SS, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01029-6
   Xie XQ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13031008
   Xie ZY, 2020, FOOD FUNCT, V11, P10397, DOI [10.1039/d0fo02272a, 10.1039/D0FO02272A]
   Xu YY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02780
   Zhang JD, 2019, J GASTROEN HEPATOL, V34, P1368, DOI 10.1111/jgh.14536
   Zhao ZJ, 2020, APPL MICROBIOL BIOT, V104, P5273, DOI 10.1007/s00253-020-10633-9
NR 44
TC 7
Z9 7
U1 14
U2 49
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD DEC 1
PY 2021
VL 192
BP 398
EP 406
DI 10.1016/j.ijbiomac.2021.09.127
EA OCT 2021
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA WM1NR
UT WOS:000710860300002
PM 34571128
DA 2023-09-14
ER

PT J
AU Liu, P
   Jiang, YQ
   Gu, SS
   Xue, YP
   Yang, HX
   Li, YZ
   Wang, YX
   Yan, CY
   Jia, P
   Lin, XT
   Qi, GY
AF Liu, Peng
   Jiang, Yiqi
   Gu, Shanshan
   Xue, Yinping
   Yang, Hongxia
   Li, Yongzhao
   Wang, Yaxuan
   Yan, Congya
   Jia, Pei
   Lin, Xiaoting
   Qi, Guoyan
TI Metagenome-wide association study of gut microbiome revealed potential
   microbial marker set for diagnosis of pediatric myasthenia gravis
SO BMC MEDICINE
LA English
DT Article
DE Myasthenia gravis; Metagenomics; SCFAs; Adenovirus; Microbial marker
ID CHAIN FATTY-ACIDS; VIROME
AB Background Myasthenia gravis (MG) is an acquired immune-mediated disorder of the neuromuscular junction that causes fluctuating skeletal muscle weakness and fatigue. Pediatric MG and adult MG have many different characteristics, and current MG diagnostic methods for children are not quite fit. Previous studies indicate that alterations in the gut microbiota may be associated with adult MG. However, it has not been determined whether the gut microbiota are altered in pediatric MG patients. Methods Our study recruited 53 pediatric MG patients and 46 age- and gender-matched healthy controls (HC). We sequenced the fecal samples of recruited individuals using whole-genome shotgun sequencing and analyzed the data with in-house bioinformatics pipeline. Results We built an MG disease classifier based on the abundance of five species, Fusobacterium mortiferum, Prevotella stercorea, Prevotella copri, Megamonas funiformis, and Megamonas hypermegale. The classifier obtained 94% area under the curve (AUC) in cross-validation and 84% AUC in the independent validation cohort. Gut microbiome analysis revealed the presence of human adenovirus F/D in 10 MG patients. Significantly different pathways and gene families between MG patients and HC belonged to P. copri, Clostridium bartlettii, and Bacteroides massiliensis. Based on functional annotation, we found that the gut microbiome affects the production of short-chain fatty acids (SCFAs), and we confirmed the decrease in SCFA levels in pediatric MG patients via serum tests. Conclusions The study indicated that altered fecal microbiota might play vital roles in pediatric MG's pathogenesis by reducing SCFAs. The microbial markers might serve as novel diagnostic methods for pediatric MG.
C1 [Liu, Peng; Gu, Shanshan; Xue, Yinping; Yang, Hongxia; Li, Yongzhao; Wang, Yaxuan; Yan, Congya; Jia, Pei; Lin, Xiaoting; Qi, Guoyan] Hebei Med Univ, Peoples Hosp Shijiazhuang, Ctr Treatment Myasthenia Gravis, Shijiazhuang, Hebei, Peoples R China.
   [Liu, Peng; Qi, Guoyan] Hebei Prov Key Lab Myasthenia Gravis, Shijiazhuang, Hebei, Peoples R China.
   [Jiang, Yiqi] City Univ Hong Kong, Hong Kong, Peoples R China.
   [Gu, Shanshan; Xue, Yinping; Yang, Hongxia; Li, Yongzhao; Qi, Guoyan] Hebei Prov Clin Res Ctr Myasthenia Gravis, Shijiazhuang, Hebei, Peoples R China.
C3 Hebei Medical University; City University of Hong Kong
RP Qi, GY (corresponding author), Hebei Med Univ, Peoples Hosp Shijiazhuang, Ctr Treatment Myasthenia Gravis, Shijiazhuang, Hebei, Peoples R China.; Qi, GY (corresponding author), Hebei Prov Key Lab Myasthenia Gravis, Shijiazhuang, Hebei, Peoples R China.
EM zzjwlsys@163.com
FU Hebei Provincial Natural Science Foundation [H2019106063]; S&T Program
   of Hebei [19277701D]
FX This work was supported by financial grants from the Hebei Provincial
   Natural Science Foundation (H2019106063) and the S&T Program of Hebei
   (19277701D). The funder had no role in the trial design, data
   collection, data analysis, data interpretation, or writing of the
   report.
CR BARKER HA, 1978, J BIOL CHEM, V253, P1219
   Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46
   Castro Diana, 2013, J Clin Neuromuscul Dis, V14, P95, DOI 10.1097/CND.0b013e318253a48e
   Cavalcante P, 2010, NEUROLOGY, V74, P1118, DOI 10.1212/WNL.0b013e3181d7d884
   Cavalcante P, 2013, AUTOIMMUN REV, V12, P863, DOI 10.1016/j.autrev.2013.03.010
   Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Feng WW, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01354
   Gilhus NE, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0079-y
   Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3
   Goncalves P, 2018, INFLAMM BOWEL DIS, V24, P558, DOI 10.1093/ibd/izx029
   Guo LX, 2020, MOLECULES, V25, DOI 10.3390/molecules25235739
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16
   Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100
   Kupersmith MJ, 2003, ARCH NEUROL-CHICAGO, V60, P243, DOI 10.1001/archneur.60.2.243
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   LeBlanc JG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0691-z
   Leis AA, 2014, MUSCLE NERVE, V49, P26, DOI 10.1002/mus.23869
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Macpherson AJ, 2017, NAT REV IMMUNOL, V17, P508, DOI 10.1038/nri.2017.58
   Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783
   Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Phillips LH, 2004, SEMIN NEUROL, V24, P17, DOI 10.1055/s-2004-829593
   Qiu DX, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02627
   Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713
   Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13
   Sandin A, 2009, ACTA PAEDIATR, V98, P823, DOI 10.1111/j.1651-2227.2008.01215.x
   Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x
   Serino M, 2019, NAT REV ENDOCRINOL, V15, P318, DOI 10.1038/s41574-019-0205-7
   Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209
   Sivaprakasam S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080856
   SRAMEK SJ, 1977, ARCH BIOCHEM BIOPHYS, V181, P525, DOI 10.1016/0003-9861(77)90259-4
   Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142
   Tan XM, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.564579
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879
   Vemuri R, 2017, CURR PHARM DESIGN, V23, P2352, DOI 10.2174/1381612823666170207100025
   WOLEVER TMS, 1989, AM J GASTROENTEROL, V84, P1027
   Wommack KE, 2012, STAND GENOMIC SCI, V6, P421, DOI 10.4056/sigs.2945050
   Yamamura R, 2020, BIOSCI MICROB FOOD H, V39, P11, DOI 10.12938/bmfh.19-010
   Zhang XF, 2007, J NEUROL NEUROSUR PS, V78, P386, DOI 10.1136/jnnp.2006.100545
   Zheng P, 2019, ADV SCI, V6, DOI 10.1002/advs.201901441
   Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918
NR 46
TC 12
Z9 12
U1 1
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD JUL 8
PY 2021
VL 19
IS 1
AR 159
DI 10.1186/s12916-021-02034-0
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA TG3XZ
UT WOS:000671342000001
PM 34233671
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Szostak, N
   Szymanek, A
   Havranek, J
   Tomela, K
   Rakoczy, M
   Samelak-Czajka, A
   Schmidt, M
   Figlerowicz, M
   Majta, J
   Milanowska-Zabel, K
   Handschuh, L
   Philips, A
AF Szostak, Natalia
   Szymanek, Agata
   Havranek, Jan
   Tomela, Katarzyna
   Rakoczy, Magdalena
   Samelak-Czajka, Anna
   Schmidt, Marcin
   Figlerowicz, Marek
   Majta, Jan
   Milanowska-Zabel, Kaja
   Handschuh, Luiza
   Philips, Anna
TI The standardisation of the approach to metagenomic human gut analysis:
   from sample collection to microbiome profiling
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DNA EXTRACTION METHODS; FECAL MICROBIOTA; MODULATION; AUTISM; TOOLS
AB In recent years, the number of metagenomic studies increased significantly. Wide range of factors, including the tremendous community complexity and variability, is contributing to the challenge in reliable microbiome community profiling. Many approaches have been proposed to overcome these problems making hardly possible to compare results of different studies. The significant differences between procedures used in metagenomic research are reflected in a variation of the obtained results. This calls for the need for standardisation of the procedure, to reduce the confounding factors originating from DNA isolation, sequencing and bioinformatics analyses in order to ensure that the differences in microbiome composition are of a true biological origin. Although the best practices for metagenomics studies have been the topic of several publications and the main aim of the International Human Microbiome Standard (IHMS) project, standardisation of the procedure for generating and analysing metagenomic data is still far from being achieved. To highlight the difficulties in the standardisation of metagenomics methods, we thoroughly examined each step of the analysis of the human gut microbiome. We tested the DNA isolation procedure, preparation of NGS libraries for next-generation sequencing, and bioinformatics analysis, aimed at identifying microbial taxa. We showed that the homogenisation time is the leading factor impacting sample diversity, with the recommendation for a shorter homogenisation time (10 min). Ten minutes of homogenisation allows for better reflection of the bacteria gram-positive/gram-negative ratio, and the obtained results are the least heterogenous in terms of beta-diversity of samples microbial composition. Besides increasing the homogenisation time, we observed further potential impact of the library preparation kit on the gut microbiome profiling. Moreover, our analysis revealed that the choice of the library preparation kit influences the reproducibility of the results, which is an important factor that has to be taken into account in every experiment. In this study, a tagmentation-based kit allowed for obtaining the most reproducible results. We also considered the choice of the computational tool for determining the composition of intestinal microbiota, with Kraken2/Bracken pipeline outperforming MetaPhlAn2 in our in silico experiments. The design of an experiment and a detailed establishment of an experimental protocol may have a serious impact on determining the taxonomic profile of the intestinal microbiome community. Results of our experiment can be helpful for a wide range of studies that aim to better understand the role of the gut microbiome, as well as for clinical purposes.
C1 [Szostak, Natalia; Tomela, Katarzyna; Rakoczy, Magdalena; Samelak-Czajka, Anna; Schmidt, Marcin; Figlerowicz, Marek; Handschuh, Luiza; Philips, Anna] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland.
   [Szymanek, Agata; Havranek, Jan; Majta, Jan; Milanowska-Zabel, Kaja] Ardigen SA, Ul Podole 7, PL-30394 Krakow, Poland.
   [Tomela, Katarzyna] Poznan Univ Med Sci, Dept Canc Immunol, Chair Med Biotechnol, PL-60806 Poznan, Poland.
   [Schmidt, Marcin] Poznan Univ Life Sci, Dept Food Biotechnol & Microbiol, PL-60627 Poznan, Poland.
C3 Polish Academy of Sciences; Institute of Bioorganic Chemistry of the
   Polish Academy of Sciences; Poznan University of Medical Sciences;
   Poznan University of Life Sciences
RP Philips, A (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland.
EM aphilips@ibch.poznan.pl
RI Schmidt, Marcin/N-2740-2019; Schmidt, Marcin/A-6997-2008; Szostak,
   Natalia/GPX-0551-2022
OI Schmidt, Marcin/0000-0001-8417-2245; Schmidt,
   Marcin/0000-0001-8417-2245; Szostak, Natalia/0000-0001-9933-0496;
   Handschuh, Luiza/0000-0001-9803-6877; Szymanek,
   Agata/0000-0001-8859-1287; Samelak-Czajka, Anna/0000-0002-0167-8265
FU European Regional Development Fund under the Smart Growth Operational
   Programme, Submeasure 4.1.2. Regional research agendas
   [POIR.04.01.02-00-0025/17-00]; Polish National Science Centre
   [2021/41/B/NZ9/03765]
FX This work was carried out under contract no. POIR.04.01.02-00-0025/17-00
   to AP, as: "Polish Microbiome Map", co-financed by the European Regional
   Development Fund under the Smart Growth Operational Programme,
   Submeasure 4.1.2. Regional research agendas. This work was also
   supported by research grant from the Polish National Science Centre to
   AP [2021/41/B/NZ9/03765].
CR Al KF, 2018, J MICROBIOL METH, V144, P117, DOI 10.1016/j.mimet.2017.11.014
   [Anonymous], 2020, VEGAN R PACKAGE COMM
   Benton Briana, 2019, MAKING SENSE OUT MIC
   BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268
   Bruggeling C., 2020, BIORXIV
   Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723
   Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158
   Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953
   Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901
   Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350
   Claassen S, 2013, J MICROBIOL METH, V94, P103, DOI 10.1016/j.mimet.2013.05.008
   Core Microbiome Sampling Protocol A (HMP-A), 2010, 07001 HMP
   D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x
   Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103
   Dore J., 2015, INT HUM MICROBIOME S
   Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354
   Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689
   Flores R, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0092-7
   Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111
   Fritz A, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0633-6
   Garcia-Gutierrez E, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.578666
   Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517
   Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802
   Hale VL, 2015, J MICROBIOL METH, V113, P16, DOI 10.1016/j.mimet.2015.03.021
   He K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41753-6
   Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787
   Hill CJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0164-3
   Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708
   Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112
   Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5
   Knudsen BE, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00095-16
   Kumar J, 2016, GENOM PROTEOM BIOINF, V14, P371, DOI 10.1016/j.gpb.2016.06.002
   Li H, 2013, 13033997V1 ARXIV, p1303.3997v1
   Lim MY, 2018, SYST APPL MICROBIOL, V41, P151, DOI 10.1016/j.syapm.2017.11.008
   Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104
   Malla MA, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02868
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044
   Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Meyer F., 2021, BIORXIV
   Mulle JG, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0337-0
   Nehra V, 2016, PHYSIOLOGY, V31, P327, DOI 10.1152/physiol.00005.2016
   Paun A, 2016, PEDIATR DIABETES, V17, P469, DOI 10.1111/pedi.12424
   Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114
   Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8
   Pulikkan J, 2019, ADV EXP MED BIOL, V1118, P253, DOI 10.1007/978-3-030-05542-4_13
   Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935
   Sato MP, 2019, DNA RES, V26, P391, DOI 10.1093/dnares/dsz017
   Schloss PD, 2018, MBIO, V9, DOI 10.1128/mBio.00525-18
   Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Seppey M, 2020, GENOME RES, V30, P1208, DOI 10.1101/gr.260398.119
   Shaw AG, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0186-x
   Singer E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.81
   Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122
   Sui HY, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00953
   Svoboda E, 2020, NATURE, V577, pS14, DOI 10.1038/d41586-020-00198-y
   Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685
   Thomas V, 2015, FUTURE MICROBIOL, V10, P1485, DOI 10.2217/fmb.15.87
   Tortora G. J., 1987, PRINCIPLES ANATOMY P, V5th
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Vesty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169877
   Walden C, 2017, J MICROBIOL METH, V141, P10, DOI 10.1016/j.mimet.2017.07.007
   Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Wu WK, 2019, J FORMOS MED ASSOC, V118, P545, DOI 10.1016/j.jfma.2018.02.005
   Ye SH, 2019, CELL, V178, P779, DOI 10.1016/j.cell.2019.07.010
   Zhang B.-z., 2020, BIORXIV
NR 70
TC 9
Z9 9
U1 2
U2 7
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 19
PY 2022
VL 12
IS 1
AR 8470
DI 10.1038/s41598-022-12037-3
PG 21
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 1J6ZE
UT WOS:000798064600073
PM 35589762
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Hughes, RL
   Frankenfeld, CL
   Gohl, DM
   Huttenhower, C
   Jackson, SA
   Vandeputte, D
   Vogtmann, E
   Comstock, SS
   Kable, ME
AF Hughes, Riley L. L.
   Frankenfeld, Cara L. L.
   Gohl, Daryl M. M.
   Huttenhower, Curtis
   Jackson, Scott A. A.
   Vandeputte, Doris
   Vogtmann, Emily
   Comstock, Sarah S. S.
   Kable, Mary E. E.
TI Methods in Nutrition & Gut Microbiome Research: An American Society for
   Nutrition Satellite Session [13 October 2022]
SO NUTRIENTS
LA English
DT Article
DE microbiota; methods; nutrition; sample collection; bioinformatics;
   sequencing
ID COLLECTION METHODS; FECAL SAMPLES; DIET; COMMUNITY; REVEALS;
   METAGENOMICS
AB The microbial cells colonizing the human body form an ecosystem that is integral to the regulation and maintenance of human health. Elucidation of specific associations between the human microbiome and health outcomes is facilitating the development of microbiome-targeted recommendations and treatments (e.g., fecal microbiota transplant; pre-, pro-, and post-biotics) to help prevent and treat disease. However, the potential of such recommendations and treatments to improve human health has yet to be fully realized. Technological advances have led to the development and proliferation of a wide range of tools and methods to collect, store, sequence, and analyze microbiome samples. However, differences in methodology at each step in these analytic processes can lead to variability in results due to the unique biases and limitations of each component. This technical variability hampers the detection and validation of associations with small to medium effect sizes. Therefore, the American Society for Nutrition (ASN) Nutritional Microbiology Group Engaging Members (GEM), sponsored by the Institute for the Advancement of Food and Nutrition Sciences (IAFNS), hosted a satellite session on methods in nutrition and gut microbiome research to review currently available methods for microbiome research, best practices, as well as tools and standards to aid in comparability of methods and results. This manuscript summarizes the topics and research discussed at the session. Consideration of the guidelines and principles reviewed in this session will increase the accuracy, precision, and comparability of microbiome research and ultimately the understanding of the associations between the human microbiome and health.
C1 [Frankenfeld, Cara L. L.] Univ Puget Sound, Publ Hlth Program, Tacoma, WA 98416 USA.
   [Gohl, Daryl M. M.] Univ Minnesota, Genom Ctr, Minneapolis, MN 55455 USA.
   [Gohl, Daryl M. M.] Univ Minnesota, Dept Genet Cell Biol & Dev Biol, Minneapolis, MN 55455 USA.
   [Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat & Immunol & Infect Dis, Boston, MA 02115 USA.
   [Huttenhower, Curtis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Harvard Chan Microbiome Publ Hlth Ctr, Boston, MA 02115 USA.
   [Jackson, Scott A. A.] NIST, Complex Microbial Syst Grp, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.
   [Vandeputte, Doris] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.
   [Vogtmann, Emily] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.
   [Comstock, Sarah S. S.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.
   [Kable, Mary E. E.] Univ Calif Davis, USDA ARS Western Human Nutr Res Ctr, Davis, CA 95616 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   University of Minnesota System; University of Minnesota Twin Cities;
   Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Massachusetts Institute of Technology (MIT); Broad
   Institute; Harvard University; Harvard T.H. Chan School of Public
   Health; National Institute of Standards & Technology (NIST) - USA;
   Cornell University; National Institutes of Health (NIH) - USA; NIH
   National Cancer Institute (NCI); Michigan State University; University
   of California System; University of California Davis
RP Comstock, SS (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.; Kable, ME (corresponding author), Univ Calif Davis, USDA ARS Western Human Nutr Res Ctr, Davis, CA 95616 USA.
EM rlh13@illinois.edu; cfrankenfeld@pugetsound.edu; dmgohl@umn.edu;
   chuttenh@hsph.harvard.edu; scott.jackson@nist.gov; dvv5@cornell.edu;
   emily.vogtmann@nih.gov; comsto37@msu.edu; mary.kable@usda.gov
RI ; Vandeputte, Doris/G-7231-2015
OI Jackson, Scott/0000-0003-4891-8323; Vandeputte,
   Doris/0000-0003-3019-5585; Frankenfeld, Cara/0000-0002-2318-0791; Kable,
   Mary/0000-0002-5485-6539
FU Institute for the Advancement of Food and Nutrition Sciences (IAFNS) Gut
   Microbiome Committee [IAFNS-HUGESRILEY-20221026]
FX This work was supported by the Institute for the Advancement of Food and
   Nutrition Sciences (IAFNS) Gut Microbiome Committee (grant number:
   IAFNS-HUGESRILEY-20221026). IAFNS is a nonprofit science organization
   that pools funding from industry and advances science through the
   in-kind and financial contributions from private and public sector
   members.
CR Abu-Ali GS, 2018, NAT MICROBIOL, V3, P356, DOI 10.1038/s41564-017-0084-4
   Amato KR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0120-7
   Amos GCA, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00856-3
   Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x
   Asnicar F, 2021, NAT MED, V27, P321, DOI 10.1038/s41591-020-01183-8
   Bassis CM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0983-9
   Bhosle A, 2022, CURR OPIN MICROBIOL, V70, DOI 10.1016/j.mib.2022.102195
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Byrd DA, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00827-19
   Byrd DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224757
   Cappellato M, 2022, PLOS COMPUT BIOL, V18, DOI 10.1371/journal.pcbi.1010467
   Chen ZG, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00271-18
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Choi Y, 2022, J NUTR, V152, P1187, DOI 10.1093/jn/nxac033
   Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025
   Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503
   Gao B, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11040530
   Ghazi AR, 2022, BIOINFORMATICS, V38, P378, DOI 10.1093/bioinformatics/btac232
   Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517
   Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224
   Gohl DM, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkab471
   Gohl DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1691-6
   Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601
   Golob JL, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1690-0
   Hu YJ, 2020, BIOINFORMATICS, V36, P4106, DOI 10.1093/bioinformatics/btaa260
   Hughes RL, 2019, ADV NUTR, V10, P953, DOI 10.1093/advances/nmz022
   Hughes RL, 2019, ADV NUTR, V10, P979, DOI 10.1093/advances/nmz049
   Jiang SQ, 2019, SCI TOTAL ENVIRON, V687, P601, DOI 10.1016/j.scitotenv.2019.06.105
   Johnson AJ, 2019, CELL HOST MICROBE, V25, P789, DOI 10.1016/j.chom.2019.05.005
   Kodikara S, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac273
   Li HZ, 2015, ANNU REV STAT APPL, V2, P73, DOI 10.1146/annurev-statistics-010814-020351
   Lin H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17041-7
   Lithgow GJ, 2017, NATURE, V548, P387, DOI 10.1038/548387a
   Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9
   Loftfield E, 2016, CANCER EPIDEM BIOMAR, V25, P1483, DOI 10.1158/1055-9965.EPI-16-0409
   Ma WJ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00921-y
   Mandal R, 2020, METABOLOMICS, V16, DOI 10.1007/s11306-020-01744-5
   Matchado MS, 2021, COMPUT STRUCT BIOTEC, V19, P2687, DOI 10.1016/j.csbj.2021.05.001
   Mirzayi C, 2021, NAT MED, V27, P1885, DOI 10.1038/s41591-021-01552-x
   Murphy R, 2019, BENEF MICROBES, V10, P5, DOI 10.3920/BM2017.0191
   Nearing JT, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28034-z
   Nearing JT, 2018, PEERJ, V6, DOI 10.7717/peerj.5364
   Pan A. Y., 2021, CURR OPIN ENDOCR MET, V19, P35, DOI DOI 10.1016/J.COEMR.2021.05.005
   Paulson J.N., 2015, THESIS U MARYLAND CO
   Rahman G, 2023, bioRxiv, DOI [10.1101/2023.01.30.526328, 10.1101/2023.01.30.526328, DOI 10.1101/2023.01.30.526328]
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sinha R, 2017, NAT BIOTECHNOL, V35, P1077, DOI 10.1038/nbt.3981
   Sinha R, 2016, CANCER EPIDEM BIOMAR, V25, P407, DOI 10.1158/1055-9965.EPI-15-0951
   Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834
   Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16
   Swift D, 2023, WIRES COMPUT STAT, V15, DOI 10.1002/wics.1586
   Thaiss CA, 2017, J MOL MED, V95, P1021, DOI 10.1007/s00109-017-1563-z
   Tkacz A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0491-7
   Tsilimigras MCB, 2016, ANN EPIDEMIOL, V26, P330, DOI 10.1016/j.annepidem.2016.03.002
   Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460
   Vogtmann E, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00361-17
   Vogtmann E, 2017, AM J EPIDEMIOL, V185, P115, DOI 10.1093/aje/kww177
   Wang DD, 2021, NAT MED, V27, P333, DOI 10.1038/s41591-020-01223-3
   Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y
   Yang L, 2022, MICROBIOME, V10, DOI 10.1186/s40168-022-01320-0
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001
   Zemb O, 2020, MICROBIOLOGYOPEN, V9, DOI 10.1002/mbo3.977
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
   Zhou HJ, 2022, GENOME BIOL, V23, DOI 10.1186/s13059-022-02655-5
   Zouiouich S, 2023, CANCER EPIDEM BIOMAR, V32, P444, DOI 10.1158/1055-9965.EPI-22-0883
   Zouiouich S, 2022, CANCER EPIDEM BIOMAR, V31, P305, DOI 10.1158/1055-9965.EPI-21-0188
NR 67
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAY 24
PY 2023
VL 15
IS 11
AR 2451
DI 10.3390/nu15112451
PG 18
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA I6HK8
UT WOS:001003773300001
PM 37299414
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Soverini, M
   Rampelli, S
   Turroni, S
   Brigidi, P
   Biagi, E
   Candela, M
AF Soverini, Matteo
   Rampelli, Simone
   Turroni, Silvia
   Brigidi, Patrizia
   Biagi, Elena
   Candela, Marco
TI Do the human gut metagenomic species possess the minimal set of core
   functionalities necessary for life?
SO BMC GENOMICS
LA English
DT Article
DE Gut microbiome; Metagenomic assembled genomes; Uncultured metagenomic
   species; Minimal bacterial genome
ID GENOME
AB Background Advances in bioinformatics recently allowed for the recovery of 'metagenomes assembled genomes' from human microbiome studies carried on with shotgun sequencing techniques. Such approach is used as a mean to discover new unclassified metagenomic species, putative biological entities having distinct metabolic traits. Results In the present analysis we compare 400 genomes from isolates available on NCBI database and 10,000 human gut metagenomic species, screening all of them for the presence of a minimal set of core functionalities necessary, but not sufficient, for life. As a result, the metagenome-assembled genomes resulted systematically depleted in genes encoding for essential functions apparently needed to support autonomous bacterial life. Conclusions The relevant degree of lacking core functionalities that we observed in metagenome-assembled genomes raises some concerns about the effective completeness of metagenome-assembled genomes, suggesting caution in extrapolating biological information about their metabolic propensity and ecology in a complex environment like the human gastrointestinal tract.
C1 [Soverini, Matteo; Rampelli, Simone; Turroni, Silvia; Brigidi, Patrizia; Biagi, Elena; Candela, Marco] Univ Bologna, Dept Pharm & Biotechnol, Unit Microbial Ecol Hlth, Via Belmeloro 6, I-40126 Bologna, Italy.
C3 University of Bologna
RP Soverini, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Unit Microbial Ecol Hlth, Via Belmeloro 6, I-40126 Bologna, Italy.
EM matteo.soverini5@unibo.it
RI Rampelli, Simone/K-5675-2016
OI Rampelli, Simone/0000-0002-5655-6695; Soverini,
   Matteo/0000-0002-3026-9460
CR Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1
   Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219
   Delmont TO, 2018, NAT MICROBIOL, V3, P804, DOI 10.1038/s41564-018-0176-9
   Devoto AE, 2019, NAT MICROBIOL, V4, P693, DOI 10.1038/s41564-018-0338-9
   Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7
   Hottes AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003617
   Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253
   Juliao PC, 2007, J BACTERIOL, V189, P4994, DOI 10.1128/JB.00146-07
   Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08
   Martinez-Garcia E, 2016, CURR OPIN BIOTECH, V42, P216, DOI 10.1016/j.copbio.2016.09.001
   Nicholls SM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz043
   Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7
   Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8
   R Core Team, 2017, R LANG ENV STAT COMP
   SADOWSKY MJ, 1986, ARCH MICROBIOL, V144, P334, DOI 10.1007/BF00409881
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Usongo V, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004543
   Venetz JE, 2019, P NATL ACAD SCI USA, V116, P8070, DOI 10.1073/pnas.1818259116
   Yuan C, 2015, BIOINFORMATICS, V31, P35, DOI 10.1093/bioinformatics/btv231
   Zechiedrich EL, 1997, GENE DEV, V11, P2580, DOI 10.1101/gad.11.19.2580
   Zeevi D, 2019, NATURE, V568, P43, DOI 10.1038/s41586-019-1065-y
   Zhao SJ, 2019, CELL HOST MICROBE, V25, P656, DOI 10.1016/j.chom.2019.03.007
NR 22
TC 1
Z9 1
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD SEP 30
PY 2020
VL 21
IS 1
AR 678
DI 10.1186/s12864-020-07087-8
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA NZ3FK
UT WOS:000576982800003
PM 32998695
OA Green Published, Green Submitted, gold
DA 2023-09-14
ER

PT J
AU Li, L
   Sohn, J
   Genco, RJ
   Wactawski-Wende, J
   Goodison, S
   Diaz, PI
   Sun, YJ
AF Li, Lu
   Sohn, Jiho
   Genco, Robert J.
   Wactawski-Wende, Jean
   Goodison, Steve
   Diaz, Patricia I.
   Sun, Yijun
TI Computational approach to modeling microbiome landscapes associated with
   chronic human disease progression
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOME; CROHNS-DISEASE; BEHAVIOR;
   HEALTH; DIET; CONSENSUS; PROFILES; SEARCH; OMICS
AB A microbial community is a dynamic system undergoing constant change in response to internal and external stimuli. These changes can have significant implications for human health. However, due to the difficulty in obtaining longitudinal samples, the study of the dynamic relationship between the microbiome and human health remains a challenge. Here, we introduce a novel computational strategy that uses massive cross-sectional sample data to model microbiome landscapes associated with chronic disease development. The strategy is based on the rationale that each static sample provides a snapshot of the disease process, and if the number of samples is sufficiently large, the footprints of individual samples populate progression trajectories, which enables us to recover disease progression paths along a microbiome landscape by using computational approaches. To demonstrate the validity of the proposed strategy, we developed a bioinformatics pipeline and applied it to a gut microbiome dataset available from a Crohn's disease study. Our analysis resulted in one of the first working models of microbial progression for Crohn's disease. We performed a series of interrogations to validate the constructed model. Our analysis suggested that the model recapitulated the longitudinal progression of microbial dysbiosis during the known clinical trajectory of Crohn's disease. By overcoming restrictions associated with complex longitudinal sampling, the proposed strategy can provide valuable insights into the role of the microbiome in the pathogenesis of chronic disease and facilitate the shift of the field from descriptive research to mechanistic studies.
C1 [Li, Lu; Sun, Yijun] SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY 10018 USA.
   [Sohn, Jiho] SUNY Buffalo, Dept Med, Buffalo, NY USA.
   [Genco, Robert J.; Diaz, Patricia I.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 10018 USA.
   [Genco, Robert J.; Diaz, Patricia I.] SUNY Buffalo, UB Microbiome Ctr, Buffalo, NY 10018 USA.
   [Wactawski-Wende, Jean] SUNY Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY USA.
   [Goodison, Steve] Mayo Clin, Dept Quantitat Hlth Sci, Jacksonville, FL USA.
   [Sun, Yijun] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 10018 USA.
C3 State University of New York (SUNY) System; State University of New York
   (SUNY) Buffalo; State University of New York (SUNY) System; State
   University of New York (SUNY) Buffalo; State University of New York
   (SUNY) System; State University of New York (SUNY) Buffalo; State
   University of New York (SUNY) System; State University of New York
   (SUNY) Buffalo; State University of New York (SUNY) System; State
   University of New York (SUNY) Buffalo; Mayo Clinic; State University of
   New York (SUNY) System; State University of New York (SUNY) Buffalo
RP Sun, YJ (corresponding author), SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY 10018 USA.; Diaz, PI (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 10018 USA.; Diaz, PI (corresponding author), SUNY Buffalo, UB Microbiome Ctr, Buffalo, NY 10018 USA.; Sun, YJ (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 10018 USA.
EM pidiazmo@buffalo.edu; yijunsun@buffalo.edu
RI Li, Lu/AAN-8838-2021; Sohn, Jiho/IAP-6300-2023
OI Li, Lu/0000-0002-1145-6308; Sohn, Jiho/0000-0001-6728-136X; Sun,
   Yijun/0000-0003-0610-6132; Wactawki-Wende, Jean/0000-0003-3096-9595
FU NIH [R01AI125982, R01DE024523, R01CA241123]
FX This work is supported in part by R01AI125982 (YS), R01DE024523 (JWW),
   and R01CA241123 (YS, SG), all funded by NIH (https://www.nih.gov/).The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ai DM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00826
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Ando RK, 2005, J MACH LEARN RES, V6, P1817
   [Anonymous], 1953, PSYCHOMETRIKA, DOI DOI 10.1007/BF02289263
   [Anonymous], 2004, DIS MATH APPLICAT
   Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9
   Bishop C. M., 2006, PATTERN RECOGNITION
   Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198
   Bucci V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0980-6
   Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chao A., 2016, WILEY STATSREF STAT, P1, DOI [10.1002/9780470015902.a0026329, 10.1002/9781118445112.stat03432.pub2]
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Colina AR, 1996, INFECT IMMUN, V64, P4514, DOI 10.1128/IAI.64.11.4514-4519.1996
   Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002
   Costa F, 2005, GUT, V54, P364, DOI 10.1136/gut.2004.043406
   Cryan JF, 2020, LANCET NEUROL, V19, P179, DOI 10.1016/S1474-4422(19)30356-4
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x
   Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013
   DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112
   Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019
   Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451
   Freeman HJ, 2003, J CLIN GASTROENTEROL, V37, P216, DOI 10.1097/00004836-200309000-00005
   Friedman JH, 2004, J ROY STAT SOC B, V66, P815, DOI 10.1111/j.1467-9868.2004.02059.x
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517
   Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224
   Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7
   Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x
   Greenacre M., 2018, COMPOSITIONAL DATA A, DOI DOI 10.1201/9780429455537
   Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4
   Henke MT, 2019, P NATL ACAD SCI USA, V116, P12672, DOI 10.1073/pnas.1904099116
   Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126
   Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001
   Imhann F, 2018, GUT, V67, P108, DOI 10.1136/gutjnl-2016-312135
   Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011
   Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386
   Jiang LJ, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00092-17
   Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Khanna S, 2017, GASTROENTEROL CLIN N, V46, P481, DOI 10.1016/j.gtc.2017.05.004
   Kim JW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1278-0
   Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009
   Kruskal J. B., 1956, P AM MATH SOC, V7, P48
   Lavoie S, 2019, ELIFE, V8, DOI 10.7554/eLife.39982
   Leng CL, 2014, ANN I STAT MATH, V66, P221, DOI 10.1007/s10463-013-0429-6
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058
   Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9
   Lo B, 2018, J CROHNS COLITIS, V12, P265, DOI 10.1093/ecco-jcc/jjx138
   Mao Q, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P765, DOI 10.1145/2783258.2783309
   Miraglia F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030222
   Mobeen F, 2018, BIOINFORMATION, V14, P560, DOI 10.6026/97320630014560
   Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002
   Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235
   Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014
   Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002
   Roager HM, 2014, APPL ENVIRON MICROB, V80, P1142, DOI 10.1128/AEM.03549-13
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909
   Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388
   Sun YJ, 2010, IEEE T PATTERN ANAL, V32, P1610, DOI 10.1109/TPAMI.2009.190
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293
   Tsilimigras MCB, 2016, ANN EPIDEMIOL, V26, P330, DOI 10.1016/j.annepidem.2016.03.002
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469
   Vapnik V., 2013, NATURE STAT LEARNING
   Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049
   Woodcroft BJ, 2018, NATURE, V560, P49, DOI 10.1038/s41586-018-0338-1
   Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465
   Yost S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0153-3
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 80
TC 1
Z9 1
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD AUG
PY 2022
VL 18
IS 8
AR e1010373
DI 10.1371/journal.pcbi.1010373
PG 24
WC Biochemical Research Methods; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA O4AG8
UT WOS:001043252900012
PM 35926003
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Zhang, X
   Cheng, K
   Ning, ZB
   Mayne, J
   Walker, K
   Chi, H
   Farnsworth, CL
   Lee, K
   Figeys, D
AF Zhang, Xu
   Cheng, Kai
   Ning, Zhibin
   Mayne, Janice
   Walker, Krystal
   Chi, Hao
   Farnsworth, Charles L.
   Lee, Kimberly
   Figeys, Daniel
TI Exploring the Microbiome-Wide Lysine Acetylation, Succinylation, and
   Propionylation in Human Gut Microbiota
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID ULTRAFAST
AB Lysine acylations are important post-translational modifications that are present in both eukaryotes and prokaryotes and regulate diverse cellular functions. Our knowledge of the microbiome lysine acylation remains limited due to the lack of efficient analytical and bioinformatics methods for complex microbial communities. Here, we show that the serial enrichment using motif antibodies successfully captures peptides containing lysine acetylation, propionylation, and succinylation from human gut microbiome samples. A new bioinformatic workflow consisting of an unrestricted database search confidently identified >60,000 acetylated, and similar to 20,000 propionylated and succinylated gut microbial peptides. The characterization of these identified modification-specific metaproteomes, i.e., meta-PTMomes, demonstrates that lysine acylations are differentially distributed in microbial species with different metabolic capabilities. This study provides an analytical framework for the study of lysine acylations in the microbiome, which enables functional microbiome studies at the post-translational level.
C1 [Zhang, Xu; Cheng, Kai; Ning, Zhibin; Mayne, Janice; Walker, Krystal; Figeys, Daniel] Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada.
   [Zhang, Xu; Cheng, Kai; Ning, Zhibin; Mayne, Janice; Walker, Krystal; Figeys, Daniel] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   [Chi, Hao] Chinese Acad Sci, Inst Comp Technol, Beijing 100190, Peoples R China.
   [Farnsworth, Charles L.; Lee, Kimberly] Cell Signaling Technol Inc, Danvers, MA 01923 USA.
C3 University of Ottawa; University of Ottawa; Chinese Academy of Sciences;
   Institute of Computing Technology, CAS; Cell Signaling Technology
RP Figeys, D (corresponding author), Univ Ottawa, Fac Med, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada.; Figeys, D (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
EM dfigeys@uottawa.ca
OI Cheng, Kai/0000-0002-6045-0244; Zhang, Xu/0000-0003-2406-9478; Figeys,
   Daniel/0000-0002-5373-7546
FU Government of Canada through Genome Canada; Ontario Genomics Institute
   [OGI-156, OGI-149]; Natural Sciences and Engineering Research Council of
   Canada (NSERC) [210034]; Ontario Ministry of Economic Development and
   Innovation [ORF-DIG-14405, 13440]
FX This work was supported by the Government of Canada through Genome
   Canada and the Ontario Genomics Institute (OGI-156 and OGI-149), the
   Natural Sciences and Engineering Research Council of Canada (NSERC,
   grant no. 210034), and the Ontario Ministry of Economic Development and
   Innovation (ORF-DIG-14405 and project 13440). The authors would like to
   thank Prof. Si-Min He at the Institute of Computing Technology, CAS, for
   his support for this project and the comments on the manuscript.
CR Cheng K, 2020, J AM SOC MASS SPECTR, V31, P1473, DOI 10.1021/jasms.0c00083
   Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236
   Chick JM, 2015, NAT BIOTECHNOL, V33, P743, DOI 10.1038/nbt.3267
   Fernandez-Veledo S, 2019, REV ENDOCR METAB DIS, V20, P439, DOI 10.1007/s11154-019-09513-z
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872
   Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]
   Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518
   Millikin RJ, 2018, J PROTEOME RES, V17, P386, DOI 10.1021/acs.jproteome.7b00608
   Okanishi H, 2014, MOL CELL PROTEOMICS, V13, P2382, DOI 10.1074/mcp.M113.035659
   Rekdal VM, 2019, SCIENCE, V364, P1055, DOI 10.1126/science.aau6323
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   van Kessel SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08294-y
   Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024
   Zhang WP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0194-x
   Zhang X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17916-9
   Zhang X, 2019, J PROTEOME RES, V18, P2370, DOI 10.1021/acs.jproteome.9b00054
NR 17
TC 6
Z9 6
U1 2
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD MAY 4
PY 2021
VL 93
IS 17
BP 6594
EP 6598
DI 10.1021/acs.analchem.1c00962
EA APR 2021
PG 5
WC Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA RZ3OF
UT WOS:000648505900004
PM 33885279
OA Green Submitted, Bronze
DA 2023-09-14
ER

PT J
AU Corral-Jara, KF
   Nuthikattu, S
   Rutledge, J
   Villablanca, A
   Morand, C
   Schroeter, H
   Milenkovic, D
AF Corral-Jara, Karla Fabiola
   Nuthikattu, Saivageethi
   Rutledge, John
   Villablanca, Amparo
   Morand, Christine
   Schroeter, Hagen
   Milenkovic, Dragan
TI Integrated Multi-Omic Analyses of the Genomic Modifications by Gut
   Microbiome-Derived Metabolites of Epicatechin, 5-(4
   '-Hydroxyphenyl)-gamma-Valerolactone, in TNFalpha-Stimulated Primary
   Human Brain Microvascular Endothelial Cells
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Article
DE valerolactones; epicatechin; genomics; multi-omics; lncRNA; brain
   endothelial cells; systems biology; nutrigenomics
AB Cerebral blood vessels are lined with endothelial cells and form the blood-brain barrier. Their dysfunction constitutes a crucial event in the physiopathology of neurodegenerative disorders and cognitive impairment. Epicatechin can improve cognitive functions and lower the risk for Alzheimer's disease or stroke. However, molecular mechanisms of epicatechin on brain vascular endothelium are still unexplored. The objective of this study was to investigate the biological effects of gut microbiome-derived metabolites of epicatechin, 5-(4 '-Hydroxyphenyl)-gamma-valerolactone-3 '-sulfate and 5-(4 '-Hydroxyphenyl)-gamma-valerolactone-3 '-O-glucuronide, in TNF-alpha-stimulated human brain microvascular endothelial cells at low (nM) concentrations by evaluating their multi-omic modification (expression of mRNA, microRNA, long non-coding RNAs, and proteins). We observed that metabolites are biologically active and can simultaneously modulate the expression of protein-coding and non-coding genes as well as proteins. Integrative bioinformatics analysis of obtained data revealed complex networks of genomics modifications by acting at different levels of regulation. Metabolites modulate cellular pathways including cell adhesion, cytoskeleton organization, focal adhesion, signaling pathways, pathways regulating endothelial permeability, and interaction with immune cells. This study demonstrates multimodal mechanisms of action by which epicatechin metabolites could preserve brain vascular endothelial cell integrity, presenting mechanisms of action underlying epicatechin neuroprotective properties.
C1 [Corral-Jara, Karla Fabiola; Morand, Christine; Milenkovic, Dragan] Univ Clermont Auvergne, INRAE, UNH, St Genes Champanelle, France.
   [Nuthikattu, Saivageethi; Rutledge, John; Villablanca, Amparo; Milenkovic, Dragan] Univ Calif Davis, Div Cardiovasc Med, Davis, CA 95616 USA.
   [Schroeter, Hagen] Mars Inc, Mclean, VA USA.
C3 Universite Clermont Auvergne (UCA); INRAE; University of California
   System; University of California Davis; Mars
RP Milenkovic, D (corresponding author), Univ Clermont Auvergne, INRAE, UNH, St Genes Champanelle, France.; Milenkovic, D (corresponding author), Univ Calif Davis, Div Cardiovasc Med, Davis, CA 95616 USA.
EM dragan.milenkovic@inrae.fr
OI Corral-Jara, Karla F./0000-0001-8608-4986; Milenkovic,
   Dragan/0000-0001-6353-0912; Schroeter, Hagen/0000-0001-6569-382X
FU Auvergne-Rhone-Alpes region as part of the AUDACE project ICARES
   (Identification and Characterization of Non-coding RNAs Under Stress
   Conditions) - CPER2017 [17 011085 01]
FX KC received fellowship from Auvergne-Rhone-Alpes region as part of the
   AUDACE project ICARES (Identification and Characterization of Non-coding
   RNAs Under Stress Conditions) supported by the CPER2017; projet number
   17 011085 01.
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Hernandez-Romero IA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01091
   Angelino D, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112678
   Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323
   Barrera-Reyes PK, 2020, PLANT FOOD HUM NUTR, V75, P1, DOI 10.1007/s11130-019-00779-x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Brickman AM, 2014, NAT NEUROSCI, V17, P1798, DOI 10.1038/nn.3850
   Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35
   Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757
   Chistiakov DA, 2017, ACTA PHYSIOL, V219, P382, DOI 10.1111/apha.12725
   Choy KW, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01295
   Claude S, 2014, MOL NUTR FOOD RES, V58, P1016, DOI 10.1002/mnfr.201300658
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   Deng SM, 2017, ARTERIOSCL THROM VAS, V37, P280, DOI 10.1161/ATVBAHA.116.308378
   Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213
   Dong H, 2016, BIOMARKERS, V21, P129, DOI 10.3109/1354750X.2015.1118544
   Fang YW, 2016, GENOM PROTEOM BIOINF, V14, P42, DOI 10.1016/j.gpb.2015.09.006
   Figueira I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11512-6
   Fukunaga T, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00462
   Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107
   Izawa Y, 2018, J CEREBR BLOOD F MET, V38, P641, DOI 10.1177/0271678X17722108
   Jasaitis A, 2012, BIOPHYS J, V103, P175, DOI 10.1016/j.bpj.2012.06.009
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Karim N, 2019, J PROTEOMICS, V201, P104, DOI 10.1016/j.jprot.2019.04.007
   Klotz L, 2007, J NEUROIMMUNOL, V190, P34, DOI 10.1016/j.jneuroim.2007.07.017
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lamport DJ, 2015, PSYCHOPHARMACOLOGY, V232, P3227, DOI 10.1007/s00213-015-3972-4
   Li HB, 2019, ONCOTARGETS THER, V12, P11701, DOI 10.2147/OTT.S220998
   Li X, 2018, INT J ONCOL, V53, P551, DOI 10.3892/ijo.2018.4418
   Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247
   Mena P, 2019, NAT PROD REP, V36, P714, DOI 10.1039/c8np00062j
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468
   Milenkovic D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33959-x
   Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032
   Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y
   Nehlig A, 2013, BRIT J CLIN PHARMACO, V75, P716, DOI 10.1111/j.1365-2125.2012.04378.x
   Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8
   Ottaviani JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep29034
   Palmer AM, 2011, J ALZHEIMERS DIS, V24, P643, DOI 10.3233/JAD-2011-110368
   Phanstiel DH, 2014, BIOINFORMATICS, V30, P2808, DOI 10.1093/bioinformatics/btu379
   Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854
   Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Shah J, 2018, CELL REP, V25, P2132, DOI 10.1016/j.celrep.2018.10.088
   Sokolov AN, 2013, NEUROSCI BIOBEHAV R, V37, P2445, DOI 10.1016/j.neubiorev.2013.06.013
   Solanki L, 2015, ADV NUTR, V6, P64, DOI 10.3945/an.114.007500
   Su Gang, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0813s47
   Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Tarantini S, 2017, EXP GERONTOL, V94, P52, DOI 10.1016/j.exger.2016.11.004
   Vogiatzoglou A, 2015, FREE RADICAL BIO MED, V84, P1, DOI 10.1016/j.freeradbiomed.2015.03.005
   Wang J, 2014, J ALZHEIMERS DIS, V41, P643, DOI 10.3233/JAD-132231
   Widlansky ME, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708046
   Wimmer I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00711
   Wu DS, 2015, J CEREBR BLOOD F MET, V35, P412, DOI 10.1038/jcbfm.2014.207
   Zhang Y, 2018, MED SCI MONITOR, V24, P7424, DOI 10.12659/MSM.910601
NR 56
TC 12
Z9 12
U1 1
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD MAR 26
PY 2021
VL 15
AR 622640
DI 10.3389/fnins.2021.622640
PG 22
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA RK4DA
UT WOS:000638246900001
PM 33841078
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Nguyen, VD
   Nguyen, TT
   Pham, TT
   Packianather, M
   Le, CH
AF Van Duy Nguyen
   Thanh Tra Nguyen
   Thu Thuy Pham
   Packianather, Michael
   Chi Hieu Le
TI Molecular screening and genetic diversity analysis of anticancer
   Azurin-encoding and Azurin-like genes in human gut microbiome deduced
   through cultivation-dependent and cultivation-independent studies
SO INTERNATIONAL MICROBIOLOGY
LA English
DT Article
DE Anticancer proteins; Azurin; Cancer therapy; Genetic diversity;
   Microbiome; NCI in vitro screening
ID NON-HDM2-MEDIATED PEPTIDE INHIBITOR; BACTERIAL CUPREDOXIN AZURIN; P53
   UBIQUITINATION; MARINE-BACTERIA; COMMUNITIES; APOPTOSIS; PRODUCTS;
   TRIAL; P-28
AB Azurin, a bacteriocin produced by a human gut bacterium Pseudomonas aeruginosa, can reveal selectively cytotoxic and induce apoptosis in cancer cells. After overcoming two phase I trials, a functional region of Azurin called p28 has been approved as a drug for the treatment of brain tumor glioma by FDA. The present study aims to improve a screening procedure and assess genetic diversity of Azurin genes in P. aeruginosa and Azurin-like genes in the gut microbiome of a specific population in Vietnam and global populations. Firstly, both cultivation-dependent and cultivation-independent techniques based on genomic and metagenomic DNAs extracted from fecal samples of the healthy specific population were performed and optimized to detect Azurin genes. Secondly, the Azurin gene sequences were analyzed and compared with global populations by using bioinformatics tools. Finally, the screening procedure improved from the first step was applied for screening Azurin-like genes, followed by the protein synthesis and NCI in vitro screening for anticancer activity. As a result, this study has successfully optimized the annealing temperatures to amplify DNAs for screening Azurin genes and applying to Azurin-like genes from human gut microbiota. The novelty of this study is the first of its kind to classify Azurin genes into five different genotypes at a global scale and confirm the potential anticancer activity of three Azurin-like synthetic proteins (Cnazu1, Dlazu11, and Ruazu12). The results contribute to the procedure development applied for screening anticancer proteins from human microbiome and a comprehensive understanding of their therapeutic response at a genetic level.
C1 [Van Duy Nguyen; Thanh Tra Nguyen; Thu Thuy Pham] Nha Trang Univ, Inst Biotechnol & Environm, Nha Trang, Vietnam.
   [Van Duy Nguyen; Packianather, Michael] Cardiff Univ, Sch Engn, Cardiff, Wales.
   [Van Duy Nguyen; Chi Hieu Le] Univ Greenwich, Fac Engn & Sci, Chatham, Kent, England.
C3 Nha Trang University; Cardiff University; University of Greenwich
RP Nguyen, VD (corresponding author), Nha Trang Univ, Inst Biotechnol & Environm, Nha Trang, Vietnam.; Nguyen, VD (corresponding author), Cardiff Univ, Sch Engn, Cardiff, Wales.; Nguyen, VD (corresponding author), Univ Greenwich, Fac Engn & Sci, Chatham, Kent, England.
EM duynv@ntu.edu.vn
RI Van, Duy Nguyen/B-6254-2011
OI Van, Duy Nguyen/0000-0001-5503-2446; Packianather,
   Michael/0000-0002-9436-8206; Pham, Thu Thuy/0009-0009-1416-267X
FU Vietnam National Foundation for Science and Technology Development
   (NAFOSTED) [106-YS.04-2014.40]
FX This work was supported by a grant no. 106-YS.04-2014.40 from the
   Vietnam National Foundation for Science and Technology Development
   (NAFOSTED) to VDN.
CR [Anonymous], 2016, WORLD CANC REPORT 20
   [Anonymous], 2015, WORLD CANC REPORT 20
   [Anonymous], 1999, NUCL ACIDS S SERIES
   ARVIDSSON RHA, 1989, EUR J BIOCHEM, V179, P195, DOI 10.1111/j.1432-1033.1989.tb14540.x
   Baindara P, 2018, APPL MICROBIOL BIOT, V102, P10393, DOI 10.1007/s00253-018-9420-8
   Bernardes N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069023
   Bernardes N, 2013, APPL MICROBIOL BIOT, V97, P5189, DOI 10.1007/s00253-013-4926-6
   Bhoo-Pathy N, 2017, EUR J CANCER, V74, P26, DOI 10.1016/j.ejca.2016.12.014
   Chakrabarty AM, 2014, ADV EXP MED BIOL, V808, P41, DOI 10.1007/978-81-322-1774-9_4
   Nguyen C, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8490482
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Fialho AM, 2007, CURR OPIN BIOTECH, V18, P279, DOI 10.1016/j.copbio.2007.04.001
   Fialho AM, 2016, AIMS MICROBIOL, V2, P292, DOI 10.3934/microbiol.2016.3.292
   Fialho AM, 2012, RECENT PAT ANTI-CANC, V7, P31
   Forman D, 2015, CANC INCIDENCE 5 CON, VX
   FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870
   Gao M, 2017, PROTEIN SCI, V26, P2334, DOI 10.1002/pro.3310
   Giraffa G, 2001, INT J FOOD MICROBIOL, V67, P19, DOI 10.1016/S0168-1605(01)00445-7
   Ishii K, 2001, APPL ENVIRON MICROB, V67, P3753, DOI 10.1128/AEM.67.8.3753-3755.2001
   Jia L, 2011, CANCER CHEMOTH PHARM, V68, P513, DOI 10.1007/s00280-010-1518-3
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426
   Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lulla RR, 2016, NEURO-ONCOLOGY, V18, P1319, DOI 10.1093/neuonc/now047
   Mehta N, 2017, MOL THER-ONCOLYTICS, V4, P1, DOI 10.1016/j.omto.2016.12.003
   Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002
   Nocker A, 2007, MICROB ECOL, V54, P276, DOI 10.1007/s00248-006-9199-5
   Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054
   Punj V, 2004, ONCOGENE, V23, P2367, DOI 10.1038/sj.onc.1207376
   Ranjard L, 2000, RES MICROBIOL, V151, P167, DOI 10.1016/S0923-2508(00)00136-4
   Sacoman JL, 2008, BRAZ J MED BIOL RES, V41, P411, DOI 10.1590/S0100-879X2008000500010
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Samarakoon SR, 2017, BIOMED RES INT-UK, V2017, DOI 10.1155/2017/9854083
   Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7
   Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951
   TAMURA K, 1992, MOL BIOL EVOL, V9, P678
   Pham TT, 2014, THAI J VET MED, V44, P345
   Nguyen VD, 2015, ADV INTELL SYST, V358, P219, DOI 10.1007/978-3-319-17996-4_20
   Nguyen VD, 2014, FISH SHELLFISH IMMUN, V40, P49, DOI 10.1016/j.fsi.2014.06.017
   Vargas E, 2017, MOLECULES, V22, DOI 10.3390/molecules22122041
   Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997
   Warso MA, 2013, BRIT J CANCER, V108, P1061, DOI 10.1038/bjc.2013.74
   Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727
   Yamada T, 2004, P NATL ACAD SCI USA, V101, P4770, DOI 10.1073/pnas.0400899101
   Yamada T, 2011, J CLIN ONCOL, V29
   Zhang Z, 2017, ONCOTARGET, V8, P43091, DOI 10.18632/oncotarget.17759
NR 48
TC 3
Z9 3
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1139-6709
EI 1618-1905
J9 INT MICROBIOL
JI Int. Microbiol.
PD DEC
PY 2019
VL 22
IS 4
BP 437
EP 449
DI 10.1007/s10123-019-00070-8
PG 13
WC Biotechnology & Applied Microbiology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Microbiology
GA KI9CV
UT WOS:000511655200005
PM 30895406
DA 2023-09-14
ER

PT J
AU Mathieu, S
   Touvrey-Loiodice, M
   Poulet, L
   Drouillard, S
   Vincentelli, R
   Henrissat, B
   Skjak-Braek, G
   Helbert, W
AF Mathieu, Sophie
   Touvrey-Loiodice, Melanie
   Poulet, Laurent
   Drouillard, Sophie
   Vincentelli, Renaud
   Henrissat, Bernard
   Skjak-Braek, Gudmund
   Helbert, William
TI Ancient acquisition of "alginate utilization loci" by human gut
   microbiota
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POLYSACCHARIDE UTILIZATION LOCI; CARBOHYDRATE-ACTIVE ENZYMES;
   FUNCTIONAL-CHARACTERIZATION; OLIGOALGINATE LYASE; HYDROLASE FAMILY;
   MARINE BACTERIUM; GENOME SEQUENCE; PROTEIN; CLASSIFICATION; SUBFAMILIES
AB In bacteria from the phylum Bacteroidetes, the genes coding for enzymes involved in polysaccharide degradation are often colocalized and coregulated in so-called "polysaccharide utilization loci" (PULs). PULs dedicated to the degradation of marine polysaccharides (e.g. laminaran, ulvan, alginate and porphyran) have been characterized in marine bacteria. Interestingly, the gut microbiome of Japanese individuals acquired, by lateral transfer from marine bacteria, the genes involved in the breakdown of porphyran, the cell wall polysaccharide of the red seaweed used in maki. Sequence similarity analyses predict that the human gut microbiome also encodes enzymes for the degradation of alginate, the main cell wall polysaccharide of brown algae. We undertook the functional characterization of diverse polysaccharide lyases from family PL17, frequently found in marine bacteria as well as those of human gut bacteria. We demonstrate here that this family is polyspecific. Our phylogenetic analysis of family PL17 reveals that all alginate lyases, which have all the same specificity and mode of action, cluster together in a very distinct subfamily. The alginate lyases found in human gut bacteria group together in a single clade which is rooted deeply in the PL17 tree. These enzymes were found in PULs containing PL6 enzymes, which also clustered together in the phylogenetic tree of PL6. Together, biochemical and bioinformatics analyses suggest that acquisition of this system appears ancient and, because only traces of two successful transfers were detected upon inspection of PL6 and PL17 families, the pace of acquisition of marine polysaccharide degradation system is probably very slow.
C1 [Mathieu, Sophie; Touvrey-Loiodice, Melanie; Poulet, Laurent; Drouillard, Sophie; Helbert, William] CNRS, CERMAV, BP53, F-38000 Grenoble 9, France.
   [Mathieu, Sophie; Touvrey-Loiodice, Melanie; Poulet, Laurent; Drouillard, Sophie; Helbert, William] Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France.
   [Vincentelli, Renaud; Henrissat, Bernard] Univ Aix Marseille, CNRS, UMR7257, F-13288 Marseille, France.
   [Vincentelli, Renaud; Henrissat, Bernard] INRA, USC AFMB 1408, F-13288 Marseille, France.
   [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia.
   [Skjak-Braek, Gudmund] Norwegian Univ Sci & Technol, Dept Biotechnol, NTNU Sem Saelands Vei 6-8, N-7491 Trondheim, Norway.
C3 Centre National de la Recherche Scientifique (CNRS); UDICE-French
   Research Universities; Communaute Universite Grenoble Alpes; Universite
   Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French
   Research Universities; Universite Grenoble Alpes (UGA); UDICE-French
   Research Universities; Aix-Marseille Universite; Centre National de la
   Recherche Scientifique (CNRS); CNRS - National Institute for Biology
   (INSB); INRAE; King Abdulaziz University; Norwegian University of
   Science & Technology (NTNU)
RP Helbert, W (corresponding author), CNRS, CERMAV, BP53, F-38000 Grenoble 9, France.; Helbert, W (corresponding author), Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France.
EM william.helbert@cermav.cnrs.fr
RI Henrissat, Bernard/J-2475-2012
OI Henrissat, Bernard/0000-0002-3434-8588; Poulet,
   Laurent/0000-0003-2795-4122
FU Brittany Regional Council; OSEO as part of the FUI-AAP14 "Poly-mer"
   project; French National Research agency [ANR-14-CE06-0017-01]; Cross
   Disciplinary Program Glyco@Alps program [ANR-15-IDEX-02]
FX The research leading to these results received funding from Brittany
   Regional Council and OSEO as part of the FUI-AAP14 "Poly-mer" project
   and from the French National Research agency under the grant
   ANR-14-CE06-0017-01. WH acknowledges the Cross Disciplinary Program
   Glyco@Alps program (ANR-15-IDEX-02). S.M. was funded by the Brittany
   Regional Council and OSEO as part of the FUI-AAP14 "Poly-mer" project.
   L.P. was funded the French National Research agency under the grant
   ANR-14-CE06-0017-01.
CR Aarstad OA, 2012, BIOMACROMOLECULES, V13, P106, DOI 10.1021/bm2013026
   Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186
   Barreteau H, 2012, CARBOHYD RES, V360, P19, DOI 10.1016/j.carres.2012.07.013
   Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021
   DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9
   De Marino S, 2003, J NAT PROD, V66, P515, DOI 10.1021/np0205046
   Draget K. I., 2005, Polysaccharides and polyamides in the food industry: properties, production, and patents, P1
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fer M, 2012, J MICROBIOL METH, V89, P222, DOI 10.1016/j.mimet.2012.03.004
   Foran E, 2017, ALGAL RES, V25, P39, DOI 10.1016/j.algal.2017.04.036
   Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003
   Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Guo SJ, 2000, PHYTOCHEMISTRY, V53, P861, DOI 10.1016/S0031-9422(99)00422-7
   Hahnke RL, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0032-y
   HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691
   Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3
   Jagtap SS, 2014, APPL ENVIRON MICROB, V80, P4207, DOI 10.1128/AEM.01285-14
   Kabisch A, 2014, ISME J, V8, P1492, DOI 10.1038/ismej.2014.4
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Khan SS, 2014, PHYTOMEDICINE, V21, P379, DOI 10.1016/j.phymed.2013.09.009
   Kraiwattanapong J, 1997, BIOSCI BIOTECH BIOCH, V61, P1853, DOI 10.1271/bbb.61.1853
   Li MM, 2017, MAR DRUGS, V15, DOI 10.3390/md15040092
   Liu L, 2012, GENOMICS, V100, P265, DOI 10.1016/j.ygeno.2012.07.012
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185
   MacDonald LC, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0455-8
   Mann AJ, 2013, APPL ENVIRON MICROB, V79, P6813, DOI 10.1128/AEM.01937-13
   Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848
   Mathieu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159415
   McDonald AG, 2014, FEBS J, V281, P583, DOI 10.1111/febs.12530
   Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15
   Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725
   Park D, 2014, J BIOL CHEM, V289, P8645, DOI 10.1074/jbc.M113.531111
   Park HH, 2012, MAR BIOTECHNOL, V14, P189, DOI 10.1007/s10126-011-9402-7
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Shin JW, 2015, KOREAN J CHEM ENG, V32, P917, DOI 10.1007/s11814-014-0282-1
   St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051
   Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044
   Sun C, 2016, APPL ENVIRON MICROB, V82, P2975, DOI 10.1128/AEM.00204-16
   Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022
   Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716
   Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x
   Voutquenne-Nazabadioko L, 2013, PHYTOCHEMISTRY, V90, P114, DOI 10.1016/j.phytochem.2013.03.001
   Wang LN, 2015, BIOTECHNOL LETT, V37, P665, DOI 10.1007/s10529-014-1706-z
   Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929
   Xing P, 2015, ISME J, V9, P1410, DOI 10.1038/ismej.2014.225
   Xua W., 2010, HELV CHIM ACTA, V93, P2017
   Yang XM, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw079
NR 53
TC 27
Z9 27
U1 1
U2 46
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 23
PY 2018
VL 8
AR 8075
DI 10.1038/s41598-018-26104-1
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GG6EO
UT WOS:000432789300053
PM 29795267
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Simopoulos, CMA
   Ning, ZB
   Li, LY
   Khamis, MM
   Zhang, X
   Lavallee-Adam, M
   Figeys, D
AF Simopoulos, Caitlin M. A.
   Ning, Zhibin
   Li, Leyuan
   Khamis, Mona M.
   Zhang, Xu
   Lavallee-Adam, Mathieu
   Figeys, Daniel
TI MetaProClust-MS1: an MS1 Profiling Approach for Large-Scale Microbiome
   Screening
SO MSYSTEMS
LA English
DT Article
DE MS1-only; microbiome; metaproteomics; drug screening; bioinformatics;
   unsupervised learning; clustering; mass spectrometry; proteomics;
   machine learning
ID MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; METAPROTEOMICS; GUIDELINES;
   PLATFORM
AB Metaproteomics is used to explore the functional dynamics of microbial communities. However, acquiring metaproteomic data by tandem mass spectrometry (MS/MS) is time-consuming and resource-intensive, and there is a demand for computational methods that can be used to reduce these resource requirements. We present MetaProClust-MS1, a computational framework for microbiome feature screening developed to prioritize samples for follow-up MS/MS. In this proof-of-concept study, we tested and compared MetaProClust-MS1 results on gut microbiome data, from fecal samples, acquired using short 15-min MS1-only chromatographic gradients and MS1 spectra from longer 60-min gradients to MS/MS-acquired data. We found that MetaProClust-MS1 identified robust gut microbiome responses caused by xenobiotics with significantly correlated cluster topologies of comparable data sets. We also used MetaProClust-MS1 to reanalyze data from both a clinical MS/MS diagnostic study of pediatric patients with inflammatory bowel disease and an experiment evaluating the therapeutic effects of a small molecule on the brain tissue of Alzheimer's disease mouse models. MetaProClust-MS1 clusters could distinguish between inflammatory bowel disease diagnoses (ulcerative colitis and Crohn's disease) using samples from mucosal luminal interface samples and identified hippocampal proteome shifts of Alzheimer's disease mouse models after small-molecule treatment. Therefore, we demonstrate that MetaProClust-MS1 can screen both microbiomes and single-species proteomes using only MS1 profiles, and our results suggest that this approach may be generalizable to any proteomics experiment. MetaProClust-MS1 may be especially useful for large-scale metaproteomic screening for the prioritization of samples for further metaproteomic characterization, using MS/MS, for instance, in addition to being a promising novel approach for clinical diagnostic screening.
   IMPORTANCE Growing evidence suggests that human gut microbiome composition and function are highly associated with health and disease. As such, high-throughput metaproteomic studies are becoming more common in gut microbiome research. However, using a conventional long liquid chromatography (LC)-MS/MS gradient metaproteomics approach as an initial screen in large-scale microbiome experiments can be slow and expensive. To combat this challenge, we introduce MetaProClust-MS1, a computational framework for microbiome screening using MS1-only profiles. In this proof-of-concept study, we show that MetaProClust-MS1 identifies clusters of gut microbiome treatments using MS1-only profiles similar to those identified using MS/MS. Our approach allows researchers to prioritize samples and treatments of interest for further metaproteomic analyses and may be generally applicable to any proteomic analysis. In particular, this approach may be especially useful for large-scale metaproteomic screening or in clinical settings where rapid diagnostic evidence is required.
C1 [Simopoulos, Caitlin M. A.; Ning, Zhibin; Li, Leyuan; Khamis, Mona M.; Zhang, Xu; Lavallee-Adam, Mathieu; Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada.
   [Simopoulos, Caitlin M. A.; Ning, Zhibin; Li, Leyuan; Khamis, Mona M.; Zhang, Xu; Lavallee-Adam, Mathieu; Figeys, Daniel] Univ Ottawa, Fac Med, Sch Pharmaceut Sci, Ottawa, ON, Canada.
   [Simopoulos, Caitlin M. A.; Ning, Zhibin; Li, Leyuan; Khamis, Mona M.; Zhang, Xu; Figeys, Daniel] Univ Ottawa, SIMM Univ Ottawa Joint Res Ctr Syst & Personalize, Ottawa, ON, Canada.
C3 University of Ottawa; University of Ottawa; University of Ottawa
RP Figeys, D (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada.; Figeys, D (corresponding author), Univ Ottawa, Fac Med, Sch Pharmaceut Sci, Ottawa, ON, Canada.; Figeys, D (corresponding author), Univ Ottawa, SIMM Univ Ottawa Joint Res Ctr Syst & Personalize, Ottawa, ON, Canada.
EM dfigeys@uottawa.ca
OI Simopoulos, Caitlin/0000-0001-9832-7797; Figeys,
   Daniel/0000-0002-5373-7546
FU Government of Canada through Genome Canada; Ontario Genomics Institute
   [OGI-156, OGI-149]; Natural Sciences and Engineering Research Council of
   Canada (NSERC) [210034]; Ontario Ministry of Economic Development and
   Innovation [ORF-DIG-14405, 13440]; NSERC discovery grant; NSERC CREATE
   in Technologies for Microbiome Science and Engineering (TECHNOMISE)
   Program
FX We thank Janice Mayne for her assistance in manuscript preparation. This
   work was funded by the Government of Canada through Genome Canada and
   the Ontario Genomics Institute (OGI-156 and OGI-149), the Natural
   Sciences and Engineering Research Council of Canada (NSERC) (grant
   number 210034), the Ontario Ministry of Economic Development and
   Innovation (ORF-DIG-14405 and project 13440), as well as an NSERC
   discovery grant to M.L.-A. C.M.A.S. was funded by a stipend from the
   NSERC CREATE in Technologies for Microbiome Science and Engineering
   (TECHNOMISE) Program. Conceptualization, C.M.A.S. and Z.N.; Methodology,
   C.M.A.S. and Z.N.; Software, C.M.A.S.; Investigation, C.M.A.S., Z.N.,
   L.L., M.M.K., and X.Z.; Formal Analysis, C.M.A.S.; Writing - Original
   Draft, C.M.A.S.; Writing - Review & Editing, C.M.A.S., Z.N., L.L.,
   M.M.K., X.Z., M.L.-A., and D.F.; Resources, D.F.; Supervision, M.L.-A.
   and D.F.; Funding Acquisition, D.F.
CR Adler P, 2019, J PROTEOME RES, V18, P3383, DOI 10.1021/acs.jproteome.9b00312
   [Anonymous], 2014, GENOME BIOL, DOI DOI 10.1186/S13059-014-0550-8
   Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271
   Biton A, 2014, CELL REP, V9, P1235, DOI 10.1016/j.celrep.2014.10.035
   Bryson S, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00027-15
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   Cheng K, 2020, J AM SOC MASS SPECTR, V31, P1473, DOI 10.1021/jasms.0c00083
   CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229
   Creese AJ, 2013, J AM SOC MASS SPECTR, V24, P431, DOI 10.1007/s13361-012-0544-2
   Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428
   Hastie T., 2019, IMPUTE IMPUTATION MI
   Ivanov MV, 2020, ANAL CHEM, V92, P4326, DOI 10.1021/acs.analchem.9b05095
   Ivanov MV, 2017, J PROTEOME RES, V16, P3989, DOI 10.1021/acs.jproteome.7b00365
   JAMES P, 1993, BIOCHEM BIOPH RES CO, V195, P58, DOI 10.1006/bbrc.1993.2009
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015
   Kleiner M, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00115-19
   Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li LY, 2020, GUT MICROBES, V11, P1348, DOI 10.1080/19490976.2020.1755413
   Li LY, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00806-z
   Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979
   MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605
   Meyer JG, 2020, NAT METHODS, V17, P1222, DOI 10.1038/s41592-020-00999-z
   Mirzayi C, 2021, NAT MED, V27, P1885, DOI 10.1038/s41591-021-01552-x
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   O'Brien JJ, 2018, ANN APPL STAT, V12, P2075, DOI 10.1214/18-AOAS1144
   PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   R Core Team, 2017, R LANG ENV STAT COMP
   Rechenberger J, 2019, PROTEOMES, V7, DOI 10.3390/proteomes7010002
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Rost HL, 2016, NAT METHODS, V13, P741, DOI [10.1038/NMETH.3959, 10.1038/nmeth.3959]
   Saelens W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03424-4
   Sastry AV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13483-w
   Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711
   Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846
   Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117
   Tanca A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0196-8
   Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715
   Van Riper SK, 2016, BIOINFORMATICS, V32, P2035, DOI 10.1093/bioinformatics/btw091
   YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514
   Zhang X, 2019, J PROTEOME RES, V18, P2370, DOI 10.1021/acs.jproteome.9b00054
   Zhang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05357-4
   Zhang X, 2017, ANAL CHEM, V89, P9407, DOI 10.1021/acs.analchem.7b02224
NR 46
TC 3
Z9 3
U1 1
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD AUG 30
PY 2022
VL 7
IS 4
DI 10.1128/msystems.00381-22
EA AUG 2022
PG 18
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 4F1JI
UT WOS:000841098200001
PM 35950762
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Cheng, K
   Ning, ZB
   Li, LY
   Zhang, X
   Serrana, JM
   Mayne, J
   Figeys, D
AF Cheng, Kai
   Ning, Zhibin
   Li, Leyuan
   Zhang, Xu
   Serrana, Joeselle M.
   Mayne, Janice
   Figeys, Daniel
TI Update on the Efficacy of Cognitive Rehabilitation After Moderate to
   Severe Traumatic Brain Injury: A Scoping Review
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE metaproteomics; human gut microbiome; isobaric labeling; label free;
   metagenome-assembled genomes; data analysis; software
ID PROTEOMICS; ULTRAFAST; STRATEGY
AB The studies of microbial communities have drawn increased attention in various research fields such as agriculture, environment, and human health. Recently, metaproteomics has become a powerful tool to interpret the roles of the community members by investigating the expressed proteins of the microbes. However, analyzing the metaproteomic data sets at genome resolution is still challenging because of the lack of efficient bioinformatics tools. Here we develop MetaLab-MAG, a specially designed tool for the characterization of microbiomes from metagenome-assembled genomes databases. MetaLab-MAG was evaluated by analyzing various human gut microbiota data sets and performed comparably or better than searching the gene catalog protein database directly. MetaLab-MAG can quantify the genome-level microbiota compositions and supports both label-free and isobaric labeling-based quantification strategies. MetaLab-MAG removes the obstacles of metaproteomic data analysis and provides the researchers with in-depth and comprehensive information from the microbiomes.
C1 [Cheng, Kai; Ning, Zhibin; Li, Leyuan; Zhang, Xu; Serrana, Joeselle M.; Mayne, Janice; Figeys, Daniel] Univ Ottawa, Fac Med, Sch Pharmaceut Sci, Ottawa, ON K1H 8M5, Canada.
C3 University of Ottawa
RP Figeys, D (corresponding author), Univ Ottawa, Fac Med, Sch Pharmaceut Sci, Ottawa, ON K1H 8M5, Canada.
EM dfigeys@uottawa.ca
RI Serrana, Joeselle/AAG-4072-2019
OI Serrana, Joeselle/0000-0002-6967-5407; Zhang, Xu/0000-0003-2406-9478;
   Figeys, Daniel/0000-0002-5373-7546; Cheng, Kai/0000-0002-6045-0244
FU Government of Canada through Genome Canada; Ontario Genomics Institute
   [OGI-156, OGI-149]; Natural Sciences and Engineering Research Council of
   Canada (NSERC) [210034]; Ontario Ministry of Economic Development and
   Innovation [ORF-DIG-14405, 13440]
FX This work was funded by the Government of Canada through Genome Canada
   and the Ontario Genomics Institute (OGI-156 and OGI-149), the Natural
   Sciences and Engineering Research Council of Canada (NSERC, grant no.
   210034), and the Ontario Ministry of Economic Development and Innovation
   (ORF-DIG-14405 and project 13440).
CR Almeida A, 2021, NAT BIOTECHNOL, V39, P105, DOI 10.1038/s41587-020-0603-3
   Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1
   Buchfink B, 2021, NAT METHODS, V18, P366, DOI 10.1038/s41592-021-01101-x
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cheng K, 2020, J AM SOC MASS SPECTR, V31, P1473, DOI 10.1021/jasms.0c00083
   Cheng K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0375-2
   Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236
   Chick JM, 2015, NAT BIOTECHNOL, V33, P743, DOI 10.1038/nbt.3267
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Jagtap PD, 2015, PROTEOMICS, V15, P3553, DOI 10.1002/pmic.201500074
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]
   Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656
   Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li L., 2021, BIORXIV, DOI [10.1101/2021.07.15.452564, DOI 10.1101/2021.07.15.452564]
   Li LY, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00806-z
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Mesuere B, 2012, J PROTEOME RES, V11, P5773, DOI 10.1021/pr300576s
   Mitchell AL, 2020, NUCLEIC ACIDS RES, V48, pD570, DOI 10.1093/nar/gkz1035
   Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419
   Muth T, 2015, J PROTEOME RES, V14, P1557, DOI 10.1021/pr501246w
   Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x
   Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200
   Schape SS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120641
   Shen XM, 2017, J PROTEOME RES, V16, P2445, DOI 10.1021/acs.jproteome.7b00061
   Stamboulian M, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01035-8
   Stewart RD, 2019, NAT BIOTECHNOL, V37, P953, DOI 10.1038/s41587-019-0202-3
   Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560
   Van den Bossche T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27542-8
   Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109
   Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595
   Witkowski M, 2020, CIRC RES, V127, P553, DOI 10.1161/CIRCRESAHA.120.316242
   Zhang X., 2022, BIORXIV, DOI [10.1101/2022.07.30.502163, DOI 10.1101/2022.07.30.502163]
   Zhang X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17916-9
   Zhang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05357-4
   Zhang X, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0176-z
NR 41
TC 0
Z9 0
U1 3
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD FEB 3
PY 2023
VL 22
IS 2
BP 387
EP 398
DI 10.1021/acs.jproteome.2c00554387J
PG 12
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA C9JD8
UT WOS:000964989300001
PM 36508259
DA 2023-09-14
ER

PT J
AU Ling, YW
   Watanabe, Y
   Okuda, S
AF Ling, Yiwei
   Watanabe, Yu
   Okuda, Shujiro
TI The Human Gut Microbiome is Structured to Optimize Molecular Interaction
   Networks
SO COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE Microbiome; Molecular interaction networks; Human gut; Metagenomics;
   Interspecific interaction
ID CATALOG
AB Microbiome studies estimate the functions of bacterial flora in situ on the basis of species composition and gene function; however, estimation of interspecies interaction networks is challenging. This study aimed to develop a method to predict the interaction networks among bacterial species from human gut metagenome data using bioinformatics methods. Our proposed method revealed that adjacent gene pairs involved in bacterial interspedes interactions are localized at boundary regions and encode membrane proteins mediating interactions between the intracellular and extracellular environments, e.g., transporters and channel proteins, and those mediating interactions between metabolic pathways. Actual human gut metagenome data displayed numerous such highly reliable interspedes interaction gene pairs in comparison with random simulated metagenome data sets, suggesting that the species composition of the actual microbiome facilitated more robust interspecific interactions. The present results indicate that molecular interaction networks in human gut flora are organized by a combination of interaction networks common to all individuals and group-specific interaction networks. (C) 2019 The Authors. Published by Elsevier B.V. behalf of Research Network of Computational and Structural Biotechnology.
C1 [Ling, Yiwei; Watanabe, Yu; Okuda, Shujiro] Niigata Univ, Grad Sch Med & Dent Sci, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.
C3 Niigata University
RP Okuda, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.
EM okd@med.niigata-u.ac.jp
RI Okuda, Shujiro/D-1700-2016
OI Okuda, Shujiro/0000-0002-7704-8104
FU Japan Society for the Promotion of Science (JSPS) [26700029]; Yakult
   Bio-Science Foundation; Institute for Fermentation, Osaka (IFO);
   Grants-in-Aid for Scientific Research [26700029] Funding Source: KAKEN
FX We thank Dr. Takuji Yamada, Dr. YukiMoriya, and Professor Susumu Goto
   for technical support and discussion. This study was partly supported by
   the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for
   Scientific Research Grant number 26700029, Yakult Bio-Science
   Foundation, and Institute for Fermentation, Osaka (IFO).
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   [Anonymous], SCIENCE
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058
   Braga RM, 2016, BRAZ J MICROBIOL, V47, P86
   Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109
   Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721
   Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Karp P. D., 2017, BRIEF BIOINFORM
   Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018
   Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Mahadevan R, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210008
   Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321
   Nakanishi Y, 2011, J PROTEOME RES, V10, P824, DOI 10.1021/pr100989c
   Pallister T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13722-4
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185
   Suzuki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103833
   Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400
   Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621
   Tiso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119712
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Venturelli OS, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178157
   von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Yamada C, 2017, CELL CHEM BIOL, V24, P515, DOI 10.1016/j.chembiol.2017.03.012
NR 31
TC 5
Z9 6
U1 3
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2001-0370
J9 COMPUT STRUCT BIOTEC
JI Comp. Struct. Biotechnol. J..
PY 2019
VL 17
BP 1040
EP 1046
DI 10.1016/j.csbj.2019.07.011
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA JY1TU
UT WOS:000504205700103
PM 31452856
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Majta, J
   Odrzywolek, K
   Milanovic, B
   Hubar, V
   Wrobel, S
   Strycharz-Angrecka, E
   Wojciechowski, S
   Milanowska, K
AF Majta, Jan
   Odrzywolek, Krzysztof
   Milanovic, Bozena
   Hubar, Vladyslav
   Wrobel, Sonia
   Strycharz-Angrecka, Emilia
   Wojciechowski, Szymon
   Milanowska, Kaja
TI Identification of Differentiating Metabolic Pathways between Infant Gut
   Microbiome Populations Reveals Depletion of Function-Level Adaptation to
   Human Milk in the Finnish Population
SO MSPHERE
LA English
DT Article
DE bioinformatics; gut microbiome; infant microbiome; machine learning;
   microbiome
ID OLIGOSACCHARIDES; TYPE-1; CONSUMPTION; NUTRIENTS; DELIVERY; HEALTH
AB A variety of autoimmune and allergy events are becoming increasingly common, especially in Western countries. Some pieces of research link such conditions with the composition of microbiota during infancy. In this period, the predominant form of nutrition for gut microbiota is oligosaccharides from human milk (HMO). A number of gut-colonizing strains, such as Bifidobacterium and Bacteroides, are able to utilize HMO, but only some Bifidobacterium strains have evolved to digest the specific composition of human oligosaccharides. Differences in the proportions of the two genera that are able to utilize HMO have already been associated with the frequency of allergies and autoimmune diseases in the Finnish and the Russian populations. Our results show that differences in terms of the taxonomic annotation do not explain the reason for the differences in the Bifidobacterium/Bacteroides ratio between the Finnish and the Russian populations. In this paper, we present the results of function-level analysis. Unlike the typical workflow for gene abundance analysis, BiomeScout technology explains the differences in the Bifidobacterium/Bacteroides ratio. Our research shows the differences in the abundances of the two enzymes that are crucial for the utilization of short type 1 oligosaccharides.
   IMPORTANCE Knowing the limitations of taxonomy-based research, there is an emerging need for the development of higher-resolution techniques. The significance of this research is demonstrated by the novel method used for the analysis of function-level metagenomes. BiomeScout-the presented technology-utilizes proprietary algorithms for the detection of differences between functionalitie spresent in metagenomic samples.
C1 [Majta, Jan; Odrzywolek, Krzysztof; Milanovic, Bozena; Hubar, Vladyslav; Wrobel, Sonia; Strycharz-Angrecka, Emilia; Wojciechowski, Szymon; Milanowska, Kaja] Ardigen, Krakow, Poland.
   [Majta, Jan] Jagiellonian Univ, Dept Computat Biophys & Bioinformat, Fac Biochem Biophys & Biotechnol, Krakow, Poland.
   [Odrzywolek, Krzysztof] AGH Univ Sci & Technol, Fac Comp Sci, Dept Comp Sci Elect & Telecommun, Krakow, Poland.
   [Milanovic, Bozena] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland.
   [Hubar, Vladyslav] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland.
   [Wrobel, Sonia] Jagiellonian Univ, Inst Phys Astron & Appl Comp Sci, Dept Med Phys, Krakow, Poland.
C3 Jagiellonian University; AGH University of Krakow; Jagiellonian
   University; Jagiellonian University; Jagiellonian University
RP Milanowska, K (corresponding author), Ardigen, Krakow, Poland.
EM milanowska@ardigen.com
OI Odrzywolek, Krzysztof/0000-0001-6938-4418; Milanowska-Zabel,
   Kaja/0000-0002-2187-7616; Wrobel, Sonia/0000-0002-7921-2334; Augustyn,
   Bozena/0000-0001-7762-8021; Majta, Jan/0000-0001-9042-754X
FU NCRD Fast Track Grant [POIR.01.01.01-00-0347/17]
FX This work was funded by NCRD Fast Track Grant POIR.01.01.01-00-0347/17
   awarded to Ardigen S.A.
CR Addou S, 2009, J MOL BIOL, V387, P416, DOI 10.1016/j.jmb.2008.12.045
   [Anonymous], 2013, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0301S42, 10.1002/0471250953.bi0301s42]
   Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002
   Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14
   Bhargava P, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0492-2
   Bode L, 2016, NUTR REV, V74, P635, DOI 10.1093/nutrit/nuw025
   Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Casaburi G., 2018, HUM MICROBIOME J, V9, P7, DOI DOI 10.1016/J.HUMIC.2018.05.001
   D'Argenio V, 2015, CLIN CHIM ACTA, V451, P97, DOI 10.1016/j.cca.2015.01.003
   Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007
   Ghaisas S, 2016, PHARMACOL THERAPEUT, V158, P52, DOI 10.1016/j.pharmthera.2015.11.012
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019
   Henrick BM, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00041-18
   Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015
   Katayama T, 2016, BIOSCI BIOTECH BIOCH, V80, P621, DOI 10.1080/09168451.2015.1132153
   Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009
   Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10
   Lerner A., 2015, INT J CELIAC DIS, V3, P151, DOI [10.12691/ijcd-3-4-8, DOI 10.12691/IJCD-3-4-8]
   Li DH, 2016, METHODS, V102, P3, DOI 10.1016/j.ymeth.2016.02.020
   Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480
   Madan JC, 2016, JAMA PEDIATR, V170, P212, DOI 10.1001/jamapediatrics.2015.3732
   Marcobal A, 2012, CLIN MICROBIOL INFEC, V18, P12, DOI 10.1111/j.1469-0691.2012.03863.x
   Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17
   Mirdita M, 2017, NUCLEIC ACIDS RES, V45, pD170, DOI 10.1093/nar/gkw1081
   Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002
   Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008
   Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88
   Odamaki T, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/567809
   Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x
   Parnanen K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06393-w
   Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139
   Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739
   Thurl S, 1996, ANAL BIOCHEM, V235, P202, DOI 10.1006/abio.1996.0113
   Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156
   Urashima T, 2012, ADV NUTR, V3, p473S, DOI 10.3945/an.111.001412
   Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2
   Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007
   Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116
   Zhu CS, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1209
NR 48
TC 1
Z9 1
U1 1
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAR-APR
PY 2019
VL 4
IS 2
AR e00152-19
DI 10.1128/mSphereDirect.00152-19
PG 11
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA HU8MX
UT WOS:000465544000025
PM 30894435
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Beraza, N
AF Beraza, Naiara
TI Fibrosis and the intestinal microbiome; a focus on chronic liver disease
SO CURRENT OPINION IN PHARMACOLOGY
LA English
DT Article
ID HUMAN GUT MICROBIOME; CIRRHOTIC-PATIENTS; PERMEABILITY; TRANSPLANTATION;
   INFLAMMATION; ENDOTOXEMIA; DIVERSITY; DYSBIOSIS; LACTULOSE; EFFICACY
AB The role of the microbiome in progression of liver disease is an exciting area of research that is advancing rapidly supported by the development of next-generation sequencing and bioinformatics tools that simultaneously identify the composition and function of the microbiome. Changes in the microbiome are associated with pathogenesis of chronic liver disease; specifically, changes in microbiome composition predict disease severity and specific microbial signatures can be used to distinguish between mild disease, advanced fibrosis and cirrhosis. Future work combining functional metagenomic analysis with preclinical mechanistic studies will be key to advancing our understanding of how the microbiome affects the pathogenesis of different chronic liver disease aetiologies and to identify personalised therapeutics based on modulation of the microbiome and its function.
C1 [Beraza, Naiara] Quadram Inst Biosci, Gut Microbes & Hlth Inst, Strateg Programme, Norwich Res Pk, Norfolk NR4 7UQ, England.
C3 UK Research & Innovation (UKRI); Biotechnology and Biological Sciences
   Research Council (BBSRC); Quadram Institute
RP Beraza, N (corresponding author), Quadram Inst Biosci, Gut Microbes & Hlth Inst, Strateg Programme, Norwich Res Pk, Norfolk NR4 7UQ, England.
EM naiara.beraza@quadram.ac.uk
OI Beraza, Naiara/0000-0003-0718-0940
FU Biotechnology and Biological Sciences Research Council (BBSRC)
   [BB/J004529/1]; BBSRC [BBS/E/F/00044509, BB/R012490/1,
   BBS/E/F/000PR10355, BB/CCG1860/1]; BBSRC [BBS/E/F/00044509,
   BBS/E/F/000PR10355] Funding Source: UKRI
FX NB is funded by the Biotechnology and Biological Sciences Research
   Council (BBSRC) Institute Strategic Programme Gut Health and Food Safety
   BB/J004529/1, the BBSRC Gut Microbes and Health BBS/E/F/00044509, the
   BBSRC Institute Strategic Programme Gut Microbes and Health BB/R012490/1
   and its constituent project BBS/E/F/000PR10355, and the BBSRC Core
   Capability Grant BB/CCG1860/1.
CR Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Bajaj JS, 2019, GASTROENTEROLOGY, V156, P1921, DOI 10.1053/j.gastro.2019.01.033
   Bajaj JS, 2017, ALCOHOL CLIN EXP RES, V41, P1857, DOI 10.1111/acer.13498
   Bajaj JS, 2017, HEPATOLOGY, V66, P1727, DOI 10.1002/hep.29306
   Bajaj JS, 2015, HEPATOLOGY, V62, P1260, DOI 10.1002/hep.27819
   Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
   Beuers U, 2015, J HEPATOL, V62, pS25, DOI 10.1016/j.jhep.2015.02.023
   Bjornsson E, 2005, SCAND J GASTROENTERO, V40, P1090, DOI 10.1080/00365520510023288
   Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
   Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886
   Caussy C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09455-9
   Caussy C, 2017, J CLIN INVEST, V127, P2697, DOI 10.1172/JCI93465
   Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423
   Dhiman RK, 2000, DIGEST DIS SCI, V45, P1549, DOI 10.1023/A:1005556826152
   Di Leo V, 2003, EUR J GASTROEN HEPAT, V15, P967, DOI 10.1097/01.meg.0000085466.12407.e9
   Dyson JK, 2015, NAT REV GASTRO HEPAT, V12, P147, DOI 10.1038/nrgastro.2015.12
   Dyson JK, 2014, FRONTLINE GASTROENTE, V5, P211, DOI 10.1136/flgastro-2013-100403
   Fukui H, 2017, J CLIN TRANSL HEPATO, V5, P249, DOI 10.14218/JCTH.2017.00008
   Gronkjaer LL, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115601122
   Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3
   Iwasawa K, 2017, GUT, V66, P1344, DOI 10.1136/gutjnl-2016-312533
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Kao D, 2016, HEPATOLOGY, V63, P339, DOI 10.1002/hep.28121
   Kelly CR, 2015, GASTROENTEROLOGY, V149, P223, DOI 10.1053/j.gastro.2015.05.008
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Kummen M, 2017, GUT, V66, P611, DOI 10.1136/gutjnl-2015-310500
   Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Llopis M, 2016, GUT, V65, P830, DOI 10.1136/gutjnl-2015-310585
   Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011
   Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1
   Podolsky SH, 2012, LANCET, V380, P1810, DOI 10.1016/S0140-6736(12)62018-2
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Quraishi MN, 2017, GUT, V66, P386, DOI 10.1136/gutjnl-2016-311915
   Sabino J, 2016, GUT, V65, P1681, DOI 10.1136/gutjnl-2015-311004
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759
   Tandon P, 2008, SEMIN LIVER DIS, V28, P26, DOI 10.1055/s-2008-1040319
   Tang RQ, 2018, GUT, V67, P534, DOI 10.1136/gutjnl-2016-313332
   Torres J, 2016, ALIMENT PHARM THER, V43, P790, DOI 10.1111/apt.13552
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653
   Watanabe A, 1997, HEPATOLOGY, V26, P1410
   Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632
   Wiest R, 2017, J HEPATOL, V67, P1084, DOI 10.1016/j.jhep.2017.05.007
   Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206
   Wijdicks EFM, 2016, NEW ENGL J MED, V375, P1660, DOI 10.1056/NEJMra1600561
NR 50
TC 10
Z9 12
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4892
EI 1471-4973
J9 CURR OPIN PHARMACOL
JI Curr. Opin. Pharmacol.
PD DEC
PY 2019
VL 49
BP 76
EP 81
DI 10.1016/j.coph.2019.09.012
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA JW5IV
UT WOS:000503086500006
PM 31670055
DA 2023-09-14
ER

PT J
AU Aslam, M
   Shehroz, M
   Hizbullah
   Shah, M
   Khan, MA
   Afridi, SG
   Khan, A
AF Aslam, Muneeba
   Shehroz, Muhammad
   Hizbullah
   Shah, Mohibullah
   Khan, Munazza Ali
   Afridi, Sahib Gul
   Khan, Asifullah
TI Potential druggable proteins and chimeric vaccine construct
   prioritization against Brucella melitensis from species core genome data
SO GENOMICS
LA English
DT Article
DE B. melitensis; Druggable genome; Reverse vaccinology; Chimeric vaccine
   designing
ID INTERACTION NETWORKS; DRUG; DESIGN; CD4(+); GENES; MODEL; TOOL
AB The Brucella melitensis chronic infection and drug resistance emerged as a severe health problem in humans and domestic cattle. The pathogens fast genome sequences availability fetched the possibility to address novel therapeutics targets in a rationale way. We acquired the core genes set from 56 B. melitensis publically available complete genome sequences. A stringent bioinformatics layout of comparative genomics and reverse vaccinology was followed to identify potential druggable proteins and multi-epitope vaccine constructs from core genes. The 23 proteins were shortlisted as novel druggable targets based on their role in pathogen-specific metabolic pathways, non-homologous to human and human gut microbiome proteins and their druggability potential. Furthermore, potential chimeric vaccine constructs were generated from lead T and B-cell overlapped epitopes in combination with immune enhancer adjuvants and linkers sequences. The molecular docking and MD simulation analyses ensured stable molecular interaction of a finally prioritized vaccine construct with human immune cells receptors.
C1 [Aslam, Muneeba; Shehroz, Muhammad; Hizbullah; Khan, Munazza Ali; Afridi, Sahib Gul; Khan, Asifullah] Abdul Wali Khan Univ, Dept Biochem, Mardan 23200, Khyber Pakhtunk, Pakistan.
   [Shah, Mohibullah] Bahauddin Zakariya Univ Multan, Dept Biochem, Lahore, Punjab, Pakistan.
C3 Abdul Wali Khan University
RP Khan, A (corresponding author), Abdul Wali Khan Univ, Dept Biochem, Mardan 23200, Khyber Pakhtunk, Pakistan.
EM asifullah111@gmail.com
RI Shah, Mohibullah/X-8961-2019; Khan, Asifullah/AGU-9005-2022; Afridi,
   Sahib Gul/AGH-9949-2022
OI Shah, Mohibullah/0000-0001-6126-7102; 
FU Higher Education Commission of Pakistan; National Research Program for
   Universities (NRPU) [2017-18]
FX We acknowledge the Higher Education Commission of Pakistan for providing
   financial support under the National Research Program for Universities
   (NRPU) 2017-18.
CR Acha P.N., 2003, PARASITOSES, V3, P21
   Agasthya A S, 2007, Indian J Med Microbiol, V25, P28
   Ahmed RKS, 2009, METHODS MOL BIOL, V524, P427, DOI 10.1007/978-1-59745-450-6_31
   Ali S, 2013, FOODBORNE PATHOG DIS, V10, P500, DOI 10.1089/fpd.2012.1360
   Ammari MG, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw103
   Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495
   [Anonymous], 2011, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0017712.
   [Anonymous], 2012, DRUGBANK PRINC PHARM, DOI [10.1017/CBO9781139051194.008, DOI 10.1017/CBO9781139051194.008]
   Asadi FT, 2017, JPN J INFECT DIS, V70, P235, DOI 10.7883/yoken.JJID.2016.133
   Bald D, 2010, FEMS MICROBIOL LETT, V308, P1, DOI 10.1111/j.1574-6968.2010.01959.x
   Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Blom J, 2016, NUCLEIC ACIDS RES, V44, pW22, DOI 10.1093/nar/gkw255
   Borrel A, 2015, J CHEM INF MODEL, V55, P882, DOI 10.1021/ci5006004
   Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153
   Cassataro J, 2005, INFECT IMMUN, V73, P8079, DOI 10.1128/IAI.73.12.8079-8088.2005
   Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088
   Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396
   Counoupas C, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.12
   Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   EL-Manzalawy Y., 2009, PREDICTING FLEXIBLE, DOI [10.1142/9781848162648_0011, DOI 10.1142/9781848162648_0011.]
   El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893
   Eskra L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031747
   Falagas ME, 2006, ANTIMICROB AGENTS CH, V50, P22, DOI 10.1128/AAC.50.1.22-33.2006
   Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058
   Fleri W, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00278
   Ghaffari-Nazari H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142563
   Gomez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059751
   Gonzalez-Bello C, 2016, CURR TOP MED CHEM, V16, P960, DOI 10.2174/1568026615666150825142527
   Goodacre NF, 2014, MBIO, V5, DOI 10.1128/mBio.00744-13
   Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376
   Gupta R, 2017, GENOMICS, V109, P51, DOI 10.1016/j.ygeno.2016.11.005
   Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073957
   Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13
   Hao P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015964
   Hashim Rohaidah, 2014, Int J Microbiol, V2014, P596245, DOI 10.1155/2014/596245
   He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088
   He YQ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00002
   Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458
   Hizbullah, 2018, MICROB PATHOGENESIS, V125, P219, DOI 10.1016/j.micpath.2018.09.033
   Hussein HA, 2017, DRUG DISCOV TODAY, V22, P404, DOI 10.1016/j.drudis.2016.11.021
   Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201
   Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Liu B, 2019, NUCLEIC ACIDS RES, V47, pD687, DOI 10.1093/nar/gky1080
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131
   Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386
   May HC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00336
   Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321
   Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89
   Pasquevich KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016203
   Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08
   Pawelczyk J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42692
   Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999
   Raman Karthik, 2014, Syst Synth Biol, V8, P73, DOI 10.1007/s11693-013-9123-5
   Rana A, 2016, IMMUNOBIOLOGY, V221, P544, DOI 10.1016/j.imbio.2015.12.004
   Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3
   Rashid MI, 2017, GENOMICS, V109, P274, DOI 10.1016/j.ygeno.2017.05.001
   Salmon-Divon M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00250
   Sanchez-Trincado JL, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2680160
   Sayers EW, 2020, NUCLEIC ACIDS RES, V48, pD9, DOI 10.1093/nar/gkz899
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9
   Seleem MN, 2008, VET MICROBIOL, V129, P1, DOI 10.1016/j.vetmic.2007.11.023
   Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021
   Solanki V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26689-7
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Turner P., 2005, XMGRACE VERSION 5 1, DOI [10.1163/_q3_SIM_00374, DOI 10.1163/_Q3_SIM_00374.]
   Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316
   Wu CY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-88
   Yang XM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003887
   Yang Y, 2015, HUM VACC IMMUNOTHER, V11, P795, DOI 10.1080/21645515.2015.1012017
   Yin DH, 2016, IMMUNOL LETT, V175, P1, DOI 10.1016/j.imlet.2016.04.016
   Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI [10.1186/1471-2164-9-S2-S27, 10.1186/1471-2105-9-40, 10.1186/1471-2164-9-203]
   Zoraghi R, 2013, CURR OPIN MICROBIOL, V16, P566, DOI 10.1016/j.mib.2013.07.010
NR 83
TC 17
Z9 17
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
EI 1089-8646
J9 GENOMICS
JI Genomics
PD MAR
PY 2020
VL 112
IS 2
BP 1734
EP 1745
DI 10.1016/j.ygeno.2019.10.009
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA KM4EJ
UT WOS:000514071600074
PM 31678593
OA hybrid
DA 2023-09-14
ER

PT J
AU Matsumoto, N
   Park, J
   Tomizawa, R
   Kawashima, H
   Hosomi, K
   Mizuguchi, K
   Honda, C
   Ozaki, R
   Iwatani, Y
   Watanabe, M
   Kunisawa, J
AF Matsumoto, Natsuko
   Park, Jonguk
   Tomizawa, Rie
   Kawashima, Hitoshi
   Hosomi, Koji
   Mizuguchi, Kenji
   Honda, Chika
   Ozaki, Ritsuko
   Iwatani, Yoshinori
   Watanabe, Mikio
   Kunisawa, Jun
TI Relationship between Nutrient Intake and Human Gut Microbiota in
   Monozygotic Twins
SO MEDICINA-LITHUANIA
LA English
DT Article
DE monozygotic twins; gut microbiome; nutrients
ID DIET; IMPACT; CONSEQUENCES; INFLAMMATION; SENSITIVITY; MODULATION;
   DIVERSITY; IMMUNITY; JAPANESE; OBESITY
AB Background and Objectives: The gut microbiota is associated with human health and dietary nutrition. Various studies have been reported in this regard, but it is difficult to clearly analyze human gut microbiota as individual differences are significant. The causes of these individual differences in intestinal microflora are genetic and/or environmental. In this study, we focused on differences between identical twins in Japan to clarify the effects of nutrients consumed on the entire gut microbiome, while excluding genetic differences. Materials and Methods: We selected healthy Japanese monozygotic twins for the study and confirmed their zygosity by matching 15 short tandem repeat loci. Their fecal samples were subjected to 16S rRNA sequencing and bioinformatics analyses to identify and compare the fluctuations in intestinal bacteria. Results: We identified 12 genera sensitive to environmental factors, and found that Lactobacillus was relatively unaffected by environmental factors. Moreover, we identified protein, fat, and some nutrient intake that can affect 12 genera, which have been identified to be more sensitive to environmental factors. Among the 12 genera, Bacteroides had a positive correlation with retinol equivalent intake (rs = 0.38), Lachnospira had a significantly negative correlation with protein, sodium, iron, vitamin D, vitamin B6, and vitamin B12 intake (rs = -0.38, -0.41, -0.39, -0.63, -0.42, -0.49, respectively), Lachnospiraceae ND3007 group had a positive correlation with fat intake (rs = 0.39), and Lachnospiraceae UCG-008 group had a negative correlation with the saturated fatty acid intake (rs = -0.45). Conclusions: Our study is the first to focus on the relationship between human gut microbiota and nutrient intake using samples from Japanese twins to exclude the effects of genetic factors. These findings will broaden our understanding of the more intuitive relationship between nutrient intake and the gut microbiota and can be a useful basis for finding useful biomarkers that contribute to human health.
C1 [Matsumoto, Natsuko; Ozaki, Ritsuko; Watanabe, Mikio] Osaka Univ, Dept Clin Lab & Biomed Sci, Div Hlth Sci, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Park, Jonguk; Kawashima, Hitoshi; Mizuguchi, Kenji] Natl Inst Biomed Innovat Hlth & Nutr, Artificial Intelligence Ctr Hlth & Biomed Res, Lab Bioinformat, Osaka 5670085, Japan.
   [Tomizawa, Rie; Hosomi, Koji; Honda, Chika; Iwatani, Yoshinori; Watanabe, Mikio; Kunisawa, Jun] Osaka Univ, Ctr Twin Res, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Hosomi, Koji; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Vaccine Mat, Ctr Vaccine & Adjuvant Res, Osaka 5670085, Japan.
   [Hosomi, Koji; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Gut Environm Syst, Osaka 5670085, Japan.
   [Mizuguchi, Kenji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan.
C3 Osaka University; Osaka University; Osaka University
RP Tomizawa, R (corresponding author), Osaka Univ, Ctr Twin Res, Grad Sch Med, Suita, Osaka 5650871, Japan.
EM creamcollon0509@gmail.com; jonguk@nibiohn.go.jp;
   r-tomizawa@sahs.med.osaka-u.ac.jp; hkawashi@nibiohn.go.jp;
   hosomi@nibiohn.go.jp; kenji@nibiohn.go.jp;
   honda-ch@sahs.med.osaka-u.ac.jp; ritsumiff1103@docomo.ne.jp;
   iwatani@sahs.med.osaka-u.ac.jp; nabe@sahs.med.osaka-u.ac.jp;
   kunisawa@nibiohn.go.jp
RI WATANABE, Mikio/AFK-8755-2022; Mizuguchi, Kenji/GVS-5857-2022
OI WATANABE, Mikio/0000-0001-5971-9296; Mizuguchi,
   Kenji/0000-0003-3021-7078; Kawashima, Hitoshi/0000-0003-3612-4294
FU JSPS KAKENHI [JP16K15385, JP17H04134]; Japanese Ministry of Education,
   Culture, Sports, Science and Technology; Ministry of Health and Welfare
   of Japan; Public/Private R&D Investment Strategic Expansion PrograM
   (PRISM) [JP20gm1010006h004]; AMED-CREST [JP20gm1010006h004]
FX This work was supported by JSPS KAKENHI Grant Numbers JP16K15385 and
   JP17H04134, University Grants from Japanese Ministry of Education,
   Culture, Sports, Science and Technology, and The Ministry of Health and
   Welfare of Japan and Public/Private R&D Investment Strategic Expansion
   PrograM (PRISM) and AMED-CREST (JP20gm1010006h004).
CR Awany D, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00637
   Bagarolli RA, 2017, J NUTR BIOCHEM, V50, P16, DOI 10.1016/j.jnutbio.2017.08.006
   Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14
   Bressa C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171352
   Bulik CM, 2003, INT J EAT DISORDER, V33, P293, DOI 10.1002/eat.10140
   Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cardoneanu A, 2021, J GASTROINTEST LIVER, V30, P46, DOI 10.15403/jgld-2823
   Caviglia GP, 2019, MINERVA BIOTECNOL, V31, P83, DOI 10.23736/S1120-4826.19.02554-0
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Elhag DA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010125
   Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543
   Gao J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00013
   Gomes AC, 2018, GUT MICROBES, V9, P308, DOI 10.1080/19490976.2018.1465157
   Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017
   Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
   Hidaka H., 1986, Bifidobacteria and Microflora, V5, P37
   Hiippala K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080988
   Hosomi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04511-0
   Joffe YT, 2013, NUTRIENTS, V5, P1672, DOI 10.3390/nu5051672
   Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430
   Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504
   Leccioli V, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111203
   Li K, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1482109
   Lim MY, 2017, GUT, V66, P1031, DOI 10.1136/gutjnl-2015-311326
   Liu JL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030910
   Marco ML, 2020, J NUTR, V150, P3061, DOI 10.1093/jn/nxaa323
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050
   Mohr AE, 2020, J INT SOC SPORT NUTR, V17, DOI 10.1186/s12970-020-00353-w
   Mohsen A, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3187-5
   Mompeo O, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061871
   Moreno-Gallego JL, 2019, CELL HOST MICROBE, V25, P261, DOI 10.1016/j.chom.2019.01.019
   Munukka E, 2017, ISME J, V11, P1667, DOI 10.1038/ismej.2017.24
   Nirmalkar K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10122009
   Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Park JS, 2018, J MED FOOD, V21, P215, DOI 10.1089/jmf.2017.3990
   Pataky Z, 2016, DIGEST DIS SCI, V61, P2721, DOI 10.1007/s10620-016-4179-1
   Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Redondo-Useros N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061776
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Sakkas H, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56020088
   Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y
   Smith-Brown P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32385
   Sun CL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-127
   Tap J, 2015, ENVIRON MICROBIOL, V17, P4954, DOI 10.1111/1462-2920.13006
   Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114
   Udayappan S, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.9
   Vamanu E, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8020039
   Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99
   Weiss GA, 2017, CELL MOL LIFE SCI, V74, P2959, DOI 10.1007/s00018-017-2509-x
   Wilson AS, 2020, DIGEST DIS SCI, V65, P723, DOI 10.1007/s10620-020-06112-w
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Xiao S, 2018, ARCH MED RES, V49, P1, DOI 10.1016/j.arcmed.2018.04.003
   Xue L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45176
   Yang C, 2019, FOOD RES INT, V116, P1202, DOI 10.1016/j.foodres.2018.10.003
   ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441
NR 63
TC 5
Z9 5
U1 3
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1010-660X
EI 1648-9144
J9 MEDICINA-LITHUANIA
JI Med. Lith.
PD MAR
PY 2021
VL 57
IS 3
AR 275
DI 10.3390/medicina57030275
PG 13
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA RE0FW
UT WOS:000633842700001
PM 33809761
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Meng, JJ
   Tao, JY
   Abu, Y
   Sussman, DA
   Girotra, M
   Franceschi, D
   Roy, S
AF Meng, Jingjing
   Tao, Junyi
   Abu, Yaa
   Sussman, Daniel Andrew
   Girotra, Mohit
   Franceschi, Dido
   Roy, Sabita
TI HIV-Positive Patients on Antiretroviral Therapy Have an Altered Mucosal
   Intestinal but Not Oral Microbiome
SO MICROBIOLOGY SPECTRUM
LA English
DT Article; Early Access
DE 16S RNA; HIV; antiretroviral therapy; human microbiome; intestinal
   microbiome; oral microbiome
ID IMMUNE ACTIVATION; INFECTION CAUSES; GUT MICROBIOME; TRANSLOCATION;
   INFLAMMATION; DIVERSITY; BARRIER; GENE
AB Over 37 million people worldwide are living with HIV. Although the availability of antiretroviral therapy has significantly reduced the number of AIDS-related deaths, individuals living with HIV are at increased risk for opportunistic infections.
   This study characterized compositional and functional shifts in the intestinal and oral microbiome in HIV-positive patients on antiretroviral therapy compared to HIV-negative individuals. Seventy-nine specimens were collected from 5 HIV-positive and 12 control subjects from five locations (colon brush, colon wash, terminal ileum [TI] brush, TI wash, and saliva) during colonoscopy and at patient visits. Microbiome composition was characterized using 16S rRNA sequencing, and microbiome function was predicted using bioinformatics tools (PICRUSt and BugBase). Our analysis indicated that the beta-diversity of all intestinal samples (colon brush, colon wash, TI brush, and TI wash) from patients with HIV was significantly different from patients without HIV. Specifically, bacteria from genera Prevotella, Fusobacterium, and Megasphaera were more abundant in samples from HIV-positive patients. On the other hand, bacteria from genera Ruminococcus, Blautia, and Clostridium were more abundant in samples from HIV-negative patients. Additionally, HIV-positive patients had higher abundances of biofilm-forming and pathogenic bacteria. Furthermore, pathways related to translation and nucleotide metabolism were elevated in HIV-positive patients, whereas pathways related to lipid and carbohydrate metabolism were positively correlated with samples from HIV-negative patients. Our analyses further showed variations in microbiome composition in HIV-positive and negative patients by sampling site. Samples from colon wash, colon brush, and TI wash were significant between groups, while samples from TI brush and saliva were not significant. Taken together, here, we report altered intestinal microbiome composition and predicted function in patients with HIV compared to uninfected patients, though we found no changes in the oral microbiome.IMPORTANCE Over 37 million people worldwide are living with HIV. Although the availability of antiretroviral therapy has significantly reduced the number of AIDS-related deaths, individuals living with HIV are at increased risk for opportunistic infections. We now know that HIV interacts with the trillions of bacteria, fungi, and viruses in the human body termed the microbiome. Only a limited number of previous studies have compared variations in the oral and gastrointestinal microbiome with HIV infection. Here, we detail how the oral and gastrointestinal microbiome changes with HIV infection, having used 5 different sampling sites to gain a more comprehensive view of these changes by location. Our results show site-specific changes in the intestinal microbiome associated with HIV infection. Additionally, we show that while there were significant changes in the intestinal microbiome, there were no significant changes in the oral microbiome.
C1 [Meng, Jingjing; Tao, Junyi; Abu, Yaa; Franceschi, Dido; Roy, Sabita] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Surg, Miami, FL 33124 USA.
   [Sussman, Daniel Andrew; Girotra, Mohit] Univ Miami, Dept Gastroenterol, Med Grp, Miami, FL USA.
C3 University of Miami; University of Miami
RP Roy, S (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Dept Surg, Miami, FL 33124 USA.
EM sabita.roy@miami.edu
OI Abu, Yaa/0000-0001-7285-0117; Roy, Sabita/0000-0002-6192-8289; TAO,
   JUNYI/0000-0003-2638-5386
CR Annavajhala MK, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00798-19
   Bandera A, 2018, CURR OPIN HIV AIDS, V13, P73, DOI [10.1097/COH.0000000000000429, 10.1097/coh.0000000000000429]
   Beck JM, 2015, AM J RESP CRIT CARE, V192, P1335, DOI 10.1164/rccm.201501-0128OC
   Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Chong J, 2020, NAT PROTOC, V15, P799, DOI 10.1038/s41596-019-0264-1
   Crakes KR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01104
   Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001
   Dillon SM, 2014, MUCOSAL IMMUNOL, V7, P983, DOI 10.1038/mi.2013.116
   Dillon SM, 2016, AIDS, V30, P2737, DOI 10.1097/QAD.0000000000001289
   Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409
   Goncalves LS, 2019, J CLIN PERIODONTOL, V46, P1192, DOI 10.1111/jcpe.13176
   Griffen AL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55703-9
   Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238
   Imahashi M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80247-8
   Ishizaka A, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00708-21
   Jimenez-Hernandez N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061346
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Klatt NR, 2013, TRENDS MICROBIOL, V21, P6, DOI 10.1016/j.tim.2012.09.001
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Li S, 2021, CHINESE MED J-PEKING, V134, P2788, DOI 10.1097/CM9.0000000000001825
   Li YH, 2014, J CLIN MICROBIOL, V52, P1400, DOI 10.1128/JCM.02954-13
   Ling ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep30673
   Lozupone CA, 2014, GUT MICROBES, V5, P562, DOI 10.4161/gmic.32132
   Lozupone CA, 2013, CELL HOST MICROBE, V14, P329, DOI 10.1016/j.chom.2013.08.006
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044
   Martinsen TC, 2005, BASIC CLIN PHARMACOL, V96, P94, DOI 10.1111/j.1742-7843.2005.pto960202.x
   Matsumoto H, 2019, J CLIN BIOCHEM NUTR, V65, P132, DOI 10.3164/jcbn.19-3
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-26
   Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011
   Mottawea W, 2019, PEDIATR RES, V85, P895, DOI 10.1038/s41390-019-0326-7
   Mukherjee PK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200285
   Mutlu EA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003829
   Noguera-Julian M, 2016, EBIOMEDICINE, V5, P135, DOI 10.1016/j.ebiom.2016.01.032
   Nowak P, 2015, AIDS, V29, P2409, DOI 10.1097/QAD.0000000000000869
   Palmer BE, 2016, CELL HOST MICROBE, V19, P270, DOI 10.1016/j.chom.2016.02.014
   Park SY, 2021, CANCERS, V13, DOI 10.3390/cancers13092124
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Presti RM, 2018, AIDS, V32, P1279, DOI 10.1097/QAD.0000000000001811
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Sarkans U, 2018, NUCLEIC ACIDS RES, V46, pD1266, DOI 10.1093/nar/gkx965
   Saxena D, 2016, ORAL DIS, V22, P73, DOI 10.1111/odi.12392
   Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Starr JR, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0484-6
   Vazquez-Castellanos JF, 2015, MUCOSAL IMMUNOL, V8, P760, DOI 10.1038/mi.2014.107
   Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438
   Wade WG, 2021, PERIODONTOL 2000, V86, P113, DOI 10.1111/prd.12365
   Ward T, 2017, bioRxiv, DOI [10.1101/133462, 10.1101/133462, DOI 10.1101/133462]
   Williams B, 2016, CELL MICROBIOL, V18, P645, DOI 10.1111/cmi.12588
   Yang LB, 2020, AM J RESP CRIT CARE, V201, P445, DOI 10.1164/rccm.201905-1016OC
   Yang LY, 2016, AIDS, V30, P19, DOI 10.1097/QAD.0000000000000935
NR 54
TC 1
Z9 1
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD 2022 DEC 13
PY 2022
DI 10.1128/spectrum.02472-22
EA DEC 2022
PG 17
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 6Y1JR
UT WOS:000896859300001
PM 36511710
OA Green Submitted, gold, Green Published
DA 2023-09-14
ER

PT J
AU Hu, Y
   Fang, L
   Nicholson, C
   Wang, K
AF Hu, Yu
   Fang, Li
   Nicholson, Christopher
   Wang, Kai
TI Implications of Error-Prone Long-Read Whole-Genome Shotgun Sequencing on
   Characterizing Reference Microbiomes
SO ISCIENCE
LA English
DT Article
ID GUT MICROBIOME; METAGENOMICS; IDENTIFICATION
AB Long-read sequencing techniques, such as the Oxford Nanopore Technology, can generate reads that are tens of kilobases in length and are therefore particularly relevant for microbiome studies. However, owing to the higher per-base error rates than typical short-read sequencing, the application of long-read sequencing on microbiomes remains largely unexplored. Here we deeply sequenced two human microbiotamock community samples (HM-276D and HM-277D) from the Human Microbiome Project. We showed that assembly programs consistently achieved high accuracy (similar to 99%) and completeness (similar to 99%) for bacterial strains with adequate coverage. We also found that long-read sequencing provides accurate estimates of species-level abundance (R = 0.94 for 20 bacteria with abundance ranging from 0.005% to 64%). Our results not only demonstrate the feasibility of characterizing complete microbial genomes and populations from error-prone Nanopore sequencing data but also highlight necessary bioinformatics improvements for future metagenomics tool development.
C1 [Hu, Yu; Fang, Li; Nicholson, Christopher; Wang, Kai] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA.
   [Nicholson, Christopher] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.
   [Wang, Kai] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of
   Philadelphia; University of Pennsylvania; University of Pennsylvania
RP Wang, K (corresponding author), Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA.; Wang, K (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM wangk@email.chop.edu
FU Children's Hospital of Philadelphia Research Institute (United States);
   NIH/NIGMS (United States) [GM132713]
FX This work was supported by Children's Hospital of Philadelphia Research
   Institute (United States) and NIH/NIGMS (United States) grant GM132713
   to K.W.. The following reagent was obtained through BEI Resources,
   NIAID, NIH as part of the Human Microbiome Project: Genomic DNA from
   Microbial Mock Community B (Staggered, High Concentration), v5.2H,
   forWhole Genome Shotgun Sequencing, HM-277D.The following reagent was
   obtained through BEI Resources, NIAID, NIH as part of the Human
   Microbiome Project: Genomic DNA from Microbial Mock Community B (Even,
   High Concentration), v5.1H, for Whole Genome Shotgun Sequencing,
   HM-276D.
CR Bertrand D, 2019, NAT BIOTECHNOL, V37, P937, DOI 10.1038/s41587-019-0191-2
   Byrd AL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-262
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   Chehoud C, 2015, INFLAMM BOWEL DIS, V21, P1948, DOI 10.1097/MIB.0000000000000454
   Chen EZ, 2017, STAT BIOSCI, V9, P13, DOI 10.1007/s12561-016-9148-x
   Francis OE, 2013, GENOME RES, V23, P1721, DOI 10.1101/gr.150151.112
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Gregor I, 2016, PEERJ, V4, DOI 10.7717/peerj.1603
   Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086
   Hao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049785
   Hong CJ, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-33
   Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888
   Huson DH, 2018, BIOL DIRECT, V13, DOI 10.1186/s13062-018-0208-7
   Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957
   Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07
   Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Kuleshov V, 2016, NAT BIOTECHNOL, V34, P64, DOI 10.1038/nbt.3416
   Laudadio I, 2018, OMICS, V22, P248, DOI 10.1089/omi.2018.0013
   Lee C.H., 2014, J OPEN SOURCE SOFTW
   Leggett RM, 2020, NAT MICROBIOL, V5, P430, DOI 10.1038/s41564-019-0626-z
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973
   Mason Christopher E, 2017, J Biomol Tech, V28, P8, DOI 10.7171/jbt.17-2801-006
   McIntyre ABR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08289-9
   Nicholls SM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz043
   Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935
   Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083
   Ruan J, 2020, NAT METHODS, V17, P155, DOI 10.1038/s41592-019-0669-3
   Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059
   Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]
   Toriumi A, 2014, 2014 7TH INTERNATIONAL SILICON-GERMANIUM TECHNOLOGY AND DEVICE MEETING (ISTDM), P17, DOI 10.1109/ISTDM.2014.6874697
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Wang F, 2016, CELL REP, V14, P945, DOI 10.1016/j.celrep.2015.12.088
   Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336
   Wenger AM, 2019, NAT BIOTECHNOL, V37, P1155, DOI 10.1038/s41587-019-0217-9
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
NR 41
TC 8
Z9 8
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD JUN 26
PY 2020
VL 23
IS 6
AR 101223
DI 10.1016/j.isci.2020.101223
PG 33
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA PH7UK
UT WOS:000600612500004
PM 32563152
OA Green Submitted, gold, Green Published
DA 2023-09-14
ER

PT J
AU Cheng, K
   Ning, ZB
   Li, LY
   Zhang, X
   Serrana, JM
   Mayne, J
   Figeys, D
AF Cheng, Kai
   Ning, Zhibin
   Li, Leyuan
   Zhang, Xu
   Serrana, Joeselle M.
   Mayne, Janice
   Figeys, Daniel
TI MetaLab-MAG: A Metaproteomic Data Analysis Platform for Genome-Level
   Characterization of Microbiomes from the Metagenome-Assembled Genomes
   Database
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article; Early Access
DE metaproteomics; human gut microbiome; isobaric labeling; label free;
   metagenome-assembled genomes; data analysis; software
ID PROTEOMICS; ULTRAFAST; STRATEGY
AB The studies of microbial communities have drawn increased attention in various research fields such as agriculture, environment, and human health. Recently, metaproteomics has become a powerful tool to interpret the roles of the community members by investigating the expressed proteins of the microbes. However, analyzing the metaproteomic data sets at genome resolution is still challenging because of the lack of efficient bioinformatics tools. Here we develop MetaLab-MAG, a specially designed tool for the characterization of microbiomes from metagenome-assembled genomes databases. MetaLab-MAG was evaluated by analyzing various human gut microbiota data sets and performed comparably or better than searching the gene catalog protein database directly. MetaLab-MAG can quantify the genome-level microbiota compositions and supports both label-free and isobaric labeling-based quantification strategies. MetaLab-MAG removes the obstacles of metaproteomic data analysis and provides the researchers with in-depth and comprehensive information from the microbiomes.
C1 [Cheng, Kai; Ning, Zhibin; Li, Leyuan; Zhang, Xu; Serrana, Joeselle M.; Mayne, Janice; Figeys, Daniel] Univ Ottawa, Fac Med, Sch Pharmaceut Sci, Ottawa, ON K1H 8M5, Canada.
C3 University of Ottawa
RP Figeys, D (corresponding author), Univ Ottawa, Fac Med, Sch Pharmaceut Sci, Ottawa, ON K1H 8M5, Canada.
EM dfigeys@uottawa.ca
RI Serrana, Joeselle/AAG-4072-2019
OI Serrana, Joeselle/0000-0002-6967-5407; Zhang, Xu/0000-0003-2406-9478;
   Figeys, Daniel/0000-0002-5373-7546; Cheng, Kai/0000-0002-6045-0244
FU Government of Canada through Genome Canada; Ontario Genomics Institute
   [OGI-156, OGI-149]; Natural Sciences and Engineering Research Council of
   Canada (NSERC) [210034]; Ontario Ministry of Economic Development and
   Innovation [ORF-DIG-14405, 13440]
FX This work was funded by the Government of Canada through Genome Canada
   and the Ontario Genomics Institute (OGI-156 and OGI-149), the Natural
   Sciences and Engineering Research Council of Canada (NSERC, grant no.
   210034), and the Ontario Ministry of Economic Development and Innovation
   (ORF-DIG-14405 and project 13440).
CR Almeida A, 2021, NAT BIOTECHNOL, V39, P105, DOI 10.1038/s41587-020-0603-3
   Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1
   Buchfink B, 2021, NAT METHODS, V18, P366, DOI 10.1038/s41592-021-01101-x
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cheng K, 2020, J AM SOC MASS SPECTR, V31, P1473, DOI 10.1021/jasms.0c00083
   Cheng K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0375-2
   Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236
   Chick JM, 2015, NAT BIOTECHNOL, V33, P743, DOI 10.1038/nbt.3267
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Jagtap PD, 2015, PROTEOMICS, V15, P3553, DOI 10.1002/pmic.201500074
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]
   Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656
   Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li L., 2021, BIORXIV, DOI [10.1101/2021.07.15.452564, DOI 10.1101/2021.07.15.452564]
   Li LY, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00806-z
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Mesuere B, 2012, J PROTEOME RES, V11, P5773, DOI 10.1021/pr300576s
   Mitchell AL, 2020, NUCLEIC ACIDS RES, V48, pD570, DOI 10.1093/nar/gkz1035
   Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419
   Muth T, 2015, J PROTEOME RES, V14, P1557, DOI 10.1021/pr501246w
   Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x
   Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200
   Schape SS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120641
   Shen XM, 2017, J PROTEOME RES, V16, P2445, DOI 10.1021/acs.jproteome.7b00061
   Stamboulian M, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01035-8
   Stewart RD, 2019, NAT BIOTECHNOL, V37, P953, DOI 10.1038/s41587-019-0202-3
   Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560
   Van den Bossche T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27542-8
   Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109
   Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595
   Witkowski M, 2020, CIRC RES, V127, P553, DOI 10.1161/CIRCRESAHA.120.316242
   Zhang X., 2022, BIORXIV, DOI [10.1101/2022.07.30.502163, DOI 10.1101/2022.07.30.502163]
   Zhang X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17916-9
   Zhang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05357-4
   Zhang X, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0176-z
NR 41
TC 0
Z9 0
U1 3
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD 2022 DEC 12
PY 2022
DI 10.1021/acs.jproteome.2c00554
EA DEC 2022
PG 12
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 6X9QX
UT WOS:000896742200001
PM 36508259
OA hybrid, Green Published
DA 2023-09-14
ER

PT J
AU Kovtun, AS
   Averina, OV
   Poluektova, EU
   Kostyuk, GP
   Danilenko, VN
AF Kovtun, A. S.
   Averina, O., V
   Poluektova, E. U.
   Kostyuk, G. P.
   Danilenko, V. N.
TI ALTERED NEUROMETABOLIC POTENTIAL OF GUT MICROBIOME IN HEALTHY CHILDREN
   OF DIFFERENT AGE
SO BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY
LA English
DT Article
DE gut microbiota; gut-brain axis; metagenomic signatures;
   neurodevelopment; neuroactive compounds
ID READ ALIGNMENT; IMPACT; IDENTIFICATION
AB Recently much attention is paid to investigation of the gut microbiome impact on children's mental health. The study was aimed to detect alterations in the taxonomic composition and content of bacterial genes encoding key enzymes involved in the metabolism of neuroactive compounds in the metagenomes of healthy young children and adolescents. The whole metagenome sequencing was used to obtain the metagenomic data of the faecal specimens. The bioinformatics algorithm developed and the catalogue of homologs created were used to identify the changes in abundance of bacterial genes and metagenomic signatures in the studied metagenomes. The core neurometabolic signature of the healthy children gut microbiota included the Bacteroides uniformis, Faecalibacterium prausnitzii and Lachnospiraceae bacterium species, as well as genes involved in production of acetic, propionic and butyric acids, glutamate and enzymes possessing antioxidant activity. Comparison of metagenomes in children of different age groups revealed significant (p < 0.1) changes in the average abundance for 3 bacterial genera and 18 species. The higher alpha diversity of the adolescents' microbiota was observed both at the genus and species level. Furthermore, in the adolescents' microbiota metagenomes the increased average relative abundances for the genes encoding enzymes involved in production of SCFAs, glutamate, tryptophan and compounds with antioxidant properties, histidine degradation and linoleic acid conjugation were observed (p < 0.1). The study results support the evidence that healthy gut microbial communities become more diverse and functional as their human hosts become older.
C1 [Kovtun, A. S.; Averina, O., V; Poluektova, E. U.; Danilenko, V. N.] Vavilov Inst Gen Genet, Moscow, Russia.
   [Kostyuk, G. P.] Psychiat Hosp 1, Moscow, Russia.
C3 Russian Academy of Sciences; Vavilov Institute of General Genetics
RP Kovtun, AS (corresponding author), Gubkina 3, Moscow 119991, Russia.
EM kovtunas25@gmail.com
RI Averina, Olga/K-4211-2017; Kostyuk, George/AAA-1682-2020
OI Kostyuk, George/0000-0002-3073-6305; Averina, Olga/0000-0003-1541-0785
FU Russian Science Foundation [20-14-00132]; Russian Science Foundation
   [20-14-00132] Funding Source: Russian Science Foundation
FX the study was supported by the Russian Science Foundation, project No
   20-14-00132.
CR Averina OV, 2020, J MED MICROBIOL, V69, P558, DOI 10.1099/jmm.0.001178
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonham KS, 2020, GUT MICROBES THEIR G, DOI [10.1101/2020.02.13.944181v3, DOI 10.1101/2020.02.13.944181V3]
   Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84
   Caspani G, 2019, MICROB CELL, V6, P454, DOI 10.15698/mic2019.10.693
   Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005
   Forde BM, 2013, BRIEF FUNCT GENOMICS, V12, P440, DOI 10.1093/bfgp/els062
   Fouhy F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09252-4
   Klimina KM, 2020, TOXINS, V12, DOI 10.3390/toxins12060388
   Kovtun AS, 2018, RUSS J GENET+, V54, P1101, DOI 10.1134/S1022795418090089
   Kovtun AS, 2020, MICROB DRUG RESIST, V26, P1307, DOI 10.1089/mdr.2019.0325
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lewis CP, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0792-z
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Nagpal R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01388
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Oleskin A.V., 2020, MICROBIAL COMMUNICAT, DOI DOI 10.52305/EGCB8622
   Oleskin AV, 2019, PROBIOTICS ANTIMICRO, V11, P1071, DOI 10.1007/s12602-019-09583-0
   Oleskin AV, 2017, PROBIOTICS ANTIMICRO, V9, P215, DOI 10.1007/s12602-017-9262-1
   Richard DM, 2009, INT J TRYPTOPHAN RES, V2, P45
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Shenderov BA, 2016, NEVROLOGIYA, V1, P7
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122
   Tanaka M, 2017, ALLERGOL INT, V66, P515, DOI 10.1016/j.alit.2017.07.010
   Warner BB, 2019, PEDIATR RES, V85, P216, DOI 10.1038/s41390-018-0191-9
   Wood Derrick E, 2019, Genome Biol, V20, P257, DOI 10.1186/s13059-019-1891-0
   Yahfoufi N, 2020, J GERONTOL A-BIOL, V75, P1251, DOI 10.1093/gerona/glaa006
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Yunes RA, 2020, PROBIOTICS ANTIMICRO, V12, P973, DOI 10.1007/s12602-019-09601-1
   Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275
NR 30
TC 0
Z9 0
U1 0
U2 4
PU PIROGOV RUSSIAN NATL RESEARCH MEDICAL UNIV
PI MOSCOW
PA UL OSTROVITYANOVA, D 1, MOSCOW, 117997, RUSSIA
SN 2500-1094
EI 2542-1204
J9 B RUSS STATE MED U
JI Bull. Russ. State Med. Univ.
PD NOV-DEC
PY 2020
IS 6
BP 66
EP 76
DI 10.24075/brsmu.2020.076
PG 11
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA PT4JC
UT WOS:000608580400008
OA hybrid
DA 2023-09-14
ER

PT J
AU Yang, YZ
   Misra, BB
   Liang, L
   Bi, DX
   Weng, WH
   Wu, W
   Cai, SJ
   Qin, HL
   Goel, A
   Li, XX
   Ma, YL
AF Yang, Yongzhi
   Misra, Biswapriya B.
   Liang, Lei
   Bi, Dexi
   Weng, Wenhao
   Wu, Wen
   Cai, Sanjun
   Qin, Huanlong
   Goel, Ajay
   Li, Xinxiang
   Ma, Yanlei
TI Integrated microbiome and metabolome analysis reveals a novel interplay
   between commensal bacteria and metabolites in colorectal cancer
SO THERANOSTICS
LA English
DT Article
DE colorectal cancer; gut; microbiome; metabolomics; biomarkers
ID GUT MICROBIOTA; DIET; STATISTICS; MODULATE
AB Rationale: Colorectal cancer (CRC) is a malignant tumor with the third highest morbidity rate among all cancers. Driven by the host's genetic makeup and environmental exposures, the gut microbiome and its metabolites have been implicated as the causes and regulators of CRC pathogenesis. We assessed human fecal samples as noninvasive and unbiased surrogates to catalog the gut microbiota and metabolome in patients with CRC.
   Methods: Fecal samples collected from CRC patients (CRC group, n = 50) and healthy volunteers (H group, n = 50) were subjected to microbiome (16S rRNA gene sequencing) and metabolome (gas chromatography-mass spectrometry, GC-MS) analyses. The datasets were analyzed individually and integrated for combined analysis using various bioinformatics approaches.
   Results: Fecal metabolomic analysis led to the identification of 164 metabolites spread across 40 metabolic pathways in both groups. In addition, there were 42 and 17 metabolites specific to the H and CRC groups, respectively. Sequencing of microbial diversity revealed 1084 operational taxonomic units (OTUs) across the two groups, and there was less species diversity in the CRC group than in the H group. Seventy-six discriminatory OTUs were identified for the microbiota of H volunteers and CRC patients. Integrated analysis correlated CRC-associated microbes with metabolites, such as polyamines (cadaverine and putrescine).
   Conclusions: Our results provide substantial evidence of a novel interplay between the gut microbiome and metabolome (i.e., polyamines), which is drastically perturbed in CRC. Microbe-associated metabolites can be used as diagnostic biomarkers in therapeutic explorations.
C1 [Yang, Yongzhi; Liang, Lei; Cai, Sanjun; Li, Xinxiang; Ma, Yanlei] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, 270 Dongan Rd, Shanghai 200032, Peoples R China.
   [Yang, Yongzhi; Liang, Lei; Cai, Sanjun; Li, Xinxiang; Ma, Yanlei] Fudan Univ, Shanghai Med Coll, Dept Oncol, 270 Dongan Rd, Shanghai 200032, Peoples R China.
   [Yang, Yongzhi; Wu, Wen; Qin, Huanlong] Tongji Univ, Shanghai Tenth Peoples Hosp, Dept GI Surg, Shanghai 200072, Peoples R China.
   [Misra, Biswapriya B.] Ctr Precis Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
   [Bi, Dexi] Tongji Univ, Shanghai Peoples Hosp 10, Dept Pathol, Shanghai 200072, Peoples R China.
   [Weng, Wenhao] Tongji Univ, Sch Med, Yangpu Hosp, Dept Clin Lab, Shanghai, Peoples R China.
   [Weng, Wenhao] Tongji Univ, Sch Med, Yangpu Hosp, Ctr Translat Med, Shanghai, Peoples R China.
   [Goel, Ajay] Baylor Scott & White Res Inst, Ctr Epigenet Canc Prevent & Canc Gen, Ctr Gastrointestinal Res, Dallas, TX USA.
   [Goel, Ajay] Charles A Sammons Canc Ctr, Dallas, TX USA.
C3 Fudan University; Fudan University; Tongji University; Tongji
   University; Tongji University; Tongji University; Baylor Health Care
   System; Baylor University Medical Center; Baylor University Medical
   Center
RP Ma, YL (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, 270 Dongan Rd, Shanghai 200032, Peoples R China.; Ma, YL (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, 270 Dongan Rd, Shanghai 200032, Peoples R China.
EM yanleima@fudan.edu.cn
RI Misra, Biswapriya B./D-2055-2012; liang, liang/IAO-8518-2023; huanlong,
   Qin/B-3844-2015
OI Misra, Biswapriya B./0000-0003-2589-6539; Bi, Dexi/0000-0001-9325-8868
FU National Natural Science Foundation of China [81230057, 81472262,
   81372615, 81802412]; Fudan Outstanding Young Talent Training Plan
   [YJYQ201601]; Shanghai Sailing Program [18YF1414900]; Shanghai Pujiang
   Program [17PJD007]
FX This work was sponsored by the grants obtained from the National Natural
   Science Foundation of China (No. 81230057, No. 81472262, No. 81372615,
   No. 81802412), the Fudan Outstanding Young Talent Training Plan (No.
   YJYQ201601), the Shanghai Sailing Program (No. 18YF1414900), and the
   Shanghai Pujiang Program (No. 17PJD007).
CR Anand S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01945
   Anantharaju PG, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0217-2
   Beger RD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1094-6
   Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Bultman SJ, 2014, CELL HOST MICROBE, V16, P143, DOI 10.1016/j.chom.2014.07.011
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Chen WHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039039
   Cockbain AJ, 2012, GUT, V61, P135, DOI 10.1136/gut.2010.233718
   Dermadi D, 2017, CANCER RES, V77, P3352, DOI 10.1158/0008-5472.CAN-16-2860
   Flemer B, 2018, GUT, V67, P1454, DOI 10.1136/gutjnl-2017-314814
   Gao XF, 2010, ANAL CHEM, V82, P6447, DOI 10.1021/ac1006552
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   Goedert JJ, 2014, CARCINOGENESIS, V35, P2089, DOI 10.1093/carcin/bgu131
   Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Machiels K, 2017, GUT, V66, P79, DOI 10.1136/gutjnl-2015-309398
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990
   Masumoto S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31208
   Monleon D, 2009, NMR BIOMED, V22, P342, DOI 10.1002/nbm.1345
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235
   Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7
   Poutahidis T, 2016, CANCER LETT, V380, P356, DOI 10.1016/j.canlet.2015.12.028
   Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610
   Shoaie S, 2015, CELL METAB, V22, P320, DOI 10.1016/j.cmet.2015.07.001
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
NR 36
TC 128
Z9 138
U1 13
U2 87
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2019
VL 9
IS 14
BP 4101
EP 4114
DI 10.7150/thno.35186
PG 14
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA IB2GK
UT WOS:000470087500009
PM 31281534
OA gold, Green Published, Green Submitted
DA 2023-09-14
ER

PT J
AU Arif, M
   Zhang, C
   Li, XY
   Gungor, C
   Cakmak, B
   Arslanturk, M
   Tebani, A
   Ozcan, B
   Subas, O
   Zhou, WY
   Piening, B
   Turkez, H
   Fagerberg, L
   Price, N
   Hood, L
   Snyder, M
   Nielsen, J
   Uhlen, M
   Mardinoglu, A
AF Arif, Muhammad
   Zhang, Cheng
   Li, Xiangyu
   Gungor, Cem
   Cakmak, Bugra
   Arslanturk, Metin
   Tebani, Abdellah
   Ozcan, Berkay
   Subas, Oguzhan
   Zhou, Wenyu
   Piening, Brian
   Turkez, Hasan
   Fagerberg, Linn
   Price, Nathan
   Hood, Leroy
   Snyder, Michael
   Nielsen, Jens
   Uhlen, Mathias
   Mardinoglu, Adil
TI iNetModels 2.0: an interactive visualization and database of multi-omics
   data
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
AB It is essential to reveal the associations between various omics data for a comprehensive understanding of the altered biological process in human wellness and disease. To date, very few studies have focused on collecting and exhibiting multi-omics associations in a single database. Here, we present iNetModels, an interactive database and visualization platform of Multi-Omics Biological Networks (MOBNs). This platform describes the associations between the clinical chemistry, anthropometric parameters, plasma proteomics, plasma metabolomics, as well as metagenomics for oral and gut microbiome obtained from the same individuals. Moreover, iNetModels includes tissue- and cancer-specific Gene Co-expression Networks (GCNs) for exploring the connections between the specific genes. This platform allows the user to interactively explore a single feature's association with other omics data and customize its particular context (e.g. male/female specific). The users can also register their data for sharing and visualization of the MOBNs and GCNs. Moreover, iNetModels allows users who do not have a bioinformatics background to facilitate human wellness and disease research. iNetModels can be accessed freely at https://inetmodels.com without any limitation.
C1 [Arif, Muhammad; Zhang, Cheng; Li, Xiangyu; Fagerberg, Linn; Uhlen, Mathias; Mardinoglu, Adil] KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden.
   [Zhang, Cheng] Zhengzhou Univ, Minist Educ, Sch Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China.
   [Zhang, Cheng] Zhengzhou Univ, Minist Educ, Key Lab Adv Drug Preparat Technol, Zhengzhou 450001, Henan, Peoples R China.
   [Gungor, Cem; Cakmak, Bugra; Arslanturk, Metin; Ozcan, Berkay; Subas, Oguzhan] Bash Biotech Inc, 600 West Broadway,Suite 700, San Diego, CA USA.
   [Tebani, Abdellah] Rouen Univ Hosp, Dept Metab Biochem, F-76000 Rouen, France.
   [Tebani, Abdellah] Normandie Univ, CHU Rouen, INSERM, UNIROUEN,U1245, F-76000 Rouen, France.
   [Zhou, Wenyu; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA.
   [Piening, Brian] Providence Canc Ctr, Oregon Area, Portland, OR USA.
   [Turkez, Hasan] Ataturk Univ, Fac Med, Dept Med Biol, Erzurum, Turkey.
   [Price, Nathan; Hood, Leroy] Inst Syst Biol, Seattle, WA USA.
   [Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.
   [Mardinoglu, Adil] Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Host Microbiome Interact, London SE1 9RT, England.
C3 Royal Institute of Technology; Zhengzhou University; Zhengzhou
   University; Universite de Rouen Normandie; CHU de Rouen; Universite de
   Rouen Normandie; CHU de Rouen; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Stanford University; Ataturk University;
   Institute for Systems Biology (ISB); Chalmers University of Technology;
   University of London; King's College London
RP Zhang, C; Mardinoglu, A (corresponding author), KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden.; Zhang, C (corresponding author), Zhengzhou Univ, Minist Educ, Sch Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China.; Zhang, C (corresponding author), Zhengzhou Univ, Minist Educ, Key Lab Adv Drug Preparat Technol, Zhengzhou 450001, Henan, Peoples R China.; Mardinoglu, A (corresponding author), Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Host Microbiome Interact, London SE1 9RT, England.
EM cheng.zhang@scilifelab.se; adilm@scilifelab.se
RI Uhlen, Mathias/AAV-8746-2021; Fagerberg, Linn/JDM-2069-2023; Arif,
   Muhammad/GSO-0267-2022; Arif, Muhammad/AFQ-6409-2022; TEBANI,
   Abdellah/ABE-5140-2021; Zhang, Cheng/L-7906-2016; Uhlen,
   Mathias/HPB-8445-2023; Li, Xiangyu/N-3409-2019
OI Arif, Muhammad/0000-0003-2261-0881; Arif, Muhammad/0000-0003-2261-0881;
   TEBANI, Abdellah/0000-0002-8901-2678; Zhang, Cheng/0000-0002-3721-8586;
   Uhlen, Mathias/0000-0002-4858-8056; Snyder, Michael/0000-0003-0784-7987;
   Li, Xiangyu/0000-0002-8301-9959
FU Robert Wood Johnson Foundation; M.J. Murdock Charitable Trust; NIH
   [2P50GM076547, ES017885, RC2HG005805]; Arivale; Common Fund of the
   Office of the Director of the National Institutes of Health; NCI; NHGRI;
   NHLBI; NIDA; NIMH; NINDS; Swedish Research Council [2018-05973]
FX We appreciate the data sharing from dbGaP. This work was supported in
   part by the Robert Wood Johnson Foundation, the M.J. Murdock Charitable
   Trust, NIH grants 2P50GM076547, ES017885, RC2HG005805, and Arivale. The
   Genotype-Tissue Expression (GTEx) Project was supported by the Common
   Fund of the Office of the Director of the National Institutes of Health,
   and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for
   theanalyses described in this manuscript were obtained from the GTEx
   Portal on 10/21/20. The results shown here are in part based upon data
   generated by the TCGA Research Network: https://www.cancer.gov/tcga.The
   computations and data handling were enabled by resources provided by the
   SwedishNational Infrastructure for Computing (SNIC) at UPPMAX, partially
   funded by the Swedish Research Council through grant agreement no.
   2018-05973.
CR Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI [10.1093/nar/gkh131, 10.1093/nar/gkw1099]
   Aron-Wisnewsky J, 2020, NAT REV GASTRO HEPAT, V17, P279, DOI 10.1038/s41575-020-0269-9
   Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
   Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009
   Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423
   Csardi G., 2006, INT J COMPLEX SYST
   David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Karczewski KJ, 2018, NAT REV GENET, V19, P299, DOI 10.1038/nrg.2018.4
   Lee S, 2018, NUCLEIC ACIDS RES, V46, pD595, DOI 10.1093/nar/gkx994
   Mardinoglu A, 2018, CELL METAB, V27, P559, DOI 10.1016/j.cmet.2018.01.005
   Mardinoglu A, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167422
   Oh TG, 2020, CELL METAB, V32, P878, DOI 10.1016/j.cmet.2020.06.005
   Piening BD, 2018, CELL SYST, V6, P157, DOI 10.1016/j.cels.2017.12.013
   Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870
   Robinson JL, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz1482
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Smarr L, 2012, BIOTECHNOL J, V7, P980, DOI 10.1002/biot.201100495
   Tebani A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18148-7
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z
   Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Zhang C, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.209495
   Zhang X, 2021, GUT, V70, P761, DOI 10.1136/gutjnl-2019-319664
NR 28
TC 12
Z9 14
U1 2
U2 24
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 2
PY 2021
VL 49
IS W1
BP W271
EP W276
DI 10.1093/nar/gkab254
EA APR 2021
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TI4NF
UT WOS:000672775800036
PM 33849075
OA gold, Green Published, Green Submitted
DA 2023-09-14
ER

PT J
AU Li, BJ
   Zhong, D
   Qiao, JM
   Jiang, XP
AF Li, Bojing
   Zhong, Duo
   Qiao, Jimei
   Jiang, Xingpeng
TI GNPI: Graph normalization to integrate phylogenetic information for
   metagenomic host phenotype prediction
SO METHODS
LA English
DT Article
DE Metagenomics; Graph normalization; Graph neural networks; Host phenotype
   prediction
ID HUMAN GUT MICROBIOME
AB Microorganisms play important roles in our lives especially on metabolism and diseases. Determining the probability of human suffering from specific diseases and the severity of the disease based on microbial genes is the crucial research for understanding the relationship between microbes and diseases. Previous could extract the topological information of phylogenetic trees and integrate them to metagenomic datasets, thus enable classifiers to learn more information in limited datasets and thus improve the performance of the models. In this paper, we proposed a GNPI model to better learn the structure of phylogenetic trees. GNPI maintained the original vector format of metagenomic datasets, while previous research had to change the input form to matrices. The vectorlike form of the input data can be easily adopted in the baseline machine learning models and is available for deep learning models. The datasets processed with GNPI help enhance the accuracy of machine learning and deep learning models in three different datasets. GNPI is an interpretable data processing method for host phenotype prediction and other bioinformatics tasks.
C1 [Li, Bojing; Zhong, Duo; Jiang, Xingpeng] Cent China Normal Univ, Hubei Key Lab Artificial Intelligence & Smart Lear, Wuhan, Peoples R China.
   [Li, Bojing; Zhong, Duo; Jiang, Xingpeng] Cent China Normal Univ, Sch Comp, Wuhan, Peoples R China.
   [Qiao, Jimei] Shanghai Normal Univ, Math & Sci Coll, Shanghai, Peoples R China.
   [Jiang, Xingpeng] Cent China Normal Univ, Natl Language Resources Monitoring & Res Ctr Netwo, Wuhan, Peoples R China.
C3 Central China Normal University; Central China Normal University;
   Shanghai Normal University; Central China Normal University
RP Jiang, XP (corresponding author), Cent China Normal Univ, Hubei Key Lab Artificial Intelligence & Smart Lear, Wuhan, Peoples R China.; Jiang, XP (corresponding author), Cent China Normal Univ, Sch Comp, Wuhan, Peoples R China.; Jiang, XP (corresponding author), Cent China Normal Univ, Natl Language Resources Monitoring & Res Ctr Netwo, Wuhan, Peoples R China.
EM xpjiang@ccnu.edu.cn
RI Xingpeng, Jiang/I-3818-2012
OI Xingpeng, Jiang/0000-0002-8848-9300
FU National Natural Science Foun-dation of China [61872157, 61932008]; Key
   Research and Development Program of Hubei Province [2020BAB017]
FX The research was supported by the National Natural Science Foun-dation
   of China (61872157, and 61932008) and the Key Research and Development
   Program of Hubei Province (2020BAB017) .
CR Abrahart R. J., 2004, NEURAL NETWORKS HYDR
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018
   Hara K, 2015, IEEE IJCNN
   Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kipf T.N., 2016, J INT C LEARNING REP
   LaPierre N, 2019, METHODS, V166, P74, DOI 10.1016/j.ymeth.2019.03.003
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Li B., 2021, P 2021 IEEE INT C BI, P456
   Liu YX, 2021, PROTEIN CELL, V12, P315, DOI 10.1007/s13238-020-00724-8
   Lo C, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2833-2
   Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935
   Reiman D, 2020, IEEE J BIOMED HEALTH, V24, P2993, DOI 10.1109/JBHI.2020.2993761
   Rong RC, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab005
   Scarselli F, 2009, IEEE T NEURAL NETWOR, V20, P61, DOI 10.1109/TNN.2008.2005605
   Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x
   Wu QT, 2019, WEB CONFERENCE 2019: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2019), P2091, DOI 10.1145/3308558.3313442
NR 24
TC 0
Z9 0
U1 2
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD SEP
PY 2022
VL 205
BP 11
EP 17
DI 10.1016/j.ymeth.2022.05.007
EA JUN 2022
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 2S5EQ
UT WOS:000821815600002
PM 35636652
DA 2023-09-14
ER

PT J
AU Tun, U
   Yildirim, Y
   elebi, ARC
   Yildiz, BK
AF Tunc, Ugur
   Yildirim, Yusuf
   Celebi, Ali Riza Cenk
   Yildiz, Burcin Kepez
TI Potential role of ocular surface microbiota in keratoconus
   etiopathogenesis
SO EXPERT REVIEW OF OPHTHALMOLOGY
LA English
DT Article
DE Corneal ectasia; keratoconus; ocular inflammation; ocular microbiota;
   ocular immunology
ID TOLL-LIKE RECEPTORS; COLLAGEN CROSS-LINKING; PENETRATING KERATOPLASTY;
   OXIDATIVE STRESS; GUT MICROBIOME; DNA-DAMAGE; IN-VITRO; EXPRESSION;
   BACTERIA; DISEASE
AB Introduction: Keratoconus is the most common corneal ectatic disease and the most common cause of corneal transplantation in developed countries. The etiopathogenesis of the disease remains unclear.
   Areas covered: The human body hosts a remarkably abundant and diverse community of microbial species called microbiota. Advances in next-generation sequencing (NGS) technology and bioinformatics have facilitated the characterization of human microbiota. Previous studies have shown that there is an alteration of ocular microbiota in inflammatory and autoimmune ocular diseases. The purpose of this review article is to evaluate the potential effect of ocular microbiota on the pathophysiology of keratoconus.
   Expert opinion: Recent studies have shown the low-level chronic inflammatory process in keratoconus. A regulatory interaction has been demonstrated between human microbiota and Toll-like receptors, which are innate immune system receptors. In addition, Toll-like receptor activity in keratoconus has been shown to be higher than in normal individuals. Therefore, the alteration of ocular microbiota may have a potential role in keratoconus etiopathogenesis. Further research is required on this subject.
C1 [Tunc, Ugur; Yildirim, Yusuf; Yildiz, Burcin Kepez] Univ Hlth Sci, Beyoglu Eye Training & Res Hosp, Ophthalmol, Istanbul, Turkey.
   [Celebi, Ali Riza Cenk] Acibadem Univ, Dept Ophthalmol, Istanbul, Turkey.
C3 University of Health Sciences Turkey; Acibadem University
RP Tun, U (corresponding author), Univ Hlth Sci, Beyoglu Eye Training & Res Hosp, Bereketzade Camii Sok 2, Istanbul, Turkey.
EM drugur09@gmail.com
RI Yildirim, Yusuf/AAD-7381-2020
OI Yildirim, Yusuf/0000-0002-4161-0919
CR Anwar HM, 2011, CLIN OPHTHALMOL, V5, P1277, DOI 10.2147/OPTH.S24532
   Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395
   Balaban N, 2007, ANTIMICROB AGENTS CH, V51, P2226, DOI 10.1128/AAC.01097-06
   Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x
   Boirivant M, 2008, GASTROENTEROLOGY, V135, P1612, DOI 10.1053/j.gastro.2008.07.028
   Bonini S, 2005, OPHTHALMOLOGY, V112, P1528, DOI 10.1016/j.ophtha.2005.04.009
   Borroni D, 2019, BMJ OPEN OPHTHALMOL, V4, DOI 10.1136/bmjophth-2018-000248
   Bosnar D, 2006, CROAT MED J, V47, P59
   Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11
   BUC MH, 1966, BIOCHEM BIOPH RES CO, V22, P459, DOI 10.1016/0006-291X(66)90295-6
   Caldeira LD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238910
   Cavuoto KM, 2019, OCUL SURF, V17, P384, DOI 10.1016/j.jtos.2019.05.006
   Cendra MD, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00130
   Champagne CP, 2007, ELECTRON J BIOTECHN, V10, P211, DOI 10.2225/vol10-issue2-fulltext-10
   Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969
   Cristina Kenney M, 2003, Cont Lens Anterior Eye, V26, P139
   Delbeke H, 2021, ACTA OPHTHALMOL, V99, P16, DOI 10.1111/aos.14508
   Derwa Y, 2017, ALIMENT PHARM THER, V46, P389, DOI 10.1111/apt.14203
   Doan T, 2016, INVEST OPHTH VIS SCI, V57, P5116, DOI 10.1167/iovs.16-19803
   Dogru M, 2003, OPHTHALMOLOGY, V110, P1110, DOI 10.1016/S0161-6420(03)00261-6
   Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939
   Dzidic M, 2018, ALLERGY, V73, P2000, DOI 10.1111/all.13449
   Feleszko W, 2006, EUR J PHARMACOL, V533, P308, DOI 10.1016/j.ejphar.2005.12.062
   Fujimoto C, 2008, OPHTHAL RES, V40, P193, DOI 10.1159/000119875
   Gajecka M, 2014, ACTA OPHTHALMOL, V92, DOI 10.1111/j.1755-3768.2014.1762.x
   Gao W, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00508
   Gaskin JCF, 2015, INVEST OPHTH VIS SCI, V56, P5831, DOI 10.1167/iovs.14-15123
   Ghosh A, 2019, INVEST OPHTH VIS SCI, V60
   Ghosheh Faris R., 2008, International Ophthalmology, V28, P147, DOI 10.1007/s10792-007-9177-z
   GODEL V, 1978, J PEDIAT OPHTH STRAB, V15, P89
   Goodrich RP, 2000, VOX SANG, V78, P211
   Gorskova E N, 1998, Vestn Oftalmol, V114, P38
   Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616
   Greiner JV, 1997, CORNEA, V16, P327
   GREINER JV, 1985, AM J OPHTHALMOL, V100, P45, DOI 10.1016/S0002-9394(14)74981-5
   Grunauer-Kloevekorn C, 2006, KLIN MONATSBL AUGENH, V223, P493, DOI 10.1055/s-2005-859021
   Gunasekaran S, 2019, MIDDLE EAST AFR J OP, V26, P23, DOI 10.4103/meajo.MEAJO_172_16
   Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203
   Hogardt M, 2004, MICROBIOL-SGM, V150, P843, DOI 10.1099/mic.0.26703-0
   Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Iovieno A, 2008, GRAEF ARCH CLIN EXP, V246, P435, DOI 10.1007/s00417-007-0682-6
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015
   Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077
   Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024
   Kang PC, 2005, CORNEA, V24, P801, DOI 10.1097/01.ico.0000157407.43699.22
   Karaca EE, 2014, CORNEA, V33, P1168, DOI 10.1097/ICO.0000000000000260
   Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549
   Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960
   Khaled ML, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7803029
   Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209
   Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053
   Kiripolsky J, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/1246818
   Kittipibul T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60794-w
   Knop E, 2005, J ANAT, V206, P271, DOI 10.1111/j.1469-7580.2005.00394.x
   KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8
   Kugadas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005855
   Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062
   Kumar V, 2004, PHOTOCHEM PHOTOBIOL, V80, P15, DOI 10.1562/2003-12-23-RA-036.1
   KUMING BS, 1977, S AFR MED J, V52, P403
   LARKIN DFP, 1991, EYE, V5, P70, DOI 10.1038/eye.1991.14
   Lema I, 2010, MOL VIS, V16, P2055
   Mahdhi A, 2018, MICROB PATHOGENESIS, V125, P448, DOI 10.1016/j.micpath.2018.10.010
   Maier P, 2007, MOL VIS, V13, P1198
   Makdoumi K, 2012, GRAEF ARCH CLIN EXP, V250, P95, DOI 10.1007/s00417-011-1754-1
   Makdoumi K, 2010, CORNEA, V29, P1353, DOI 10.1097/ICO.0b013e3181d2de91
   Malfeito M., 2018, OCUL IMMUNOL INFLAMM, P1
   Mandathara PS, 2018, CONTACT LENS ANTERIO, V41, P219, DOI 10.1016/j.clae.2017.10.005
   Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957
   McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014
   McMonnies CW, 2009, CORNEA, V28, P607, DOI 10.1097/ICO.0b013e318198384f
   Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253
   Miller D, 2009, CURR OPIN ALLERGY CL, V9, P466, DOI 10.1097/ACI.0b013e3283303e1b
   Nemet AY, 2010, CORNEA, V29, P1261, DOI 10.1097/ICO.0b013e3181cb410b
   Ospelt C, 2010, INT J BIOCHEM CELL B, V42, P495, DOI 10.1016/j.biocel.2009.10.010
   Ozkan J, 2019, CURR EYE RES, V44, P685, DOI 10.1080/02713683.2019.1570526
   Ozkan J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10494-9
   Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12
   Pearlman E, 2008, OCUL SURF, V6, P108, DOI 10.1016/S1542-0124(12)70279-3
   Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997
   Petrillo F, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8071033
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7
   Redfern RL, 2015, EXP EYE RES, V134, P80, DOI 10.1016/j.exer.2015.03.018
   Regueiro U, 2021, GRAEF ARCH CLIN EXP, V259, P459, DOI 10.1007/s00417-020-04929-9
   Reinisch W, 2017, DIGEST DIS, V35, P123, DOI 10.1159/000449092
   Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006
   Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427
   Saee-Rad S, 2013, MOL VIS, V19, P2501
   Saghizadeh M, 2001, EXP EYE RES, V73, P179, DOI 10.1006/exer.2001.1028
   Sahebjada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084067
   Sanz Y, 2015, PEDIATR RES, V77, P236, DOI 10.1038/pr.2014.170
   Sartor RB, 2017, GASTROENTEROLOGY, V152, P327, DOI 10.1053/j.gastro.2016.10.012
   SAWAGUCHI S, 1989, ARCH OPHTHALMOL-CHIC, V107, P1507, DOI 10.1001/archopht.1989.01070020581044
   Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121
   SHAPIRO MB, 1985, AM J OPHTHALMOL, V99, P659, DOI 10.1016/S0002-9394(14)76031-3
   Shimizu E, 2019, OCUL SURF, V17, P265, DOI 10.1016/j.jtos.2019.02.001
   Shin H, 2016, MBIO, V7, DOI 10.1128/mBio.00198-16
   Sobrino T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13525-7
   Sorkhabi R, 2015, INT OPHTHALMOL, V35, P467, DOI 10.1007/s10792-014-9971-3
   Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]
   Ueta M, 2004, J IMMUNOL, V173, P3337, DOI 10.4049/jimmunol.173.5.3337
   Ueta M, 2010, BRAIN RES BULL, V81, P219, DOI 10.1016/j.brainresbull.2009.10.001
   Valentini M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/586939
   van Casteren WHM, 1998, CARBOHYD POLYM, V37, P123, DOI 10.1016/S0144-8617(98)00044-7
   Versura P, 2015, CURR EYE RES, V40, P162, DOI 10.3109/02713683.2014.966847
   Wang Y, 2000, AM J MED GENET, V93, P403, DOI 10.1002/1096-8628(20000828)93:5<403::AID-AJMG11>3.0.CO;2-A
   Wheeler Joshua, 2012, Reprod Syst Sex Disord
   Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
   Wu TG, 2003, CURR EYE RES, V26, P33, DOI 10.1076/ceyr.26.1.33.14253
   Yau JWK, 2019, PEDIAT ALLERG IMM-UK, V30, P624, DOI 10.1111/pai.13088
   Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1
   Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117
   Zhou Y, 2019, CARBOHYD POLYM, V207, P317, DOI 10.1016/j.carbpol.2018.11.093
   Zhou Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0099-x
   Zhu H, 2008, OPTOMETRY VISION SCI, V85, P292, DOI 10.1097/OPX.0b013e31816bea0f
NR 118
TC 1
Z9 1
U1 0
U2 5
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1746-9899
EI 1746-9902
J9 EXPERT REV OPHTHALMO
JI Expert Rev. Ophthalmol.
PD SEP 3
PY 2021
VL 16
IS 5
BP 333
EP 341
DI 10.1080/17469899.2021.1942844
EA JUN 2021
PG 9
WC Ophthalmology
WE Emerging Sources Citation Index (ESCI)
SC Ophthalmology
GA US7HN
UT WOS:000664150900001
DA 2023-09-14
ER

PT J
AU Wang, HH
   Ong, E
   Kao, JY
   Sun, DX
   He, YQ
AF Wang, Haihe
   Ong, Edison
   Kao, John Y.
   Sun, Duxin
   He, Yongqun
TI Reverse Microbiomics: A New Reverse Dysbiosis Analysis Strategy and Its
   Usage in Prediction of Autoantigens and Virulent Factors in Dysbiotic
   Gut Microbiomes From Rheumatoid Arthritis Patients
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE reverse microbiomics; reverse vaccinology; microbiome; gut microbiota;
   rheumatoid arthritis; ontology; bioinformatics
ID STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; IRON UPTAKE; TRANSPORTERS;
   PROLIFERATION; PROTECTION; RELEVANCE; VACCINES; SORTASE; TARGETS
AB Alterations in the gut microbiome have been associated with various human diseases. Most existing gut microbiome studies stopped at the stage of identifying microbial alterations between diseased or healthy conditions. As inspired by reverse vaccinology (RV), we developed a new strategy called Reverse Microbiomics (RM) that turns this process around: based on the identified microbial alternations, reverse-predicting the molecular mechanisms underlying the disease and microbial alternations. Our RM methodology starts by identifying significantly altered microbiota profiles, performing bioinformatics analysis on the proteomes of the microbiota identified, and finally predicting potential virulence or protective factors relevant to a microbiome-associated disease. As a use case study, this reverse methodology was applied to study the molecular pathogenesis of rheumatoid arthritis (RA), a common autoimmune and inflammatory disease. Those bacteria differentially associated with RA were first identified and annotated from published data and then modeled and classified using the Ontology of Host-Microbiome Interactions (OHMI). Our study identified 14 species increased and 9 species depleted in the gut microbiota of RA patients. Vaxign was used to comparatively analyze 15 genome sequences of the two pairs of species: Gram-negative Prevotella copri (increased) and Prevotella histicola (depleted), as well as Gram-positive Bifidobacterium dentium (increased) and Bifidobacterium bifidum (depleted). In total, 21 auto-antigens were predicted to be related to RA, and five of them were previously reported to be associated with RA with experimental evidence. Furthermore, we identified 94 potential adhesive virulence factors including 24 microbial ABC transporters. While eukaryotic ABC transporters are key RA diagnosis markers and drug targets, we identified, for the first-time, RA-associated microbial ABC transporters and provided a novel hypothesis of RA pathogenesis. Our study showed that RM, by broadening the scope of RV, is a novel and effective strategy to study from bacterial level to molecular level factors and gain further insight into how these factors possibly contribute to the development of microbial alterations under specific diseases.
C1 [Wang, Haihe] Harbin Med Univ Daqing, Dept Pathogen Biol, Daqing, Peoples R China.
   [Wang, Haihe; He, Yongqun] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.
   [Ong, Edison] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA.
   [Kao, John Y.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI USA.
   [Sun, Duxin] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.
   [He, Yongqun] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.
   [He, Yongqun] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.
C3 Harbin Medical University; University of Michigan System; University of
   Michigan; University of Michigan System; University of Michigan;
   University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; University of Michigan System; University of
   Michigan
RP Wang, HH (corresponding author), Harbin Med Univ Daqing, Dept Pathogen Biol, Daqing, Peoples R China.; Wang, HH; He, YQ (corresponding author), Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.; He, YQ (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.; He, YQ (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.
EM wanghaihe4@aliyun.com; yongqunh@med.umich.edu
RI Sun, Duxin/AAA-1774-2022
FU Natural Science Foundation of Heilongjiang Province [LH2019C074];
   Research Foundation of Harbin Medical University [2018XN-19]; Michigan
   Medicine-Peking University Health Sciences Center Joint Institute for
   Clinical and Translational Research [U063430]
FX This work was supported by the Natural Science Foundation of
   Heilongjiang Province (Grant No. LH2019C074) awarded to HW, Research
   Foundation of Harbin Medical University (Grant No. 2018XN-19) awarded to
   HW, and a grant to YH and JK from the Michigan Medicine-Peking
   University Health Sciences Center Joint Institute for Clinical and
   Translational Research (U063430).
CR Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847
   Arevalo P, 2019, CELL, V178, P820, DOI 10.1016/j.cell.2019.06.033
   Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002
   Atisha-Fregoso Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159556
   Baothman OA, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0278-4
   Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6
   Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002
   Breban M, 2016, JOINT BONE SPINE, V83, P645, DOI 10.1016/j.jbspin.2016.04.005
   Cao Y, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1088-4
   Carr R, 2012, BIOINFORMATICS, V28, P734, DOI 10.1093/bioinformatics/btr721
   Colquhoun C, 2020, DISEASES-BASEL, V8, DOI 10.3390/diseases8020013
   Curtis MA, 1999, J PERIODONTAL RES, V34, P400, DOI 10.1111/j.1600-0765.1999.tb02273.x
   Derksen VFAM, 2017, SEMIN IMMUNOPATHOL, V39, P437, DOI 10.1007/s00281-017-0627-z
   FALKENBACH A, 1991, MED KLIN, V86, P465
   Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x
   Forbes JD, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0603-4
   Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004
   Hasanuzzaman M, 2019, J PHARM SCI-US, V108, P3106, DOI 10.1016/j.xphs.2019.04.009
   He YQ, 2019, J BIOMED SEMANT, V10, DOI 10.1186/s13326-019-0217-1
   He YQ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/297505
   He YQ, 2010, J BIOMED BIOTECHNOL, P1, DOI [10.1155/2010/218590, 10.1155/2010/297505]
   Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486
   Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998
   Huh JW, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01887-4
   Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505
   Kirillina O, 2006, INFECT IMMUN, V74, P6171, DOI 10.1128/IAI.00874-06
   Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005
   Kotlarz A, 2013, CELL STRESS CHAPERON, V18, P653, DOI 10.1007/s12192-013-0407-1
   Lee Y.H., 2020, ANN RHEUM DIS, V2020
   Levy R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0588-y
   Logan AC, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0590-5
   Lu TB, 2018, CLIN RHEUMATOL, V37, P117, DOI 10.1007/s10067-017-3832-1
   Lucas C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061310
   Maeda Y, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0283-6
   Maeda Y, 2017, J CLIN MED, V6, DOI 10.3390/jcm6060060
   Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783
   Mankia K, 2016, CURR OPIN RHEUMATOL, V28, P260, DOI 10.1097/BOR.0000000000000268
   Marki-Zay J, 2013, CLIN EXP RHEUMATOL, V31, P779
   Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999
   Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1877
   Musen Mark A, 2015, AI Matters, V1, P4
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999
   Ni ZH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020458
   Ong E, 2020, BIOINFORMATICS, V36, P3185, DOI 10.1093/bioinformatics/btaa119
   Ong E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01382
   Pascual-Ramos V, 2016, GAC MED MEX, V152, P741
   Pianta A, 2017, ARTHRITIS RHEUMATOL, V69, P964, DOI 10.1002/art.40003
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223
   Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3
   Rosenthal KS, 2015, EXPERT REV VACCINES, V14, P891, DOI 10.1586/14760584.2015.1026330
   Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202
   SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x
   Schrijver IA, 2001, RHEUMATOLOGY, V40, P438, DOI 10.1093/rheumatology/40.4.438
   Smolen JS, 2016, LANCET, V388, P1984
   Tamura GS, 2002, INFECT IMMUN, V70, P2877, DOI 10.1128/IAI.70.6.2877-2885.2002
   Tanaka KJ, 2018, BBA-BIOMEMBRANES, V1860, P868, DOI 10.1016/j.bbamem.2017.08.011
   Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715
   Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139
   Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424
   Tsujimura S, 2018, MOD RHEUMATOL, V28, P276, DOI 10.1080/14397595.2017.1341458
   Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500
   van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1
   Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83
   Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208
   Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06
   Weber CA, 2009, ADV DRUG DELIVER REV, V61, P965, DOI 10.1016/j.addr.2009.07.001
   Wei B, 2001, INFECT IMMUN, V69, P6044, DOI 10.1128/IAI.69.10.6044-6054.2001
   Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001
   Xiang ZS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S4-S2
   Xiang Zuoshuang, 2010, BMC Res Notes, V3, P175, DOI 10.1186/1756-0500-3-175
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
   Zhu DL, 2019, ENVIRON MICROBIOL, V21, P3076, DOI 10.1111/1462-2920.14706
NR 73
TC 5
Z9 5
U1 0
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 25
PY 2021
VL 12
AR 633732
DI 10.3389/fmicb.2021.633732
PG 13
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA QU5XR
UT WOS:000627355200001
PM 33717026
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Galanis, A
   Vardakas, P
   Reczko, M
   Harokopos, V
   Hatzis, P
   Skoulakis, EMC
   Pavlopoulos, GA
   Patalano, S
AF Galanis, Anastasios
   Vardakas, Philippos
   Reczko, Martin
   Harokopos, Vaggelis
   Hatzis, Pantelis
   Skoulakis, Efthimios M. C.
   Pavlopoulos, Georgios A.
   Patalano, Solenn
TI Bee foraging preferences, microbiota and pathogens revealed by direct
   shotgun metagenomics of honey
SO MOLECULAR ECOLOGY RESOURCES
LA English
DT Article
DE biomonitoring; gut microbiome; honeybee; plant foraging; shotgun
   sequencing; Varroa
ID GUT MICROBIOTA; CLIMATE-CHANGE; ALIGNMENT
AB Honeybees (Apis mellifera) continue to succumb to human and environmental pressures despite their crucial role in providing essential ecosystem services. Owing to their foraging and honey production activities, honeybees form complex relationships with species across all domains, such as plants, viruses, bacteria and other hive pests, making honey a valuable biomonitoring tool for assessing their ecological niche. Thus, the application of honey shotgun metagenomics (SM) has paved the way for a detailed description of the species honeybees interact with. Nevertheless, SM bioinformatics tools and DNA extraction methods rely on resources not necessarily optimized for honey. In this study, we compared five widely used taxonomic classifiers using simulated species communities commonly found in honey. We found that Kraken 2 with a threshold of 0.5 performs best in assessing species distribution. We also optimized a simple NaOH-based honey DNA extraction methodology (Direct-SM), which profiled species seasonal variability similarly to an established column-based DNA extraction approach (SM). Both approaches produce results consistent with melissopalinology analysis describing the botanical landscape surrounding the apiary. Interestingly, we detected a strong stability of the bacteria constituting the core and noncore gut microbiome across seasons, pointing to the potential utility of honey for noninvasive assessment of bee microbiota. Finally, the Direct-SM approach to detect Varroa correlates well with the biomonitoring of mite infestation observed in hives. These observations suggest that Direct-SM methodology has the potential to comprehensively describe honeybee ecological niches and can be tested as a building block for large-scale studies to assess bee health in the field.
C1 [Galanis, Anastasios; Vardakas, Philippos; Reczko, Martin; Harokopos, Vaggelis; Hatzis, Pantelis; Skoulakis, Efthimios M. C.; Pavlopoulos, Georgios A.; Patalano, Solenn] BSRC Alexander Fleming, Inst Fundamental Biomed Res IFBR, 34 Fleming St, Vari 16672, Greece.
   [Galanis, Anastasios] Natl & Kapodistrian Univ Athens, Dept Biol, Div Anim & Human Physiol, Athens, Greece.
   [Vardakas, Philippos] Inst Anim Sci, Dept Apiculture, Nea Moudania, Greece.
C3 Alexander Fleming Biomedical Sciences Research Center; National &
   Kapodistrian University of Athens
RP Patalano, S (corresponding author), BSRC Alexander Fleming, Inst Fundamental Biomed Res IFBR, 34 Fleming St, Vari 16672, Greece.
EM patalano@fleming.gr
RI Reczko, Martin/O-8935-2019; Pavlopoulos, Georgios A./L-7544-2017;
   Patalano, Solenn/ABG-4932-2021
OI Pavlopoulos, Georgios A./0000-0002-4577-8276; Patalano,
   Solenn/0000-0002-1880-7692; Reczko, Martin/0000-0002-0005-8718; Galanis,
   Anastasios/0000-0002-8118-5355; Charokopos,
   Evangelos/0000-0001-9260-8459; SKOULAKIS, EFTHIMIOS/0000-0001-5113-6192;
   Vardakas, Philippos/0000-0003-0781-1204
FU Marie Skodowska-Curie Individual Fellowship [798082]; "Fondation Sante"
   research grant; Greek Ministry of Rural Development and Food grant
   (programme for production and marketing of beekeeping); Operational
   Program Competitiveness, Entrepreneurship and Innovation, NSRF 2014-2020
   [MIS 5002562]; European Union (European Regional Development Fund);
   Marie Curie Actions (MSCA) [798082] Funding Source: Marie Curie Actions
   (MSCA)
FX This work was funded by a Marie Skodowska-Curie Individual Fellowship
   (798082), a "Fondation Sante" research grant to S.P. and by a Greek
   Ministry of Rural Development and Food grant (programme for production
   and marketing of beekeeping) to E.S. G.A.P. was supported by the
   Operational Program Competitiveness, Entrepreneurship and Innovation,
   NSRF 2014-2020, Action code: MIS 5002562, cofinanced by Greece and the
   European Union (European Regional Development Fund). We would like to
   thank Charlotta Wiren for field assistance, Nikolaos Kalavros and
   Alexandros Dimopoulos for assistance in bioinformatic analyses, and
   Foteini Ravini and Anastasios Kampolis from the CheMa Laboratories.
   Finally, we thank the anonymous reviewers for their contribution in
   improving the manuscript.
CR Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071
   Belsky J, 2019, INSECTS, V10, DOI 10.3390/insects10080233
   Bovo S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66127-1
   Bovo S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205575
   Branchiccela B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46453-9
   Breed MF, 2019, NAT REV GENET, V20, P615, DOI 10.1038/s41576-019-0152-0
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Castelli L, 2020, MICROB ECOL, V80, P908, DOI 10.1007/s00248-020-01538-1
   Chari A, 2015, INT J SYST EVOL MICR, V65, P1400, DOI 10.1099/ijs.0.000091
   Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562
   D'Alvise P, 2019, ECOL EVOL, V9, P10241, DOI 10.1002/ece3.5544
   de Vere N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42838
   Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350
   Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.4.12, 10.3896/IBRA.1.52.1.03]
   Delcour I, 2015, FOOD RES INT, V68, P7, DOI 10.1016/j.foodres.2014.09.030
   Di Pasquale G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162818
   Dynes TL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216286
   Eleftherianos I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00046
   Ellegaard KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08303-0
   Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109
   European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3594
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Gilioli G, 2019, ECOL INDIC, V101, P341, DOI 10.1016/j.ecolind.2019.01.024
   Girotti S, 2020, EURO-MEDITERR J ENVI, V5, DOI 10.1007/s41207-020-00204-9
   Glenny W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182814
   Goodhead I, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000285
   Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957
   Hawkins J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134735
   Jones JC, 2018, ECOL EVOL, V8, P441, DOI 10.1002/ece3.3597
   Jones L, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01562-4
   Kafantaris I, 2021, EUR FOOD RES TECHNOL, V247, P309, DOI 10.1007/s00217-020-03634-5
   Kammerer M, 2021, GLOBAL CHANGE BIOL, V27, P1250, DOI 10.1111/gcb.15485
   Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3_13
   Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031
   Kesnerova L, 2020, ISME J, V14, P801, DOI 10.1038/s41396-019-0568-8
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4
   Klein AM, 2018, CURR OPIN INSECT SCI, V26, P82, DOI 10.1016/j.cois.2018.02.011
   Klein S, 2017, TRENDS ECOL EVOL, V32, P268, DOI 10.1016/j.tree.2016.12.009
   Kwadha CA, 2017, INSECTS, V8, DOI 10.3390/insects8020061
   Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Liberti J, 2020, CURR OPIN INSECT SCI, V39, P6, DOI 10.1016/j.cois.2020.01.004
   Lopez-Uribe MM, 2020, ANNU REV ANIM BIOSCI, V8, P269, DOI 10.1146/annurev-animal-020518-115045
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maitner BS, 2018, METHODS ECOL EVOL, V9, P373, DOI 10.1111/2041-210X.12861
   Marcelino VR, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6592-2
   Marcelino VR, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02014-2
   Matzrafi M, 2019, PEST MANAG SCI, V75, P9, DOI 10.1002/ps.5121
   Meric G, 2019, bioRxiv, DOI [10.1101/712166, 10.1101/712166v1, DOI 10.1101/712166, 10.1101/712166]
   Motta EVS, 2018, P NATL ACAD SCI USA, V115, P10305, DOI 10.1073/pnas.1803880115
   Muth F, 2016, ANIM BEHAV, V111, P93, DOI 10.1016/j.anbehav.2015.09.029
   Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007
   Osmundson TW, 2013, MOL ECOL RESOUR, V13, P66, DOI 10.1111/1755-0998.12031
   Pantano Lorena, 2017, Bioconductor, DOI 10.18129/B9.BIOC.DEGREPORT
   Paris L, 2020, J INVERTEBR PATHOL, V172, DOI 10.1016/j.jip.2020.107348
   Patel V, 2021, AMBIO, V50, P49, DOI 10.1007/s13280-020-01333-9
   Pearman WS, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3528-4
   Peel N, 2019, METHODS ECOL EVOL, V10, P1690, DOI 10.1111/2041-210X.13265
   Pereira MB, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4637-6
   Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112
   Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588
   Quigley TP, 2019, CURR OPIN INSECT SCI, V35, P132, DOI 10.1016/j.cois.2019.08.012
   Samuelson AE, 2020, APIDOLOGIE, V51, P746, DOI 10.1007/s13592-020-00758-1
   Schwarz RS, 2014, MICROBIOLOGYOPEN, V3, P341, DOI 10.1002/mbo3.172
   Settele J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.92, 10.1038/nplants.2016.92]
   Shcherbina Anna, 2014, BMC Res Notes, V7, P533, DOI 10.1186/1756-0500-7-533
   Simone-Finstrom M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32023
   Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2
   Smith M.L., 2021, BIORXIV, DOI [10.1101/2021.04.15.440020, DOI 10.1101/2021.04.15.440020]
   Snyder AK, 2011, FEMS MICROBIOL LETT, V317, P143, DOI 10.1111/j.1574-6968.2011.02221.x
   Sponsler DB, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.3102
   Su Qi, 2013, Communicative & Integrative Biology, V6, pe23804, DOI 10.4161/cib.23804
   Tsigouri A, 2004, GRANA, V43, P122, DOI 10.1080/00173130310017643
   Wirta H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84174-0
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Yun JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19860-7
   Zheng H, 2019, P NATL ACAD SCI USA, V116, P25909, DOI 10.1073/pnas.1916224116
   Zheng H, 2017, P NATL ACAD SCI USA, V114, P4775, DOI 10.1073/pnas.1701819114
   Zhu LZ, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113671
NR 79
TC 1
Z9 1
U1 7
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-098X
EI 1755-0998
J9 MOL ECOL RESOUR
JI Mol. Ecol. Resour.
PD OCT
PY 2022
VL 22
IS 7
BP 2506
EP 2523
DI 10.1111/1755-0998.13626
EA MAY 2022
PG 18
WC Biochemistry & Molecular Biology; Ecology; Evolutionary Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology;
   Evolutionary Biology
GA 4H9MR
UT WOS:000797833700001
PM 35593171
OA Green Submitted
DA 2023-09-14
ER

PT J
AU Li, LH
   Yang, KB
   Li, C
   Zhang, H
   Yu, HH
   Chen, K
   Yang, XH
   Liu, L
AF Li, Lihua
   Yang, Kaibo
   Li, Cong
   Zhang, Han
   Yu, Honghua
   Chen, Kang
   Yang, Xiaohong
   Liu, Lei
TI Metagenomic shotgun sequencing and metabolomic profiling identify
   specific human gut microbiota associated with diabetic retinopathy in
   patients with type 2 diabetes
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE diabetic retinopathy; gut microbiome; metagenomic; metabolomics;
   diabetes
ID ALIGNMENT
AB BackgroundDiabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus (DM) and is one of the leading causes of blindness among DM patients. However, the molecular mechanism involving DR remains unclear. MethodsA case-control study with age-, sex-, and duration-matched diabetic patients and controls was conducted, which included 15 type 2 DM (T2DM) patients with DR and 15 T2DM patients without DR. Shotgun sequencing and non-targeted metabolomic profiling analyses of fecal samples were performed, and comprehensive bioinformatics analyses were conducted. ResultsUsing metagenomic analyses, we identified 293,460 unique genes in the non-DR group, while that in the DR group was 283,235, and the number of overlapping genes was 1,237,914. Regarding phylum levels, Actinobacteria decreased but Bacteroidetes increased in the DR group when compared with those in the control group. Regarding genus levels, Bifidobacterium and Lactobacillus decreased. Cellular processes, environmental information processes, and metabolism-related pathways were found at higher levels in the gut microbiome of DR patients. Using metabolomic analyses, we found 116 differentially expressed metabolites with a positive ion model and 168 differentially expressed metabolites with a negative ion model between the two groups. Kyoto Encyclopedia of Genes and Genomes annotation revealed six pathways with different levels between DR and diabetic controls, namely, cellular processes, environmental information processing, genetic information processing, human diseases, organismal systems and metabolism. Moreover, lysine biosynthesis and lysine degradation were enriched using a positive model, but histidine metabolism and beta-alanine metabolism were enriched using a negative model. ConclusionsTogether, the metagenomic profiles of DR patients indicated different gut microbiota compositions and characteristic fecal metabolic phenotypes in DR patients. Our findings of microbial pathways therefore provided potential etiological and therapeutic targets for DR patients.
C1 [Li, Lihua] Weifang Med Univ, Dept Ophthalmol, Affiliated Hosp, Weifang, Peoples R China.
   [Yang, Kaibo; Zhang, Han; Chen, Kang] China Med Univ, Dept Ophthalmol, Hosp 1, Shenyang, Peoples R China.
   [Li, Cong; Yu, Honghua; Yang, Xiaohong; Liu, Lei] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Eye Inst, Dept Ophthalmol, Guangzhou, Peoples R China.
C3 Weifang Medical University; China Medical University; Guangdong Academy
   of Medical Sciences & Guangdong General Hospital; Southern Medical
   University - China
RP Chen, K (corresponding author), China Med Univ, Dept Ophthalmol, Hosp 1, Shenyang, Peoples R China.; Yang, XH; Liu, L (corresponding author), Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Eye Inst, Dept Ophthalmol, Guangzhou, Peoples R China.
EM akanger@sina.com; syyangxh@scut.edu.cn; liuleijiao@163.com
RI LI, XIAO/JCE-6169-2023; yang, xiao/HJI-7815-2023
FU Science and Technology Program of Guangzhou, China; Project of Special
   Research on Cardiovascular Diseases; GDPH Supporting Fund for Talent
   Program;  [202002020049];  [2020XXG007]
FX Funding This study was supported by Science and Technology Program of
   Guangzhou, China (202002020049) (XY); Project of Special Research on
   Cardiovascular Diseases (2020XXG007) (XY) and GDPH Supporting Fund for
   Talent Program (LL).
CR Avershina E, 2013, MICROBES ENVIRON, V28, P211, DOI 10.1264/jsme2.ME12157
   Becker K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88698-3
   Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y
   Beli E, 2018, DIABETES, V67, P1867, DOI 10.2337/db18-0158
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3
   Cunningham AL, 2021, GUT PATHOG, V13, DOI 10.1186/s13099-021-00446-0
   Dang FF, 2018, FOOD FUNCT, V9, P3630, DOI [10.1039/C8FO00081F, 10.1039/c8fo00081f]
   Das T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82538-0
   Du MR, 2018, VASC PHARMACOL, V108, P46, DOI 10.1016/j.vph.2018.05.004
   Engels C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00713
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Fotiou P, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/807209
   Geng JF, 2022, BIOMED PHARMACOTHER, V147, DOI 10.1016/j.biopha.2022.112678
   Gil Jeovanis, 2022, Methods Mol Biol, V2420, P73, DOI 10.1007/978-1-0716-1936-0_7
   Guo Y, 2019, EXP THER MED, V17, P2641, DOI 10.3892/etm.2019.7223
   Hiippala K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080988
   Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x
   Huang CY, 2019, AMINO ACIDS, V51, P1515, DOI 10.1007/s00726-019-02788-1
   Huang YH, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.646348
   Jayasudha R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243077
   Jiao JH, 2021, J INFLAMM RES, V14, P6929, DOI 10.2147/JIR.S336148
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kartal E, 2022, GUT, V71, P1359, DOI 10.1136/gutjnl-2021-324755
   Liu H, 2021, OSTEOARTHR CARTILAGE, V29, P1346, DOI 10.1016/j.joca.2021.04.016
   Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9
   Menini S, 2020, CURR MED CHEM, V27, P1744, DOI 10.2174/0929867326666190711102718
   Noval Rivas M, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026
   Osborne G, 2020, GUT MICROBES, V11, P63, DOI 10.1080/19490976.2019.1614394
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Scuderi G, 2022, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.726792
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shi C, 2020, EYE VISION, V7, DOI 10.1186/s40662-020-00199-y
   Sikalidis AK, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8010008
   St Leger AJ, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800046
   Tanase DM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123719
   Turroni F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01030
   Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5
   Wu IW, 2020, THERANOSTICS, V10, P5398, DOI 10.7150/thno.41725
   Xue L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45176
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yang G, 2021, METABOLISM, V117, DOI 10.1016/j.metabol.2021.154712
   Ye PP, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.667632
   Ye P, 2021, APPL MICROBIOL BIOT, V105, P8457, DOI 10.1007/s00253-021-11593-4
   Zhang Y, 2022, CELL DEATH DISCOV, V8, DOI 10.1038/s41420-022-00861-5
   Zhou ZX, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.732204
   Zhu F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15457-9
   Zhu TT, 2020, CURR NUTR REP, V9, P83, DOI 10.1007/s13668-020-00307-3
NR 48
TC 3
Z9 3
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 17
PY 2022
VL 13
AR 943325
DI 10.3389/fimmu.2022.943325
PG 14
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 4G3UI
UT WOS:000849125600001
PM 36059453
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Martino, A
   Giuliani, A
   Todde, V
   Bizzarri, M
   Rizzi, A
AF Martino, Alessio
   Giuliani, Alessandro
   Todde, Virginia
   Bizzarri, Mariano
   Rizzi, Antonello
TI Metabolic networks classification and knowledge discovery by information
   granulation
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Granular computing; Embedding spaces; Support vector machines;
   Computational biology; Metabolic pathways; Complex networks
ID HUMAN GUT MICROBIOME; COMPUTING TECHNIQUES; SIGNALING PATHWAY; DISTANCE;
   INOSITOL; KEGG; SELECTION; PROTEINS; ARCHAEA; HEALTH
AB Graphs are powerful structures able to capture topological and semantic information from data, hence suitable for modelling a plethora of real-world (complex) systems. For this reason, graph-based pattern recognition gained a lot of attention in recent years. In this paper, a general-purpose classification system in the graphs domain is presented. When most of the information of the available patterns can be encoded in edge labels, an information granulation-based approach is highly discriminant and allows for the identification of semantically meaningful edges. The proposed classification system has been tested on the entire set of organisms (5299) for which metabolic networks are known, allowing for both a perfect mirroring of the underlying taxonomy and the identification of most discriminant metabolic reactions and pathways. The widespread diffusion of graph (network) structures in biology makes the proposed pattern recognition approach potentially very useful in many different fields of application. More specifically, the possibility to have a reliable metric to compare different metabolic systems is instrumental in emerging fields like microbiome analysis and, more in general, for proposing metabolic networks as a universal phenotype spanning the entire tree of life and in direct contact with environmental cues.
C1 [Martino, Alessio; Rizzi, Antonello] Univ Roma La Sapienza, Dept Informat Engn Elect & Telecommun, Via Eudossiana 18, I-00184 Rome, Italy.
   [Giuliani, Alessandro; Todde, Virginia] Ist Super Sanita, Dept Environm & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Bizzarri, Mariano] Univ Roma La Sapienza, Syst Biol Grp Lab, Dept Expt Med, Rome, Italy.
C3 Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza
   University Rome
RP Martino, A (corresponding author), Univ Roma La Sapienza, Dept Informat Engn Elect & Telecommun, Via Eudossiana 18, I-00184 Rome, Italy.
EM alessio.martino@uniroma1.it; alessandro.giuliani@iss.it;
   virginia.todde@iss.it; mariano.bizzarri@uniroma1.it;
   antonello.rizzi@uniroma1.it
RI Martino, Alessio/S-8362-2019; Giuliani, Alessandro/K-7589-2016
OI Martino, Alessio/0000-0003-1730-5436; Giuliani,
   Alessandro/0000-0002-4640-804X
CR Alberts B., 2015, ESSENTIAL CELL BIOL
   [Anonymous], 2018, 2018 INT JOINT C NEU, DOI DOI 10.1109/IJCNN.2018.8489115
   [Anonymous], 2017, P 9 INT JOINT C COMP, DOI DOI 10.5220/0006515003380347
   [Anonymous], 1989, GENETIC ALGORITHMS S
   [Anonymous], GRANULAR COMPUTING I
   [Anonymous], 2008, HDB GRANULAR COMPUTI
   [Anonymous], 2012, P 1 INT C PATTERN RE, DOI DOI 10.5220/0003733201860191
   [Anonymous], 2002, LEARNING KERNELS SUP
   [Anonymous], 2007, BRIDGING GAP GRAPH E
   [Anonymous], 2011, J MACH LEARN TECHNOL
   [Anonymous], 2004, KERNEL METHODS PATTE, DOI DOI 10.1017/CB09780511809682
   [Anonymous], GRANULAR COMPUT
   [Anonymous], 2000, INTRO SUPPORT VECTOR
   Baldini L, 2019, IJCCI: PROCEEDINGS OF THE 11TH INTERNATIONAL JOINT CONFERENCE ON COMPUTATIONAL INTELLIGENCE, P391, DOI 10.5220/0008149403910402
   Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115
   Beni Z, 2018, MOLECULES, V23, DOI 10.3390/molecules23051082
   Bergstra J, 2012, J MACH LEARN RES, V13, P281
   Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016
   Bianchi FM, 2016, COGN COMPUT, V8, P442, DOI 10.1007/s12559-015-9369-1
   Bianchi FM, 2014, SOFT COMPUT, V18, P393, DOI 10.1007/s00500-013-1065-z
   Bordbar A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46249
   Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401
   Brenner D.J., 2015, BERGEYS MANUAL SYSTE, P1
   Bunke H, 1997, PATTERN RECOGN LETT, V18, P689, DOI 10.1016/S0167-8655(97)00060-3
   Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723
   Cinti A, 2020, COGN COMPUT, V12, P369, DOI 10.1007/s12559-019-09646-y
   Cokelaer T, 2013, BIOINFORMATICS, V29, P3241, DOI 10.1093/bioinformatics/btt547
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018
   COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964
   COVER TM, 1965, IEEE TRANS ELECTRON, VEC14, P326, DOI 10.1109/PGEC.1965.264137
   Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007
   Del Vescovo G, 2007, GRC: 2007 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING, PROCEEDINGS, P410
   Di Noia A, 2020, SOFT COMPUT, V24, P4393, DOI 10.1007/s00500-019-04200-2
   Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356
   Di Paola L., 2017, PROTEIN INTERACTIONS, P1, DOI [10.1002/9780470015902.A0001346.PUB2, DOI 10.1002/9780470015902.A0001346.PUB2]
   Dibrova DV, 2014, ENVIRON MICROBIOL, V16, P907, DOI 10.1111/1462-2920.12359
   Duecker FL, 2019, ORG BIOMOL CHEM, V17, P1624, DOI 10.1039/c8ob02325e
   Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2
   Ereshefsky M, 2010, BIOL PHILOS, V25, P553, DOI 10.1007/s10539-010-9211-9
   Fan RE, 2008, J MACH LEARN RES, V9, P1871
   Ferry James G., 2015, Life-Basel, V5, P1454, DOI 10.3390/life5021454
   Giuliani A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00083
   Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475
   HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x
   Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752
   Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667
   Howard N, 2014, COGN COMPUT, V6, P35, DOI 10.1007/s12559-012-9171-2
   Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9
   Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200
   Kirchmair J, 2015, NAT REV DRUG DISCOV, V14, P387, DOI 10.1038/nrd4581
   Knoll AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016121
   Krishnan A, 2008, CURR PROTEIN PEPT SC, V9, P28
   LEVENSHT.VI, 1965, DOKL AKAD NAUK SSSR+, V163, P845
   Lin T. Y., 2013, DATA MINING ROUGH SE, V95
   Livi L, 2016, GRANULAR COMPUT, V1, P13, DOI 10.1007/s41066-015-0003-0
   Livi L, 2015, APPL SOFT COMPUT, V27, P567, DOI 10.1016/j.asoc.2014.08.072
   Livi L, 2014, INFORM SCIENCES, V266, P47, DOI 10.1016/j.ins.2014.01.005
   Livi L, 2013, PATTERN ANAL APPL, V16, P253, DOI 10.1007/s10044-012-0284-8
   Livi L, 2013, FUZZY SET SYST, V221, P24, DOI 10.1016/j.fss.2013.01.001
   Mackenzie RWA, 2014, DIABETES METAB SYNDR, V7, P55, DOI 10.2147/DMSO.S48260
   Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669
   Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990
   Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002
   Martin W, 2005, CURR OPIN MICROBIOL, V8, P630, DOI 10.1016/j.mib.2005.10.004
   Martinetti A, 2019, INT J OCCUP SAF ERGO, V25, P66, DOI 10.1080/10803548.2018.1444724
   Martino A, 2018, IEEE IJCNN
   Martino A, 2019, ALGORITHMS, V12, DOI 10.3390/a12110223
   Martino A, 2017, LECT NOTES COMPUT SC, V10269, P285, DOI 10.1007/978-3-319-59126-1_24
   Martino A, 2018, STUD COMPUT INTELL, V777, P53, DOI 10.1007/978-3-319-89629-8_3
   Mercer J, 1909, PHILOS T R SOC LOND, V209, P415, DOI 10.1098/rsta.1909.0016
   Olivares-Rubio HF, 2016, ENVIRON POLLUT, V218, P297, DOI 10.1016/j.envpol.2016.07.005
   Palumbo MC, 2005, FEBS LETT, V579, P4642, DOI 10.1016/j.febslet.2005.07.033
   Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229
   Pedrycz W, 2013, APPL SOFT COMPUT, V13, P4209, DOI 10.1016/j.asoc.2013.06.017
   Pekalska E, 2006, PATTERN RECOGN, V39, P189, DOI 10.1016/j.patcog.2005.06.012
   Pekalska E, 2005, DISSIMILARITY REPRES, V64, DOI [10.1142/5965, DOI 10.1142/5965]
   Reuveni E, 2012, PHYSICA A, V391, P1172, DOI 10.1016/j.physa.2011.08.050
   Rizzi A, 2012, IEEE IJCNN
   Roberts Mary F., 2006, V39, P103
   SCHAFER T, 1993, ARCH MICROBIOL, V159, P72, DOI 10.1007/BF00244267
   Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044
   Scholkopf B, 2000, NEURAL COMPUT, V12, P1207, DOI 10.1162/089976600300015565
   Singh PK, 2018, COGN COMPUT, V10, P228, DOI 10.1007/s12559-017-9527-8
   Suarez-Causado A, 2015, BBA-MOL CELL RES, V1853, P2453, DOI 10.1016/j.bbamcr.2015.05.017
   Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925
   Tun K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-24
   Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949
   Wang G, 2017, GRANULAR COMPUT, V2, P105, DOI 10.1007/s41066-016-0032-3
   Wasser SP, 2010, INT J MED MUSHROOMS, V12, P1, DOI 10.1615/IntJMedMushr.v12.i1.10
   Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957
   Yang J, 2018, INFORM SCIENCES, V448, P18, DOI 10.1016/j.ins.2018.03.026
   Yao YY, 2008, 2008 INTERNATIONAL FORUM ON KNOWLEDGE TECHNOLOGY, P299
   Yao YY, 2016, GRANULAR COMPUT, V1, P145, DOI 10.1007/s41066-015-0011-0
   Yao YY, 2012, INFORM SCIENCES, V213, P1, DOI 10.1016/j.ins.2012.05.021
   YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   Zhu J, 2004, ADV NEUR IN, V16, P49
NR 100
TC 18
Z9 18
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD FEB
PY 2020
VL 84
AR 107187
DI 10.1016/j.compbiolchem.2019.107187
PG 16
WC Biology; Computer Science, Interdisciplinary Applications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA KH9CT
UT WOS:000510947400007
PM 31923821
DA 2023-09-14
ER

PT J
AU Afolayan, AO
   Ayeni, FA
   Moissl-Eichinger, C
   Gorkiewicz, G
   Halwachs, B
   Hogenauer, C
AF Afolayan, Ayorinde O.
   Ayeni, Funmilola A.
   Moissl-Eichinger, Christine
   Gorkiewicz, Gregor
   Halwachs, Bettina
   Hoegenauer, Christoph
TI Impact of a Nomadic Pastoral Lifestyle on the Gut Microbiome in the
   Fulani Living in Nigeria
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE gut microbiota; Fulani; Jarawa; lifestyle; diet
ID INTESTINAL MICROBIOTA; VAGINAL MICROBIOME; FECAL MICROBIOTA;
   HUMAN-NUTRITION; HEALTH; RESOURCE; INFANT; GENE; AGE
AB The co-evolution of the gut microbiota with its human host has revolutionized our current scientific viewpoint about the contribution of diet and lifestyle on human health. Most studies so far have focused on populations living in the United States and Europe or compared those with communities from other geographic areas in the world. In order to determine the taxonomic and predicted functional profile of the gut microbiome of a hitherto unstudied human community, we investigated the phylogenetic diversity of the gut microbiota in a community of Fulani nomadic pastoralists, and their semi-urbanized neighbors - the Jarawa. The Jarawa reside in a city (Jos) in the north-central part of Nigeria, and are adapted in part to a westernized lifestyle. The nomadic Fulani lifestyle resembles a mix of Paleolithic and Neolithic lifestyle patterns with a greater predisposition to diseases. The fecal microbiota of the Fulani and the Jarawa were characterized by paired-end Illumine MiSeq sequencing of the 16S rRNA gene, followed by downstream bioinformatics analysis of the sequence reads. The Fulani harbored increased numbers of signatures of microbes that are known to be associated with a foraging lifestyle such as the Bacteroidetes, Spirochaetes, and Prevotellaceae, while the Jarawa were dominated by signatures of Firmicutes, Ruminococcaceae, Lachnospiraceae, and Christensenellaceae. Notably, the gut microbiota of the Fulani showed less taxonomic diversity than those of the Jarawa. Although they reside in the same geographical zone, microbial community composition was significantly different between the two groups. Pathogens were predicted to be more abundant in the gut microbiota of the Fulani than of the Jarawa. Predicted pathogenic pathways and pathways associated with the breakdown of fiber-rich diet were enriched in the Fulani, including glutathione metabolism, while pathways associated with the consumption of low-fiber diet and xenobiotics, including fructose and mannose metabolic pathways, and nitrotoluene degradation pathways, respectively, were enriched in the Jarawa. Significant differences in composition between both groups were likely due to differences in diet and lifestyle and exposure to pathogens. These results suggest that microbial diversity may not always be higher in non-industrialized societies than in westernized societies, as previously assumed.
C1 [Afolayan, Ayorinde O.; Ayeni, Funmilola A.] Univ Ibadan, Dept Pharmaceut Microbiol, Fac Pharm, Ibadan, Nigeria.
   [Moissl-Eichinger, Christine] Med Univ Graz, Dept Internal Med, Div Infect Dis & Trop Med, Graz, Austria.
   [Moissl-Eichinger, Christine; Gorkiewicz, Gregor; Halwachs, Bettina] Interuniv Cooperat, BioTechMed, Graz, Austria.
   [Gorkiewicz, Gregor; Halwachs, Bettina; Hoegenauer, Christoph] Med Univ Graz, Inst Pathol, Graz, Austria.
   [Gorkiewicz, Gregor; Halwachs, Bettina; Hoegenauer, Christoph] Theodor Escherich Lab Microbiome Res, Graz, Austria.
   [Hoegenauer, Christoph] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria.
C3 University of Ibadan; Medical University of Graz; Medical University of
   Graz; Medical University of Graz
RP Ayeni, FA (corresponding author), Univ Ibadan, Dept Pharmaceut Microbiol, Fac Pharm, Ibadan, Nigeria.; Hogenauer, C (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.; Hogenauer, C (corresponding author), Theodor Escherich Lab Microbiome Res, Graz, Austria.; Hogenauer, C (corresponding author), Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria.
EM funmiyeni@yahoo.co.uk; christoph.hoegenauer@medunigraz.at
RI Halwachs, Bettina/AAD-4347-2019; Ayeni, Funmilola Abidemi/AAA-9902-2020;
   Moissl-Eichinger, Christine/A-6682-2015; Gorkiewicz,
   Gregor/ABF-1602-2021
OI Ayeni, Funmilola Abidemi/0000-0002-2379-0135; Moissl-Eichinger,
   Christine/0000-0001-6755-6263; Gorkiewicz, Gregor/0000-0003-1149-4782;
   Afolayan, Ayorinde/0000-0003-1405-2365; Hogenauer,
   Christoph/0000-0003-4566-0806
FU Austrian Agency for International Mobility and Cooperation in Education,
   Science, and Research (OEAD-GmbH); Centre for International Cooperation
   and Mobility (ICM) [ICM2016-03232]
FX This research was funded by the Austrian Agency for International
   Mobility and Cooperation in Education, Science, and Research
   (OEAD-GmbH); and Centre for International Cooperation and Mobility (ICM)
   with reference number ICM2016-03232.
CR Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343
   Akogun OB, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-5
   [Anonymous], NIG WORLD FACTB
   Ayeni FA, 2018, CELL REP, V23, P3056, DOI 10.1016/j.celrep.2018.05.018
   Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042
   Burdet C, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02244-18, 10.1128/aac.02244-18]
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183
   De Filippo C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01979
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Freitas AC, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0502-8
   Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013
   Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162
   Haak BW, 2019, J ANTIMICROB CHEMOTH, V74, P782, DOI 10.1093/jac/dky471
   Hochschulraum-Strukturmittel, 2016, BIOTECHMED 2017 INFR
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Klymiuk I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02012
   Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
   Kump P, 2018, ALIMENT PHARM THER, V47, P67, DOI 10.1111/apt.14387
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lockett CT, 2000, INT J FOOD SCI NUTR, V51, P195, DOI [10.1080/09637480050029700, 10.1080/096374899101238]
   Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157
   Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049
   Metlay JP, 2003, PHARMACOEPIDEM DR S, V12, P9, DOI 10.1002/pds.772
   Morton ER, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005658
   Muhammad H, 2016, SUB SAHARAN AFRICAN, V3, P205, DOI [10.4103/ssajm.ssajm_40_16, DOI 10.4103/SSAJM.SSAJM_40_16]
   Nakayama J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00197
   Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x
   Obi C. N., 2007, International Journal of Dairy Science, V2, P95
   Okonkwo O. I, 2011, INT J DAIRY SCI, V6, P181, DOI 10.3923/ijds.2011.181.189
   Oksanen J., 2016, VEGAN COMMUNITY ECOL, DOI [DOI 10.1186/S12866-016-0748-X, 10.1186/s12866-016-0748-x]
   Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Ramadass B, 2017, INDIAN J MED RES, V145, P236, DOI 10.4103/ijmr.IJMR_639_14
   Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294
   Rashid MU, 2015, CLIN INFECT DIS, V60, pS77, DOI 10.1093/cid/civ137
   Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107
   Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654
   Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Vieira AT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01884
   Walker A, 2007, MICROBIOLOGY, V5, P572, DOI DOI 10.1038/NRMICR01720
   Ward T, 2017, BIORXIV, DOI [10.1101/133462, DOI 10.1101/133462]
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725
NR 48
TC 15
Z9 16
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 13
PY 2019
VL 10
AR 2138
DI 10.3389/fmicb.2019.02138
PG 11
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA IW9RW
UT WOS:000485332400001
PM 31572342
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Van Camp, PJ
   Porollo, A
AF Van Camp, Pieter-Jan
   Porollo, Aleksey
TI SEQ2MGS: an effective tool for generating realistic artificial
   metagenomes from the existing sequencing data
SO NAR GENOMICS AND BIOINFORMATICS
LA English
DT Article
ID ALTERED SCHAEDLER FLORA; HUMAN GUT MICROBIOTA; HEALTH
AB Assessment of bioinformatics tools for the metagenomics analysis from the whole genome sequencing data requires realistic benchmark sets. We developed an effective and simple generator of artificial metagenomes from real sequencing experiments. The tool (SEQ2MGS) analyzes the input FASTQ files, precomputes genomic content, and blends shotgun reads from different sequenced isolates, or spike isolate(s) in real metagenome, in desired proportions. SEQ2MGS eliminates the need for simulation of sequencing platform variations, reads distributions, presence of plasmids, viruses, and contamination. The tool is especially useful for a quick generation of multiple complex samples that include new or understudied organisms, even without assembled genomes. For illustration, we first demonstrated the ease of SEQ2MGS use for the simulation of altered Schaedler flora (ASF) in comparison with de novo metagenomics generators Grinder and CAMISIM. Next, we emulated the emergence of a pathogen in the human gut microbiome and observed that Kraken, Centrifuge, and MetaPhlAn, while correctly identified Klebsiella pneumoniae, produced inconsistent results for the rest of real metagenome. Finally, using the MG-RAST platform, we affirmed that SEQ2MGS properly transfers genomic information from an isolate into the simulated metagenome by the correct identification of antimicrobial resistance genes anticipated to appear compared to the original metagenome.
C1 [Van Camp, Pieter-Jan] Univ Cincinnati, Dept Biomed Informat, Cincinnati, OH 45221 USA.
   [Porollo, Aleksey] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA.
   [Porollo, Aleksey] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA.
   [Porollo, Aleksey] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA.
C3 University System of Ohio; University of Cincinnati; Cincinnati
   Children's Hospital Medical Center; Cincinnati Children's Hospital
   Medical Center; University System of Ohio; University of Cincinnati;
   University System of Ohio; University of Cincinnati
RP Porollo, A (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA.; Porollo, A (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA.; Porollo, A (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA.
EM Alexey.Porollo@cchmc.org
RI Porollo, Alexey/HOH-4697-2023
OI Porollo, Alexey/0000-0002-3202-5099; Van Camp,
   Pieter-Jan/0000-0003-0675-2011
FU Academic Research Committee at Cincinnati Children's Hospital Medical
   Center; National Institutes of Health (NIAID) [R21-AI143467]
FX Academic Research Committee at Cincinnati Children's Hospital Medical
   Center (in part); National Institutes of Health (NIAID) [R21-AI143467];
   Oracle Cloud credits and related resources provided by the Oracle for
   Research program.
CR Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251
   Ballenghien M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0366-6
   Beghini F, 2020, bioRxiv, DOI [10.1101/2020.11.19.388223, 10.1101/2020.11.19.388223, DOI 10.1101/2020.11.19.388223]
   Brand MW, 2015, ILAR J, V56, P169, DOI 10.1093/ilar/ilv012
   Breitwieser FP, 2020, BIOINFORMATICS, V36, P1303, DOI 10.1093/bioinformatics/btz715
   Breitwieser FP, 2019, GENOME RES, V29, P954, DOI 10.1101/gr.245373.118
   Fritz A, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0633-6
   Galbraith DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27164-z
   Gu W, 2019, ANNU REV PATHOL-MECH, V14, P319, DOI 10.1146/annurev-pathmechdis-012418-012751
   Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Kremer JM, 2021, NAT PROTOC, V16, DOI 10.1038/s41596-021-00504-6
   Lavin Richard, 2018, Curr Protoc Immunol, V121, pe48, DOI 10.1002/cpim.48
   Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808
   Maus I, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0947-1
   Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Michan C, 2021, MICROB BIOTECHNOL, V14, P870, DOI 10.1111/1751-7915.13763
   Miossec MJ, 2020, PEERJ, V8, DOI 10.7717/peerj.9688
   Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8
   Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083
   Ricotta C, 2017, ECOL COMPLEX, V31, P201, DOI 10.1016/j.ecocom.2017.07.003
   Rohrmann G.F., 2013, BACULOVIRUS MOL BIOL, V3rd, P1
   Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]
   Sergaki C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01205
   Shimasaki T, 2019, CLIN INFECT DIS, V68, P2053, DOI 10.1093/cid/ciy796
   SRA Toolkit Development Team, 2019, SRA TOOLK NCBI NAT C
   Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008
   Thomas S, 2017, CANCER RES, V77, P1783, DOI 10.1158/0008-5472.CAN-16-2929
   Vorobev A, 2020, GENOME RES, V30, P647, DOI 10.1101/gr.253070.119
   Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4
   Wallace TC, 2011, NUTR REV, V69, P392, DOI 10.1111/j.1753-4887.2011.00402.x
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Ye SH, 2019, CELL, V178, P779, DOI 10.1016/j.cell.2019.07.010
NR 37
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2631-9268
J9 NAR GENOM BIOINFORM
JI NAR Genom. Bioinform.
PD JUL 9
PY 2022
VL 4
IS 3
AR lqac050
DI 10.1093/nargab/lqac050
PG 10
WC Genetics & Heredity; Mathematical & Computational Biology
WE Emerging Sources Citation Index (ESCI)
SC Genetics & Heredity; Mathematical & Computational Biology
GA 3D7YH
UT WOS:000829513100002
PM 35899079
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Lim, JJ
   Dutta, M
   Dempsey, JL
   Lehmler, HJ
   MacDonald, J
   Bammler, T
   Walker, C
   Kavanagh, TJ
   Gu, HW
   Mani, S
   Cui, JY
AF Lim, Joe Jongpyo
   Dutta, Moumita
   Dempsey, Joseph L.
   Lehmler, Hans-Joachim
   MacDonald, James
   Bammler, Theo
   Walker, Cheryl
   Kavanagh, Terrance J.
   Gu, Haiwei
   Mani, Sridhar
   Cui, Julia Yue
TI Neonatal Exposure to BPA, BDE-99, and PCB Produces Persistent Changes in
   Hepatic Transcriptome Associated With Gut Dysbiosis in Adult Mouse
   Livers
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE adverse health outcomes; bioinformatics; environmental chemicals;
   epigenetic; microbiome; toxicogenomics
ID POLYBROMINATED DIPHENYL ETHERS; BISPHENOL-A; POLYCHLORINATED-BIPHENYLS;
   HEPATOCELLULAR-CARCINOMA; DEVELOPMENTAL ORIGINS; PERINATAL EXPOSURE;
   ORGANIC POLLUTANTS; GENE-EXPRESSION; BREAST-CANCER; CELL-CYCLE
AB Recent evidence suggests that complex diseases can result from early life exposure to environmental toxicants. Polybrominated diphenyl ethers (PBDEs), and polychlorinated biphenyls (PCBs) are persistent organic pollutants (POPs) and remain a continuing risk to human health despite being banned from production. Developmental BPA exposure mediated-adult onset of liver cancer via epigenetic reprogramming mechanisms has been identified. Here, we investigated whether the gut microbiome and liver can be persistently reprogrammed following neonatal exposure to POPs, and the associations between microbial biomarkers and disease-prone changes in the hepatic transcriptome in adulthood, compared with BPA. C57BL/6 male and female mouse pups were orally administered vehicle, BPA, BDE-99 (a breast milk-enriched PBDE congener), or the Fox River PCB mixture (PCBs), once daily for three consecutive days (postnatal days [PND] 2-4). Tissues were collected at PND5 and PND60. Among the three chemicals investigated, early life exposure to BDE-99 produced the most prominent developmental reprogramming of the gut-liver axis, including hepatic inflammatory and cancer-prone signatures. In adulthood, neonatal BDE-99 exposure resulted in a persistent increase in Akkermansia muciniphila throughout the intestine, accompanied by increased hepatic levels of acetate and succinate, the known products of A. muciniphila. In males, this was positively associated with permissive epigenetic marks H3K4me1 and H3K27, which were enriched in loci near liver cancer-related genes that were dysregulated following neonatal exposure to BDE-99. Our findings provide novel insights that early life exposure to POPs can have a life-long impact on disease risk, which may partly be regulated by the gut microbiome.
C1 [Lim, Joe Jongpyo; Dutta, Moumita; MacDonald, James; Bammler, Theo; Kavanagh, Terrance J.; Cui, Julia Yue] Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE, Seattle, WA 98105 USA.
   [Dempsey, Joseph L.] Univ Washington, Sch Med, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA.
   [Dempsey, Joseph L.] Univ Washington, Sch Med, Ctr Microbiome Sci & Therapeut, Seattle, WA USA.
   [Lehmler, Hans-Joachim] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA.
   [Walker, Cheryl] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA.
   [Walker, Cheryl] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
   [Walker, Cheryl] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Walker, Cheryl] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.
   [Walker, Cheryl] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Gu, Haiwei] Arizona State Univ, Coll Hlth Solut, Arizona Metabol Lab, Phoenix, AZ 85004 USA.
   [Mani, Sridhar] Albert Einstein Coll Med, Dept Med Mol Pharmacol & Genet, Bronx, NY 10461 USA.
C3 University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle; University of
   Washington; University of Washington Seattle; University of Iowa; Baylor
   College of Medicine; Baylor College of Medicine; Baylor College of
   Medicine; Baylor College of Medicine; Baylor College of Medicine;
   Arizona State University; Arizona State University-Downtown Phoenix;
   Yeshiva University; Albert Einstein College of Medicine
RP Cui, JY (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE, Seattle, WA 98105 USA.
EM juliacui@uw.edu
RI Lehmler, Hans-Joachim/AAG-9692-2019
OI Lehmler, Hans-Joachim/0000-0001-9163-927X; Dutta,
   Moumita/0000-0002-4893-4377
FU National Institutes of Health (NIH) [R01ES025708, R01ES030197,
   R01GM111381, R01ES031098]; University of Washington Center for
   Exposures, Diseases, Genomics, and Environment [P30ES007033];
   Environmental Pathology/Toxicology Training Program [T32ES007032];
   Baylor College of Medicine Gulf Coast Center for Precision Environmental
   Health [P30ES030285]; University of Washington Sheldon Murphy Endowment
FX This work was supported by the National Institutes of Health (NIH)
   (grants R01ES025708, R01ES030197, R01GM111381, and R01ES031098), the
   University of Washington Center for Exposures, Diseases, Genomics, and
   Environment (P30ES007033), Environmental Pathology/Toxicology Training
   Program (T32ES007032), Baylor College of Medicine Gulf Coast Center for
   Precision Environmental Health (P30ES030285), and the University of
   Washington Sheldon Murphy Endowment.
CR Albert O, 2018, ENVIRON INT, V116, P165, DOI 10.1016/j.envint.2018.04.012
   Alexa A., 2020, TOPGO ENRICHMENT ANA
   Allen JG, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0141-0
   Almeida DL, 2019, J DEV ORIG HLTH DIS, V10, P608, DOI 10.1017/S2040174419000151
   Astakhova L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154102
   Bachem A, 2019, IMMUNITY, V51, P285, DOI 10.1016/j.immuni.2019.06.002
   Bassols J, 2016, PEDIATR RES, V80, P777, DOI 10.1038/pr.2016.155
   Benetatos L, 2014, CELL MOL LIFE SCI, V71, P4421, DOI 10.1007/s00018-014-1698-9
   Bisteau X, 2014, CANCERS, V6, P79, DOI 10.3390/cancers6010079
   Blanco J, 2014, TOXICOL SCI, V137, P491, DOI 10.1093/toxsci/kft257
   Bolduc JF, 2017, J VIROL, V91, DOI 10.1128/JVI.01943-16
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011
   Bruchajzer E, 2014, INT J OCCUP MED ENV, V27, P808, DOI 10.2478/s13382-014-0312-6
   Budkova Z, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00461
   Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114
   Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35
   Cheng SL, 2018, TOXICOL SCI, V166, P269, DOI 10.1093/toxsci/kfy208
   Chia LW, 2018, ANTON LEEUW INT J G, V111, P859, DOI 10.1007/s10482-018-1040-x
   Choi YJ, 2010, ENVIRON HEALTH PERSP, V118, P976, DOI 10.1289/ehp.0901751
   CORLESS JK, 1983, ARCH INTERN MED, V143, P2291
   Cowell WJ, 2019, THYROID, V29, P631, DOI 10.1089/thy.2018.0417
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S
   de Water E, 2019, J CHILD PSYCHOL PSYC, V60, P1010, DOI 10.1111/jcpp.13040
   Deane NG, 2001, CANCER RES, V61, P5389
   Dempsey JL, 2019, TOXICOL SCI, V168, P40, DOI 10.1093/toxsci/kfy271
   Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104
   Dong ZG, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00608
   Dorman DC, 2018, J TOXICOL ENV HEAL B, V21, P269, DOI 10.1080/10937404.2018.1514829
   Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6
   Dunnick JK, 2018, ARCH TOXICOL, V92, P3415, DOI 10.1007/s00204-018-2292-y
   Dzierlenga MW, 2019, ENVIRON INT, V125, P291, DOI 10.1016/j.envint.2018.12.036
   Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005
   Gan L, 2010, ONCOL REP, V23, P1037, DOI 10.3892/or_00000730
   Garry MR, 2015, REGUL TOXICOL PHARM, V73, P378, DOI 10.1016/j.yrtph.2015.07.023
   Georgiadis P, 2019, ENVIRON INT, V126, P24, DOI 10.1016/j.envint.2019.01.068
   Ghosh S, 2018, ENVIRON SCI POLLUT R, V25, P16493, DOI 10.1007/s11356-017-0149-1
   Gibson EA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081636
   Gomez MV, 2021, TOXICOL SCI, V179, P14, DOI 10.1093/toxsci/kfaa161
   Goyal D, 2019, J ENDOCRINOL, V242, pT105, DOI 10.1530/JOE-19-0009
   Gu H., 2021, CURR PROTOC, V1, pE177
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313
   Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761
   Hakk H, 2002, XENOBIOTICA, V32, P369, DOI 10.1080/00498250110119117
   He YF, 2017, ENVIRON SCI POLLUT R, V24, P4778, DOI 10.1007/s11356-016-8208-6
   Heindel JJ, 2015, CURR OPIN PEDIATR, V27, P248, DOI 10.1097/MOP.0000000000000191
   Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966
   Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829
   Hillman ET, 2017, MICROBES ENVIRON, V32, P300, DOI 10.1264/jsme2.ME17017
   Hoffman DJ, 2017, NUTR REV, V75, P951, DOI 10.1093/nutrit/nux053
   Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520
   Huang YL, 2019, CANCER MANAG RES, V11, P1725, DOI 10.2147/CMAR.S182001
   Iszatt N, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0645-2
   Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015
   Jasbi P, 2019, FOOD FUNCT, V10, P7343, DOI [10.1039/c9fo01082c, 10.1039/C9FO01082C]
   Jensen A. A, 1989, HALOGENATED BIPHENYL, p[345, New York]
   Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534
   Kaur S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67709-9
   Khalil A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00548
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kim HI, 2018, BIOMOL THER, V26, P335, DOI 10.4062/biomolther.2018.103
   Kim S, 2021, BIOCHEM PHARMACOL, V193, DOI 10.1016/j.bcp.2021.114698
   Kinch R A, 1982, Can Med Assoc J, V127, P812
   Konieczna Aleksandra, 2015, Rocz Panstw Zakl Hig, V66, P5
   Konturek Peter Christopher, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6030079
   Kostyniak PJ, 2005, TOXICOL SCI, V88, P400, DOI 10.1093/toxsci/kfi338
   Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110
   Lai KP, 2016, ENVIRON POLLUT, V218, P923, DOI 10.1016/j.envpol.2016.08.039
   Lapidot Y, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00153-20
   Laue Hannah E, 2019, Environ Epidemiol, V3, DOI 10.1097/EE9.0000000000000039
   Leng L, 2016, ENVIRON INT, V88, P133, DOI 10.1016/j.envint.2015.12.022
   Li CY, 2018, DRUG METAB DISPOS, V46, P1226, DOI 10.1124/dmd.118.081547
   Li CYF, 2017, DRUG METAB DISPOS, V45, P1197, DOI 10.1124/dmd.117.077024
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li NS, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102508
   Lim JJ, 2020, TOXICOL SCI, V177, P168, DOI 10.1093/toxsci/kfaa090
   Lorber M, 2008, J EXPO SCI ENV EPID, V18, P2, DOI 10.1038/sj.jes.7500572
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luisier R, 2014, TOXICOL SCI, V139, P501, DOI 10.1093/toxsci/kfu038
   Luk JM, 2011, J BIOL CHEM, V286, P30706, DOI 10.1074/jbc.M111.229831
   Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14
   Ma RS, 2006, ENVIRON HEALTH PERSP, V114, P898, DOI 10.1289/ehp.8748
   Makey CM, 2016, ENVIRON HEALTH PERSP, V124, P420, DOI 10.1289/ehp.1509755
   Malaise Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15196-w
   Malloy MA, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00951
   Mancabelli L, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix153
   Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663
   Mandy M, 2018, INT HEALTH, V10, P66, DOI 10.1093/inthealth/ihy006
   Martinez FD, 2018, AM J RESP CRIT CARE, V197, P573, DOI 10.1164/rccm.201706-1091PP
   Meek EC, 2019, J TOXICOL ENV HEAL A, V82, P387, DOI 10.1080/15287394.2019.1610678
   Miguel V, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101580
   Mishra D, 2020, J INFECT PUBLIC HEAL, V13, P998, DOI 10.1016/j.jiph.2020.01.007
   Murphy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40597
   Pacyniak EK, 2007, TOXICOL SCI, V97, P94, DOI 10.1093/toxsci/kfm025
   Perez-Lloret J, 2016, P NATL ACAD SCI USA, V113, pE568, DOI 10.1073/pnas.1522287113
   Petriello MC, 2018, ENVIRON POLLUT, V242, P1022, DOI 10.1016/j.envpol.2018.07.039
   Pinero J, 2020, NUCLEIC ACIDS RES, V48, pD845, DOI 10.1093/nar/gkz1021
   Qiu J, 2019, CELL REP, V27, P2063, DOI 10.1016/j.celrep.2019.04.022
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Quinn CL, 2011, ENVIRON HEALTH PERSP, V119, P641, DOI 10.1289/ehp.1002415
   R Core Team, 2017, R LANG ENV STAT COMP
   Rahman ML, 2019, ENVIRON INT, V124, P249, DOI 10.1016/j.envint.2019.01.027
   Reddivari L, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00093-17
   Rude KM, 2019, ENVIRON POLLUT, V253, P708, DOI 10.1016/j.envpol.2019.07.066
   Sabari BR, 2017, NAT REV MOL CELL BIO, V18, P90, DOI 10.1038/nrm.2016.140
   Schecter A, 2006, ENVIRON HEALTH PERSP, V114, P1515, DOI 10.1289/ehp.9121
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018
   Scott FI, 2016, GASTROENTEROLOGY, V151, P120, DOI 10.1053/j.gastro.2016.03.006
   Scoville DK, 2019, DRUG METAB DISPOS, V47, P928, DOI 10.1124/dmd.119.086538
   Seachrist DD, 2016, REPROD TOXICOL, V59, P167, DOI 10.1016/j.reprotox.2015.09.006
   Shkoporov AN, 2016, INT J SYST EVOL MICR, V66, P3041, DOI 10.1099/ijsem.0.001143
   Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385
   Smestad J, 2018, ISCIENCE, V2, P63, DOI 10.1016/j.isci.2018.03.012
   Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3
   Song YG, 2014, J MICROBIOL, V52, P504, DOI 10.1007/s12275-014-4241-7
   Sookoian S, 2020, GUT, V69, P1483, DOI 10.1136/gutjnl-2019-318811
   Spanogiannopoulos P, 2016, NAT REV MICROBIOL, V14, P273, DOI 10.1038/nrmicro.2016.17
   Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749
   Suvorov A, 2020, EPIGENOMICS-UK, V12, P235, DOI 10.2217/epi-2019-0315
   Tao Y, 2017, J BIOTECHNOL, V259, P91, DOI 10.1016/j.jbiotec.2017.07.036
   TeSlaa T, 2016, CELL METAB, V24, P485, DOI 10.1016/j.cmet.2016.07.002
   Tornevi A, 2019, ENVIRON RES, V174, P35, DOI 10.1016/j.envres.2019.04.017
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trevino LS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15847-z
   Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z
   Troisi R, 2016, PEDIATRICS, V138, pS42, DOI 10.1542/peds.2015-4268G
   von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871
   Vyas AK, 2019, J APPL TOXICOL, V39, P1516, DOI 10.1002/jat.3836
   Wang PR, 2012, P NATL ACAD SCI USA, V109, P11264, DOI 10.1073/pnas.1117032109
   Wassenaar PNH, 2017, CHEMOSPHERE, V188, P174, DOI 10.1016/j.chemosphere.2017.08.165
   Wassermann M, 1979, Ann N Y Acad Sci, V320, P69
   Weinhouse C, 2015, EPIGENETICS-US, V10, P1099, DOI 10.1080/15592294.2015.1107694
   Weinhouse C, 2014, ENVIRON HEALTH PERSP, V122, P485, DOI 10.1289/ehp.1307449
   Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112
   Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yuan Y, 2017, SCI TOTAL ENVIRON, V575, P400, DOI 10.1016/j.scitotenv.2016.10.028
   Zhang R, 2020, CANCER SCI, V111, P406, DOI 10.1111/cas.14262
   Zhao T, 2017, ONCOTARGET, V8, P53819, DOI 10.18632/oncotarget.17734
   Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3
NR 145
TC 7
Z9 7
U1 6
U2 34
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD NOV
PY 2021
VL 184
IS 1
BP 83
EP 103
DI 10.1093/toxsci/kfab104
EA AUG 2021
PG 21
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA WT0MN
UT WOS:000715567900007
PM 34453844
OA Green Published, Bronze
DA 2023-09-14
ER

PT J
AU Donovan, SM
   Aghaeepour, N
   Andres, A
   Azad, MB
   Becker, M
   Carlson, SE
   Jarvinen, KM
   Lin, WL
   Lonnerdal, B
   Slupsky, CM
   Steiber, AL
   Raiten, DJ
AF Donovan, Sharon M.
   Aghaeepour, Nima
   Andres, Aline
   Azad, Meghan B.
   Becker, Martin
   Carlson, Susan E.
   Jarvinen, Kirsi M.
   Lin, Weili
   Lonnerdal, Bo
   Slupsky, Carolyn M.
   Steiber, Alison L.
   Raiten, Daniel J.
TI Evidence for human milk as a biological system and recommendations for
   study design-a report from "Breastmilk Ecology: Genesis of Infant
   Nutrition (BEGIN)" Working Group 4
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE human milk; infant development; immune; microbiome; systems biology
ID FATTY-ACID-COMPOSITION; BOVINE LACTOFERRIN SUPPLEMENTATION; LOW-PROTEIN
   FORMULA; COWS MILK; BODY-COMPOSITION; GUT MICROBIOME; GASTROINTESTINAL
   DEVELOPMENT; INTESTINAL PERMEABILITY; LYMPHOCYTE SUBSETS; FEEDING
   PRACTICES
AB Human milk contains all of the essential nutrients required by the infant within a complex matrix that enhances the bioavailability of many of those nutrients. In addition, human milk is a source of bioactive components, living cells and microbes that facilitate the transition to life outside the womb. Our ability to fully appreciate the importance of this matrix relies on the recognition of short- and long-term health benefits and, as highlighted in previous sections of this supplement, its ecology (i.e., interactions among the lactating parent and breastfed infant as well as within the context of the human milk matrix itself). Designing and interpreting studies to address this complexity depends on the availability of new tools and technologies that account for such complexity. Past efforts have often compared human milk to infant formula, which has provided some insight into the bioactivity of human milk, as a whole, or of individual milk components supplemented with formula. However, this experimental approach cannot capture the contributions of the individual components to the human milk ecology, the interaction between these components within the human milk matrix, or the significance of the matrix itself to enhance human milk bioactivity on outcomes of interest. This paper presents approaches to explore human milk as a biological system and the functional implications of that system and its components. Specifically, we discuss study design and data collection considerations and how emerging analytical technologies, bioinformatics, and systems biology approaches could be applied to advance our understanding of this critical aspect of human biology.
C1 [Donovan, Sharon M.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61820 USA.
   [Aghaeepour, Nima; Becker, Martin] Stanford Univ, Sch Med, Dept Anesthesiol Pain & Perioperat Med, Dept Pediat, Stanford, CA USA.
   [Aghaeepour, Nima; Becker, Martin] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA USA.
   [Andres, Aline] Univ Arkansas Med Sci, Arkansas Childrens Nutr, Little Rock, AR USA.
   [Andres, Aline] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR USA.
   [Azad, Meghan B.] Univ Manitoba, Manitoba Interdisciplinary Lactat Ctr MILC, Childrens Hosp Res, Inst Manitoba,Dept Pediat &Child Hlth, Winnipeg, MB, Canada.
   [Azad, Meghan B.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.
   [Carlson, Susan E.] Univ Kansas, Med Ctr, Dept Nutr & Dietet, Kansas City, KS USA.
   [Jarvinen, Kirsi M.] Univ Rochester, Med Ctr, Div Allergy & Immunol, Dept Pediat, New York, NY USA.
   [Jarvinen, Kirsi M.] Univ Rochester, Med Ctr, Ctr Food Allergy, New York, NY USA.
   [Lin, Weili] Univ North Carolina Chapel Hill, Biomed Res Imaging Ctr, Chapel Hill, NC USA.
   [Lin, Weili; Lonnerdal, Bo] Univ North Carolina Chapel Hill, Dept Radiol, Chapel Hill, NC USA.
   [Lonnerdal, Bo; Slupsky, Carolyn M.] Univ Calif Davis, Dept Nutr, Davis, CA USA.
   [Slupsky, Carolyn M.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA USA.
   [Steiber, Alison L.] Acad Nutr & Dietet, Chicago, IL USA.
   [Raiten, Daniel J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Natl Inst Hlth, Pediat Growth & Nutr Branch, Bethesda, MD USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   Stanford University; Stanford University; University of Arkansas System;
   University of Arkansas Medical Sciences; University of Arkansas System;
   University of Arkansas Medical Sciences; University of Manitoba;
   Children's Hospital Research Institute of Manitoba; University of
   Manitoba; University of Kansas; University of Kansas Medical Center;
   University of Rochester; University of Rochester; University of North
   Carolina; University of North Carolina Chapel Hill; University of North
   Carolina School of Medicine; University of North Carolina School of
   Medicine; University of North Carolina; University of North Carolina
   Chapel Hill; University of California System; University of California
   Davis; University of California System; University of California Davis;
   National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver
   National Institute of Child Health & Human Development (NICHD)
RP Donovan, SM (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61820 USA.
EM sdonovan@illinois.edu
FU USDA-ARS Project Plan [6026-51000-010-05S]; NIH [R35 GM138353, R01
   DK107516, R01 ES032176, U01DA055352, R01 HD099099-01, R01 HD083292, R01
   HD086001-A1, R01 DK11822-001, R01 DK107561, R01 HL153306, R01 GM127347,
   U01 AI131344, U01 AI131344-04S1, R21 AI163571, R03 AI151965, U01
   MH110274, R34 DA050262, R21 AG071156]; Burroughs Wellcome Fund; Bill and
   Melinda Gates Foundation; Tier 2 Canada Research Chair in the
   Developmental Origins of Chronic Disease at the University of Manitoba;
   Canadian Institutes of Health Research; Canada Foundation for
   Innovation; Manitoba Children's Hospital Foundation; Prolacta
   Biosciences; CIFAR; Garfield Weston Foundation; DSM; Mead Johnson
   Nutrition; Danone; March of Dimes; USDA AFRI [2016-08909]; ByHeart;
   Gerber Foundation; International Flavors and Fragrances; Kyowa Hakka
   Bio; National Dairy Council; Janssen RD; Aimmune; Nestec; USDA-NIFA
   [2021-67017-35783]; USDA-NIFA Hatch project [1021411]; Arla Foods
   Ingredients; Kinsella Endowed Chair in Food, Nutrition, and Health;
   NICHD; Research Manitoba; Mitacs; Health Data Research UK; Canadian
   COVID Immunity Task Force
FX There was no committed funding for the writing of this manuscript for
   any author. However, during the period of manuscript preparation authors
   were funded from the following sources: AA (USDA-ARS Project Plan
   6026-51000-010-05S, NIH R01 DK107516, NIH R01 ES032176, NIH U01DA055352,
   NIH R01 HD099099-01); NA (NIH R35 GM138353, Burroughs Wellcome Fund, the
   Bill and Melinda Gates Foundation, March of Dimes); MBA (Tier 2 Canada
   Research Chair in the Developmental Origins of Chronic Disease at the
   University of Manitoba and is a Fellow in the Canadian Institutes for
   Advanced Research (CIFAR) Humans and the Microbiome Program. Research
   funding from the Canadian Institutes of Health Research, Research
   Manitoba, the Canada Foundation for Innovation, the Bill and Melinda
   Gates Foundation, the Manitoba Children's Hospital Foundation, Prolacta
   Biosciences, Mitacs, CIFAR, the GarfieldWeston Foundation, Health Data
   Research UK, and Canadian COVID Immunity Task Force); MB (NIH R35
   GM138353, Burroughs Wellcome Fund, the Bill and Melinda Gates
   Foundation, March of Dimes); SEC (NIH R01 HD083292, NIH R01 HD086001-A1,
   NIH R01 DK11822-001, DSM, Mead Johnson Nutrition, Danone); SMD (NIH R01
   DK107561, NIH R01 HL153306, NIH R01 GM127347, USDA AFRI 2016-08909,
   ByHeart, Gerber Foundation, International Flavors and Fragrances, Kyowa
   Hakka Bio, National Dairy Council); KJ (NIH U01 AI131344, NIH U01
   AI131344-04S1, NIH R21 AI163571, R03 AI151965, Aimmune, Janssen R & D);
   WL (NIH U01 MH110274, NIH R34 DA050262, Nestec S.A.); BL (ByHeart); CS
   (NIH R21 AG071156; USDA-NIFA 2021-67017-35783; USDA-NIFA Hatch project
   1021411; Arla Foods Ingredients; Kinsella Endowed Chair in Food,
   Nutrition, and Health).; The BEGIN Project was initiated by the
   Pediatric Growth and Nutrition Branch of the Eunice Kennedy Shriver
   National Institute of Child Health and Human Development (NICHD) of the
   NIH in partnership with the Bill & Melinda Gates Foundation and the
   Academy of Nutrition and Dietetics. The publication of this supplement
   was made possible by the NICHD, and support for assistance (by
   BioCentric, Inc.) with editing, proofing, and submitting the manuscript
   was also provided by the NICHD.
CR Adjibade M, 2022, ALLERGY, V77, P1522, DOI 10.1111/all.15137
   Aksan A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082670
   Alderete TL, 2015, AM J CLIN NUTR, V102, P1381, DOI 10.3945/ajcn.115.115451
   Allen LH, 2021, CURR DEV NUTR, V5, DOI 10.1093/cdn/nzab116
   Anderson JW, 1999, AM J CLIN NUTR, V70, P525
   Andersson Y, 2009, J IMMUNOL, V183, P4322, DOI 10.4049/jimmunol.0900829
   Andres A, 2012, PEDIATRICS, V129, P1134, DOI 10.1542/peds.2011-3121
   [Anonymous], 2013, LONG TERM EFFECTS BR
   Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791
   Arvinen KMJ, 2015, J ALLERGY CLIN IMMUN, V135, P1390, DOI 10.1016/j.jaci.2014.10.051
   Azad M.B., 2021, HUMAN MILK, P3
   Azad MB, 2021, MATERN CHILD NUTR, V17, DOI 10.1111/mcn.13109
   Azad MB, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1092
   Baltrusaitis T, 2019, IEEE T PATTERN ANAL, V41, P423, DOI 10.1109/TPAMI.2018.2798607
   Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3
   Bell KA, 2017, AM J CLIN NUTR, V106, P491, DOI 10.3945/ajcn.116.151126
   BENOLKEN RM, 1973, SCIENCE, V182, P1253, DOI 10.1126/science.182.4118.1253
   Bernard JY, 2017, J PEDIATR-US, V183, P43, DOI 10.1016/j.jpeds.2016.12.039
   Beverly RL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052377
   Biorepository MsMHMR, 2022, US
   Birch EE, 2010, AM J CLIN NUTR, V91, P848, DOI 10.3945/ajcn.2009.28557
   Bjerregaard LG, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12869
   Bode L, 2020, SCIENCE, V367, P1070, DOI 10.1126/science.aaw6147
   Boughrara Lemya, CHEST, V205, P651, DOI [10.1016/j.ijbiomac.2022.02.087, DOI 10.1016/J.CHEST.2021.10.032]
   Brink LR, 2020, AM J CLIN NUTR, V111, P1190, DOI 10.1093/ajcn/nqaa076
   Brink LR, 2020, J DAIRY SCI, V103, P3002, DOI 10.3168/jds.2019-17179
   Cabrera-Rubio R, 2019, J PEDIATR GASTR NUTR, V68, P256, DOI 10.1097/MPG.0000000000002216
   Cacho NT, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00584
   Cardwell CR, 2012, DIABETES CARE, V35, P2215, DOI 10.2337/dc12-0438
   Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734
   CARVER JD, 1991, J CLIN LAB ANAL, V5, P54, DOI 10.1002/jcla.1860050110
   CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003
   Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010
   Chapkin Robert S., AM J PHYSIOL-GASTR L, V298, pG582, DOI [10.1152/ajpgi.00004.2010, DOI 10.1152/AJPGI.00004.2010, DOI 10.1152/AJPGI.00530]
   Cheatham CL, 2015, NUTRIENTS, V7, P9079, DOI 10.3390/nu7115452
   Cheema AS, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23052865
   Chen K, 2016, NUTRITION, V32, P222, DOI 10.1016/j.nut.2015.08.010
   Chen YY, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9091847
   Christian P, 2021, AM J CLIN NUTR, V113, P1063, DOI [10.1093/ajcn/ngab075, 10.1093/ajcn/nqab075]
   Chung NC, 2019, METHODS, V166, P66, DOI 10.1016/j.ymeth.2019.03.004
   CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X
   CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8
   Colombo J, 2013, AM J CLIN NUTR, V98, P403, DOI 10.3945/ajcn.112.040766
   Cooke N.J., 2015, DIVISION BEHAV SOCIA
   Covey S. R., 1989, 7 HABITS HIGHLY EFFE
   Cummins AG, 1997, IMMUNOL CELL BIOL, V75, P419, DOI 10.1038/icb.1997.67
   Currie LM, 2015, PROSTAG LEUKOTR ESS, V98, P1, DOI 10.1016/j.plefa.2015.04.001
   Dalmeijer GW, 2016, EUR J NUTR, V55, P2199, DOI 10.1007/s00394-015-1030-y
   Dawod B, 2021, CURR OPIN GASTROEN, V37, P547, DOI 10.1097/MOG.0000000000000778
   Dawod B, 2020, J ALLERGY CLIN IMMUN, V146, P631, DOI 10.1016/j.jaci.2020.01.049
   Puentes AD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092154
   Delgado-Noguera MF, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007901.pub3
   Deoni S, 2018, NEUROIMAGE, V178, P649, DOI 10.1016/j.neuroimage.2017.12.056
   Dewey KG, 2021, AM J CLIN NUTR, V114, P1774, DOI 10.1093/ajcn/nqab206
   DEWEY KG, 1986, ACTA PAEDIATR SCAND, V75, P893, DOI 10.1111/j.1651-2227.1986.tb10313.x
   Dingess KA, 2017, AM J CLIN NUTR, V105, P177, DOI 10.3945/ajcn.116.132464
   Dogra SK, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9102110
   Dogra SK, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9091939
   Donovan SM, 2006, J PEDIATR-US, V149, pS49, DOI 10.1016/j.jpeds.2006.06.052
   DONOVAN SM, 1994, ANNU REV NUTR, V14, P147, DOI 10.1146/annurev.nu.14.070194.001051
   El-Amir Mostafa I, 2019, Egypt J Immunol, V26, P113
   Fang Z, 2018, BIOINFORMATICS, V34, P3801, DOI 10.1093/bioinformatics/bty775
   Fehr K, 2020, CELL HOST MICROBE, V28, P285, DOI 10.1016/j.chom.2020.06.009
   Fernandez L, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.586667
   Fleddermann M, 2014, CLIN NUTR, V33, P588, DOI 10.1016/j.clnu.2013.12.007
   Forbes JD, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.1161
   Gale C, 2012, AM J CLIN NUTR, V95, P656, DOI 10.3945/ajcn.111.027284
   Gallagher D, 2020, OBES REV, V21, DOI 10.1111/obr.13033
   Gao C, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007090.pub2, 10.1002/4651858.CD007090.pub2]
   Georgieff MK, 2018, ACTA PAEDIATR, V107, P1310, DOI 10.1111/apa.14287
   Ghaemi MS, 2019, BIOINFORMATICS, V35, P95, DOI 10.1093/bioinformatics/bty537
   Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x
   Goehring KC, 2016, J NUTR, V146, P2559, DOI 10.3945/jn.116.236919
   Gridneva Z., 2018, NUTRIENTS, V10
   Griffiths J, 2019, LANCET, V393, P423, DOI 10.1016/S0140-6736(18)32221-9
   Grip T, 2018, PEDIATR RES, V84, P726, DOI 10.1038/s41390-018-0130-9
   Groh-Wargo S, 2005, PEDIATR RES, V57, P712, DOI 10.1203/01.PDR.0000156509.29310.55
   Gungor D, 2019, AM J CLIN NUTR, V109, p817S, DOI 10.1093/ajcn/nqy311
   Gustafsson PA, 2004, ACTA PAEDIATR, V93, P1280, DOI 10.1080/08035250410033123
   HALLER G., 2009, BRIT J NUTR, V525, P1, DOI [10.1017/S0022112004002526, DOI 10.1017/S0007114509990559]
   HARRIS WS, 1984, AM J CLIN NUTR, V40, P780, DOI 10.1093/ajcn/40.4.780
   Harutyunyan H, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0103-9
   Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1
   Hasselbalch H, 1999, EUR J PEDIATR, V158, P964, DOI 10.1007/s004310051258
   Hawkes JS, 1999, PEDIATR RES, V45, P648, DOI 10.1203/00006450-199905010-00006
   He X, 2020, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00563
   He X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47953-4
   He X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36292-5
   He X, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00128-16
   Henrick BM, 2021, CELL, V184, P3884, DOI 10.1016/j.cell.2021.05.030
   Hernell O, 2002, AM J CLIN NUTR, V76, P858, DOI 10.1093/ajcn/76.4.858
   Hernell O, 2011, NESTLE NUTR WORKS SE, V67, P17, DOI 10.1159/000325572
   Hibel LC, 2016, J HUM LACT, V32, pNP44, DOI 10.1177/0890334415610578
   Horta BL, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1121-x
   Hossny EM, 2020, EUR J NUTR, V59, P111, DOI 10.1007/s00394-018-01891-5
   Hou LY, 2021, BREASTFEED MED, V16, P687, DOI 10.1089/bfm.2020.0364
   Hu D, 2022, J NEUROSCI, V42, P377, DOI 10.1523/JNEUROSCI.0480-21.2021
   Jacobson SW, 2002, ACTA PAEDIATR, V91, P258, DOI 10.1080/08035250252833851
   Jarvinen KM, 2014, CLIN EXP ALLERGY, V44, P69, DOI 10.1111/cea.12228
   Jansen MAE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126019
   Jarvinen KM, 2000, PEDIATR RES, V48, P457, DOI 10.1203/00006450-200010000-00007
   Jasani B, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000376.pub4
   Jehan F, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.29655
   Jeppesen DL, 2004, PEDIATR ALLERGY IMMU, V15, P127, DOI 10.1111/j.1399-3038.2004.00032.x
   Jiang R, 2019, PEDIATR RES, V85, P502, DOI 10.1038/s41390-018-0271-x
   Kainonen E, 2013, BRIT J NUTR, V109, P1962, DOI 10.1017/S0007114512004229
   Karav S, 2016, APPL ENVIRON MICROB, V82, P3622, DOI 10.1128/AEM.00547-16
   Khaleva E, 2019, CLIN EXP ALLERGY, V49, P1201, DOI 10.1111/cea.13409
   King JC, 2007, J PEDIATR GASTR NUTR, V44, P245, DOI 10.1097/01.mpg.0000243435.54958.68
   Kirchberg FF, 2015, J CLIN ENDOCR METAB, V100, P149, DOI 10.1210/jc.2014-3157
   Koh HWL, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0099-y
   Korpela K, 2021, ANN NUTR METAB, V77, P11, DOI 10.1159/000518498
   Korpela K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32037-6
   Kramer MS, 2007, AM J CLIN NUTR, V86, P1717
   Kramer MS, 2007, BMJ-BRIT MED J, V335, P815, DOI 10.1136/bmj.39304.464016.AE
   Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413
   Krassowski M, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.610798
   Krebs N.F, 2023, WORKING GROUP 3 AM J, V117, pS43
   Kunz C, 2017, J PEDIATR GASTR NUTR, V64, P789, DOI 10.1097/MPG.0000000000001402
   Lackey KA, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00045
   Larsson MW, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00297
   Lee B, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01381
   Lee HN, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000603
   Lehner A, 2021, NUTR REV, V79, P585, DOI 10.1093/nutrit/nuaa060
   LeMay-Nedjelski L, 2021, J NUTR, V151, P3431, DOI 10.1093/jn/nxab270
   Lepping RJ, 2019, DEV PSYCHOBIOL, V61, P5, DOI 10.1002/dev.21780
   Lewis ZT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40932
   Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z
   Ley Sylvia H, AM J CLIN NUTR, V95, P867, DOI [10.3945/ajcn.111.028431, DOI 10.3945/AJCN.114.091785]
   Li EC, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-019-0556-x
   Li F, 2019, J PEDIATR-US, V215, P24, DOI 10.1016/j.jpeds.2019.08.030
   Li YF, 2018, BRIEF BIOINFORM, V19, P325, DOI 10.1093/bib/bbw113
   Li YM, 2019, IEEE T KNOWL DATA EN, V31, P1863, DOI 10.1109/TKDE.2018.2872063
   Liao K, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12455
   Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697
   Liu F, 2021, J AGR FOOD CHEM, V69, P3032, DOI 10.1021/acs.jafc.0c04575
   Liu L, 2019, J NUTR BIOCHEM, V69, P10, DOI 10.1016/j.jnutbio.2019.03.016
   Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132
   Lodge CJ, 2021, J ALLERGY CLIN IMMUN, V147, P1041, DOI 10.1016/j.jaci.2020.06.027
   Lonnerdal B, 2016, J PEDIATR GASTR NUTR, V62, P650, DOI 10.1097/MPG.0000000000001005
   Loennerdal B, 2011, J PEDIATR GASTR NUTR, V53, P606, DOI 10.1097/MPG.0b013e318230a419
   Lonnerdal B, 2021, BIOCHEM CELL BIOL, V99, P35, DOI 10.1139/bcb-2020-0182
   Lonnerdal B, 2009, CURR OPIN CLIN NUTR, V12, P293, DOI 10.1097/MCO.0b013e328328d13e
   de Maturana EL, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030238
   Love M, US
   Luna E, 2022, APPL ENVIRON MICROB, V88, DOI 10.1128/AEM.01487-21
   Manfredi M, 2012, HELICOBACTER, V17, P254, DOI 10.1111/j.1523-5378.2012.00944.x
   MANNERS MJ, 1972, BRIT J NUTR, V28, P113, DOI 10.1079/BJN19720014
   Manzoni P, 2014, EARLY HUM DEV, V90, pS60, DOI 10.1016/S0378-3782(14)70020-9
   Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403
   Maric I, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100100
   Marriage BJ, 2015, J PEDIATR GASTR NUTR, V61, P649, DOI 10.1097/MPG.0000000000000889
   Martens PJ, 2012, J HUM LACT, V28, P335, DOI 10.1177/0890334412438264
   Martin FPJ, 2014, PEDIATR RES, V75, P535, DOI 10.1038/pr.2013.250
   Mazzocchi A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081845
   McGuire M.K., 2021, HUMAN MILK SAMPLING
   McGuire MK, 2021, BREASTFEED MED, V16, P29, DOI 10.1089/bfm.2020.0296
   ( MILC) MILC, US
   Miliku K, 2018, ALLERGY, V73, P2070, DOI 10.1111/all.13476
   Mirza AH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02543
   Moon K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub5
   Moubareck CA, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041123
   Murphy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40597
   Neu J, 2007, EARLY HUM DEV, V83, P767, DOI 10.1016/j.earlhumdev.2007.09.009
   NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202
   Neville M.C., 2023, WORKING GROUP 1 AM J, V117, pS11
   Nevins JEH, 2021, J NUTR, V151, P3483, DOI 10.1093/jn/nxab238
   Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308
   Ngiam J., US
   Ngom PT, 2004, AM J CLIN NUTR, V80, P722
   Nguyen ND, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007677
   Nommsen-Rivers L., 2023, WORKING GROUP 5 AM J, V117, pS87
   O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702
   Ochoa TJ, 2020, J PEDIATR-US, V219, P118, DOI 10.1016/j.jpeds.2019.12.038
   Ogawa J, 2004, EARLY HUM DEV, V77, P67, DOI 10.1016/j.earlhumdev.2004.01.005
   Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043
   Pace RM, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9061153
   Pannaraj PS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01162
   Park Jay J H, 2019, Gates Open Res, V3, P1720, DOI 10.12688/gatesopenres.13082.2
   Parschat K, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082871
   Patelarou E, 2012, NUTR REV, V70, P509, DOI 10.1111/j.1753-4887.2012.00513.x
   Patro-Golab B, 2019, BREASTFEED MED, V14, P218, DOI 10.1089/bfm.2018.0187
   Patro-Golab B, 2016, J NUTR, V146, P551, DOI 10.3945/jn.115.223651
   Piirainen L, 2009, PEDIATR ALLERGY IMMU, V20, P295, DOI 10.1111/j.1399-3038.2008.00776.x
   Princisval L, 2022, NUTR REV, V80, P113, DOI 10.1093/nutrit/nuab008
   Puccio G, 2017, J PEDIATR GASTR NUTR, V64, P624, DOI 10.1097/MPG.0000000000001520
   PUTNAM JC, 1982, AM J CLIN NUTR, V36, P106, DOI 10.1093/ajcn/36.1.106
   Raiten DJ, 2023, AM J CLIN NUTR, V117, pS1, DOI 10.1016/j.ajcnut.2022.12.020
   Reyes SM, 2021, AM J CLIN NUTR, V114, P1960, DOI 10.1093/ajcn/nqab273
   ROBERTS SA, 1977, LANCET, V2, P1131
   Ruder S, 2017, Arxiv, DOI [arXiv:1706.05098, DOI 10.48550/ARXIV.1706.05098]
   Saben JL, 2020, AM J CLIN NUTR, V112, P1228, DOI 10.1093/ajcn/nqaa216
   Sajjad A, 2015, J EPIDEMIOL COMMUN H, V69, P775, DOI 10.1136/jech-2014-204486
   Sakanaka M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010071
   Samuel TM, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.576133
   Sanchez C, 2021, FOODS, V10, DOI 10.3390/foods10061429
   SANDERS TAB, 1979, BRIT J NUTR, V41, P619, DOI 10.1079/BJN19790077
   Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360
   Schwartz S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r32
   Seppo AE, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.741513
   Seppo AE, 2021, ALLERGY, V76, P3489, DOI 10.1111/all.14877
   Seppo AE, 2017, J ALLERGY CLIN IMMUN, V139, P708, DOI 10.1016/j.jaci.2016.08.031
   Shan T, 2007, J ANIM SCI, V85, P2140, DOI 10.2527/jas.2006-754
   Shenhav L, 2022, MSYSTEMS, V7, DOI 10.1128/msystems.01132-21
   Singh A, 2020, BIOL OPEN, V9, DOI 10.1242/bio.049304
   Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x
   Slupsky CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03975-4
   Smilowitz JT, 2023, AM J CLIN NUTR, V117, pS28, DOI 10.1016/j.ajcnut.2022.11.027
   Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638
   Sobik S, 2021, PEDIATR RES, V90, P140, DOI 10.1038/s41390-020-01157-z
   Spivak Aaron T., 2011, NUCLEIC ACIDS RES, V40, pD162, DOI [10.1093/nar/gkr1180, DOI 10.1093/NAR/GKZ569]
   Stelzer IA, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd9898
   Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x
   Stewart Christopher J., 2018, NATURE, V562, P583, DOI [10.1038/s41586-018-0538-8., DOI 10.1038/S41586-018-0538-8, 10.1038/s41586-018-0617-x, DOI 10.1038/S41586-018-0617-X]
   Stinson LF, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124445
   strapi-lactahub, US
   Subramanian I, 2020, BIOINFORM BIOL INSIG, V14, DOI 10.1177/1177932219899051
   Tannock GW, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.01449-21
   Tarazona S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16937-8
   TAYLOR CE, 1984, ARCH DIS CHILD, V59, P48, DOI 10.1136/adc.59.1.48
   Thompson FM, 1998, J PEDIATR GASTR NUTR, V26, P506, DOI 10.1097/00005176-199805000-00004
   Timby N, 2021, AM J CLIN NUTR, V113, P586, DOI 10.1093/ajcn/nqaa354
   Timby N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169831
   Timby N, 2015, J PEDIATR GASTR NUTR, V60, P384, DOI 10.1097/MPG.0000000000000624
   Timby N, 2014, ACTA PAEDIATR, V103, P1072, DOI 10.1111/apa.12721
   Timby N, 2014, AM J CLIN NUTR, V99, P860, DOI 10.3945/ajcn.113.064295
   Tomita M, 2009, BIOCHIMIE, V91, P52, DOI 10.1016/j.biochi.2008.05.021
   U.S. Department of Agriculture U.S. Department of Health and Human Services, 2020, DIET GUID AM, V9, P2020
   van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x
   Vandenplas Y, 2020, NUTRITION, V78, DOI 10.1016/j.nut.2020.110812
   Vandenplas Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091161
   Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2
   Verfuerden ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241800
   Verfurden ML, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-065805
   Wang B, 2003, AM J CLIN NUTR, V78, P1024, DOI 10.1093/ajcn/78.5.1024
   WEAVER LT, 1987, J PEDIATR GASTR NUTR, V6, P351, DOI 10.1097/00005176-198705000-00008
   West CE, 2017, PEDIATR RES, V82, P63, DOI 10.1038/pr.2017.77
   Williams JE, 2021, GENOMICS, V113, P1867, DOI 10.1016/j.ygeno.2021.04.004
   Williams JE, 2019, J NUTR, V149, P902, DOI 10.1093/jn/nxy299
   Wood H, 2021, ALLERGY, V76, P2447, DOI 10.1111/all.14736
   Woodburn M, 2021, NEUROIMAGE, V238, DOI 10.1016/j.neuroimage.2021.118232
   Wu Cen, 2019, High Throughput, V8, DOI 10.3390/ht8010004
   X. Phen, US
   Xiao L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22052-y
   Yan JW, 2018, BRIEF BIOINFORM, V19, P1370, DOI 10.1093/bib/bbx066
   Ye LH, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.194936
   Zavaleta N, 2011, J PEDIATR GASTR NUTR, V53, P561, DOI 10.1097/MPG.0b013e318225cdaf
   Zhang L, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00477
   Zhang Y, 2022, IEEE T KNOWL DATA EN, V34, P5586, DOI 10.1109/TKDE.2021.3070203
   Zheng L., P 2019 SIAM INT C DA, P10
   Zhu L, 2019, ANN APPL STAT, V13, P2611, DOI 10.1214/19-AOAS1271
NR 251
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD MAY
PY 2023
VL 117
SU 1
BP S61
EP S86
DI 10.1016/j.ajcnut.2022.12.021
PG 26
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA P2WU2
UT WOS:001049301300005
PM 37173061
OA Green Published, hybrid
DA 2023-09-14
ER

PT J
AU Hadzega, D
   Minarik, G
   Karaba, M
   Kalavska, K
   Benca, J
   Ciernikova, S
   Sedlackova, T
   Nemcova, P
   Bohac, M
   Pindak, D
   Klucar, L
   Mego, M
AF Hadzega, Dominik
   Minarik, Gabriel
   Karaba, Marian
   Kalavska, Katarina
   Benca, Juraj
   Ciernikova, Sona
   Sedlackova, Tatiana
   Nemcova, Petra
   Bohac, Martin
   Pindak, Daniel
   Klucar, Lubos
   Mego, Michal
TI Uncovering Microbial Composition in Human Breast Cancer Primary Tumour
   Tissue Using Transcriptomic RNA-seq
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE breast cancer; metatranscriptomics; microbiome; microbiota; Kraken2;
   primary tumour; circulating tumour cells; RNA-seq
ID GUT MICROBIOME; CELLS
AB Recent research studies are showing breast tissues as a place where various species of microorganisms can thrive and cannot be considered sterile, as previously thought. We analysed the microbial composition of primary tumour tissue and normal breast tissue and found differences between them and between multiple breast cancer phenotypes. We sequenced the transcriptome of breast tumours and normal tissues (from cancer-free women) of 23 individuals from Slovakia and used bioinformatics tools to uncover differences in the microbial composition of tissues. To analyse our RNA-seq data (rRNA depleted), we used and tested Kraken2 and Metaphlan3 tools. Kraken2 has shown higher reliability for our data. Additionally, we analysed 91 samples obtained from SRA database, originated in China and submitted by Sichuan University. In breast tissue, the most enriched group were Proteobacteria, then Firmicutes and Actinobacteria for both datasets, in Slovak samples also Bacteroides, while in Chinese samples Cyanobacteria were more frequent. We have observed changes in the microbiome between cancerous and healthy tissues and also different phenotypes of diseases, based on the presence of circulating tumour cells and few other markers.
C1 [Hadzega, Dominik; Klucar, Lubos] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia.
   [Minarik, Gabriel; Mego, Michal] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava 81372, Slovakia.
   [Karaba, Marian; Benca, Juraj; Bohac, Martin; Pindak, Daniel] Natl Canc Inst, Dept Oncosurg, Bratislava 83310, Slovakia.
   [Kalavska, Katarina; Bohac, Martin] Comenius Univ, Fac Med, Translat Res Unit, Bratislava 83310, Slovakia.
   [Kalavska, Katarina; Bohac, Martin; Mego, Michal] Natl Canc Inst, Bratislava 83310, Slovakia.
   [Benca, Juraj] St Elizabeth Univ, Dept Med, Bratislava 81000, Slovakia.
   [Ciernikova, Sona] Slovak Acad Sci, Canc Res Inst, Dept Genet, Biomed Res Ctr, Bratislava 84505, Slovakia.
   [Sedlackova, Tatiana] Comenius Univ, Comenius Univ Sci Pk, Bratislava 84215, Slovakia.
   [Nemcova, Petra] Medirex Inc, Bratislava 82104, Slovakia.
   [Mego, Michal] Comenius Univ, Fac Med, Dept Oncol 2, Bratislava 83310, Slovakia.
C3 Slovak Academy of Sciences; Comenius University Bratislava; National
   Institute of Oncology (NOU); Comenius University Bratislava; National
   Institute of Oncology (NOU); Slovak Academy of Sciences; Comenius
   University Bratislava; Comenius University Bratislava
RP Klucar, L (corresponding author), Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia.
EM dominik.hadzega@savba.sk; gabriel.minarik@gmail.com;
   marian.karaba@nou.sk; katarina.hainova@gmail.com; juraj.benca@nou.sk;
   sona.ciernikova@savba.sk; tatiana.sedlackova@gmail.com;
   petra.nemcova@medirexgroup.sk; martin.bohac@uniba.sk;
   daniel.pindak@nou.sk; lubos.klucar@sayba.sk; michal.mego@nou.sk
RI Ciernikova, Sona/ABB-3569-2021; Klucar, Lubos/H-7507-2016
OI Ciernikova, Sona/0000-0002-8139-6945; Klucar, Lubos/0000-0003-0203-2738
FU Slovak Research and Development Agency (APVV) [APVV-16-0010]
FX This research was funded by the Slovak Research and Development Agency
   (APVV), grant number APVV-16-0010.
CR Alexander JL, 2017, NAT REV GASTRO HEPAT, V14, P356, DOI 10.1038/nrgastro.2017.20
   [Anonymous], BABRAHAM BIOINFORMAT
   [Anonymous], SEQUENCE READ ARCHIV
   Garrido-Cardenas JA, 2017, CURR GENET, V63, P819, DOI 10.1007/s00294-017-0693-8
   Banerjee S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00951
   Banerjee S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15162
   Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302
   Beghini F, 2021, ELIFE, V10, DOI 10.7554/eLife.65088
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Borchmann S, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01039-4
   Bush SJ, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000393
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chadha J, 2021, SEMIN CANCER BIOL, V70, P112, DOI 10.1016/j.semcancer.2020.07.010
   Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061
   Chen J, 2019, BREAST CANCER RES TR, V178, P493, DOI 10.1007/s10549-019-05407-5
   Costantini L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35329-z
   Cresci GA, 2015, NUTR CLIN PRACT, V30, P734, DOI 10.1177/0884533615609899
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7
   Fernandez MF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081747
   Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253
   Flores R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039745
   Goodman B, 2018, J PATHOL, V244, P667, DOI 10.1002/path.5047
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Hieken TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30751
   Hill A, 2004, AM J CLIN ONCOL-CANC, V27, P361, DOI 10.1097/01.COC.0000071418.12121.C2
   Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708
   Kosaka A, 2012, INT IMMUNOPHARMACOL, V14, P729, DOI 10.1016/j.intimp.2012.10.007
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lugli GA, 2019, ENV MICROBIOL REP, V11, P840, DOI 10.1111/1758-2229.12805
   Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008
   Mego M, 2019, ANTICANCER RES, V39, P1829, DOI 10.21873/anticanres.13290
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385
   Picard Broad Institute, GITHUB REPOSITORY
   Schlaeppi K, 2015, MOL PLANT MICROBE IN, V28, P212, DOI 10.1094/MPMI-10-14-0334-FI
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shakya M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00904
   Smolkova B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249460
   Thompson KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188873
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16
   Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14
   Wang HN, 2017, ONCOTARGET, V8, P88122, DOI 10.18632/oncotarget.21490
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744
   Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z
NR 47
TC 7
Z9 8
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2021
VL 22
IS 16
AR 9058
DI 10.3390/ijms22169058
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA UG6AE
UT WOS:000689331900001
PM 34445764
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Sharma, D
   Xu, W
AF Sharma, Divya
   Xu, Wei
TI phyLoSTM: a novel deep learning model on disease prediction from
   longitudinal microbiome data
SO BIOINFORMATICS
LA English
DT Article
ID GUT MICROBIOME; REGRESSION; DYNAMICS
AB Motivation: Research shows that human microbiome is highly dynamic on longitudinal timescales, changing dynamically with diet, or due to medical interventions. In this article, we propose a novel deep learning framework 'phyLoSTM', using a combination of Convolutional Neural Networks and Long Short Term Memory Networks (LSTM) for feature extraction and analysis of temporal dependency in longitudinal microbiome sequencing data along with host's environmental factors for disease prediction. Additional novelty in terms of handling variable timepoints in subjects through LSTMs, as well as, weight balancing between imbalanced cases and controls is proposed.
   Results: We simulated 100 datasets across multiple time points for model testing. To demonstrate the model's effectiveness, we also implemented this novel method into two real longitudinal human microbiome studies: (i) DIABIMMUNE three country cohort with food allergy outcomes (Milk, Egg, Peanut and Overall) and (ii) DiGiulio study with preterm delivery as outcome. Extensive analysis and comparison of our approach yields encouraging performance with an AUC of 0.897 (increased by 5%) on simulated studies and AUCs of 0.762 (increased by 19%) and 0.713 (increased by 8%) on the two real longitudinal microbiome studies respectively, as compared to the next best performing method, Random Forest. The proposed methodology improves predictive accuracy on longitudinal human microbiome studies containing spatially correlated data, and evaluates the change of microbiome composition contributing to outcome prediction.
   Supplementary information: Supplementary data are available at Bioinformatics online.
C1 [Sharma, Divya; Xu, Wei] Univ Hlth Network, Princess Margaret Canc Ctr, Biostat Dept, Toronto, ON M5G 2C1, Canada.
   [Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON M5T 3M7, Canada.
C3 University of Toronto; University Health Network Toronto; Princess
   Margaret Cancer Centre; University of Toronto
RP Xu, W (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Biostat Dept, Toronto, ON M5G 2C1, Canada.; Xu, W (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON M5T 3M7, Canada.
EM wei.xu@uhnresearch.ca
RI xu, wei/HHD-2891-2022
OI Sharma, Divya/0000-0003-3832-8987
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
   [RGPIN-2017-06672]; Crohn's and Colitis Canada (CCC Grant CCC-GEMIII);
   Helmsley Charitable Trust; NSERC [RGPIN-2017-06672]
FX Wei Xu was funded by Natural Sciences and Engineering Research Council
   of Canada (NSERC Grant RGPIN-2017-06672), Crohn's and Colitis Canada
   (CCC Grant CCC-GEMIII), and Helmsley Charitable Trust. Divya Sharma was
   supported by NSERC Grant RGPIN-2017-06672 and CCC Grant CCCGEMIII.
CR [Anonymous], NEURAL COMPUT, DOI DOI 10.1162/NECO.1997.9.8.1735
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]
   Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324
   Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50
   Chen B, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008108
   Chung J., 2015, ADV NEURAL INF PROCE, V28, P2980, DOI DOI 10.3109/02713683.2016.1141962
   DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112
   etal Rish I, 2001, P IJCAI 2001 WORKSH, V3, P41, DOI DOI 10.1039/B104835J
   Faust K, 2015, CURR OPIN MICROBIOL, V25, P56, DOI 10.1016/j.mib.2015.04.004
   Gerber GK, 2014, FEBS LETT, V588, P4131, DOI 10.1016/j.febslet.2014.02.037
   Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517
   Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017
   Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
   Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042
   Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947
   Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x
   HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871
   Hochreiter S, 2007, BIOINFORMATICS, V23, P1728, DOI 10.1093/bioinformatics/btm247
   HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634
   Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1
   Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001
   Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386
   LaPierre N, 2019, METHODS, V166, P74, DOI 10.1016/j.ymeth.2019.03.003
   Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791
   Lugo-Martinez J, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0660-3
   Metwally AA, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006693
   Morris A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0183-0
   Neubig G, 2017, ADV NEUR IN, V30
   Oh M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63159-5
   Ridenhour BJ, 2017, ISME J, V11, P2526, DOI 10.1038/ismej.2017.107
   Ryo M, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1976
   Sainath TN, 2015, INT CONF ACOUST SPEE, P4580, DOI 10.1109/ICASSP.2015.7178838
   Schmidhuber J, 2002, NEURAL COMPUT, V14, P2039, DOI 10.1162/089976602320263980
   Schuster-Bockler Benjamin, 2007, Curr Protoc Bioinformatics, VAppendix 3, p3A, DOI 10.1002/0471250953.bia03as18
   Sharma D, 2020, BIOINFORMATICS, V36, P4544, DOI 10.1093/bioinformatics/btaa542
   Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388
   Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742
   Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007
   Wei WW., 2006, OXFORD HDB QUANTITAT, DOI DOI 10.1093/OXFORDHB/9780199934898.013.0022
   Xingjian S., 2015, NEURAL INFORM PROCES, DOI DOI 10.5555/2969239.2969329
NR 42
TC 9
Z9 9
U1 2
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1367-4811
J9 BIOINFORMATICS
JI Bioinformatics
PD NOV 1
PY 2021
VL 37
IS 21
BP 3707
EP 3714
DI 10.1093/bioinformatics/btab482
EA JUL 2021
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA XT8LN
UT WOS:000733832700005
PM 34213529
DA 2023-09-14
ER

PT J
AU Singh, Y
   Trautwein, C
   Romani, J
   Salker, MS
   Neckel, PH
   Fraccaroli, I
   Abeditashi, M
   Woerner, N
   Admard, J
   Dhariwal, A
   Dueholm, MKD
   Schafer, KH
   Lang, FR
   Otzen, DE
   Lashuel, HA
   Riess, O
   Casadei, N
AF Singh, Yogesh
   Trautwein, Christoph
   Romani, Joan
   Salker, Madhuri S. S.
   Neckel, Peter H. H.
   Fraccaroli, Isabel
   Abeditashi, Mahkameh
   Woerner, Nils
   Admard, Jakob
   Dhariwal, Achal
   Dueholm, Morten K. D.
   Schaefer, Karl-Herbert
   Lang, Florian
   Otzen, Daniel E. E.
   Lashuel, Hilal A. A.
   Riess, Olaf
   Casadei, Nicolas
TI Overexpression of human alpha-Synuclein leads to dysregulated
   microbiome/metabolites with ageing in a rat model of Parkinson disease
SO MOLECULAR NEURODEGENERATION
LA English
DT Article
DE Gut microbiome; PD; Intestinal inflammation; alpha-Synuclein;
   Antibiotics
ID ENTERIC NERVOUS-SYSTEM; CHAIN FATTY-ACIDS; GUT-MICROBIOTA; BRAIN;
   INFLAMMATION; CONTROVERSY; PREMOTOR; COLON; AXIS
AB Background Braak's hypothesis states that sporadic Parkinson's disease (PD) follows a specific progression of pathology from the peripheral to the central nervous system, and this progression can be monitored by detecting the accumulation of alpha-Synuclein (alpha-Syn) protein. Consequently, there is growing interest in understanding how the gut (commensal) microbiome can regulate alpha-Syn accumulation, as this could potentially lead to PD.
   Methods We used 16S rRNA and shotgun sequencing to characterise microbial diversity. H-1-NMR was employed to understand the metabolite production and intestinal inflammation estimated using ELISA and RNA-sequencing from feces and the intestinal epithelial layer respectively. The Na+ channel current and gut permeability were measured using an Ussing chamber. Immunohistochemistry and immunofluorescence imaging were applied to detect the alpha-Syn protein. LC-MS/MS was used for characterization of proteins from metabolite treated neuronal cells. Finally, Metascape and Ingenuity Pathway Analysis (IPA) bioinformatics tools were used for identification of dysregulated pathways.
   Results We studied a transgenic (TG) rat model overexpressing the human SNCA gene and found that a progressive gut microbial composition alteration characterized by the reduction of Firmicutes to Bacteroidetes ratio could be detected in the young TG rats. Interestingly, this ratio then increased with ageing. The dynamics of Lactobacillus and Alistipes were monitored and reduced Lactobacillus and increased Alistipes abundance was discerned in ageing TG rats. Additionally, the SNCA gene overexpression resulted in gut alpha-Syn protein expression and increased with advanced age. Further, older TG animals had increased intestinal inflammation, decreased Na+ current and a robust alteration in metabolite production characterized by the increase of succinate levels in feces and serum. Manipulation of the gut bacteria by short-term antibiotic cocktail treatment revealed a complete loss of short-chain fatty acids and a reduction in succinate levels. Although antibiotic cocktail treatment did not change alpha-Syn expression in the enteric nervous system of the colon, however, reduced alpha-Syn expression was detected in the olfactory bulbs (forebrain) of the TG rats.
   Conclusion Our data emphasize that the gut microbiome dysbiosis synchronous with ageing leads to a specific alteration of gut metabolites and can be modulated by antibiotics which may affect PD pathology.
C1 [Singh, Yogesh; Fraccaroli, Isabel; Abeditashi, Mahkameh; Woerner, Nils; Admard, Jakob; Riess, Olaf; Casadei, Nicolas] Univ Tubingen, Inst Med Genet & Appl Genom, Calwerstasse 7, D-72076 Tubingen, Germany.
   [Singh, Yogesh; Riess, Olaf; Casadei, Nicolas] Univ Tubingen, NGS Competence Ctr Tubingen NCCT, Calwerstasse 7, D-72076 Tubingen, Germany.
   [Singh, Yogesh; Salker, Madhuri S. S.] Univ Tubingen, Res Inst Womens Hlth, Calwerstasse 7-6, D-72076 Tubingen, Germany.
   [Trautwein, Christoph] Univ Tubingen, Werner Siemens Imaging Ctr WSIC, Dept Preclin Imaging & Radiopharm, Rontgenweg 13, D-72076 Tubingen, Germany.
   [Romani, Joan; Lashuel, Hilal A. A.] Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Sch Life Sci, Lab Mol & Chem Biol Neurodegenerat, SV LMNN Stn 19, CH-1015 Lausanne, Switzerland.
   [Neckel, Peter H. H.] Univ Tubingen, Inst Clin Anat & Cell Anal, Osterbergstr 3, D-72074 Tubingen, Germany.
   [Dhariwal, Achal] Univ Oslo, Inst Oral Biol, Sognsvannsveien 10, N-0316 Oslo, Norway.
   [Dueholm, Morten K. D.] Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark.
   [Schaefer, Karl-Herbert] Univ Appl Sci Kaiserslautern, Enter Nervous Syst Working Grp, Zweibrucken Campus,Amerikastr 1, D-66482 Zweibrucken, Germany.
   [Lang, Florian] Univ Tubingen, Inst Vegetat Physiol, Wilhelmstasse 56, D-72074 Tubingen, Germany.
   [Otzen, Daniel E. E.] Aarhus Univ, Interdisciplinary Naonscience Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University of
   Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls
   University of Tubingen; Swiss Federal Institutes of Technology Domain;
   Ecole Polytechnique Federale de Lausanne; Eberhard Karls University of
   Tubingen; University of Oslo; Aalborg University; University of
   Kaiserslautern; Eberhard Karls University of Tubingen; Aarhus University
RP Singh, Y; Riess, O; Casadei, N (corresponding author), Univ Tubingen, Inst Med Genet & Appl Genom, Calwerstasse 7, D-72076 Tubingen, Germany.; Singh, Y; Riess, O; Casadei, N (corresponding author), Univ Tubingen, NGS Competence Ctr Tubingen NCCT, Calwerstasse 7, D-72076 Tubingen, Germany.; Singh, Y (corresponding author), Univ Tubingen, Res Inst Womens Hlth, Calwerstasse 7-6, D-72076 Tubingen, Germany.
EM yogesh.singh@med.uni-tuebingen.de; olaf.riess@med.uni-tuebingen.de;
   nicolas.casadei@med.uni-tuebingen.de
RI Singh, Yogesh/T-8230-2017; Dueholm, Morten Kam Dahl/T-6718-2018
OI Singh, Yogesh/0000-0001-6919-6273; Trautwein,
   Christoph/0000-0003-4672-6395; Admard, Jakob/0000-0003-0466-582X;
   Neckel, Peter/0000-0003-1976-0512; Dueholm, Morten Kam
   Dahl/0000-0003-4135-2670
FU Deutsche Forschungsgemeinschaft, DFG through the NGS Competent Centre
   Tubingen (NCCT-DFG); Tubingen university, Tubingen [JPCOFUND_FP-829047];
   Projekt DEAL; EU Joint Programme-Neurodegenerative Disease Research
   (JPND) [26420-0]; funding organization Deutschland, Bundesministerium
   fur Bildung und Forschung (BMBF, FKZ)
FX Open Access funding enabled and organized by Projekt DEAL. This research
   project is an EU Joint Programme-Neurodegenerative Disease Research
   (JPND) (JPCOFUND_FP-829-047 aSynProtect) and is supported through the
   funding organization Deutschland, Bundesministerium fur Bildung und
   Forschung (BMBF, FKZ).This research was also supported by the Deutsche
   Forschungsgemeinschaft, DFG through the funding of the NGS Competent
   Centre Tubingen (NCCT-DFG).This study was also supported by the Fortune
   funds (Fortune grant No.2642-0-0), Tubingen university, Tubingen.
   Funders have no role in the study design and data analysis.
CR Antunes L, 2016, MOVEMENT DISORD, V31, P1567, DOI 10.1002/mds.26702
   Ayyanna R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03063
   Boertien JM, 2022, NPJ PARKINSONS DIS, V8, DOI 10.1038/s41531-022-00395-8
   Borghammer P, 2022, NPJ PARKINSONS DIS, V8, DOI 10.1038/s41531-022-00436-2
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Bullich C, 2019, MOV DISORD CLIN PRAC, V6, P639, DOI 10.1002/mdc3.12840
   Campos-Acuna J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00239
   Challis C, 2020, NAT NEUROSCI, V23, P327, DOI 10.1038/s41593-020-0589-7
   Chandra R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92295
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017
   Derkinderen P, 2011, NEUROLOGY, V77, P1761, DOI 10.1212/WNL.0b013e318236ef60
   Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295
   Fernandez-Veledo S, 2019, REV ENDOCR METAB DIS, V20, P439, DOI 10.1007/s11154-019-09513-z
   Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032
   Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112
   Haikal C, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0175-7
   Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164
   Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x
   Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942
   Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6
   Hopfner F, 2017, BRAIN RES, V1667, P41, DOI 10.1016/j.brainres.2017.04.019
   Horsager J, 2020, BRAIN, V143, P3077, DOI 10.1093/brain/awaa238
   Houser MC, 2018, MOVEMENT DISORD, V33, P793, DOI 10.1002/mds.27326
   Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957
   Huuskonen J, 2004, BRIT J PHARMACOL, V141, P874, DOI 10.1038/sj.bjp.0705682
   Jackson A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01245
   Johnson DB, 2019, NAT MED, V25, P1243, DOI 10.1038/s41591-019-0523-2
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3
   Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307
   Krashia P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11928-w
   Kumari S, 2020, CLIN CHIM ACTA, V510, P442, DOI 10.1016/j.cca.2020.08.005
   Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406
   Lee JS, 2018, J BIOL CHEM, V293, P6039, DOI 10.1074/jbc.RA117.000269
   Li CX, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00171
   Liddle RA, 2018, BRAIN RES, V1693, P201, DOI 10.1016/j.brainres.2018.01.010
   Lin CH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1528-y
   Liu XM, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1875796
   Ma CX, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.598457
   Mao CJ, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.867
   Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008
   Mirabile A, 2019, CANCERS, V11, DOI 10.3390/cancers11030296
   Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808
   Morshedi M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1611-4
   Moschen AR, 2016, CELL HOST MICROBE, V19, P455, DOI 10.1016/j.chom.2016.03.007
   Mu QH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00598
   Mulak A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00992
   Mulak A, 2018, MOVEMENT DISORD, V33, P398, DOI 10.1002/mds.27304
   Mulak A, 2015, WORLD J GASTROENTERO, V21, P10609, DOI 10.3748/wjg.v21.i37.10609
   Nuber S, 2013, BRAIN, V136, P412, DOI 10.1093/brain/aws358
   Peng HR, 2022, NEUROSCI BULL, V38, P871, DOI 10.1007/s12264-022-00848-3
   Pereira PAB, 2017, PARKINSONISM RELAT D, V38, P61, DOI 10.1016/j.parkreldis.2017.02.026
   Perez-Pardo P, 2018, BENEF MICROBES, V9, P799, DOI [10.3920/BM2017.0202, 10.3920/bm2017.0202]
   Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7
   Pfeiffer RF, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0539-9
   Qian YW, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00156
   Salker MS, 2016, CELL PHYSIOL BIOCHEM, V39, P1295, DOI 10.1159/000447834
   Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018
   Santaella A, 2020, NPJ PARKINSONS DIS, V6, DOI 10.1038/s41531-020-00124-z
   Santos SF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00574
   Scheperjans F, 2016, CURR OPIN NEUROL, V29, P773, DOI 10.1097/WCO.0000000000000389
   Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069
   Schwiertz A, 2018, PARKINSONISM RELAT D, V50, P104, DOI 10.1016/j.parkreldis.2018.02.022
   Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020
   Singh Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72903-w
   Singh Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01032
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   Takahashi H, 2005, PARKINSONISM RELAT D, V11, pS31, DOI 10.1016/j.parkreldis.2005.02.011
   Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400
   Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019
   Van Den Berge N, 2019, ACTA NEUROPATHOL, V138, P535, DOI 10.1007/s00401-019-02040-w
   Vascellari S, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00561-20
   Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2
   Voigt RM, 2022, NEUROBIOL DIS, V170, DOI 10.1016/j.nbd.2022.105780
   Wallen ZD, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-34667-x
   Wallen ZD, 2020, NPJ PARKINSONS DIS, V6, DOI 10.1038/s41531-020-0112-6
   Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628
   Yang Y, 2017, CURR OPIN GASTROEN, V33, P422, DOI 10.1097/MOG.0000000000000399
   Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011
   Zhong CB, 2017, NEUROSCI BULL, V33, P483, DOI 10.1007/s12264-017-0179-1
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
NR 82
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1326
J9 MOL NEURODEGENER
JI Mol. Neurodegener.
PD JUL 4
PY 2023
VL 18
IS 1
AR 44
DI 10.1186/s13024-023-00628-1
PG 28
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA L6PA0
UT WOS:001024449700001
PM 37403161
OA Green Submitted, Green Published, gold
DA 2023-09-14
ER

PT J
AU Wang, HH
   Zhang, KB
   Wu, L
   Qin, Q
   He, YQ
AF Wang, Haihe
   Zhang, Kaibo
   Wu, Lin
   Qin, Qian
   He, Yongqun
TI Prediction of Pathogenic Factors in Dysbiotic Gut Microbiomes of
   Colorectal Cancer Patients Using Reverse Microbiomics
SO FRONTIERS IN ONCOLOGY
LA English
DT Article
DE reverse microbiomics; ontology; gut microbiome; colorectal cancer;
   bioinformatics; reverse vaccinology
ID FUSOBACTERIUM-NUCLEATUM; WIDE ASSOCIATION; TUMOR-SUPPRESSOR; PROTEIN;
   EXPRESSION; BINDING; GENE; TUMORIGENESIS; INFLAMMATION; QUALITY
AB Background: Gut microbiome plays a crucial role in the formation and progression of colorectal cancer (CRC). To better identify the underlying gene-level pathogenic mechanisms of microbiome-associated CRC, we applied our newly developed Reverse Microbiomics (RM) to predict potential pathogenic factors using the data of microbiomes in CRC patients.
   Results: Our literature search first identified 40 bacterial species enriched and 23 species depleted in the guts of CRC patients. These bacteria were systematically modeled and analyzed using the NCBI Taxonomy ontology. Ten species, including 6 enriched species (e.g., Bacteroides fragilis, Fusobacterium nucleatum and Streptococcus equinus) and 4 depleted species (e.g., Bacteroides uniformis and Streptococcus thermophilus) were chosen for follow-up comparative genomics analysis. Vaxign was used to comparatively analyze 47 genome sequences of these ten species. In total 18 autoantigens were predicted to contribute to CRC formation, six of which were reported with experimental evidence to be correlated with drug resistance and/or cell invasiveness of CRC. Interestingly, four human homology proteins (EDK89078.1, EDK87700.1, EDK89777.1, and EDK89145.1) are conserved among all enriched strains. Furthermore, we predicted 76 potential virulence factors without homology to human proteins, including two riboflavin synthase proteins, three ATP-binding cassettes (ABC) transporter protein family proteins, and 12 outer membrane proteins (OMPs). Riboflavin synthase is present in all the enriched strains but not in depleted species. The critical role of riboflavin synthase in CRC development was further identified from its hub role in our STRING-based protein-protein interaction (PPI) network analysis and from the finding of the riboflavin metabolism as the most significantly enriched pathway in our KEGG pathway analysis. A novel model of the CRC pathogenesis involving riboflavin synthase and other related proteins including TpiA and GrxC was further proposed.
   Conclusions: The RM strategy was used to predict 18 autoantigens and 76 potential virulence factors from CRC-associated microbiome data. In addition to many of these autoantigens and virulence factors experimentally verified as reported in the literature, our study predicted many new pathogenetic factors and developed a new model of CRC pathogenesis involving the riboflavin synthase from the enriched colorectal bacteria and other associated proteins.
C1 [Wang, Haihe; Zhang, Kaibo; Qin, Qian] Lishui Univ, Dept Immunol & Pathogen Biol, Lishui, Peoples R China.
   [Wu, Lin] Lishui Univ, Ctr Comp Expt, Lishui, Peoples R China.
   [He, Yongqun] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.
   [He, Yongqun] Univ Michigan, Dept Microbiol & Immunol, Med Sch, Ann Arbor, MI 48109 USA.
   [He, Yongqun] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.
   [He, Yongqun] Univ Michigan, Comprehens Canc Ctr, Med Sch, Ann Arbor, MI 48109 USA.
C3 Lishui University; Lishui University; University of Michigan System;
   University of Michigan; University of Michigan System; University of
   Michigan; University of Michigan System; University of Michigan;
   University of Michigan System; University of Michigan
RP Wang, HH (corresponding author), Lishui Univ, Dept Immunol & Pathogen Biol, Lishui, Peoples R China.; He, YQ (corresponding author), Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.; He, YQ (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Med Sch, Ann Arbor, MI 48109 USA.; He, YQ (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; He, YQ (corresponding author), Univ Michigan, Comprehens Canc Ctr, Med Sch, Ann Arbor, MI 48109 USA.
EM wanghaihe4@aliyun.com; yongqunh@med.umich.edu
FU Natural Science Foundation of Heilongjiang Province [LH2019C074];
   Michigan Medicine-Peking University Health Sciences Center Joint
   Institute for Clinical and Translational Research [U063430]
FX This work was supported by a grant to HW from the Natural Science
   Foundation of Heilongjiang Province (Grant No. LH2019C074) and a grant
   to YH from the Michigan Medicine-Peking University Health Sciences
   Center Joint Institute for Clinical and Translational Research
   (U063430).
CR Alkhayyat M, 2021, INFLAMM BOWEL DIS, V27, P1052, DOI 10.1093/ibd/izaa252
   Garcia-Angulo VA, 2017, CRIT REV MICROBIOL, V43, P196, DOI 10.1080/1040841X.2016.1192578
   Arevalo P, 2019, CELL, V178, P820, DOI 10.1016/j.cell.2019.06.033
   Bahrami A, 2020, EUR J CANCER PREV, V29, P222, DOI 10.1097/CEJ.0000000000000550
   BARBER GN, 1994, P NATL ACAD SCI USA, V91, P4278, DOI 10.1073/pnas.91.10.4278
   Ben S, 2019, EUR J NUTR, V58, P1591, DOI 10.1007/s00394-018-1702-5
   Berzins SP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00949
   Bo L, 2018, FREE RADICAL RES, V52, P390, DOI 10.1080/10715762.2018.1435871
   Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513
   Cheng YW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.615056
   Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11
   Dekoninck K, 2020, ELIFE, V9, DOI 10.7554/eLife.60861
   Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178
   Giddings EL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23071-6
   Godfrey DI, 2019, NAT IMMUNOL, V20, P1110, DOI 10.1038/s41590-019-0444-8
   Goradel NH, 2019, J CELL PHYSIOL, V234, P2337, DOI 10.1002/jcp.27250
   Guevarra LA, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0184-7
   Guo Q, 2018, J BIOL CHEM, V293, P11166, DOI 10.1074/jbc.RA118.003187
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Haghi F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6115-1
   Haro-Moreno JM, 2020, FEMS MICROBIOL ECOL, V96, DOI 10.1093/femsec/fiaa218
   He F, 2016, ONCOTARGET, V7, P37000, DOI 10.18632/oncotarget.9454
   He XW, 2020, CANCER BIOMARK, V29, P531, DOI 10.3233/CBM-200023
   He YQ, 2019, J BIOMED SEMANT, V10, DOI 10.1186/s13326-019-0217-1
   He YQ, 2010, J BIOMED BIOTECHNOL, P1, DOI [10.1155/2010/218590, 10.1155/2010/297505]
   Huang CY, 2020, BRIT J NUTR, V123, P1277, DOI 10.1017/S0007114520000501
   Hur J, 2017, J BIOMED SEMANT, V8, DOI 10.1186/s13326-017-0122-4
   Janney A, 2020, NATURE, V585, P509, DOI 10.1038/s41586-020-2729-3
   Jiang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32320
   Johnson SAS, 2017, ONCOTARGET, V8, P48832, DOI 10.18632/oncotarget.16384
   Kelly J, 2019, IMMUNOL CELL BIOL, V97, P689, DOI 10.1111/imcb.12281
   Keskin H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255322
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Lee JA, 2021, CANCER IMMUNOL IMMUN, V70, P47, DOI 10.1007/s00262-020-02657-x
   Lesiow MK, 2019, METALLOMICS, V11, P2066, DOI 10.1039/c9mt00179d
   Levy R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0588-y
   Li L, 2019, EBIOMEDICINE, V48, P301, DOI 10.1016/j.ebiom.2019.09.021
   Li SM, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100039
   Ling LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20358
   Liu AY, 2013, MOL NUTR FOOD RES, V57, P721, DOI 10.1002/mnfr.201200180
   Liu GH, 2015, MOL MED REP, V12, P7643, DOI 10.3892/mmr.2015.4335
   Lone SN, 2018, J CELL PHYSIOL, V233, P8919, DOI 10.1002/jcp.26821
   Magalashvili L, 2008, FEMS IMMUNOL MED MIC, V53, P252, DOI 10.1111/j.1574-695X.2008.00423.x
   Muller MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072055
   Musen Mark A, 2015, AI Matters, V1, P4
   Ong E, 2020, BIOINFORMATICS, V36, P3185, DOI 10.1093/bioinformatics/btaa119
   Otasek D, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1758-4
   Ouyang P, 2018, GENE, V647, P61, DOI 10.1016/j.gene.2018.01.014
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960
   Shimonosono M, 2019, INT J ONCOL, V54, P673, DOI 10.3892/ijo.2018.4657
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Tanaka KJ, 2018, BBA-BIOMEMBRANES, V1860, P868, DOI 10.1016/j.bbamem.2017.08.011
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Uitterlinden AG, 2016, SEMIN REPROD MED, V34, P196, DOI 10.1055/s-0036-1585406
   Villar-Ortega Paola, 2021, Enferm Infecc Microbiol Clin (Engl Ed), DOI [10.1016/j.eimce.2022.02.007, 10.1016/j.eimc.2021.01.005]
   Wang HH, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.633732
   Wang S, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.710165
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Xia YS, 2020, MBIO, V11, DOI 10.1128/mBio.02079-19
   Xiang KM, 2014, ASIAN PAC J CANCER P, V15, P3767, DOI 10.7314/APJCP.2014.15.8.3767
   Xiang Zuoshuang, 2010, BMC Res Notes, V3, P175, DOI 10.1186/1756-0500-3-175
   Yildiz Mehmet Taha, 2022, Methods Mol Biol, V2257, P293, DOI 10.1007/978-1-0716-1170-8_15
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zabijak L, 2015, CANCER IMMUNOL IMMUN, V64, P1601, DOI 10.1007/s00262-015-1764-7
   Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75
   Zhu WH, 2019, J EXP MED, V216, P2378, DOI 10.1084/jem.20181939
NR 69
TC 0
Z9 0
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2234-943X
J9 FRONT ONCOL
JI Front. Oncol.
PD APR 27
PY 2022
VL 12
AR 882874
DI 10.3389/fonc.2022.882874
PG 12
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 6I7RZ
UT WOS:000886331300001
PM 35574378
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Luan, SD
   Zhang, SY
   Pan, LT
   Hu, WJ
   Cui, HH
   Wei, X
   Lin, RY
   Li, CD
   Zeng, P
   Wang, X
   Li, WL
   Xu, ZG
   Zhang, YW
   Hu, B
   Gao, HC
AF Luan, Shaodong
   Zhang, Shuyuan
   Pan, Litao
   Hu, Wenjun
   Cui, Haihong
   Wei, Xing
   Lin, Renyong
   Li, Chundi
   Zeng, Ping
   Wang, Xi
   Li, Weilong
   Xu, Zigan
   Zhang, Yingwei
   Hu, Bo
   Gao, Hanchao
TI Salivary microbiota analysis of patients with membranous nephropathy
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE 16S ribosomal RNA gene; membranous nephropathy; oral microbiota;
   biomarkers
ID GUT MICROBIOME; KIDNEY-DISEASE; JOURNEY; HEALTH
AB The oral microbiota are closely related to human health. Nonetheless, to the best of our knowledge, their relationship with membranous nephropathy (MN) remains unstudied. The saliva microbiota collected from 22 patients with MN and 15 healthy controls were analyzed by next-generation sequencing, and bioinformatics analysis of the 16S ribosomal RNA gene was subsequently carried out. The Chao1 and Shannon indices in patients with MN were higher than those in healthy controls. Analysis of similarities revealed that the oral microbiota in the patient group were significantly different from those in the healthy controls. At the genus level, the abundance of Alloprevotella, Granulicatella, Prevotella, Streptococcus and Prevotella_7 was markedly higher in patients with MN than in healthy controls. Six operational taxonomic units (OTUs; OTU5, OTU28, OTU9, OTU15, OTU33 and OTU38) were found to be markedly correlated with the clinical factors creatinine, proteinuria in 24 h, estimated glomerular filtration rate and systolic blood pressure. A total of 28 Kyoto Encyclopedia of Genes and Genomes pathways were obtained from the significant OTUs. The oral microbiota of patients with MN were investigated and it was found that OTU5, OTU28, OTU9, OTU15, OTU33 and OTU38 may be used as biomarkers. The present findings may assist in the diagnosis of patients with MN.
C1 [Luan, Shaodong; Zhang, Shuyuan; Wei, Xing; Lin, Renyong; Li, Chundi; Zeng, Ping; Wang, Xi; Li, Weilong; Xu, Zigan; Zhang, Yingwei; Gao, Hanchao] Guangdong Med Univ, Dept Nephrol, Affiliated Cent Hosp Shenzhen Longhua Dist, Shenzhen Longhua Dist Cent Hosp, Shenzhen 518110, Peoples R China.
   [Pan, Litao] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Acupuncture & Massage, Shenzhen 518037, Guangdong, Peoples R China.
   [Hu, Wenjun; Cui, Haihong] 305 Hosp PLA, Dept Anesthesiol, Beijing 100036, Peoples R China.
   [Hu, Bo] Jinan Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510630, Guangdong, Peoples R China.
C3 Shenzhen Longhua District Central Hospital; Guangdong Medical
   University; Shenzhen University; Jinan University
RP Gao, HC (corresponding author), Guangdong Med Univ, Affiliated Cent Hosp Shenzhen Longhua Dist, Shenzhen Longhua Dist Cent Hosp, Dept Nephrol, 187 Guanlan Rd, Shenzhen 518110, Guangdong, Peoples R China.; Hu, B (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Nephrol, 613 West Huangpu Dadao, Guangzhou 510630, Guangdong, Peoples R China.
EM 42089537@qq.com; hcgao@foxmail.com
RI Gao, Hanchao/AGW-6043-2022; Zhang, shuyuan/IUN-4098-2023; Hu,
   Wenjun/U-6955-2019
OI Hu, Wenjun/0000-0001-8563-8844
CR de Azevedo FVA, 2018, RHEUMATOL INT, V38, P1777, DOI 10.1007/s00296-018-4040-2
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cai Q, 2020, SEMIN DIAGN PATHOL, V37, P116, DOI 10.1053/j.semdp.2020.01.001
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028
   Cattran DC, 2001, KIDNEY INT, V59, P1983, DOI 10.1046/j.1523-1755.2001.0590051983.x
   Duan XB, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02009-y
   Edgar R, 2018, PEERJ, V6, DOI 10.7717/peerj.5030
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Ehrenreich T., 1968, PATHOL ANNU, P145
   Escapa IF, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00187-18
   Francis JM, 2016, AM J KIDNEY DIS, V68, P138, DOI 10.1053/j.ajkd.2016.01.030
   Fu M, 2020, MBIO, V11, DOI 10.1128/mBio.03242-19
   Kanehisa M, 2021, NUCLEIC ACIDS RES, V49, pD545, DOI 10.1093/nar/gkaa970
   Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602
   Lin CZ, 2019, DIGESTION, V100, P72, DOI 10.1159/000494052
   Luan SD, 2019, MOL MED REP, V20, P2219, DOI 10.3892/mmr.2019.10480
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421
   Piccolo M, 2015, MICROB ECOL, V70, P557, DOI 10.1007/s00248-015-0592-9
   R Core Team, 2017, R LANG ENV STAT COMP
   Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Sharma S, 2019, J NUTR BIOCHEM, V63, P101, DOI 10.1016/j.jnutbio.2018.10.003
   Tang LJ, 2017, NEPHROLOGY, V22, P168, DOI 10.1111/nep.12739
   Turrent-Carriles A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01008
   Wang J, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00409
   Wang L, 2020, J DIABETES INVEST, V11, P1285, DOI 10.1111/jdi.13262
   Yu W, 2020, RENAL FAILURE, V42, P1100, DOI 10.1080/0886022X.2020.1837869
NR 34
TC 3
Z9 3
U1 0
U2 9
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD MAY
PY 2022
VL 25
IS 5
AR 190
DI 10.3892/mmr.2022.12706
PG 9
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA 0L0YN
UT WOS:000781210100001
PM 35362547
OA Green Published, hybrid
DA 2023-09-14
ER

PT J
AU Tovo, A
   Menzel, P
   Krogh, A
   Lagomarsino, MC
   Suweis, S
AF Tovo, Anna
   Menzel, Peter
   Krogh, Anders
   Lagomarsino, Marco Cosentino
   Suweis, Samir
TI Taxonomic classification method for metagenomics based on core protein
   families with Core-Kaiju
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID RNA GENE DATABASE; GUT MICROBIOME; GREENGENES; HEALTH
AB Characterizing species diversity and composition of bacteria hosted by biota is revolutionizing our understanding of the role of symbiotic interactions in ecosystems. Determining microbiomes diversity implies the assignment of individual reads to taxa by comparison to reference databases. Although computational methods aimed at identifying the microbe(s) taxa are available, it is well known that inferences using different methods can vary widely depending on various biases. In this study, we first apply and compare different bioinformatics methods based on 16S ribosomal RNA gene and shotgun sequencing to three mock communities of bacteria, of which the compositions are known. We show that none of these methods can infer both the true number of taxa and their abundances. We thus propose a novel approach, named Core-Kaiju, which combines the power of shotgun metagenomics data with a more focused marker gene classification method similar to 16S, but based on emergent statistics of core protein domain families. We thus test the proposed method on various mock communities and we show that Core-Kaiju reliably predicts both number of taxa and abundances. Finally, we apply our method on human gut samples, showing how Core-Kaiju may give more accurate ecological characterization and a fresh view on real microbiomes.
C1 [Tovo, Anna; Suweis, Samir] Univ Padua, LIPh Lab, Phys & Astron Dept, Via Marzolo 8, I-35131 Padua, Italy.
   [Tovo, Anna] Univ Padua, Math Dept, Via Trieste 63, I-35121 Padua, Italy.
   [Menzel, Peter] Lab Berlin Charite Vivantes GmbH, Sylter Str 2, D-13353 Berlin, Germany.
   [Krogh, Anders] Univ Copenhagen, Dept Comp Sci, Universitetsparken 1, DK-2100 Copenhagen, Denmark.
   [Lagomarsino, Marco Cosentino] FIRC Inst Mol Oncol, IFOM, Via Adamello 16, I-20143 Milan, Italy.
   [Lagomarsino, Marco Cosentino] Univ Milan, Phys Dept, Via Celoria 16, I-20133 Milan, Italy.
   [Lagomarsino, Marco Cosentino] Ist Nazl Fis Nucl, Phys Dept, Via Celoria 16, I-20133 Milan, Italy.
   [Suweis, Samir] Univ Padua, Padova Neurosci Ctr, Via Orus 2-B, I-35131 Padua, Italy.
C3 University of Padua; University of Padua; University of Copenhagen; IFOM
   - FIRC Institute of Molecular Oncology; University of Milan; Istituto
   Nazionale di Fisica Nucleare (INFN); University of Padua
RP Suweis, S (corresponding author), Univ Padua, LIPh Lab, Phys & Astron Dept, Via Marzolo 8, I-35131 Padua, Italy.; Suweis, S (corresponding author), Univ Padua, Padova Neurosci Ctr, Via Orus 2-B, I-35131 Padua, Italy.
EM samir.suweis@unipd.it
RI Suweis, Samir/G-7001-2014; Menzel, Peter/I-2974-2019; Krogh,
   Anders/M-1541-2014
OI Suweis, Samir/0000-0002-1603-8375; Menzel, Peter/0000-0003-4964-0685;
   Krogh, Anders/0000-0002-5147-6282
FU STARS GRANT UNIPD 2018 BioReACT; UNIPD DFA DOR
FX STARS GRANT UNIPD 2018 BioReACT (to S.S.). Funding for open access
   charge: UNIPD DFA DOR Funding.
CR Alberti A, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.93
   Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16
   Angly FE, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-11
   Bashan A, 2016, NATURE, V534, P259, DOI 10.1038/nature18301
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Bork P, 2015, SCIENCE, V348, P873, DOI 10.1126/science.aac5605
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Chan CS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00177
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   De Lazzari E, 2017, NUCLEIC ACIDS RES, V45, P7615, DOI 10.1093/nar/gkx510
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Earl JP, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0569-2
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995
   Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292
   Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377
   Gilbert JA, 2019, NAT MED, V25, P884, DOI 10.1038/s41591-019-0464-9
   Goldford JE, 2018, SCIENCE, V361, P469, DOI 10.1126/science.aat1168
   Grilli J, 2012, NUCLEIC ACIDS RES, V40, P530, DOI 10.1093/nar/gkr711
   Grilli J, 2014, NUCLEIC ACIDS RES, V42, P6850, DOI 10.1093/nar/gku378
   Haegeman B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-196
   Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108
   Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743
   Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Koonin EV, 2009, COLD SH Q B, V74, P205, DOI 10.1101/sqb.2009.74.006
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Lobkovsky AE, 2013, GENOME BIOL EVOL, V5, P233, DOI 10.1093/gbe/evt002
   Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Mazzolini A, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.012315
   Mazzolini A, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021023
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257
   Mitra S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S16
   Pang TY, 2013, P NATL ACAD SCI USA, V110, P6235, DOI 10.1073/pnas.1217795110
   Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5
   Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827
   Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8
   Puigbo P, 2019, METHODS MOL BIOL, V1910, P241, DOI 10.1007/978-1-4939-9074-0_8
   Puigbo P, 2010, GENOME BIOL EVOL, V2, P745, DOI 10.1093/gbe/evq062
   Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]
   Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139
   Tessler M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06665-3
   Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460
   Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540
   Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209
NR 65
TC 13
Z9 13
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD SEP 18
PY 2020
VL 48
IS 16
DI 10.1093/nar/gkaa568
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA NV4ZW
UT WOS:000574332700003
PM 32633756
OA Green Submitted, gold, Green Published
DA 2023-09-14
ER

PT J
AU Shah, MS
   DeSantis, TZ
   Weinmaier, T
   McMurdie, PJ
   Cope, JL
   Altrichter, A
   Yamal, JM
   Hollister, EB
AF Shah, Manasi S.
   DeSantis, Todd Z.
   Weinmaier, Thomas
   McMurdie, Paul J.
   Cope, Julia L.
   Altrichter, Adam
   Yamal, Jose-Miguel
   Hollister, Emily B.
TI Leveraging sequence-based faecal microbial community survey data to
   identify a composite biomarker for colorectal cancer
SO GUT
LA English
DT Article
ID HUMAN GUT MICROBIOME; OCCULT BLOOD-TESTS; METAANALYSES; SENSITIVITY;
   BACTERIAL; OBESITY
AB Objective Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality in the USA. The faecal microbiome may provide non-invasive biomarkers of CRC and indicate transition in the adenoma-carcinoma sequence. Re-analysing raw sequence and metadata from several studies uniformly, we sought to identify a composite and generalisable microbial marker for CRC.
   Design Raw 16S rRNA gene sequence data sets from nine studies were processed with two pipelines, (1) QIIME closed reference (QIIME-CR) or (2) a strain-specific method herein termed SS-UP (Strain Select, UPARSE bioinformatics pipeline). A total of 509 samples (79 colorectal adenoma, 195 CRC and 235 controls) were analysed. Differential abundance, meta-analysis random effects regression and machine learning analyses were carried out to determine the consistency and diagnostic capabilities of potential microbial biomarkers.
   Results Definitive taxa, including Parvimonas micra ATCC 33270, Streptococcus anginosus and yet-to-be-cultured members of Proteobacteria, were frequently and significantly increased in stools from patients with CRC compared with controls across studies and had high discriminatory capacity in diagnostic classification. Microbiome-based CRC versus control classification produced an area under receiver operator characteristic (AUROC) curve of 76.6% in QIIME-CR and 80.3% in SS-UP. Combining clinical and microbiome markers gave a diagnostic AUROC of 83.3% for QIIME-CR and 91.3% for SS-UP.
   Conclusions Despite technological differences across studies and methods, key microbial markers emerged as important in classifying CRC cases and such could be used in a universal diagnostic for the disease. The choice of bioinformatics pipeline influenced accuracy of classification. Strain-resolved microbial markers might prove crucial in providing a microbial diagnostic for CRC.
C1 [Shah, Manasi S.; Yamal, Jose-Miguel] Univ Texas Sch Publ Hlth, Dept Epidemiol, Houston, TX USA.
   [Shah, Manasi S.; DeSantis, Todd Z.; Weinmaier, Thomas; McMurdie, Paul J.; Altrichter, Adam] Second Genome Inc, Bioinformat, San Francisco, CA USA.
   [Shah, Manasi S.; Cope, Julia L.; Hollister, Emily B.] Texas Childrens Hosp, Texas Childrens Microbiome Ctr, Dept Pathol, Houston, TX 77030 USA.
   [McMurdie, Paul J.] Whole Biome Inc, Bioinformat, San Francisco, CA USA.
   [Shah, Manasi S.; Cope, Julia L.; Hollister, Emily B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Cope, Julia L.] Diversigen Inc, Houston, TX USA.
C3 University of Texas System; University of Texas Health Science Center
   Houston; University of Texas School Public Health; Baylor College of
   Medicine; Baylor College of Medicine
RP Shah, MS (corresponding author), 3450 Cent Expressway, Santa Clara, CA 95051 USA.
EM manasishah86@gmail.com
RI Weinmaier, Thomas/K-5780-2013
OI Weinmaier, Thomas/0000-0002-9552-3220; McMurdie,
   Paul/0000-0001-8879-3954
CR Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0108-3
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   [Anonymous], 2016, CANC FACTS FIG
   Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324
   Brim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081352
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607
   Chen WHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039039
   Chustecka Z., 2014, MEDSCAPE MED NEWS
   Dingemanse C, 2015, CARCINOGENESIS, V36, P1388, DOI 10.1093/carcin/bgv120
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]
   Fekry MI, 2016, ENV MICROBIOL REP, V8, P201, DOI 10.1111/1758-2229.12369
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Flynn KJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00102-16
   Giacosa A, 1999, EUR J CANCER PREV, V8, pS53
   Goedert JJ, 2015, EBIOMEDICINE, V2, P597, DOI 10.1016/j.ebiom.2015.04.010
   Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559
   Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x
   Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Oksanen J., 2020, VEGAN COMMUNITY ECOL
   Parkin DM, 2009, EUR J CANCER PREV, V18, P179, DOI 10.1097/CEJ.0b013e32830c8d83
   Richardson Lisa C., 2011, Morbidity and Mortality Weekly Report, V60, P884
   Samadder NJ, 2014, GASTROENTEROLOGY, V146, P950, DOI 10.1053/j.gastro.2014.01.013
   Senore C, 2014, NEW ENGL J MED, V371, P185, DOI [10.1056/NEJMc1405215, 10.1056/NEJMoa1311194]
   Shah MS, 2015, CANCER-AM CANCER SOC, V121, P2968, DOI 10.1002/cncr.29440
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wong CKW, 2012, INT J COLORECTAL DIS, V27, P1657, DOI 10.1007/s00384-012-1518-3
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 45
TC 111
Z9 116
U1 3
U2 103
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD MAY
PY 2018
VL 67
IS 5
BP 882
EP 891
DI 10.1136/gutjnl-2016-313189
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GC4DL
UT WOS:000429733600012
PM 28341746
DA 2023-09-14
ER

PT J
AU Monti, GS
   Filzmoser, P
AF Monti, Gianna Serafina
   Filzmoser, Peter
TI Sparse least trimmed squares regression with compositional covariates
   for high-dimensional data
SO BIOINFORMATICS
LA English
DT Article
ID VARIABLE SELECTION; ROBUST; MICROBIOME; REGULARIZATION; SHRINKAGE;
   MODELS
AB Motivation: High-throughput sequencing technologies generate a huge amount of data, permitting the quantification of microbiome compositions. The obtained data are essentially sparse compositional data vectors, namely vectors of bacterial gene proportions which compose the microbiome. Subsequently, the need for statistical and computational methods that consider the special nature of microbiome data has increased. A critical aspect in microbiome research is to identify microbes associated with a clinical outcome. Another crucial aspect with high-dimensional data is the detection of outlying observations, whose presence affects seriously the prediction accuracy.
   Results: In this article, we connect robustness and sparsity in the context of variable selection in regression with compositional covariates with a continuous response. The compositional character of the covariates is taken into account by a linear log-contrast model, and elastic-net regularization achieves sparsity in the regression coefficient estimates. Robustness is obtained by performing trimming in the objective function of the estimator. A reweighting step increases the efficiency of the estimator, and it also allows for diagnostics in terms of outlier identification. The numerical performance of the proposed method is evaluated via simulation studies, and its usefulness is illustrated by an application to a microbiome study with the aim to predict caffeine intake based on the human gut microbiome composition.
   Supplementary information: Supplementary data are available at Bioinformatics online.
C1 [Monti, Gianna Serafina] Univ Milano Bicocca, Dept Econ Management & Stat, I-20126 Milan, Italy.
   [Filzmoser, Peter] Vienna Univ Technol, Inst Stat & Math Methods Econ, A-1040 Vienna, Austria.
C3 University of Milano-Bicocca; Technische Universitat Wien
RP Monti, GS (corresponding author), Univ Milano Bicocca, Dept Econ Management & Stat, I-20126 Milan, Italy.
EM gianna.monti@unimib.it
RI Filzmoser, Peter/A-7737-2015; Monti, Gianna S./ABC-1932-2020
OI Monti, Gianna S./0000-0002-7952-3618
FU University of Milano-Bicocca
FX This research was supported by local funds from University of
   Milano-Bicocca [FAR 2018 to G.S.M.].
CR Aitchison, 1986, STAT ANAL COMPOSITIO
   AITCHISON J, 1984, BIOMETRIKA, V71, P323
   AITCHISON J, 1980, BIOMETRIKA, V67, P261, DOI 10.2307/2335470
   Alfons A, 2013, ANN APPL STAT, V7, P226, DOI 10.1214/12-AOAS575
   Altenbuchinger M, 2017, BIOINFORMATICS, V33, P219, DOI 10.1093/bioinformatics/btw598
   [Anonymous], 2001, MATH INTELL
   [Anonymous], 2009, WILEY SERIES PROBABI, DOI DOI 10.1002/9780470434697
   Bates S, 2019, BIOMETRICS, V75, P613, DOI 10.1111/biom.12995
   Filzmoser P., 2018, WORKED EXAMPLES R
   Freue GVC, 2019, ANN APPL STAT, V13, P2065, DOI 10.1214/19-AOAS1269
   Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   Kurnaz FS, 2018, CHEMOMETR INTELL LAB, V172, P211, DOI 10.1016/j.chemolab.2017.11.017
   Li HZ, 2015, ANNU REV STAT APPL, V2, P73, DOI 10.1146/annurev-statistics-010814-020351
   Lin W, 2014, BIOMETRIKA, V101, P785, DOI 10.1093/biomet/asu031
   Lubbe S, 2021, CHEMOMETR INTELL LAB, V210, DOI 10.1016/j.chemolab.2021.104248
   Maronna R., 2006, ROBUST STAT
   Maronna RA, 2002, TECHNOMETRICS, V44, P307, DOI 10.1198/004017002188618509
   Maronna RA, 2011, TECHNOMETRICS, V53, P44, DOI 10.1198/TECH.2010.09114
   Meinshausen N, 2007, COMPUT STAT DATA AN, V52, P374, DOI 10.1016/j.csda.2006.12.019
   Quinn TP, 2018, BIOINFORMATICS, V34, P2870, DOI 10.1093/bioinformatics/bty175
   Rousseeuw PJ, 2006, DATA MIN KNOWL DISC, V12, P29, DOI 10.1007/s10618-005-0024-4
   ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718
   Shi PX, 2016, ANN APPL STAT, V10, P1019, DOI 10.1214/16-AOAS928
   Smucler E, 2017, COMPUT STAT DATA AN, V111, P116, DOI 10.1016/j.csda.2017.02.002
   Tibshirani R, 1996, J ROY STAT SOC B, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Xiao J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03112
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
NR 32
TC 4
Z9 4
U1 1
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1367-4811
J9 BIOINFORMATICS
JI Bioinformatics
PD NOV 1
PY 2021
VL 37
IS 21
BP 3805
EP 3814
DI 10.1093/bioinformatics/btab572
EA AUG 2021
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA XT8LN
UT WOS:000733832700017
PM 34358286
OA Green Published
DA 2023-09-14
ER

PT J
AU Pu, LR
   Shamir, R
AF Pu, Lianrong
   Shamir, Ron
TI 3CAC: improving the classification of phages and plasmids in metagenomic
   assemblies using assembly graphs
SO BIOINFORMATICS
LA English
DT Article
ID VIRUSES
AB Motivation: Bacteriophages and plasmids usually coexist with their host bacteria in microbial communities and play important roles in microbial evolution. Accurately identifying sequence contigs as phages, plasmids and bacterial chromosomes in mixed metagenomic assemblies is critical for further unraveling their functions. Many classification tools have been developed for identifying either phages or plasmids in metagenomic assemblies. However, only two classifiers, PPR-Meta and viralVerify, were proposed to simultaneously identify phages and plasmids in mixed metagenomic assemblies. Due to the very high fraction of chromosome contigs in the assemblies, both tools achieve high precision in the classification of chromosomes but perform poorly in classifying phages and plasmids. Short contigs in these assemblies are often wrongly classified or classified as uncertain. Results: Here we present 3CAC, a new three-class classifier that improves the precision of phage and plasmid classification. 3CAC starts with an initial three-class classification generated by existing classifiers and improves the classification of short contigs and contigs with low confidence classification by using proximity in the assembly graph. Evaluation on simulated metagenomes and on real human gut microbiome samples showed that 3CAC outperformed PPR-Meta and viralVerify in both precision and recall, and increased F1-score by 10-60 percentage points. Availability and implementation The 3CAC software is available on . Supplementary information are available at Bioinformatics online.
C1 [Pu, Lianrong; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.
C3 Tel Aviv University
RP Shamir, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.
EM rshamir@tau.ac.il
RI Shamir, Ron/E-6514-2011
OI Shamir, Ron/0000-0003-1889-9870
FU ECCB2022; United State-Israel Binational Science Foundation (BSF),
   Jerusalem, Israel [2016694]; United States National Science Foundation
   (NSF); Edmond J. Safra Center for Bioinformatics at Tel-Aviv University;
   Planning and Budgeting Committee (PBC) of the Council for Higher
   Education (CHE) in Israel
FX This paper was published as part of a special issue financially
   supported by ECCB2022. This study was supported in part by grant 2016694
   from the United State-Israel Binational Science Foundation (BSF),
   Jerusalem, Israel and the United States National Science Foundation
   (NSF). L.P. was supported in part by a fellowship from the Edmond J.
   Safra Center for Bioinformatics at Tel-Aviv University. L.P. was also
   supported in part by postdoctoral fellowships from the Planning and
   Budgeting Committee (PBC) of the Council for Higher Education (CHE) in
   Israel.
CR Antipov D, 2020, BIOINFORMATICS, V36, P4126, DOI 10.1093/bioinformatics/btaa490
   Antipov D, 2019, GENOME RES, V29, P961, DOI 10.1101/gr.241299.118
   Arredondo-Alonso S, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000128
   Auslander N, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa856
   Barnum TP, 2018, ISME J, V12, P1568, DOI 10.1038/s41396-018-0081-5
   Bickhart DM, 2022, NAT BIOTECHNOL, V40, P711, DOI 10.1038/s41587-021-01130-z
   Calero-Caceres W, 2019, TRENDS MICROBIOL, V27, P570, DOI 10.1016/j.tim.2019.02.008
   Fang ZC, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz066
   Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235
   Gourle H, 2019, BIOINFORMATICS, V35, P521, DOI 10.1093/bioinformatics/bty630
   Guo JR, 2021, MICROBIOME, V9, DOI 10.1186/s40168-020-00990-y
   Hurwitz BL, 2016, CURR OPIN MICROBIOL, V31, P161, DOI 10.1016/j.mib.2016.04.002
   Kieft K, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00867-0
   Kolmogorov M, 2020, NAT METHODS, V17, P1103, DOI 10.1038/s41592-020-00971-x
   Kraushaar B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02175-4
   Krawczyk PS, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1321
   Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Lopatkin AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01532-1
   Mallawaarachchi V, 2020, BIOINFORMATICS, V36, P3307, DOI 10.1093/bioinformatics/btaa180
   Nurk S, 2016, Arxiv, DOI arXiv:1604.03071
   Pellow D, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01068-z
   Pellow D, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007781
   Ren J, 2020, QUANT BIOL, V8, P64, DOI 10.1007/s40484-019-0187-4
   Ren J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0283-5
   Rosenwasser S, 2016, TRENDS MICROBIOL, V24, P821, DOI 10.1016/j.tim.2016.06.006
   Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985
   Sarowska J, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0290-0
   Siren K, 2021, NAR GENOM BIOINFORM, V3, DOI 10.1093/nargab/lqaa109
   Sitaraman R, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0551-z
   Smalla K, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.PLAS-0038-2014
   Starikova EV, 2020, BIOINFORMATICS, V36, P3882, DOI 10.1093/bioinformatics/btaa250
   Suzuki Y, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0737-z
   Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234
   Wein T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10600-7
   West PT, 2018, GENOME RES, V28, P569, DOI 10.1101/gr.228429.117
   Yahara K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20199-9
   Yang C, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix010
   Zhou FF, 2010, BIOINFORMATICS, V26, P2051, DOI 10.1093/bioinformatics/btq299
NR 39
TC 1
Z9 1
U1 1
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1367-4811
J9 BIOINFORMATICS
JI Bioinformatics
PD SEP 16
PY 2022
VL 38
SU 2
SI SI
BP ii56
EP ii61
DI 10.1093/bioinformatics/btac468
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 5D1MO
UT WOS:000864714500009
PM 36124804
OA Green Submitted, Bronze
DA 2023-09-14
ER

PT J
AU Telalovic, JH
   Music, A
AF Hasic Telalovic, Jasminka
   Music, Azra
TI Using data science for medical decision making case: role of gut
   microbiome in multiple sclerosis
SO BMC MEDICAL INFORMATICS AND DECISION MAKING
LA English
DT Article
DE Machine learning; Microbiome; Data science; Multiple sclerosis
AB Background A decade ago, the advancements in the microbiome data sequencing techniques initiated the development of research of the microbiome and its relationship with the host organism. The development of sophisticated bioinformatics and data science tools for the analysis of large amounts of data followed. Since then, the analyzed gut microbiome data, where microbiome is defined as a network of microorganisms inhabiting the human intestinal system, has been associated with several conditions such as irritable bowel syndrome - IBS, colorectal cancer, diabetes, obesity, and metabolic syndrome, and lately in the study of Parkinson's and Alzheimer's diseases as well. This paper aims to provide an understanding of differences between microbial data of individuals who have been diagnosed with multiple sclerosis and those who were not by exploiting data science techniques on publicly available data. Methods This study examines the relationship between multiple sclerosis (MS), an autoimmune central nervous system disease, and gut microbial community composition, using the samples acquired by 16s rRNA sequencing technique. We have used three different sets of MS samples sequenced during three independent studies (Jangi et al, Nat Commun 7:1-11, 2016), (Miyake et al, PLoS ONE 10:0137429, 2015), (McDonald et al, Msystems 3:00031-18, 2018) and this approach strengthens our results. Analyzed sequences were from healthy control and MS groups of sequences. The extracted set of statistically significant bacteria from the (Jangi et al, Nat Commun 7:1-11, 2016) dataset samples and their statistically significant predictive functions were used to develop a Random Forest classifier. In total, 8 models based on two criteria: bacteria abundance (at six taxonomic levels) and predictive functions (at two levels), were constructed and evaluated. These include using taxa abundances at different taxonomy levels as well as predictive function analysis at different hierarchical levels of KEGG pathways. Results The highest accuracy of the classification model was obtained at the genus level of taxonomy (76.82%) and the third hierarchical level of KEGG pathways (70.95%). The second dataset's 18 MS samples (Miyake et al, PLoS ONE 10:0137429, 2015) and 18 self-reported healthy samples from the (McDonald et al, Msystems 3:00031-18, 2018) dataset were used to validate the developed classification model. The significance of this step is to show that the model is not overtrained for a specific dataset but can also be used on other independent datasets. Again, the highest classification model accuracy for both validating datasets combined was obtained at the genus level of taxonomy (70.98%) and third hierarchical level of KEGG pathways (67.24%). The accuracy of the independent set remained very relevant. Conclusions Our results demonstrate that the developed classification model provides a good tool that can be used to suggest the presence or absence of MS condition by collecting and analyzing gut microbiome samples. The accuracy of the model can be further increased by using sequencing methods that allow higher taxa resolution (i.e. shotgun metagenomic sequencing).
C1 [Hasic Telalovic, Jasminka; Music, Azra] Univ Sarajevo, Sch Sci & Technol, Hrasnicka Cesta 3a, Ilidza 71210, Bosnia & Herceg.
C3 University of Sarajevo
RP Telalovic, JH (corresponding author), Univ Sarajevo, Sch Sci & Technol, Hrasnicka Cesta 3a, Ilidza 71210, Bosnia & Herceg.
EM jasminka.hasic@ssst.edu.ba
RI Hasic Telalovic, Jasminka/S-9016-2019
OI Hasic Telalovic, Jasminka/0000-0002-8540-5052
CR [Anonymous], 2014, THESIS U LIEGE LIEGE
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Branton WG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37344
   Budhram A, 2017, MULT SCLER J, V23, P628, DOI 10.1177/1352458516682105
   Cantarel BL, 2015, J INVEST MED, V63, P729, DOI 10.1097/JIM.0000000000000192
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chenge J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26628
   Chu FN, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8168717
   Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192
   Hasic Telalovic J, 2019, INT C MED BIOL ENG, P349
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Karlsson FH, 2014, SYSTEMS BIOL GUT MIC
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x
   L. WH, GUT MICROBIOME MAY A
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429
   Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808
   Morton JT, 2018, ROB KNIGHT MSYSTEMS, V3, pe00031
   Parashar A, 2017, PARKINSONISM RELAT D, V38, P1, DOI 10.1016/j.parkreldis.2017.02.002
   Plummer E., 2015, J PROTEOM BIOINFORM, V8, P283, DOI DOI 10.4172/JPB.1000381
   Prados A., GUT MICROBIOTA RES P
   Proctor L, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0620-y
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y
   Statnikov A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-11
   Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779
   Tremlett H, 2016, EUR J NEUROL, V23, P1308, DOI 10.1111/ene.13026
   Westfall S, 2017, CELL MOL LIFE SCI, V74, P3769, DOI 10.1007/s00018-017-2550-9
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
   Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089
   Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212
NR 35
TC 1
Z9 1
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6947
J9 BMC MED INFORM DECIS
JI BMC Med. Inform. Decis. Mak.
PD OCT 12
PY 2020
VL 20
IS 1
AR 262
DI 10.1186/s12911-020-01263-2
PG 11
WC Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Informatics
GA NZ0ZS
UT WOS:000576822300001
PM 33046051
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Dioletis, E
   Paiva, RS
   Kaffe, E
   Secor, ER
   Weiss, TR
   Fields, MR
   Ouyang, XS
   Ali, A
AF Dioletis, Evangelos
   Paiva, Ricardo S.
   Kaffe, Eleanna
   Secor, Eric R.
   Weiss, Theresa R.
   Fields, Maxine R.
   Ouyang, Xinshou
   Ali, Ather
TI The fermented soy beverage Q-CAN (R) plus induces beneficial changes in
   the oral and intestinal microbiome
SO BMC NUTRITION
LA English
DT Article
DE Soy; Gut microbiome; Oral microbiome; Commensals; Obesity
AB Background Soy products are associated with many beneficial health consequences, but their effects on the human intestinal microbiome are poorly characterized. Objectives To identify the changes in the oral and fecal microbiome in lean and obese participants due to consumption of Q-CAN (R), and to assess the expected consequences of these changes based on the published literature. Methods Prospective study of lean (10) and obese (9) participants consuming Q-CAN (R) twice daily for 4 weeks with 8 weeks follow-up. Microbial DNA was extracted from saliva and stool samples, amplified against the V4 region of the 16S ribosomal RNA gene and data analyzed using QIIME 1.9.1 bioinformatics. Four hundred forty-four samples were collected in total, 424 of which were productive and yielded good quality data. Results STOOL. In the lean population Bifidobacteria and Blautia show a significant increase while taking Q-CAN (R), and there was a trend for this in the obese population. ORAL. There were relatively fewer major changes in the oral microbiome with an increase in the family Veillonellaceae in the lean population while on Q-CAN (R). Conclusion Q-CAN (R) consumption induced a number of significant changes in the fecal and oral microbiome. Most notably an increase in the stool microbiome of Bifidobacteria and Blautia, both of which are associated with positive health benefits, and in the saliva an increase in Veillonellaceae.
C1 [Dioletis, Evangelos; Paiva, Ricardo S.; Kaffe, Eleanna; Ouyang, Xinshou] Yale Univ, Sch Med, Internal Med Digest Dis, One Gilbert St,TAC Bldg,Room S241, New Haven, CT 06519 USA.
   [Secor, Eric R.] Hartford Hosp, Hartford, CT USA.
   [Secor, Eric R.] Univ Connecticut, Hartford, CT 06112 USA.
   [Weiss, Theresa R.; Fields, Maxine R.; Ali, Ather] Yale Univ, Sch Med, Dept Pediat Gen Pediat, New Haven, CT USA.
C3 Yale University; University of Connecticut; Yale University
RP Ouyang, XS (corresponding author), Yale Univ, Sch Med, Internal Med Digest Dis, One Gilbert St,TAC Bldg,Room S241, New Haven, CT 06519 USA.
EM xinshou.ouyang@yale.edu
FU BESO Biological Research Inc.
FX This project was funded by BESO Biological Research Inc., who also
   provided Q-CAN (R). BESO Biological Research Inc., had no role in the
   conceptualization, design, execution of the study or in the data
   analysis and manuscript writing.
CR Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172
   Ambalam P, 2016, BEST PRACT RES CL GA, V30, P119, DOI 10.1016/j.bpg.2016.02.009
   Backhed F, 2010, BBA-MOL CELL BIOL L, V1801, P240, DOI 10.1016/j.bbalip.2009.09.009
   Binda C, 2018, DIGEST LIVER DIS, V50, P421, DOI 10.1016/j.dld.2018.02.012
   Boue S, 2016, OBESITY, V24, P87, DOI 10.1002/oby.21197
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Cheng IC, 2005, WORLD J GASTROENTERO, V11, P1225, DOI 10.3748/wjg.v11.i8.1225
   COUNOTTE GHM, 1981, APPL ENVIRON MICROB, V42, P649, DOI 10.1128/AEM.42.4.649-655.1981
   Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005
   Duca FA, 2013, J NUTR BIOCHEM, V24, P1663, DOI 10.1016/j.jnutbio.2013.05.005
   Fernandez-Raudales D, 2012, GUT MICROBES, V3, P490, DOI 10.4161/gmic.21578
   Fukuda S, 2012, GUT MICROBES, V3, P449, DOI [10.4161.gmic.21214, 10.4161/gmic.21214]
   Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330
   Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9
   Goodman B., 2019, US Patent Office, Patent No. 0240268
   Hardy H, 2013, NUTRIENTS, V5, P1869, DOI 10.3390/nu5061869
   Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x
   Inoguchi S, 2012, INT J FOOD SCI NUTR, V63, P402, DOI 10.3109/09637486.2011.630992
   Jayachandran M, 2019, FOOD CHEM, V271, P362, DOI 10.1016/j.foodchem.2018.07.158
   Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016
   Kim EK, 2011, NUTR RES, V31, P436, DOI 10.1016/j.nutres.2011.05.011
   Kim MS, 2018, BIOCHEM BIOPH RES CO, V495, P1744, DOI 10.1016/j.bbrc.2017.12.003
   Kolodziejczyk AA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809302
   Kwon DY, 2007, HORM METAB RES, V39, P752, DOI 10.1055/s-2007-990287
   Kwon DY, 2010, NUTR RES, V30, P1, DOI 10.1016/j.nutres.2009.11.004
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee Y, 2017, J MED FOOD, V20, P610, DOI 10.1089/jmf.2016.3911
   Loman BR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52893-0
   Lourenco JM, 2019, FRONT SUSTAIN FOOD S, V3, P1, DOI [10.3389/fsufs.2019.00001, DOI 10.3389/FSUFS.2019.00001]
   Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104
   McCarville JL, 2016, THER ADV GASTROENTER, V9, P580, DOI 10.1177/1756283X16637819
   Messina M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120754
   Miele L, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0671-z
   Nozue M, 2017, J NUTR, V147, P1749, DOI 10.3945/jn.117.250282
   Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2
   Ozato N, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0101-x
   Peters BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28126-1
   Piacentini G, 2010, J PEDIATR GASTR NUTR, V51, P71, DOI 10.1097/MPG.0b013e3181dc8b02
   Pinto-Sanchez MI, 2017, GASTROENTEROLOGY, V153, P448, DOI 10.1053/j.gastro.2017.05.003
   Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003
   Scarpellini E, 2012, DIGEST DIS, V30, P148, DOI 10.1159/000336664
   Scott KP, 2014, FEMS MICROBIOL ECOL, V87, P30, DOI 10.1111/1574-6941.12186
   Sears CL, 2018, ELIFE, V7, DOI 10.7554/eLife.28434
   Selinger CP, 2013, J HOSP INFECT, V84, P159, DOI 10.1016/j.jhin.2013.02.019
   Song JL, 2014, J MED FOOD, V17, P1027, DOI 10.1089/jmf.2013.3119
   Stanton TB, 2011, APPL ENVIRON MICROB, V77, P7158, DOI 10.1128/AEM.00647-11
   Sun M, 2015, MUCOSAL IMMUNOL, V8, P969, DOI 10.1038/mi.2015.49
   Takagi A, 2015, INT J MOL SCI, V16, P10907, DOI 10.3390/ijms160510907
   Vazquez L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070727
   Virgili E, 2018, J HLTH MED INF, V9, P1
   Younes H, 2001, BRIT J NUTR, V86, P479, DOI 10.1079/BJN2001430
   Yu LX, 2017, NAT REV GASTRO HEPAT, V14, P527, DOI 10.1038/nrgastro.2017.72
   Yusof HM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/274274
NR 53
TC 2
Z9 2
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2055-0928
J9 BMC NUTR
JI BMC Nutr.
PD MAR 4
PY 2021
VL 7
IS 1
AR 6
DI 10.1186/s40795-021-00408-4
PG 15
WC Nutrition & Dietetics
WE Emerging Sources Citation Index (ESCI)
SC Nutrition & Dietetics
GA QR3UH
UT WOS:000625137200001
PM 33658080
OA Green Submitted, Green Published, gold
DA 2023-09-14
ER

PT J
AU Naseri, M
   Palizban, F
   Yadegar, A
   Khodarahmi, M
   Aghdaei, HA
   Houri, H
   Zahiri, J
AF Naseri, Mohadeseh
   Palizban, Fahimeh
   Yadegar, Abbas
   Khodarahmi, Mohsen
   Aghdaei, Hamid Asadzadeh
   Houri, Hamidreza
   Zahiri, Javad
TI Investigation and characterization of human gut phageome in advanced
   liver cirrhosis of defined etiologies
SO GUT PATHOGENS
LA English
DT Article
DE Liver cirrhosis; Phageome; Metagenomics; Nonalcoholic fatty liver
   disease
ID READ ALIGNMENT; MICROBIOME; VIROME; TWINS
AB Background Liver cirrhosis is a major public health problem, accounting for high rates of morbidity and mortality worldwide. The cirrhosis etiology is a broad and essential step in planning a treatment strategy. Many recent studies have documented that gut microbiome alterations play a vital role in the development and progression of cirrhosis and its complications. Nevertheless, there is insufficient data on the correlation between liver cirrhosis and gut phageome alterations in patients with advanced liver diseases. This study aimed to analyze the taxonomic structure and functional attributes of the gut phageome in six different etiologies of advanced liver cirrhosis. Methods We first retrieved metagenomic sequencing data from three datasets of fecal samples taken from cirrhotic patients with various etiologies. Subsequently, several bioinformatics pipelines were used to analyze bacteriophage composition and determine their functionality. Results A gene catalog of 479,425 non-redundant genes was developed as a reference to measure gene prevalence. The results of the analysis revealed a few significant differences among the cohorts at the phage species level. However, the alternations were more evident as there were more in-depth analyses of the functional resolution of the gut phageome. Conclusions Our findings suggest that the functional analysis of the gut phageome would provide meaningful markers to predict the progression of liver cirrhosis and facilitate the development of novel treatment approaches.
C1 [Naseri, Mohadeseh; Khodarahmi, Mohsen] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Bioinformat & Computat Omics Lab BioCOOL, Tehran, Iran.
   [Palizban, Fahimeh] Univ Tehran, Inst Biochem & Biophys IBB, Lab Complex Biol Syst & Bioinformat CBB, Tehran, Iran.
   [Yadegar, Abbas; Houri, Hamidreza] Shahid Beheshti Univ Med Sci, Foodborne & Waterborne Dis Res Ctr, Res Inst Gastroenterol & Liver Dis, Shahid Arabi Ave,Yemen St, Tehran, Iran.
   [Khodarahmi, Mohsen] Med Imaging Ctr, Karaj, Alborz, Iran.
   [Aghdaei, Hamid Asadzadeh] Shahid Beheshti Univ Med Sci, Basic & Mol Epidemiol Gastrointestinal Disorders, Res Inst Gastroenterol & Liver Dis, Tehran, Iran.
   [Zahiri, Javad] Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.
C3 Tarbiat Modares University; University of Tehran; Shahid Beheshti
   University Medical Sciences; Shahid Beheshti University Medical
   Sciences; University of California System; University of California San
   Diego
RP Houri, H (corresponding author), Shahid Beheshti Univ Med Sci, Foodborne & Waterborne Dis Res Ctr, Res Inst Gastroenterol & Liver Dis, Shahid Arabi Ave,Yemen St, Tehran, Iran.; Zahiri, J (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM hr.houri@sbmu.ac.ir; jzahiri@health.ucsd.edu
OI Houri, Hamidreza/0000-0002-6813-0229; Naseri,
   Mohadeseh/0000-0001-6741-9605
CR Acharya C, 2019, CLIN GASTROENTEROL H, V17, P307, DOI 10.1016/j.cgh.2018.08.008
   Anand G, 2016, SEMIN LIVER DIS, V36, P37, DOI 10.1055/s-0035-1571276
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723
   d'Humieres C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47656-w
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x
   Duan Y, 2019, NATURE, V575, P505, DOI 10.1038/s41586-019-1742-x
   Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360
   Hoyles L, 2014, RES MICROBIOL, V165, P803, DOI 10.1016/j.resmic.2014.10.006
   Hsu BB, 2019, CELL HOST MICROBE, V25, P803, DOI 10.1016/j.chom.2019.05.001
   Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248
   Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006
   Knezevic P, 2015, VIROLOGY, V483, P64, DOI 10.1016/j.virol.2015.04.008
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lapidot Y, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00153-20
   Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581
   Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001
   Ma YF, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0410-y
   Manrique P, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060141
   Manrique P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/pnas.1601060113
   Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Mirzaei MK, 2017, NAT REV MICROBIOL, V15, P397, DOI 10.1038/nrmicro.2017.30
   Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011
   Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002
   Oikonomou T, 2018, WORLD J GASTROENTERO, V24, P3813, DOI 10.3748/wjg.v24.i34.3813
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977
   Perez-Brocal V, 2015, INFLAMM BOWEL DIS, V21, P2515, DOI 10.1097/MIB.0000000000000549
   Pinzani M, 2011, BEST PRACT RES CL GA, V25, P281, DOI 10.1016/j.bpg.2011.02.009
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Reyesa A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/pnas.1514285112
   Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sarin SK, 2016, NAT REV GASTRO HEPAT, V13, P131, DOI 10.1038/nrgastro.2015.219
   Sausset R, 2020, MUCOSAL IMMUNOL, V13, P205, DOI 10.1038/s41385-019-0250-5
   Shkoporov AN, 2019, CELL HOST MICROBE, V25, P195, DOI 10.1016/j.chom.2019.01.017
   Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320
   Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41
   Tetz G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29173-4
   Tithi SS, 2018, PEERJ, V6, DOI 10.7717/peerj.4227
   Tyakht AV, 2017, DATA BRIEF, V11, P98, DOI 10.1016/j.dib.2017.01.008
   Uchiyama T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126967
   Wickham H, 2011, WIRES COMPUT STAT, V3, P180, DOI 10.1002/wics.147
   Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006
   Zhao YZ, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00518
NR 53
TC 0
Z9 0
U1 1
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1757-4749
J9 GUT PATHOG
JI Gut Pathogens
PD FEB 15
PY 2022
VL 14
IS 1
AR 9
DI 10.1186/s13099-022-00482-4
PG 12
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA ZA0QQ
UT WOS:000755872800001
PM 35168645
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Bazant, W
   Blevins, AS
   Crouch, K
   Beiting, DP
AF Bazant, Wojtek
   Blevins, Ann S. S.
   Crouch, Kathryn
   Beiting, Daniel P. P.
TI Improved eukaryotic detection compatible with large-scale automated
   analysis of metagenomes
SO MICROBIOME
LA English
DT Article
DE Metagenome; Shotgun metagenomics; Microbial eukaryotes; Bioinformatics;
   Fungi; Mycobiome
ID GUT MICROBIOME; BIOLOGY
AB Background Eukaryotes such as fungi and protists frequently accompany bacteria and archaea in microbial communities. Unfortunately, their presence is difficult to study with "shotgun" metagenomic sequencing since prokaryotic signals dominate in most environments. Recent methods for eukaryotic detection use eukaryote-specific marker genes, but they do not incorporate strategies to handle the presence of eukaryotes that are not represented in the reference marker gene set, and they are not compatible with web-based tools for downstream analysis.Results Here, we present CORRAL (for Clustering Of Related Reference ALignments), a tool for the identification of eukaryotes in shotgun metagenomic data based on alignments to eukaryote-specific marker genes and Markov clustering. Using a combination of simulated datasets, mock community standards, and large publicly available human microbiome studies, we demonstrate that our method is not only sensitive and accurate but is also capable of inferring the presence of eukaryotes not included in the marker gene reference, such as novel strains. Finally, we deploy CORRAL on our MicrobiomeDB.org resource, producing an atlas of eukaryotes present in various environments of the human body and linking their presence to study covariates.Conclusions CORRAL allows eukaryotic detection to be automated and carried out at scale. Implementation of CORRAL in MicrobiomeDB.org creates a running atlas of microbial eukaryotes in metagenomic studies. Since our approach is independent of the reference used, it may be applicable to other contexts where shotgun metagenomic reads are matched against redundant but non-exhaustive databases, such as the identification of bacterial virulence genes or taxonomic classification of viral reads.
C1 [Bazant, Wojtek; Crouch, Kathryn] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Scotland.
   [Blevins, Ann S. S.; Beiting, Daniel P. P.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.
C3 University of Glasgow; University of Pennsylvania
RP Crouch, K (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Scotland.; Beiting, DP (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.
EM kathryn.crouch@glasgow.ac.uk; beiting@upenn.edu
RI Crouch, Kathryn/HDO-6240-2022
OI Crouch, Kathryn/0000-0001-9310-4762
FU Bill and Melinda Gates Foundation; Astarte Medical
FX This work was partially supported by a grant from the Bill and Melinda
   Gates Foundation (D.P.B. and A.S.B.) and Astarte Medical (D.P.B. and
   W.B.). The funders had no role in the data collection and analysis,
   decision to publish, or preparation of this manuscript.
CR Alcock BP, 2020, NUCLEIC ACIDS RES, V48, pD517, DOI 10.1093/nar/gkz935
   Beghini F, 2021, ELIFE, V10, DOI 10.7554/eLife.65088
   Beghini F, 2017, ISME J, V11, P2848, DOI 10.1038/ismej.2017.139
   Breitwieser FP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1568-0
   Chang Winston, 2021, CRAN
   Doan T, 2019, NAT MED, V25, P1370, DOI 10.1038/s41591-019-0533-0
   Doron I, 2021, NAT MICROBIOL, V6, P1493, DOI 10.1038/s41564-021-00983-z
   Doron I, 2021, CELL, V184, P1017, DOI 10.1016/j.cell.2021.01.016
   Gasparrini AJ, 2019, NAT MICROBIOL, V4, P2285, DOI 10.1038/s41564-019-0550-2
   Geneva: World Health Organization, 2022, WHO FUNG PRIOR PATH
   Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]
   github, IH3 WGSIM READS SIMU
   Goodacre N, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00069-18
   Hayden HS, 2020, NAT MED, V26, P215, DOI 10.1038/s41591-019-0714-x
   Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013
   Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001
   Kriventseva EV, 2019, NUCLEIC ACIDS RES, V47, pD807, DOI 10.1093/nar/gky1053
   Laforest-Lapointe I, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00201-17
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310
   Leonardi I, 2022, CELL, V185, P831, DOI 10.1016/j.cell.2022.01.017
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lind AL, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01015-y
   Liu B, 2022, NUCLEIC ACIDS RES, V50, pD912, DOI 10.1093/nar/gkab1107
   Marcelino VR, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6592-2
   Meyer F, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1646-y
   Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127
   Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4
   Oliveira FS, 2018, NUCLEIC ACIDS RES, V46, pD684, DOI 10.1093/nar/gkx1027
   Olm MR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax5727
   Olm MR, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0638-1
   Ost KS, 2021, NATURE, V596, P114, DOI 10.1038/s41586-021-03722-w
   Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109
   Silberman JD, 1996, NATURE, V380, P398, DOI 10.1038/380398a0
   Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642
   Tee MZ, 2022, MICROBIOME, V10, DOI 10.1186/s40168-022-01385-x
   Thankaswamy-Kosalai S, 2017, GENOMICS, V109, P186, DOI 10.1016/j.ygeno.2017.03.001
   Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007
   Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002
   Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032
   Yang FM, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa071
NR 41
TC 0
Z9 0
U1 9
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PD APR 10
PY 2023
VL 11
IS 1
AR 72
DI 10.1186/s40168-023-01505-1
PG 18
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA D2UM7
UT WOS:000967324800002
PM 37032329
OA gold, Green Accepted, Green Published, Green Submitted
DA 2023-09-14
ER

PT J
AU Rodrigues, VCD
   Duque, ALRF
   Fino, LD
   Simabuco, FM
   Sartoratto, A
   Cabral, L
   Noronha, MF
   Sivieri, K
   Antunes, AEC
AF Rodrigues, Vivian Cristina da Cruz
   Duque, Ana Luiza Rocha Faria
   Fino, Luciana de Carvalho
   Simabuco, Fernando Moreira
   Sartoratto, Adilson
   Cabral, Lucelia
   Noronha, Melline Fontes
   Sivieri, Katia
   Antunes, Adriane Elisabete Costa
TI Modulation of the intestinal microbiota and the metabolites produced by
   the administration of ice cream and a dietary supplement containing the
   same probiotics
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE SHIME (R); Lactobacillus acidophilus; Bifidobacterium animalis; Fatty
   acids; Ammonia
ID CHAIN FATTY-ACIDS; HUMAN GUT MICROBIOME; FAECALIBACTERIUM-PRAUSNITZII;
   FECAL MICROBIOTA; FERMENTATION PROFILE; IN-VITRO; SIMULATOR; ECOSYSTEM;
   QUANTIFICATION; SEQUENCES
AB The aim of the present work was to compare the capacity to modulate the intestinal microbiota and the production of metabolites after 14 d administration of a commercial dietary supplement and a manufactured ice cream, both containing the same quantity of inulin and the same viable counts of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis BB-12, using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME (R)) model. Samples of the colonic contents were evaluated microbiologically by real-time quantitative PCR (qRT-PCR) and next-generation sequencing and chemically by the production of SCFA (acetate, propionate and butyrate) and ammonium ions (NHthorn 4). Statistical analyses were carried out for all the variables using the two-way ANOVA followed by the Tukey multiple comparisons test (P < 0.05) for metabolite production, qRT-PCR and the bioinformatics analysis for microbiota diversity. Dietary supplement and ice cream were able to deliver the probiotic L. acidophilus and B. animalis to the simulated colon and modulate the microbiota, increasing beneficial micro-organisms such as Bifidobacterium spp., Bacteroides spp. and Faecalibacterium spp. for dietary supplement administration, and Lactobacillus spp. for ice cream supplementation. However, the ice cream matrix was probably more favourable for the maintenance of the metabolic activity of the probiotics in the SHIME (R) model, due to the larger amounts of acetate, propionate, butyrate and ammonium ions obtained after 14 d of supplementation. In conclusion, both ways of probiotic supplementation could be efficient, each with its own particularities.
C1 [Rodrigues, Vivian Cristina da Cruz; Fino, Luciana de Carvalho; Simabuco, Fernando Moreira; Antunes, Adriane Elisabete Costa] Univ Estadual Campinas, Sch Appl Sci FCA, BR-13484350 Limeira, SP, Brazil.
   [Duque, Ana Luiza Rocha Faria; Sivieri, Katia] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Food & Nutr, BR-14800903 Araraquara, SP, Brazil.
   [Sartoratto, Adilson] Univ Estadual Campinas, Pluridisciplinary Ctr Chem Biol & Agr Res CPQBA, Div Organ & Pharmaceut Chem, BR-13148218 Paulinia, SP, Brazil.
   [Cabral, Lucelia] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biorenewables Natl Lab LNBR, BR-13083970 Campinas, SP, Brazil.
   [Noronha, Melline Fontes] Univ Illinois, Res Resource Ctr, Res Informat Core, Genome Res Div, Chicago, IL USA.
C3 Universidade Estadual de Campinas; Universidade Estadual Paulista;
   Universidade Estadual de Campinas; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital
RP Antunes, AEC (corresponding author), Univ Estadual Campinas, Sch Appl Sci FCA, BR-13484350 Limeira, SP, Brazil.
EM adriane.antunes@fca.unicamp.br
RI Simabuco, Fernando M/GQA-4176-2022; Simabuco, Fernando M/G-8421-2017;
   Cabral, Lucélia/G-1253-2019; Sivieri, Katia/I-2626-2017
OI Simabuco, Fernando M/0000-0002-1672-9686; Simabuco, Fernando
   M/0000-0002-1672-9686; Sivieri, Katia/0000-0001-8632-1478; Rodrigues,
   Vivian/0000-0001-9622-652X; Cabral, Lucelia/0000-0003-1743-6364; Fontes
   Noronha, Melline/0000-0003-0914-4679
FU Sao Paulo Research Foundation (FAPESP) [2017/25007-9]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001];
   Fundo de Apoio ao Ensino, a Pesquisa e ExtensAo (FAEPEX) [519.292]
FX This work was supported by the Sao Paulo Research Foundation (FAPESP) -
   Project number 2017/25007-9; the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001; and the
   Fundo de Apoio ao Ensino, a Pesquisa e ExtensAo (FAEPEX) - Number
   519.292. None of the funders had a role in the design, analysis or
   writing of this article.
CR Agencia Nacional de Vigilancia Sanitaria (ANVISA) (Brazilian Health Regulatory Agency), 2000, REG TECN FIX ID QUAL
   Allsopp P, 2013, ANAEROBE, V22, P38, DOI 10.1016/j.anaerobe.2013.05.006
   Andriamihaja M, 2010, AM J PHYSIOL-GASTR L, V299, pG1030, DOI 10.1152/ajpgi.00149.2010
   [Anonymous], 2009, DIG LIVER DIS SUPPLE
   [Anonymous], [No title captured]
   [Anonymous], 2012, OFFICIAL METHODS ANA
   Association of Official Analytical Chemists (AOAC), 1996, J AOAC INT, V71, P898
   Aura A. M., 2015, IMPACT FOOD BIOACTIV, P281
   Barroso E., 2015, IMPACT FOOD BIOACTIV, P319, DOI DOI 10.1007/978-3-319-16104-4_28
   Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849
   Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10
   Bianchi F, 2014, FOOD RES INT, V64, P43, DOI 10.1016/j.foodres.2014.05.072
   Blouin JM, 2011, INT J CANCER, V128, P2591, DOI 10.1002/ijc.25599
   Bottcher MF, 2000, CLIN EXP ALLERGY, V30, P1590, DOI 10.1046/j.1365-2222.2000.00982.x
   Breban M, 2016, JOINT BONE SPINE, V83, P645, DOI 10.1016/j.jbspin.2016.04.005
   Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690
   Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Chaikham P, 2017, FOOD BIOSCI, V17, P35, DOI 10.1016/j.fbio.2016.12.005
   Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x
   Christoff AP, 2017, BACTERIAL IDENTIFICA
   Cruz AG, 2009, FOOD RES INT, V42, P1233, DOI 10.1016/j.foodres.2009.03.020
   Rodrigues VCD, 2019, J FUNCT FOODS, V55, P126, DOI 10.1016/j.jff.2019.01.046
   Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Dinan TG, 2013, BIOL PSYCHIAT, V74, P720, DOI 10.1016/j.biopsych.2013.05.001
   Dominika S, 2011, INT J FOOD MICROBIOL, V145, P267, DOI 10.1016/j.ijfoodmicro.2011.01.002
   Dore J, 2013, UNITED EUR GASTROENT, V1, P311, DOI 10.1177/2050640613502477
   Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI 10.1099/00207713-52-6-2141
   Duysburgh C, 2019, INT J PHARM-X, V1, DOI 10.1016/j.ijpx.2019.100021
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Nader-Macias MEF, 2015, ADV DRUG DELIVER REV, V92, P84, DOI 10.1016/j.addr.2015.03.016
   Feng WW, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01354
   Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073
   Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378
   Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7
   GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97
   Hamer HM, 2012, AM J PHYSIOL-GASTR L, V302, pG1, DOI 10.1152/ajpgi.00048.2011
   Hemaiswarya S, 2013, BRAZ ARCH BIOL TECHN, V56, P113, DOI 10.1590/S1516-89132013000100015
   Herbel SR, 2013, J APPL MICROBIOL, V115, P1402, DOI 10.1111/jam.12341
   Hijova E, 2007, BRATISL MED J, V108, P354
   Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66
   Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024
   Hu GX, 2010, MED HYPOTHESES, V74, P123, DOI 10.1016/j.mehy.2009.07.022
   Huda-Faujan N, 2010, Open Biochem J, V4, P53, DOI 10.2174/1874091X01004010053
   Instituto Adolfo Lutz (IAL), 2008, METH FIS QUIM AN AL
   Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016
   Junick J, 2012, APPL ENVIRON MICROB, V78, P2613, DOI 10.1128/AEM.07749-11
   Khosravi A, 2013, CURR OPIN MICROBIOL, V16, P221, DOI 10.1016/j.mib.2013.03.009
   KOTARSKI SF, 1979, INFECT IMMUN, V26, P966, DOI 10.1128/IAI.26.3.966-975.1979
   Lee MY, 2016, ANAEROBE, V38, P36, DOI 10.1016/j.anaerobe.2015.11.006
   Lopez-Siles M, 2017, ISME J, V11, P841, DOI 10.1038/ismej.2016.176
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane
   Macfarlane GT, 1994, HUMAN HLTH CONTRIBUT, P17, DOI DOI 10.1007/978-1-4471-3443-5_2
   Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207
   Magarinos H, 2007, INT J DAIRY TECHNOL, V60, P128, DOI 10.1111/j.1471-0307.2007.00307.x
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Martin R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0400-1
   Marzorati M, 2015, J FUNCT FOODS, V16, P211, DOI 10.1016/j.jff.2015.04.039
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   MCNEIL NI, 1978, GUT, V19, P819, DOI 10.1136/gut.19.9.819
   Moens F, 2019, INT J PHARMACEUT, V555, P1, DOI 10.1016/j.ijpharm.2018.11.020
   MOLLY K, 1994, MICROB ECOL HEALTH D, V7, P191, DOI 10.3109/08910609409141354
   Natividad JMM, 2013, PHARMACOL RES, V69, P42, DOI 10.1016/j.phrs.2012.10.007
   O'Flaherty S, 2010, GUT MICROBES, V1, P293, DOI 10.4161/gmic.1.5.12924
   O'Toole PW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.57
   Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277
   Pittayanon R, 2019, GASTROENTEROLOGY, V157, P97, DOI 10.1053/j.gastro.2019.03.049
   Possemiers S, 2004, FEMS MICROBIOL ECOL, V49, P495, DOI 10.1016/j.femsec.2004.05.002
   Possemiers S, 2010, INT J FOOD MICROBIOL, V141, P97, DOI 10.1016/j.ijfoodmicro.2010.03.008
   Possemiers S, 2006, J NUTR, V136, P1862, DOI 10.1093/jn/136.7.1862
   Ranadheera RDCS, 2010, FOOD RES INT, V43, P1, DOI 10.1016/j.foodres.2009.09.009
   Rettedal EA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00458
   Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014
   Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Duque ALRF, 2016, FOOD RES INT, V84, P160, DOI 10.1016/j.foodres.2016.03.028
   Rochet V, 2008, J MOL MICROB BIOTECH, V14, P128, DOI 10.1159/000106092
   Saad N, 2013, LWT-FOOD SCI TECHNOL, V50, P1, DOI 10.1016/j.lwt.2012.05.014
   Saarela MH, 2019, CURR OPIN FOOD SCI, V30, P8, DOI 10.1016/j.cofs.2018.09.001
   Sanders ME, 2010, ANNU REV FOOD SCI T, V1, P65, DOI 10.1146/annurev.food.080708.100743
   Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044
   Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020
   Sharma BC, 2009, GASTROENTEROLOGY, V137, P885, DOI 10.1053/j.gastro.2009.05.056
   Slykerman RF, 2017, EBIOMEDICINE, V24, P159, DOI 10.1016/j.ebiom.2017.09.013
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Takada M, 2016, NEUROGASTROENT MOTIL, V28, P1027, DOI 10.1111/nmo.12804
   Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049
   Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x
   Terpend K, 2013, ENV MICROBIOL REP, V5, P595, DOI 10.1111/1758-2229.12056
   Tito RY, 2017, ARTHRITIS RHEUMATOL, V69, P114, DOI 10.1002/art.39802
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   Unno T, 2015, J DAIRY SCI, V98, P3568, DOI 10.3168/jds.2014-8943
   Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x
   van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x
   Van de Wiele T, 2004, FEMS MICROBIOL ECOL, V51, P143, DOI 10.1016/j.femsec.2004.07.014
   Van de Wiele T., 2015, IMPACT FOOD BIOACTIV, P305, DOI 10.1007/978-3-319-16104-4
   Venema K., 2015, IMPACT FOOD BIOACTIV, P293, DOI [10.1007/978-3-319-16104-4_26, DOI 10.1007/978-3-319-16104-4_26]
   Verbeke KA, 2015, NUTR RES REV, V28, P42, DOI 10.1017/S0954422415000037
   Verhoeckx K, 2015, IMPACT FOOD BIOACTIV, P275
   Wang MM, 2019, TRENDS FOOD SCI TECH, V88, P1, DOI 10.1016/j.tifs.2019.03.005
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Watanabe A, 1997, HEPATOLOGY, V26, P1410
   Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542
   Yang JY, 2013, ANAEROBE, V23, P74, DOI 10.1016/j.anaerobe.2013.06.012
   Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108
   Zhang MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109146
   Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108
   Zhuang ZQ, 2018, J ALZHEIMERS DIS, V63, P1337, DOI 10.3233/JAD-180176
NR 115
TC 17
Z9 17
U1 1
U2 26
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUL 14
PY 2020
VL 124
IS 1
BP 57
EP 68
DI 10.1017/S0007114520000896
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA LX4JG
UT WOS:000539798300006
PM 32138793
OA Bronze
DA 2023-09-14
ER

PT J
AU Chen, DQ
   Huang, TY
   Wang, Q
   Bai, CY
   Yang, L
AF Chen, Ding-Qiang
   Huang, Tengyi
   Wang, Qun
   Bai, Caiying
   Yang, Ling
TI Analysis on the virulomes and resistomes of multi-drug resistance
   clinical Escherichia coli isolates, as well as the interactome with gut
   microbiome
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Escherichia coli; Multi-drug resistance; Genome; Virulence
ID ISOTHERMAL AMPLIFICATION METHOD; STAPHYLOCOCCUS-AUREUS; RAPID DETECTION;
   SOUTHERN CHINA; VIBRIO-PARAHAEMOLYTICUS; ANTIBIOTIC-RESISTANCE;
   BACTERICIDAL ACTIVITY; SPOILAGE CAPABILITY; PATHOGENIC FEATURES; E. COLI
AB Escherichia coli is one of the most diverse microbial species. Pathogenic E. coli is capable of causing various diseases in humans, including several types of diarrhea, urinary tract infections, sepsis, and meningitis. This study focused on the antibiotic susceptibility profile and genomic analysis of a clinical E. coli Guangzhou-Eco330 isolated from a hospitalized 8-year-old female patient suffered from pulmonary infection in 2017. Susceptibility to 15 antibiotics were determined using Vitek2 (TM) Automated Susceptibility System and Etest strips and interpreted based on CLSI guidelines. The genome was sequenced using Illumina Hiseq 2500 platform and assembled de novo using Velvet, followed by bioinformatics analysis. The genome has a length of 5,132,642 bp and contains 4989 predicted genes with an average GC content of 50.51%. The carriage of rfbE gene suggested the strain belonging to O157. In the genome, 70 non-coding RNAs, 50 repeat sequences, 18 transposons, 78 GIs, 9 CRISPRs, and 3 large prophages were identified. 37 PHI related genes and 108 virulence genes were determined to contribute to its pathogenicity. Specifically, the acquisition of multiple antibiotic resistance genes including bla(CTX-M-55), bla(OXA-10), bla(CMY-48), tetB, and qnrS1 contributed to its resistance to penicillins, telracyclines, cephalosporin, and quinolones. The understanding of the genome may aid in further study on the clinical control of multi-drug resistance E. coli.
C1 [Chen, Ding-Qiang] Southern Med Univ, Zhujiang Hosp, Dept Lab Med, Guangzhou, Guangdong, Peoples R China.
   [Huang, Tengyi] Shantou Univ, Med Coll, Affiliated Hosp 2, Dept Lab Med, Shantou, Guangdong, Peoples R China.
   [Wang, Qun; Yang, Ling] Guangzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China.
   [Bai, Caiying] Guangdong Women & Children Hosp, Guangzhou 510010, Peoples R China.
C3 Southern Medical University - China; Shantou University; Guangzhou
   Medical University
RP Yang, L (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China.
EM jyksys@126.com; h-hty@hotmail.com; 1196248216@qq.com; 592971535@qq.com;
   jykresearch@126.com
RI Liu, Jun/K-4045-2015
OI Liu, Jun/0000-0002-7078-8046
FU Natural Science Foundation of China [81974318]; Natural Science
   Foundation of Guangdong Province [2018A030310170, 2018A030313279];
   Guangdong Province Science and Technology Innovation Strategy Special
   Fund [2019B020209001]; Guangdong Bureau of Traditional Chinese Medicine
   [20191206]
FX This work is supported by the research grants from the Natural Science
   Foundation of China (No. 81974318), Natural Science Foundation of
   Guangdong Province (Nos. 2018A030310170 and 2018A030313279), Guangdong
   Province Science and Technology Innovation Strategy Special Fund (No.
   2019B020209001), and the Guangdong Bureau of Traditional Chinese
   Medicine (No. 20191206).
CR An HY, 1999, ADV EXP MED BIOL, V473, P179
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baldwin TK, 2006, MOL PLANT MICROBE IN, V19, P1451, DOI 10.1094/MPMI-19-1451
   Bao XR, 2017, MICROB PATHOGENESIS, V110, P359, DOI 10.1016/j.micpath.2017.07.022
   Bao XR, 2017, MICROB PATHOGENESIS, V109, P280, DOI 10.1016/j.micpath.2017.05.030
   Bao XR, 2017, MICROB PATHOGENESIS, V106, P16, DOI 10.1016/j.micpath.2016.12.012
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   COHEN SP, 1989, ANTIMICROB AGENTS CH, V33, P1318, DOI 10.1128/AAC.33.8.1318
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009
   Deng Y, 2015, INT J FOOD MICROBIOL, V206, P96, DOI 10.1016/j.ijfoodmicro.2015.04.046
   Gao QQ, 2015, INFECT GENET EVOL, V30, P267, DOI 10.1016/j.meegid.2014.12.038
   HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x
   Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x
   Jepson MA, 2003, CELL MICROBIOL, V5, P773, DOI 10.1046/j.1462-5822.2003.00315.x
   Jia XY, 2018, MICROB PATHOGENESIS, V121, P232, DOI 10.1016/j.micpath.2018.05.033
   Kalvari Ioanna, 2018, Curr Protoc Bioinformatics, V62, pe51, DOI 10.1002/cpbi.51
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Karami N, 2017, EUR J CLIN MICROBIOL, V36, P721, DOI 10.1007/s10096-016-2854-y
   Kazuya U, J BIOCH, P173
   Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160
   Lin SQ, 2016, BASIC CLIN PHARMACOL, V118, P33
   Lin SQ, 2017, MICROB PATHOGENESIS, V111, P285, DOI 10.1016/j.micpath.2017.08.005
   Liu JY, 2016, BASIC CLIN PHARMACOL, V118, P34
   Liu JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21380
   Liu JY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02076
   Liu JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28949-y
   Liu JY, 2018, MICROB PATHOGENESIS, V119, P216, DOI 10.1016/j.micpath.2018.04.025
   Liu JY, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.506
   Liu JY, 2017, MICROB PATHOGENESIS, V111, P497, DOI 10.1016/j.micpath.2017.09.017
   Liu JY, 2017, MICROB PATHOGENESIS, V110, P257, DOI 10.1016/j.micpath.2017.06.044
   Liu JY, 2017, MICROB PATHOGENESIS, V107, P219, DOI 10.1016/j.micpath.2017.03.043
   Liu JY, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw201
   Liu LY, 2018, MICROB PATHOGENESIS, V115, P154, DOI 10.1016/j.micpath.2017.12.062
   Liu LY, 2018, MICROB PATHOGENESIS, V117, P73, DOI 10.1016/j.micpath.2018.02.007
   Liu YT, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0335-4
   Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955
   Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003
   Miao J, 2016, BASIC CLIN PHARMACOL, V118, P33
   Miao J, 2018, MICROB PATHOGENESIS, V125, P246, DOI 10.1016/j.micpath.2018.09.031
   Miao Jian, 2019, SCI REP, V9, P1313
   Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104
   Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41
   Tokano DV, 2008, BRAZ ARCH BIOL TECHN, V51, P473, DOI 10.1590/S1516-89132008000300006
   Wang L, 2011, AFR J MICROBIOL RES, V5, P5765, DOI 10.5897/AJMR11.1237
   Wang L, 2012, MOL BIOL REP, V39, P445, DOI 10.1007/s11033-011-0757-7
   Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483
   Xie JH, 2017, MICROB PATHOGENESIS, V107, P206, DOI 10.1016/j.micpath.2017.03.038
   Xu Z, 2007, CLIN MICROBIOL INFEC, V13, P980, DOI 10.1111/j.1469-0691.2007.01782.x
   Xu Z, 2011, CLIN MICROBIOL INFEC, V17, P714, DOI 10.1111/j.1469-0691.2010.03379.x
   Xu ZB, 2016, BASIC CLIN PHARMACOL, V118, P33
   Xu ZB, 2008, CURR MICROBIOL, V57, P264, DOI 10.1007/s00284-008-9187-8
   Xu ZB, 2008, FEMS MICROBIOL LETT, V278, P223, DOI 10.1111/j.1574-6968.2007.00994.x
   Xu ZB, 2017, MICROB PATHOGENESIS, V103, P80, DOI 10.1016/j.micpath.2016.11.013
   Xu ZB, 2012, AFR J MICROBIOL RES, V6, P6295, DOI 10.5897/AJMR12.1075
   Xu ZB, 2012, FOOD RES INT, V47, P166, DOI 10.1016/j.foodres.2011.04.042
   Xu ZB, 2011, AFR J MICROBIOL RES, V5, P1869
   Xu ZB, 2011, MOL BIOL REP, V38, P5261, DOI 10.1007/s11033-011-0676-7
   Xu ZB, 2010, DIAGN MICR INFEC DIS, V68, P315, DOI 10.1016/j.diagmicrobio.2010.05.014
   Xu ZB, 2009, J CLIN MICROBIOL, V47, P230, DOI 10.1128/JCM.02027-08
   You R, 2012, AFR J MICROBIOL RES, V6, P7131, DOI DOI 10.5897/AJMR12.708
   Yu GC, 2016, MICROB PATHOGENESIS, V95, P62, DOI 10.1016/j.micpath.2016.02.021
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zhao XH, 2011, WORLD J MICROB BIOT, V27, P181, DOI 10.1007/s11274-010-0429-0
   Zhao XH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01591
   Zhao XH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01236
   Zhao XH, 2010, FOOD SCI BIOTECHNOL, V19, P1655, DOI 10.1007/s10068-010-0234-4
   Zhao XH, 2010, FOOD SCI BIOTECHNOL, V19, P1191, DOI 10.1007/s10068-010-0170-3
   Zhao XH, 2010, MOL BIOL REP, V37, P2183, DOI 10.1007/s11033-009-9700-6
   Zhong NJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-65
   Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485
NR 73
TC 2
Z9 2
U1 2
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
EI 1096-1208
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD NOV
PY 2020
VL 148
AR 104423
DI 10.1016/j.micpath.2020.104423
PG 7
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA OV9FN
UT WOS:000592506700004
PM 32768515
DA 2023-09-14
ER

PT J
AU Fan, HN
   Zhu, P
   Lu, YM
   Guo, JH
   Zhang, J
   Qu, GQ
   Zhu, JS
AF Fan, Hui-Ning
   Zhu, Pei
   Lu, Yun-Min
   Guo, Jing-Hui
   Zhang, Jing
   Qu, Guo-Qiang
   Zhu, Jin-Shui
TI Mild changes in the mucosal microbiome during terminal ileum
   inflammation
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Microbiota; Terminal ileum; Inflammation; Biopsies
ID HUMAN GUT MICROBIOME; MULTIVARIATE ANALYSES; GASTROINTESTINAL
   MICROBIOTA; COMMENSAL; COLONIZATION; PATHOGENESIS; DIVERSITY; LOCATION;
   GENETICS; BACTERIA
AB Patients with inflammation in the terminal ileum have high morbidity. In genetically susceptible hosts, chronic intestinal inflammation targeting the resident intestinal microbiota develops, but the microbial signature of the terminal ileum is poorly studied. To improve understanding of the mechanisms underlying the high prevalence of terminal ileum inflammation, we used 16S rRNA sequencing to analyse the mucosa-associated microbiota of the terminal ileum under intestinal homeostasis and inflammation conditions. Mucosal biopsy is the most commonly used sampling technique for assessing microbial communities associated with the intestinal mucosa. Thirty patients (15 with terminal ileum inflammation and 15 controls) underwent colonoscopy and biopsies were taken from the terminal ileum. Diagnosis depended on a combination of endoscopic and histological factors. To determine the composition and diversity of the microbiota, the 16S rRNA was analysed, and a variety of bioinformatics analyses were performed. Among the patients, composition analysis showed that the most abundant phyla identified in the terminal ileum samples were Fusobacteria, Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria. At the phylum level, the relative proportion of Bacteroidetes was lower in patients with inflammation than in control patients. In addition, there was an increase in the abundance of the phyla Proteobacteria and Lentisphaerae in patients with inflammation. The abundances of the dominant microbes in the terminal ileum were not significantly different between patients in an inflammatory state and controls. These results confirm that partial dysbiosis of the intestinal mucosa-associated microbiota composition is associated with terminal ileum inflammation.
C1 [Fan, Hui-Ning; Zhu, Pei; Lu, Yun-Min; Guo, Jing-Hui; Zhang, Jing; Zhu, Jin-Shui] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gastroenterol, 600 Yishan Rd, Shanghai 200233, Peoples R China.
   [Qu, Guo-Qiang] Shanghai Univ Med & Hlth Sci, Dept Gastroenterol, Affiliated Peoples Hosp 6, East Campus, Shanghai 201306, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai University of Medicine & Health
   Sciences
RP Zhang, J; Zhu, JS (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Gastroenterol, 600 Yishan Rd, Shanghai 200233, Peoples R China.; Qu, GQ (corresponding author), Shanghai Univ Med & Hlth Sci, Dept Gastroenterol, Affiliated Peoples Hosp 6, East Campus, Shanghai 201306, Peoples R China.
EM zhujs1803@163.com
FU Shanghai Sixth People's Hospital [ynlc201729]; Shanghai University of
   Medicine & Health Sciences Seed Foundation [SFP-18-22-14-006]; Shanghai
   University of Medicine and Health Sciences [2017019]
FX We thank all the patients for their participation in this study. We also
   appreciate the contributions of the nurses and staff of the Department
   of Gastroenterology. We truly appreciate the staff at the Shanghai
   Personal Biotechnology Company. This research was supported by the
   Shanghai Sixth People's Hospital (ynlc201729), Shanghai University of
   Medicine & Health Sciences Seed Foundation (SFP-18-22-14-006) and
   Shanghai University of Medicine and Health Sciences Affiliated Sixth
   People's Hospital East Campus (Academy Discipline 2017019).
CR Alkadhi S, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-25
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anderson JR, 2017, SLEEP MED, V38, P104, DOI 10.1016/j.sleep.2017.07.018
   Armstrong H, 2019, MICROBIOME, V7, DOI 10.1186/s40168-018-0604-3
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012
   Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604
   Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7
   Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324
   Butto LF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00555
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chen H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00508
   Chen LP, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000051
   CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x
   Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Franks Isobel, 2013, Nat Rev Gastroenterol Hepatol, V10, P3, DOI 10.1038/nrgastro.2012.227
   Freitas M, 2003, BIOL CELL, V95, P503, DOI 10.1016/j.biolcel.2003.08.004
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001
   Hemmings SMJ, 2017, PSYCHOSOM MED, V79, P936, DOI 10.1097/PSY.0000000000000512
   Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888
   Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881
   Hopkins MJ, 2003, APPL ENVIRON MICROB, V69, P1920, DOI 10.1128/AEM.69.4.1920-1927.2003
   Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448
   Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x
   Li GP, 2015, J MICROBIOL BIOTECHN, V25, P1136, DOI 10.4014/jmb.1412.12047
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x
   Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x
   Raoult D, 2014, EUR J EPIDEMIOL, V29, P307, DOI 10.1007/s10654-014-9905-4
   Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118
   Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095
   Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63
   Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   Wang ZK, 2013, WORLD J GASTROENTERO, V19, P1541, DOI 10.3748/wjg.v19.i10.1541
   Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x
   Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07
   White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352
   Yasuda K, 2015, CELL HOST MICROBE, V17, P385, DOI 10.1016/j.chom.2015.01.015
   Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259
   Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185
NR 54
TC 8
Z9 8
U1 3
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
EI 1096-1208
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD MAY
PY 2020
VL 142
AR 104104
DI 10.1016/j.micpath.2020.104104
PG 8
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA LK1WV
UT WOS:000530650200044
PM 32120004
DA 2023-09-14
ER

PT J
AU Song, WZ
   Wemheuer, B
   Zhang, S
   Steensen, K
   Thomas, T
AF Song, Weizhi
   Wemheuer, Bernd
   Zhang, Shan
   Steensen, Kerrin
   Thomas, Torsten
TI MetaCHIP: community-level horizontal gene transfer identification
   through the combination of best-match and phylogenetic approaches
SO MICROBIOME
LA English
DT Article
DE Metagenomics; Horizontal gene transfer; HGT identification;
   Bioinformatics
ID VISUALIZATION; METABOLISM; ALGORITHMS; SEQUENCES; GENOMES
AB BackgroundMetagenomic datasets provide an opportunity to study horizontal gene transfer (HGT) on the level of a microbial community. However, current HGT detection methods cannot be applied to community-level datasets or require reference genomes. Here, we present MetaCHIP, a pipeline for reference-independent HGT identification at the community level.ResultsAssessment of MetaCHIP's performance on simulated datasets revealed that it can predict HGTs with various degrees of genetic divergence from metagenomic datasets. The results also indicated that the detection of very recent gene transfers (i.e. those with low levels of genetic divergence) from metagenomics datasets is largely affected by the read assembly step. Comparison of MetaCHIP with a previous analysis on soil bacteria showed a high level of consistency for the prediction of recent HGTs and revealed a large number of additional non-recent gene transfers, which can provide new biological and ecological insight. Assessment of MetaCHIP's performance on real metagenomic datasets confirmed the role of HGT in the spread of genes related to antibiotic resistance in the human gut microbiome. Further testing also showed that functions related to energy production and conversion as well as carbohydrate transport and metabolism are frequently transferred among free-living microorganisms.ConclusionMetaCHIP provides an opportunity to study HGTs among members of a microbial community and therefore has several applications in the field of microbial ecology and evolution. MetaCHIP is implemented in Python and freely available at https://github.com/songweizhi/MetaCHIP.
C1 [Song, Weizhi; Wemheuer, Bernd; Zhang, Shan; Steensen, Kerrin; Thomas, Torsten] Univ New South Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia.
   [Song, Weizhi; Zhang, Shan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Wemheuer, Bernd; Thomas, Torsten] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia.
   [Steensen, Kerrin] Georg August Univ Gottingen, Dept Genom & Appl Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.
C3 University of New South Wales Sydney; University of New South Wales
   Sydney; University of New South Wales Sydney; University of Gottingen
RP Thomas, T (corresponding author), Univ New South Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia.; Thomas, T (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia.
EM t.thomas@unsw.edu.au
OI Song, Weizhi/0000-0001-5890-5361
FU Australian Research Council - China Scholarship Council
FX This research is funded by the Australian Research Council. Weizhi Song
   and Shan Zhang are funded by the China Scholarship Council.
CR Adato O, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004408
   Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   [Anonymous], SOL STAT CIRC C
   [Anonymous], 2015, FRONT MICROBIOL
   Bansal MS, 2012, BIOINFORMATICS, V28, pI283, DOI 10.1093/bioinformatics/bts225
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bolotin E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01536
   Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679
   Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486
   Caro-Quintero A, 2015, ISME J, V9, P958, DOI 10.1038/ismej.2014.193
   Coyne MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01305-14
   Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105
   David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649
   Duranti S, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02894-16
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128
   Hasan MS, 2012, BIOINFORMATION, V8, P203, DOI 10.6026/97320630008203
   Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028
   Ji M, 2017, NATURE, V552, P400, DOI 10.1038/nature25014
   Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018
   Langille Morgan G I, 2009, F1000 Biol Rep, V1, P25, DOI 10.3410/B1-25
   Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030
   Lin HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24175
   Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656
   Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18
   MANTEL N, 1967, CANCER RES, V27, P209
   McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74
   Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263
   Moitinho-Silva L, 2017, ISME J, V11, P1651, DOI 10.1038/ismej.2017.25
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229
   Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Podell S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r16
   Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077
   Pritchard L, 2006, BIOINFORMATICS, V22, P616, DOI 10.1093/bioinformatics/btk021
   Probst AJ, 2018, NAT MICROBIOL, V3, P328, DOI 10.1038/s41564-017-0098-y
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853
   Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002
   Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352
   Sangwan N, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0154-5
   Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571
   Song WZ, 2017, BIOINFORMATICS, V33, P1873, DOI 10.1093/bioinformatics/btx086
   Song WZ, 2017, PEERJ, V5, DOI 10.7717/peerj.4015
   Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631
   Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117
   von Wintersdorff CJH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00173
   Wemheuer B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00805
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zhu QY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-717
NR 58
TC 41
Z9 45
U1 4
U2 45
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PD MAR 4
PY 2019
VL 7
AR 36
DI 10.1186/s40168-019-0649-y
PG 14
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA HN9QV
UT WOS:000460534900001
PM 30832740
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Elmassry, MM
   Kim, S
   Busby, B
AF Elmassry, Moamen M.
   Kim, Sunghwan
   Busby, Ben
TI Predicting drug-metagenome interactions: Variation in the microbial
   beta-glucuronidase level in the human gut metagenomes
SO PLOS ONE
LA English
DT Article
ID LIQUID-CHROMATOGRAPHY; ENZYMATIC-HYDROLYSIS; METABOLITES; EXPRESSION;
   IRINOTECAN; CANCER; INDOMETHACIN; BACTEROIDES; FRAMEWORK; TOXICITY
AB Characterizing the gut microbiota in terms of their capacity to interfere with drug metabolism is necessary to achieve drug efficacy and safety. Although examples of drug-microbiome interactions are well-documented, little has been reported about a computational pipeline for systematically identifying and characterizing bacterial enzymes that process particular classes of drugs. The goal of our study is to develop a computational approach that compiles drugs whose metabolism may be influenced by a particular class of microbial enzymes and that quantifies the variability in the collective level of those enzymes among individuals. The present paper describes this approach, with microbial beta-glucuronidases as an example, which break down drug-glucuronide conjugates and reactivate the drugs or their metabolites. We identified 100 medications that may be metabolized by beta-glucuronidases from the gut microbiome. These medications included morphine, estrogen, ibuprofen, midazolam, and their structural analogues. The analysis of metagenomic data available through the Sequence Read Archive (SRA) showed that the level of beta-glucuronidase in the gut metagenomes was higher in males than in females, which provides a potential explanation for the sex-based differences in efficacy and toxicity for several drugs, reported in previous studies. Our analysis also showed that infant gut metagenomes at birth and 12 months of age have higher levels of beta-glucuronidase than the metagenomes of their mothers and the implication of this observed variability was discussed in the context of breastfeeding as well as infant hyperbilirubinemia. Overall, despite important limitations discussed in this paper, our analysis provided useful insights on the role of the human gut metagenome in the variability in drug response among individuals. Importantly, this approach exploits drug and metagenome data available in public databases as well as open-source cheminformatics and bioinformatics tools to predict drug-metagenome interactions.
C1 [Elmassry, Moamen M.; Kim, Sunghwan; Busby, Ben] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.
   [Elmassry, Moamen M.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.
   [Elmassry, Moamen M.] Princeton Univ, Dept Mol Biol, Princeton, NJ USA.
   [Busby, Ben] DNAnexus, Mountain View, CA USA.
C3 National Institutes of Health (NIH) - USA; NIH National Library of
   Medicine (NLM); Texas Tech University System; Texas Tech University;
   Princeton University
RP Kim, S (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.
EM kimsungh@ncbi.nlm.nih.gov
RI Kim, Sunghwan/A-6738-2008; Elmassry, Moamen M/J-9335-2015
OI Kim, Sunghwan/0000-0001-9828-2074; Elmassry, Moamen
   M/0000-0002-1193-7822
FU Intramural Research Program of the National Library of Medicine,
   National Institutes of Health; U.S. Department of Energy; National
   Library of Medicine
FX This work was supported in part by the Intramural Research Program of
   the National Library of Medicine, National Institutes of Health. M.M.E
   was supported by an appointment to the National Center for Biotechnology
   Information Scientific Visitors Program at Oak Ridge Institute for
   Science and Education (ORISE) through an interagency agreement between
   the U.S. Department of Energy and the National Library of Medicine. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. No additional
   external funding was received for this study.
CR [Anonymous], **DATA OBJECT**
   Appelhans T, 2016, INT J CLIMATOL, V36, P3245, DOI 10.1002/joc.4552
   Aziz RK, 2018, EXPERT OPIN DRUG MET, V14, P1043, DOI 10.1080/17425255.2018.1530216
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]
   Baker JM, 2017, MATURITAS, V103, P45, DOI 10.1016/j.maturitas.2017.06.025
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BERGMAN DA, 1994, PEDIATRICS, V94, P558
   Bezabeh T, 2009, MAGN RESON MATER PHY, V22, P267, DOI 10.1007/s10334-009-0171-5
   Boelsterli UA, 2013, TOXICOL SCI, V131, P654, DOI 10.1093/toxsci/kfs310
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307
   Chankhamjon P, 2019, BIORXIV, DOI [10.1101/538215, DOI 10.1101/538215]
   Chen KLA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26506-1
   Dahn T, 2010, METHODS MOL BIOL, V603, P411, DOI 10.1007/978-1-60761-459-3_40
   Dashnyam P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34678-z
   DELSOLDATO P, 1977, FARMACO-ED SCI, V32, P845
   DIXON R, 1987, J CLIN PHARMACOL, V27, P233, DOI 10.1002/j.1552-4604.1987.tb02191.x
   Doestzada M, 2018, PROTEIN CELL, V9, P432, DOI 10.1007/s13238-018-0547-2
   Dou C, 2001, J FORENSIC SCI, V46, P335
   DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041
   el-Kholy M S, 1992, J Egypt Public Health Assoc, V67, P237
   ElSohly MA, 2005, J ANAL TOXICOL, V29, P570, DOI 10.1093/jat/29.6.570
   Ervin SM, 2019, ACS CHEM BIOL, V14, P2737, DOI 10.1021/acschembio.9b00663
   Ervin SM, 2019, J BIOL CHEM, V294, P18586, DOI 10.1074/jbc.RA119.010950
   Fagerland MW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-78
   Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253
   Fujita D, 2016, DRUG METAB DISPOS, V44, P1, DOI 10.1124/dmd.115.066712
   Gao Y, 2014, DRUG DISCOV TODAY, V19, P326, DOI 10.1016/j.drudis.2013.11.020
   Guthrie L, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0034-1
   HANKINS GDV, 1990, AM J OBSTET GYNECOL, V163, P728, DOI 10.1016/0002-9378(90)91057-J
   HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577
   Hussain Aziza M, 2013, J Anaesthesiol Clin Pharmacol, V29, P337, DOI 10.4103/0970-9185.117095
   INCE Z, 1995, ACTA PAEDIATR, V84, P237, DOI 10.1111/j.1651-2227.1995.tb13621.x
   Jariwala PB, 2020, ACS CHEM BIOL, V15, P217, DOI 10.1021/acschembio.9b00788
   Kim S., 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI [10.1093/nar/gky1033, DOI 10.1093/NAR/GKY1033]
   King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171
   Koonin EV, 2003, SEQUENCE EVOLUTION F
   Kowalczyk I, 2000, J PHARMACEUT BIOMED, V22, P803, DOI 10.1016/S0731-7085(00)00244-2
   La Torre A, 1999, BIOL NEONATE, V75, P82, DOI 10.1159/000014081
   Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019
   Leung JW, 2001, GASTROINTEST ENDOSC, V54, P346, DOI 10.1067/mge.2001.117546
   Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973
   Little MS, 2018, PROTEIN SCI, V27, P2010, DOI 10.1002/pro.3507
   Little MS, 2018, P NATL ACAD SCI USA, V115, pE152, DOI 10.1073/pnas.1716241115
   Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4
   Maisels MJ, 2006, PEDIATRICS, V117, P1169, DOI 10.1542/peds.2005-0744
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Molan AL, 2014, PHYTOTHER RES, V28, P416, DOI 10.1002/ptr.5009
   Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007
   Pan DH, 2017, PEDIATR REV, V38, P499, DOI 10.1542/pir.2015-0132
   PARKER RJ, 1980, XENOBIOTICA, V10, P689, DOI 10.3109/00498258009108376
   Patel AG, 2010, SCIENCE, V330, P766, DOI 10.1126/science.1198310
   Pedroso SHSP, 2015, MICROBIOL-SGM, V161, P1950, DOI 10.1099/mic.0.000149
   Pellock SJ, 2018, J BIOL CHEM, V293, P18559, DOI 10.1074/jbc.RA118.005414
   Pollet RM, 2017, STRUCTURE, V25, P967, DOI 10.1016/j.str.2017.05.003
   R Core Team, 2017, R LANG ENV STAT COMP
   Raftogianis R, 2000, J Natl Cancer Inst Monogr, P113
   Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216
   Rizkallah Mariam Reyad, 2010, Current Pharmacogenomics & Personalized Medicine, V8, P182
   Roden DM, 2011, CIRCULATION, V123, P1661, DOI 10.1161/CIRCULATIONAHA.109.914820
   Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8
   Saitta KS, 2014, XENOBIOTICA, V44, P28, DOI 10.3109/00498254.2013.811314
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Sitasuwan P, 2016, J ANAL TOXICOL, V40, P601, DOI 10.1093/jat/bkw085
   Son HJ, 2019, J CANCER PREV, V24, P173, DOI 10.15430/JCP.2019.24.3.173
   Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940
   Sundstrom I, 2001, J CHROMATOGR B, V763, P121, DOI 10.1016/S0378-4347(01)00375-9
   Taylor MR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2358
   Walker JS, 1998, ANESTH ANALG, V86, P1257, DOI 10.1097/00000539-199806000-00023
   Wang Y, 2013, BIOINFORMATICS, V29, P2792, DOI 10.1093/bioinformatics/btt475
   WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.1093/biomet/34.1-2.28
   Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07
   Wickham H., 2016, GGPLOT2, DOI DOI 10.1007/978-3-319-24277-4
   Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01
   Wickham H, 2007, J STAT SOFTW, V21, P1
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Wozniak PJ, 1991, TECHNOMETRICS, V33, P364, DOI [10.1080/00401706.1991.10484849, DOI 10.1080/00401706.1991.10484849]
   Wright AWE, 1998, LIFE SCI, V63, P401, DOI 10.1016/S0024-3205(98)00288-4
   Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029
   Yang ZL, 2017, GYNECOL ENDOCRINOL, V33, P87, DOI 10.1080/09513590.2016.1248932
   Yau K I, 1992, J Formos Med Assoc, V91, P287
   Yauw STK, 2018, SURG INFECT, V19, P417, DOI 10.1089/sur.2017.245
   Yigit S, 2001, TURKISH J PEDIATR, V43, P118
   Yip LY, 2018, HEPATOLOGY, V67, P282, DOI 10.1002/hep.29327
   Yu LS, 2007, BIOCHEM PHARMACOL, V73, P1842, DOI 10.1016/j.bcp.2007.02.004
   Zaheer R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24280-8
   Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3
NR 88
TC 12
Z9 14
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 7
PY 2021
VL 16
IS 1
AR e0244876
DI 10.1371/journal.pone.0244876
PG 21
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA PS6NW
UT WOS:000608044300005
PM 33411719
OA Green Published, gold, Green Submitted
DA 2023-09-14
ER

PT J
AU Souai, N
   Zidi, O
   Mosbah, A
   Kosai, I
   El Manaa, J
   Mokhtar, NB
   Asimakis, E
   Stathopoulou, P
   Cherif, A
   Tsiamis, G
   Kouidhi, S
AF Souai, Nessrine
   Zidi, Oumaima
   Mosbah, Amor
   Kosai, Imen
   El Manaa, Jameleddine
   Mokhtar, Naima Bel
   Asimakis, Elias
   Stathopoulou, Panagiota
   Cherif, Ameur
   Tsiamis, George
   Kouidhi, Soumaya
TI Impact of the Post-Transplant Period and Lifestyle Diseases on Human Gut
   Microbiota in Kidney Graft Recipients
SO MICROORGANISMS
LA English
DT Article
DE 16S rRNA gene; amplicon sequencing; dysbiosis; bioinformatics; kidney
   transplantation
ID TRANSPLANTATION; ASSOCIATION; BACTEREMIA; METAGENOME; BACTERIAL;
   PRODUCTS
AB Gaining long-term graft function and patient life quality remain critical challenges following kidney transplantation. Advances in immunology, gnotobiotics, and culture-independent molecular techniques have provided growing insights into the complex relationship of the microbiome and the host. However, little is known about the over time-shift of the gut microbiota in the context of kidney transplantation and its impact on both graft and health stability. Here we aimed to characterize the structure of gut microbiota within stable kidney graft recipients. We enrolled forty kidney transplant patients after at least three months of transplantation and compared them to eighteen healthy controls. The overall microbial community structure of the kidney transplanted group was clearly different from control subjects. We found lower relative abundances of Actinobacteria, Bacteroidetes, and Verrucomicrobia within the patient group and a higher abundance of Proteobacteria compared to the control group. Both richness and Shannon diversity indexes were significantly lower in the kidney graft recipients than in healthy controls. Post-graft period was positively correlated with the relative abundance of the Proteobacteria phylum, especially Escherichia.Shigella genus. Interestingly, only Parabacteroides was found to significantly differentiate patients that were not suffering from lifestyle diseases and those who suffer from post-graft complications. Furthermore, network analysis showed that the occurrence of lifestyle diseases was significantly linked with a higher number of negative interactions of Sutterella and Succinivibrio genera within patients. This study characterizes gut microbiome fluctuation in stable kidney transplant patients after a long post-allograft period. Analysis of fecal microbiota could be useful for nephrologists as a new clinical tool that can improve kidney allograft monitoring and outcomes.
C1 [Souai, Nessrine; Zidi, Oumaima; Mosbah, Amor; Cherif, Ameur; Kouidhi, Soumaya] Univ Manouba, Higher Inst Biotechnol Sidi Thabet, Lab Biotechnol & Valorisat BiogeoRessources, BiotechPole Sidi Thabet, Ariana 2020, Tunisia.
   [Souai, Nessrine; Zidi, Oumaima] Univ Tunis El Manar, Fac Sci Tunis, Dept Biol, Farhat Hachad Univ Campus, Tunis 1068, Tunisia.
   [Kosai, Imen; El Manaa, Jameleddine] Mil Training Hosp, Unit Organ Transplant, Tunis 1008, Tunisia.
   [Mokhtar, Naima Bel; Asimakis, Elias; Stathopoulou, Panagiota; Tsiamis, George] Univ Patras, Dept Environm Engn, Lab Syst Microbiol & Appl Genom, 2 Seferi St, Agrinion 30100, Greece.
C3 Institut National de Recherche d'Analyse Physico-Chimique; Universite de
   la Manouba; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis
   (FST); University of Patras
RP Kouidhi, S (corresponding author), Univ Manouba, Higher Inst Biotechnol Sidi Thabet, Lab Biotechnol & Valorisat BiogeoRessources, BiotechPole Sidi Thabet, Ariana 2020, Tunisia.
EM nessrine.souai@fst.utm.tn; oumaima.zidi@hotmail.fr;
   amor.mosbah@gmail.com; imenelkosai@gmail.com; Manaajamel@yahoo.fr;
   naima1503@gmail.com; eliasasim@gmail.com;
   panayotastathopoulou@gmail.com; ameur.cherif@uma.tn;
   gtsiamis@upatras.gr; soumayakouidhi@gmail.com
RI Cherif, Ameur/AAC-6136-2021; Kouidhi, Soumaya/AFA-9002-2022
OI Tsiamis, George/0000-0001-5616-8505; Mosbah, Amor/0000-0001-5642-8805;
   Asimakis, Elias/0000-0001-9109-1750; BEL MOKHTAR,
   Naima/0000-0002-7094-5849; zidi, oumaima/0000-0003-2953-2193; souai,
   Nessrine/0000-0002-6128-3185; Stathopoulou,
   Panagiota/0000-0003-3941-0990; /0000-0001-7310-3842
FU higher education Erasmus plus grant [KA107, LR11ES31]
FX This research was funded by a higher education Erasmus plus grant
   (KA107) and the LR11ES31 project.
CR Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x
   Andrade-Oliveira V, 2015, J AM SOC NEPHROL, V26, P1877, DOI 10.1681/ASN.2014030288
   [Anonymous], 2015, NONPARAMETRIC STAT M
   Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15
   Basha JA, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070988
   Bhat M, 2020, TRANSPLANTATION, V104, P211, DOI 10.1097/TP.0000000000002815
   Boente RF, 2010, ANAEROBE, V16, P190, DOI 10.1016/j.anaerobe.2010.02.003
   Bureau U.C, 2015, AN AGING WORLD
   Chiu CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906168
   Ding HT, 2017, J AUTISM DEV DISORD, V47, P480, DOI 10.1007/s10803-016-2960-9
   Doycheva I, 2016, TRANSPLANTATION, V100, P61, DOI 10.1097/TP.0000000000001008
   Edgar R. C., 2017, SEARCH 16S NEW ALGOR, DOI DOI 10.1101/124131
   Edgar RC, 2016, IMPOSE2 IMPROVED ERR, DOI DOI 10.1101/081257
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939
   Faust Karoline, 2016, F1000Res, V5, P1519
   Fricke WF, 2014, AM J TRANSPLANT, V14, P416, DOI 10.1111/ajt.12588
   Gaston RS, 2003, AM J TRANSPLANT, V3, P64, DOI 10.1034/j.1600-6143.3.s4.7.x
   Guirong Y E, 2018, Nan Fang Yi Ke Da Xue Xue Bao, V38, P1401, DOI 10.12122/j.issn.1673-4254.2018.12.01
   Hiippala K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01706
   Huang W, 2017, METABOLISM, V68, P20, DOI 10.1016/j.metabol.2016.11.006
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Ijaz, 2017, ISCB AFRICA ASBCB C, DOI [10.13140/RG.2.2.17108.71047, DOI 10.13140/RG.2.2.17108.71047]
   Ito K, 2016, CLIN EXP NEPHROL, V20, P309, DOI 10.1007/s10157-015-1155-6
   Jiang SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02989-2
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122399
   Lee JR, 2014, TRANSPLANTATION, V98, P697, DOI 10.1097/TP.0000000000000370
   Lee JR, 2019, AM J TRANSPLANT, V19, P488, DOI 10.1111/ajt.14974
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Li FX, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00206
   Lun HZ, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.678
   Mahmoodpoor F, 2017, BIOMED PHARMACOTHER, V93, P412, DOI 10.1016/j.biopha.2017.06.066
   Nellore A, 2016, CLIN MICROBIOL REV, V29, P191, DOI 10.1128/CMR.00063-15
   Nordstokke D., 2014, ENCY QUALITY LIFE WE, P4575, DOI 10.1007/978-94-007-0753-5_2059
   Oh PL, 2012, AM J TRANSPLANT, V12, P753, DOI 10.1111/j.1600-6143.2011.03860.x
   Onal EM, 2019, HYPERTENS RES, V42, P123, DOI 10.1038/s41440-018-0144-z
   Peabody J, 2019, INT J NEPHROL, V2019, DOI 10.1155/2019/5303284
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rizzatti G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9351507
   Rousee JM, 2002, J CLIN MICROBIOL, V40, P3871, DOI 10.1128/JCM.40.10.3871-3873.2002
   SOUTHERN PM, 1975, AM J CLIN PATHOL, V64, P540
   Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24
   Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580
   Ticinesi A, 2019, KIDNEY INT, V96, P25, DOI 10.1016/j.kint.2019.03.020
   Turunc V, 2015, TRANSPL P, V47, P1518, DOI 10.1016/j.transproceed.2015.04.007
   Venkataramanan R, 1995, CLIN PHARMACOKINET, V29, P404, DOI 10.2165/00003088-199529060-00003
   Wang JH, 2016, ADV CHRONIC KIDNEY D, V23, P281, DOI 10.1053/j.ackd.2016.07.001
   Wang WL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0640-8
   Wilmes D, 2018, RESP MED, V137, P89, DOI 10.1016/j.rmed.2018.02.022
   Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303
   Xiao J, 2018, AM J TRANSL RES, V10, P3330
   Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315
   Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11
NR 58
TC 9
Z9 9
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD NOV
PY 2020
VL 8
IS 11
AR 1724
DI 10.3390/microorganisms8111724
PG 19
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA OX0EG
UT WOS:000593248800001
PM 33158078
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Deng, XQ
   Si, JT
   Qu, YL
   Jie, L
   He, YS
   Wang, CG
   Zhang, YP
AF Deng, Xinqi
   Si, Jiangtao
   Qu, Yonglong
   Jie, Li
   He, Yuansong
   Wang, Chunguo
   Zhang, Yuping
TI Vegetarian diet duration's influence on women's gut environment
SO GENES AND NUTRITION
LA English
DT Article
DE Vegetarian diet; Gut microbiota; Fecal metabolites; Female
ID OVARIAN-FUNCTION; BREAST-CANCER; HEART-DISEASE; MICROBIOTA; RISK;
   VITAMIN-B-6; ASSOCIATION; METABOLISM; FOLATE; PROGESTERONE
AB Background Nutrient composition of vegetarian diets is greatly different from that of omnivore diets, which may fundamentally influence the gut microbiota and fecal metabolites. The interactions between diet pattern and gut environment need further illustration. This study aims to compare the difference in the gut microbiota and fecal metabolites between vegetarian and omnivore female adults and explore associations between dietary choices/duration and gut environment changes. Methods In this study, investigations on the fecal metabolome together with the gut microbiome were performed to describe potential interactions with quantitative functional annotation. In order to eliminate the differences brought by factors of gender and living environment, 80 female adults aged 20 to 48 were recruited in the universities in Beijing, China. Quantitative Insights Into Microbial Ecology (QIIME) analysis and Ingenuity Pathway Analysis (IPA) were applied to screen differential data between groups from gut microbiota and fecal metabolites. Furthermore, weighted gene correlation network analysis (WGCNA) was employed as the bioinformatics analysis tool for describing the correlations between gut microbiota and fecal metabolites. Moreover, participants were further subdivided by the vegetarian diet duration for analysis. Results GPCR-mediated integration of enteroendocrine signaling was predicted to be one of the regulatory mechanisms of the vegetarian diet. Intriguingly, changes in the gut environment which occurred along with the vegetarian diet showed attenuated trend as the duration increased. A similar trend of returning to "baseline" after a 10-year vegetarian diet was detected in both gut microbiota and fecal metabolome. Conclusions The vegetarian diet is beneficial more than harmful to women. Gut microbiota play roles in the ability of the human body to adapt to external changes.
C1 [Deng, Xinqi] Beijing Univ Chinese Med, Sch Life Sci, Beijing, Peoples R China.
   [Si, Jiangtao] Chinese Acad Tradit Chinese Med, Special Treatment Ctr, Wang Jing Hosp, Beijing, Peoples R China.
   [Qu, Yonglong; Jie, Li; Zhang, Yuping] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China.
   [He, Yuansong] Sichuan Vocat Coll Nursing, Chengdu, Peoples R China.
   [Wang, Chunguo] Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing, Peoples R China.
C3 Beijing University of Chinese Medicine; China Academy of Chinese Medical
   Sciences; Beijing University of Chinese Medicine; Beijing University of
   Chinese Medicine
RP Zhang, YP (corresponding author), Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China.; Wang, CG (corresponding author), Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing, Peoples R China.
EM wangcg1119@126.com; jewelapple78@sina.com
RI ZHANG, YUTING/HOH-4131-2023; Li, Li/IAQ-0885-2023; zhang,
   yu/HNS-5948-2023
OI Deng, Xinqi/0000-0001-7518-4439; Wang, Chunguo/0000-0002-2711-1144
FU Young Teacher Project of Beijing University of Chinese Medicine
   [2018-JYBZZ-JS014, 2017-JYB-JS022]
FX This work was supported by the Young Teacher Project of Beijing
   University of Chinese Medicine (grant number [No. 2018-JYBZZ-JS014 and
   2017-JYB-JS022]).
CR ADLERCREUTZ H, 1990, SCAND J CLIN LAB INV, V50, P3, DOI 10.3109/00365519009085798
   Agrawal S, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-89
   AGUADO LI, 1984, ENDOCRINOLOGY, V114, P1845, DOI 10.1210/endo-114-5-1845
   [Anonymous], GASTROINTESTINAL MIC, DOI 10.1007/978-1-4615-4111-0_9
   Baker JM, 2017, MATURITAS, V103, P45, DOI 10.1016/j.maturitas.2017.06.025
   BARBOSA JC, 1990, AM J CLIN NUTR, V51, P798, DOI 10.1093/ajcn/51.5.798
   BARR SI, 1994, AM J CLIN NUTR, V60, P887
   Berkow SE, 2005, NUTR REV, V63, P1, DOI 10.1111/j.1753-4887.2005.tb00104.x
   Blancquaert L, 2018, BRIT J NUTR, V119, P759, DOI [10.1017/S000711451800017X, 10.1017/s000711451800017x]
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Brathwalte N, 2003, ETHNIC DIS, V13, P148
   Chang-Claude J, 2005, CANCER EPIDEM BIOMAR, V14, P963, DOI 10.1158/1055-9965.EPI-04-0696
   Chen J, 2011, J PROTEOME RES, V10, P2625, DOI 10.1021/pr200173q
   Chia JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075471
   Chiu THT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088547
   Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874
   Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027
   Craig WJ, 2010, NUTR CLIN PRACT, V25, P613, DOI 10.1177/0884533610385707
   Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155
   De Bortoli MA, 2000, J STEROID BIOCHEM, V74, P19, DOI 10.1016/S0960-0760(00)00084-4
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Di Ciaula A, 2017, ANN HEPATOL, V16, pS4, DOI 10.5604/01.3001.0010.5493
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/nmeth.2604, 10.1038/NMETH.2604]
   Martinez-Gonzalez AE, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080408
   Flanagan JL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-30
   Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463
   Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s
   Glick-Bauer M, 2014, NUTRIENTS, V6, P4822, DOI 10.3390/nu6114822
   GOLDIN BR, 1981, CANCER RES, V41, P3771
   GOLDIN BR, 1988, AM J CLIN NUTR, V48, P787, DOI 10.1093/ajcn/48.3.787
   Grigor'eva IN, 2021, J PERS MED, V11, DOI 10.3390/jpm11010013
   Harris HR, 2012, INT J CANCER, V131, pE518, DOI 10.1002/ijc.26455
   Hjorth MF, 2020, AM J CLIN NUTR, V111, P1079, DOI 10.1093/ajcn/nqaa007
   Hjorth MF, 2019, INT J OBESITY, V43, P149, DOI 10.1038/s41366-018-0093-2
   Ho CL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090538
   Ho-Pham LT, 2009, AM J CLIN NUTR, V90, P943, DOI 10.3945/ajcn.2009.27521
   Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882
   HSU JM, 1963, VITAM HORM, V21, P113
   Jaacks LM, 2016, NUTRITION, V32, P975, DOI 10.1016/j.nut.2016.02.011
   Jayanthi V, 2001, PERITON DIALYSIS INT, V21, pS322
   Jenkins DJA, 2003, AM J CLIN NUTR, V78, p610S, DOI 10.1093/ajcn/78.3.610S
   Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1
   Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107
   Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009
   Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734
   Lotto V, 2011, BRIT J NUTR, V106, P183, DOI 10.1017/S0007114511000407
   Mace OJ, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.155
   Marchesi G, 2014, J DENT, V42, P603, DOI 10.1016/j.jdent.2013.12.008
   Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153
   Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6
   Munyaka PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142536
   Nakamura Y, 2003, FERTIL STERIL, V80, P1012, DOI 10.1016/S0015-0282(03)01008-2
   Naz S, 2014, J CHROMATOGR A, V1353, P99, DOI 10.1016/j.chroma.2014.04.071
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   Peuhkuri K, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.17252
   Phillips F, 2005, NUTR BULL, V30, P132, DOI 10.1111/j.1467-3010.2005.00467.x
   POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359
   Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8
   Santoru ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10034-5
   SAWYER CH, 1978, BRAIN RES, V146, P83, DOI 10.1016/0006-8993(78)90219-6
   Senghor B., 2018, HUM MICROBIOM J, V7-8, P1, DOI [10.1016/j.humic.2018.01.001, DOI 10.1016/J.HUMIC.2018.01.001]
   Shultz TD., 1982, NUTRIENT INTAKE HORM, DOI [10.1080/01635588209513765, DOI 10.1080/01635588209513765]
   Simpson JL, 2010, J MATERN-FETAL NEO M, V23, P1323, DOI 10.3109/14767051003678234
   Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089
   Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005
   Stojanov S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111715
   Tomova A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00047
   Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wang FL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002408
   [王晓 Wang Xiao], 2020, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V35, P2007
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Wu W, 2013, BRIT J CANCER, V109, P1926, DOI 10.1038/bjc.2013.438
   Wurtman RJ., 1964, PITUITARY, V3, P544
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Yin PY, 2006, J PROTEOME RES, V5, P2135, DOI 10.1021/pr060256p
   Zeisel SH, 2017, ANNU REV NUTR, V37, P157, DOI 10.1146/annurev-nutr-071816-064732
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
   Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27
   Zhang M, 2017, FRONT IMMUNOL, V8, P1, DOI 10.3389/fimmu.2017.00942
   Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555
   Zhang XH, 2013, WORLD J GASTROENTERO, V19, P1005, DOI 10.3748/wjg.v19.i7.1005
NR 90
TC 3
Z9 3
U1 2
U2 28
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1555-8932
EI 1865-3499
J9 GENES NUTR
JI Genes Nutr.
PD DEC
PY 2021
VL 16
IS 1
AR 16
DI 10.1186/s12263-021-00697-1
PG 15
WC Genetics & Heredity; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Nutrition & Dietetics
GA WA3HK
UT WOS:000702780000002
PM 34600491
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Jeong, Y
   Jhun, J
   Lee, SY
   Na, HS
   Choi, J
   Cho, KH
   Lee, SY
   Lee, AR
   Park, SJ
   You, HJ
   Kim, JW
   Park, MS
   Kwon, B
   Cho, ML
   Ji, GE
   Park, SH
AF Jeong, Yunju
   Jhun, JooYeon
   Lee, Seon-Yeong
   Na, Hyun Sik
   Choi, JeongWon
   Cho, Keun-Hyung
   Lee, Seung Yoon
   Lee, A. Ram
   Park, Sang-Jun
   You, Hyun Ju
   Kim, Ji-Won
   Park, Myeong Soo
   Kwon, Bin
   Cho, Mi-La
   Ji, Geun Eog
   Park, Sung-Hwan
TI Therapeutic Potential of a Novel Bifidobacterium Identified Through
   Microbiome Profiling of RA Patients With Different RF Levels
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE rheumatoid arthritis; rheumatoid factor; microbiome; Bifidobacterium
   longum; T helper 17 cell
ID EPSTEIN-BARR-VIRUS; RHEUMATOID-ARTHRITIS; INFECTION; INFLAMMATION;
   ANTIBODIES; STRINGTIE; GENES; HISAT
AB The potential therapeutic effects of probiotic bacteria in rheumatoid arthritis (RA) remain controversial. Thus, this study aimed to discover potential therapeutic bacteria based on the relationship between the gut microbiome and rheumatoid factor (RF) in RA. Bacterial genomic DNA was extracted from the fecal samples of 93 RA patients and 16 healthy subjects. Microbiota profiling was conducted through 16S rRNA sequencing and bioinformatics analyses. The effects of Bifidobacterium strains on human peripheral blood mononuclear cells and collagen-induced arthritis (CIA) mice were assessed. Significant differences in gut microbiota composition were observed in patients with different RF levels. The relative abundance of Bifidobacterium and Collinsella was lower in RF-high than in RF-low and RF-negative RA patients, while the relative abundance of Clostridium of Ruminococcaceae family was higher in RF-high than in RF-low and RF-negative patients. Among 10 differentially abundant Bifidobacterium, B. longum RAPO exhibited the strongest ability to inhibit IL-17 secretion. Oral administration of B. longum RAPO in CIA mice, obese CIA, and humanized avatar model significantly reduced RA incidence, arthritis score, inflammation, bone damage, cartilage damage, Th17 cells, and inflammatory cytokine secretion. Additionally, B. longum RAPO significantly inhibited Th17 cells and Th17-related genes-IL-17A, IRF4, RORC, IL-21, and IL-23R-in the PBMCs of rheumatoid arthritis patients. Our findings suggest that B. longum RAPO may alleviate RA by inhibiting the production of IL-17 and other proinflammatory mediators. The safety and efficacy of B. longum RAPO in patients with RA and other autoimmune disorders merit further investigation.
C1 [Jeong, Yunju; Ji, Geun Eog] Seoul Natl Univ, Res Inst Human Ecol, Dept Food & Nutr, Seoul, South Korea.
   [Jeong, Yunju; Park, Sang-Jun; Park, Myeong Soo; Kwon, Bin; Ji, Geun Eog] BIFIDO Co Ltd, Res Ctr, Hongcheon, South Korea.
   [Jhun, JooYeon; Lee, Seon-Yeong; Na, Hyun Sik; Choi, JeongWon; Cho, Keun-Hyung; Lee, Seung Yoon; Lee, A. Ram; Cho, Mi-La] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.
   [Jhun, JooYeon; Lee, Seon-Yeong; Na, Hyun Sik; Choi, JeongWon; Cho, Keun-Hyung; Lee, Seung Yoon; Lee, A. Ram; Cho, Mi-La] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Lab Translat ImmunoMed, Seoul, South Korea.
   [Jhun, JooYeon; Na, Hyun Sik; Cho, Keun-Hyung; Lee, Seung Yoon; Lee, A. Ram] Catholic Univ Korea, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea.
   [You, Hyun Ju] Seoul Natl Univ, Sch Publ Hlth, Inst Environm Hlth, Seoul, South Korea.
   [You, Hyun Ju] Seoul Natl Univ, N Bio, Seoul, South Korea.
   [Kim, Ji-Won] Daegu Catholic Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea.
   [Cho, Mi-La] Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea.
   [Park, Sung-Hwan] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea.
C3 Seoul National University (SNU); BIFIDO Co. Ltd.; Catholic University of
   Korea; Catholic University of Korea; Catholic University of Korea; Seoul
   National University (SNU); Seoul National University (SNU); Catholic
   University of Daegu; Catholic University of Korea; Catholic University
   of Korea; Seoul St. Mary's Hospital
RP Ji, GE (corresponding author), Seoul Natl Univ, Res Inst Human Ecol, Dept Food & Nutr, Seoul, South Korea.; Ji, GE (corresponding author), BIFIDO Co Ltd, Res Ctr, Hongcheon, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Lab Translat ImmunoMed, Seoul, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea.; Park, SH (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea.
EM iammila@catholic.ac.kr; geji@snu.ac.kr; rapark@catholic.ac.kr
RI Lee, Ah Ram/ABE-8789-2020; Jeong, Yunju/GRS-0008-2022; Jeong,
   Yunju/HNB-7386-2023; You, Hyun Ju/A-4811-2012
OI Jeong, Yunju/0000-0002-0453-3475; Kim, Ji-Won/0000-0002-0498-5762
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) - Korean Government (MSIT) [NRF-2017M3A9F3041045]
FX Funding This research was supported by the Bio & Medical Technology
   Development Program of the National Research Foundation (NRF) and funded
   by the Korean Government (MSIT) (No. NRF-2017M3A9F3041045).
CR Aletaha D, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0736-9
   Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584
   Alpizar-Rodriguez D, 2019, ANN RHEUM DIS, V78, P590, DOI 10.1136/annrheumdis-2018-214514
   ALSPAUGH MA, 1978, J EXP MED, V147, P1018, DOI 10.1084/jem.147.4.1018
   ALSPAUGH MA, 1981, J CLIN INVEST, V67, P1134, DOI 10.1172/JCI110127
   Bag S, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01361-17
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284
   Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7
   Choi ST, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195550
   Elagib KEE, 1999, CLIN EXP IMMUNOL, V117, P388
   Hayahara Chie, 2010, Rinsho Byori, V58, P211
   Ingegnoli F, 2013, DIS MARKERS, V2013, P727, DOI 10.1155/2013/726598
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Jeong Y, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050693
   Jhun J, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1809-3
   Kharlamova N, 2016, ARTHRITIS RHEUMATOL, V68, P604, DOI 10.1002/art.39491
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kurilshikov A, 2021, NAT GENET, V53, P156, DOI 10.1038/s41588-020-00763-1
   Kuriya B, 2009, ANN RHEUM DIS, V68, P1482, DOI 10.1136/ard.2008.092676
   Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32
   Lee SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09767-0
   Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Mehraein Y, 2004, MODERN PATHOL, V17, P781, DOI 10.1038/modpathol.3800119
   Mohammed AT, 2017, CLIN RHEUMATOL, V36, P2697, DOI 10.1007/s10067-017-3814-3
   Na HS, 2017, AM J PATHOL, V187, P1049, DOI 10.1016/j.ajpath.2016.12.023
   Naciute M, 2016, J GEN VIROL, V97, P3302, DOI 10.1099/jgv.0.000621
   Nielsen SF, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5244
   Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546
   Pan HD, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0719-1
   Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Pianta A, 2017, ARTHRITIS RHEUMATOL, V69, P964, DOI 10.1002/art.40003
   Picchianti-Diamanti A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102938
   Pineda MD, 2011, MED SCI MONITOR, V17, pCR347
   Qin PP, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030078
   Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075
   Santos-Moreno P, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014181
   Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202
   Tan EM, 2016, J EXP MED, V213, P1937, DOI 10.1084/jem.20160792
   Tsuji H, 2012, BENEF MICROBES, V3, P113, DOI 10.3920/BM2011.0038
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Witte T, 2000, RHEUMATOL INT, V19, P107, DOI 10.1007/s002960050112
   Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x
   Yamashita M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01159
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zamani B, 2016, INT J RHEUM DIS, V19, P869, DOI 10.1111/1756-185X.12888
NR 48
TC 8
Z9 8
U1 1
U2 19
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 15
PY 2021
VL 12
AR 736196
DI 10.3389/fimmu.2021.736196
PG 14
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA XH8CX
UT WOS:000725656900001
PM 34867956
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Premkrishnan, BNV
   Heinle, CE
   Uchida, A
   Purbojati, RW
   Kushwaha, KK
   Putra, A
   Santhi, PS
   Khoo, BWY
   Wong, A
   Vettath, VK
   Drautz-Moses, DI
   Junqueira, ACM
   Schuster, SC
AF Premkrishnan, Balakrishnan N. V.
   Heinle, Cassie E.
   Uchida, Akira
   Purbojati, Rikky W.
   Kushwaha, Kavita K.
   Putra, Alexander
   Santhi, Puramadathil Sasi
   Khoo, Benjamin W. Y.
   Wong, Anthony
   Vettath, Vineeth Kodengil
   Drautz-Moses, Daniela I.
   Junqueira, Ana Carolina M.
   Schuster, Stephan C.
TI The genomic characterisation and comparison of Bacillus cereus strains
   isolated from indoor air
SO GUT PATHOGENS
LA English
DT Article
DE Bacillus cereus; Food poisoning; Antibiotic resistance; Enterotoxins
ID BIOINFORMATICS RESOURCE; PLCR; RESISTANCE; SEQUENCE; IDENTIFICATION;
   THURINGIENSIS; OUTBREAKS; ANTHRACIS; REGULON; GROWTH
AB Background Bacillus cereus is ubiquitous in nature, found in environments such as soil, plants, air, and part of the insect and human gut microbiome. The ability to produce endospores and biofilms contribute to their pathogenicity, classified in two types of food poisoning: diarrheal and emetic syndromes. Here we report gap-free, whole-genome sequences of two B. cereus strains isolated from air samples and analyse their emetic and diarrheal potential. Results Genome assemblies of the B. cereus strains consist of one chromosome and seven plasmids each. The genome size of strain SGAir0260 is 6.30-Mb with 6590 predicted coding sequences (CDS) and strain SGAir0263 is 6.47-Mb with 6811 predicted CDS. Macrosynteny analysis showed 99% collinearity between the strains isolated from air and 90.2% with the reference genome. Comparative genomics with 57 complete B. cereus genomes suggests these strains from air are closely associated with strains isolated from foodborne illnesses outbreaks. Due to virulence potential of B. cereus and its reported involvement in nosocomial infections, antibiotic resistance analyses were performed and confirmed resistance to ampicillin and fosfomycin, with susceptibility to ciprofloxacin, tetracycline and vancomycin in both strains. Conclusion Phylogenetic analysis combined with detection of haemolytic (hblA, hblC, and hblD) and non-haemolytic (nheA, nheB, and nheC) enterotoxin genes in both air-isolated strains point to the diarrheic potential of the air isolates, though not emetic. Characterization of these airborne strains and investigation of their potential disease-causing genes could facilitate identification of environmental sources of contamination leading to foodborne illnesses and nosocomial infections transported by air.
C1 [Premkrishnan, Balakrishnan N. V.; Heinle, Cassie E.; Uchida, Akira; Purbojati, Rikky W.; Kushwaha, Kavita K.; Putra, Alexander; Santhi, Puramadathil Sasi; Khoo, Benjamin W. Y.; Wong, Anthony; Vettath, Vineeth Kodengil; Drautz-Moses, Daniela I.; Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.
   [Junqueira, Ana Carolina M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
C3 Nanyang Technological University & National Institute of Education (NIE)
   Singapore; Nanyang Technological University; Universidade Federal do Rio
   de Janeiro
RP Schuster, SC (corresponding author), Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore.; Junqueira, ACM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
EM anacmj@gmail.com; SCSchuster@ntu.edu.sg
RI Junqueira, Ana Carolina Martins/K-6439-2013
OI Junqueira, Ana Carolina Martins/0000-0003-2382-9842; Putra,
   Alexander/0000-0002-4864-9744
FU Singapore Ministry of Education Academic Research Fund Tier 3 Grant
   [MOE2013-T3-1-013]
FX This work was supported by the Singapore Ministry of Education Academic
   Research Fund Tier 3 Grant (MOE2013-T3-1-013).
CR Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x
   Arahal DR, 2014, METHOD MICROBIOL, V41, P103, DOI 10.1016/bs.mim.2014.07.002
   Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x
   ASH C, 1993, ANTON LEEUW INT J G, V64, P253
   Balm MND, 2012, J HOSP INFECT, V81, P224, DOI 10.1016/j.jhin.2012.04.022
   Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005
   Bennett SD, 2013, CLIN INFECT DIS, V57, P425, DOI 10.1093/cid/cit244
   Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09
   Bullied WJ, 2002, CAN J PLANT SCI, V82, P291
   Carroll LM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01096-17
   Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163
   Davis JJ, 2020, NUCLEIC ACIDS RES, V48, pD606, DOI 10.1093/nar/gkz943
   Davis JJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00118
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20
   Ehling-Schulz M, 2019, MICROBIOL SPECTR, V7, DOI [10.1128/microbiolspec.GPP3-0032-2018, 10.1128/microbiolspec.gpp3-0032-2018]
   Frankland GC, 1887, PHILOS T R SOC LON B, V178, P257, DOI DOI 10.1098/RSTB.1887.0011
   Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11
   Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793
   Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09
   Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x
   Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000
   Huck JR, 2007, J DAIRY SCI, V90, P4872, DOI 10.3168/jds.2007-0196
   Hunt M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0849-0
   Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582
   Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004
   Junqueira ACM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16353-x
   Kilcullen K, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2076.00069, 10.3389/fmicb.2016.00069]
   Kovac J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2883-z
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Le Gentil C, 2010, J FOOD ENG, V96, P37, DOI 10.1016/j.jfoodeng.2009.06.040
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Liu B, 2019, NUCLEIC ACIDS RES, V47, pD687, DOI 10.1093/nar/gky1080
   Mao L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46343
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129
   Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Miller RA, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.02479-17, 10.1128/aem.02479-17]
   Okstad OA, 1999, MICROBIOL-UK, V145, P3129, DOI 10.1099/00221287-145-11-3129
   Osimani A, 2018, INT J HOSP MANAG, V72, P145, DOI 10.1016/j.ijhm.2018.01.013
   Ozkocaman V, 2006, J HOSP INFECT, V64, P169, DOI 10.1016/j.jhin.2006.05.014
   Patino-Navarrete R, 2017, RES MICROBIOL, V168, P309, DOI 10.1016/j.resmic.2016.07.002
   Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005
   Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917
   Thompson MK, 2013, BIOCHEMISTRY-US, V52, P7350, DOI 10.1021/bi4009648
   Turner SW, 2014, GOOGLE PATENTS
   Vilain S, 2006, APPL ENVIRON MICROB, V72, P4970, DOI 10.1128/AEM.03076-05
   Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963
   Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06
   Yap M, 2019, J FOOD PROTECT, V82, P615, DOI [10.4315/0362-028X.JFP-18-349, 10.4315/0362-028x.jfp-18-349]
   Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261
   Zhu K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00718
NR 53
TC 5
Z9 5
U1 0
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1757-4749
J9 GUT PATHOG
JI Gut Pathogens
PD JAN 30
PY 2021
VL 13
IS 1
AR 6
DI 10.1186/s13099-021-00399-4
PG 10
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA QF1CL
UT WOS:000616636800001
PM 33516253
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Ma, ZS
AF Ma, Zhanshan (Sam)
TI Assessing and Interpreting the Metagenome Heterogeneity With Power Law
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE metagenome ecology; metagenomic gene abundance (MGA) table; Taylor's
   power law; power law extensions; metagenome spatial heterogeneity;
   metagenome functional gene cluster (MFGC); medical ecology of metagenome
ID WIDE ASSOCIATION; TAYLORS LAW; BODY-SIZE; DIVERSITY; AGGREGATION;
   VARIANCE; CATALOG; DISTRIBUTIONS; STABILITY; DYNAMICS
AB There are two major sequencing technologies for investigating the microbiome: the amplicon sequencing that generates the OTU (operational taxonomic unit) tables of marker genes (e.g., bacterial 16S-rRNA), and the metagenomic shotgun sequencing that generates metagenomic gene abundance (MGA) tables. The OTU table is the counterpart of species abundance tables in macrobial ecology of plants and animals, and has been the target of numerous ecological and network analyses in recent gold rush for microbiome research and in great efforts for establishing an inclusive theoretical ecology. Nevertheless, MGA analyses have been largely limited to bioinformatics pipelines and ad hoc statistical methods, and systematic approaches to MGAs guided by classic ecological theories are still few. Here, we argue that, the difference between "gene kinds" and "gene species" are nominal, and the metagenome that a microbiota carries is essentially a 'community' of metagenomic genes (MGs). Each row of a MGA table represents a metagenome of a microbiota, and the whole MGA table represents a 'meta-metagenome' (or an assemblage of metagenomes) of N microbiotas (microbiome samples). Consequently, the same ecological/network analyses used in OTU analyses should be equally applicable to MGA tables. Here we choose to analyze the heterogeneity of metagenome by introducing classic Taylor's power law (TPL) and its recent extensions in community ecology. Heterogeneity is a fundamental property of metagenome, particularly in the context of human microbiomes. Recent studies have shown that the heterogeneity of human metagenomes is far more significant than that of human genomes. Therefore, without deep understanding of the human metagenome heterogeneity, personalized medicine of the human microbiome-associated diseases is hardly feasible. The TPL extensions have been successfully applied to measure the heterogeneity of human microbiome based on amplicon-sequencing reads of marker genes (e.g., 16s-rRNA). In this article, we demonstrate the analysis of the metagenomic heterogeneity of human gut microbiome at whole metagenome scale (with type-I power law extension) and metagenomic gene scale (type-III), as well as the heterogeneity of gene clusters, respectively. We further examine the influences of obesity, IBD and diabetes on the heterogeneity, which is of important ramifications for the diagnosis and treatment of human microbiome-associated diseases.
C1 [Ma, Zhanshan (Sam)] Chinese Acad Sci, Computat Biol & Med Ecol Lab, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.
   [Ma, Zhanshan (Sam)] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.
C3 Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese
   Academy of Sciences
RP Ma, ZS (corresponding author), Chinese Acad Sci, Computat Biol & Med Ecol Lab, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.; Ma, ZS (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.
EM ma@vandals.uidaho.edu
RI Ma, Zhanshan (Sam)/AAZ-3896-2020
FU National Natural Science Foundation of China (NSFC) Grant on the Medical
   Ecology of Human Microbiome [31970116]; Cloud-Ridge Industry Technology
   Leader Award; International Cooperation Grant (YNST) on Genomics &
   Metagenomics Big Data
FX This study received funding from the following sources: A National
   Natural Science Foundation of China (NSFC) Grant (No. 31970116) on the
   Medical Ecology of Human Microbiome; The Cloud-Ridge Industry Technology
   Leader Award; An International Cooperation Grant (YNST) on Genomics &
   Metagenomics Big Data. The funders played no roles in interpreting the
   results.
CR Barberan Albert, 2014, Front Microbiol, V5, P203, DOI 10.3389/fmicb.2014.00203
   Cohen JE, 2016, ECOLOGY, V97, P3402, DOI 10.1002/ecy.1575
   Cohen JE, 2015, P NATL ACAD SCI USA, V112, P7749, DOI 10.1073/pnas.1503824112
   Cohen JE, 2014, THEOR ECOL-NETH, V7, P77, DOI 10.1007/s12080-013-0199-z
   Cohen JE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2955
   Cohen JE, 2012, P NATL ACAD SCI USA, V109, P15829, DOI 10.1073/pnas.1212883109
   Collingridge DS, 2013, J MIX METHOD RES, V7, P81, DOI 10.1177/1558689812454457
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   LI H, 1995, OIKOS, V73, P280, DOI 10.2307/3545921
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Li W, 2019, ZOOL RES, V40, P587, DOI 10.24272/j.issn.2095-8137.2019.068
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Ma Z.S., 1991, T ECOL SOC CHINA, V1, P284
   Ma ZS, 2019, ADV SCI, V6, DOI 10.1002/advs.201902054
   Ma ZS, 2019, J BIOGEOGR, V46, P2024, DOI 10.1111/jbi.13636
   Ma ZS, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1358
   Ma ZS, 2019, ISME J, V13, P1911, DOI 10.1038/s41396-019-0395-y
   Ma Z, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2477
   Ma ZS, 2018, ECOL EVOL, V8, P10023, DOI 10.1002/ece3.4425
   Ma ZS, 2018, MOL ECOL RESOUR, V18, P1339, DOI 10.1111/1755-0998.12923
   Ma ZS, 2015, MOL ECOL, V24, P5428, DOI 10.1111/mec.13394
   Ma ZS, 2013, FUND INFORM, V122, P173, DOI 10.3233/FI-2013-787
   Ma ZS, 2012, APPL SOFT COMPUT, V12, P2409, DOI 10.1016/j.asoc.2012.03.001
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Quist CW, 2017, MOL ECOL RESOUR, V17, P1257, DOI 10.1111/1755-0998.12672
   Reuman DC, 2017, P NATL ACAD SCI USA, V114, P6788, DOI 10.1073/pnas.1703593114
   Reuman DC, 2014, J ANIM ECOL, V83, P963, DOI 10.1111/1365-2656.12194
   Reuman DC, 2009, ADV ECOL RES, V41, P1, DOI 10.1016/S0065-2504(09)00401-2
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]
   Shavit A., 2016, 2 ROADS DIVERGE WOOD
   Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142
   TAYLOR LR, 1983, NATURE, V303, P801, DOI 10.1038/303801a0
   TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0
   TAYLOR LR, 1984, ANNU REV ENTOMOL, V29, P321, DOI 10.1146/annurev.en.29.010184.001541
   TAYLOR LR, 1988, NATURE, V332, P721, DOI 10.1038/332721a0
   TAYLOR LR, 1982, J ANIM ECOL, V51, P879, DOI 10.2307/4012
   TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0
   TAYLOR RAJ, 1981, J ANIM ECOL, V50, P573, DOI 10.2307/4075
   Taylor RAJ, 2007, J ANIM ECOL, V76, P630, DOI 10.1111/j.1365-2656.2007.01243.x
   Tippett MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10668
   Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83
   Wearn OR, 2013, SCIENCE, V339, P271, DOI 10.1126/science.1231618
   Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]
   Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353
   Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185
   Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275
NR 56
TC 5
Z9 5
U1 6
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 6
PY 2020
VL 11
AR 648
DI 10.3389/fmicb.2020.00648
PG 12
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA LS9KE
UT WOS:000536696600001
PM 32435232
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Petruschke, H
   Schori, C
   Canzler, S
   Riesbeck, S
   Poehlein, A
   Daniel, R
   Frei, D
   Segessemann, T
   Zimmerman, J
   Marinos, G
   Kaleta, C
   Jehmlich, N
   Ahrens, CH
   von Bergen, M
AF Petruschke, Hannes
   Schori, Christian
   Canzler, Sebastian
   Riesbeck, Sarah
   Poehlein, Anja
   Daniel, Rolf
   Frei, Daniel
   Segessemann, Tina
   Zimmerman, Johannes
   Marinos, Georgios
   Kaleta, Christoph
   Jehmlich, Nico
   Ahrens, Christian H.
   von Bergen, Martin
TI Discovery of novel community-relevant small proteins in a simplified
   human intestinal microbiome
SO MICROBIOME
LA English
DT Article
DE Small proteins (sProteins); SIHUMIx; Human gut microbiome;
   Proteogenomics; iPtgxDB; Metatranscriptomics; Metaproteomics; Metabolic
   modelling
ID ANTIMICROBIAL PEPTIDES; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; GUT
   MICROBIOTA; BACTERIAL; TRANSLATION; ANNOTATION; PROTEOMICS; GENE;
   IDENTIFICATION
AB Background: The intestinal microbiota plays a crucial role in protecting the host from pathogenic microbes, modulating immunity and regulating metabolic processes. We studied the simplified human intestinal microbiota (SIHUMIx) consisting of eight bacterial species with a particular focus on the discovery of novel small proteins with less than 100 amino acids (= sProteins), some of which may contribute to shape the simplified human intestinal microbiota. Although sProteins carry out a wide range of important functions, they are still often missed in genome annotations, and little is known about their structure and function in individual microbes and especially in microbial communities.
   Results: We created a multi-species integrated proteogenomics search database (iPtgxDB) to enable a comprehensive identification of novel sProteins. Six of the eight SIHUMIx species, for which no complete genomes were available, were sequenced and de novo assembled. Several proteomics approaches including two earlier optimized sProtein enrichment strategies were applied to specifically increase the chances for novel sProtein discovery. The search of tandem mass spectrometry (MS/MS) data against the multi-species iPtgxDB enabled the identification of 31 novel sProteins, of which the expression of 30 was supported by metatranscriptomics data. Using synthetic peptides, we were able to validate the expression of 25 novel sProteins. The comparison of sProtein expression in each single strain versus a multi-species community cultivation showed that six of these sProteins were only identified in the SIHUMIx community indicating a potentially important role of sProteins in the organization of microbial communities. Two of these novel sProteins have a potential antimicrobial function. Metabolic modelling revealed that a third sProtein is located in a genomic region encoding several enzymes relevant for the community metabolism within SIHUMIx.
   Conclusions: We outline an integrated experimental and bioinformatics workflow for the discovery of novel sProteins in a simplified intestinal model system that can be generically applied to other microbial communities. The further analysis of novel sProteins uniquely expressed in the SIHUMIx multi-species community is expected to enable new insights into the role of sProteins on the functionality of bacterial communities such as those of the human intestinal tract.
C1 [Petruschke, Hannes; Canzler, Sebastian; Riesbeck, Sarah; Jehmlich, Nico; von Bergen, Martin] Helmholtz Ctr Environm Res UFZ GmbH, Dept Mol Syst Biol, Leipzig, Germany.
   [Schori, Christian; Frei, Daniel; Segessemann, Tina; Ahrens, Christian H.] Agroscope Mol Diagnost Genom & Bioinformat, Wadenswil, Switzerland.
   [Schori, Christian; Frei, Daniel; Segessemann, Tina; Ahrens, Christian H.] SIB Swiss Inst Bioinformat, Wadenswil, Switzerland.
   [Poehlein, Anja; Daniel, Rolf] Georg August Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany.
   [Zimmerman, Johannes; Marinos, Georgios; Kaleta, Christoph] Christian Albrechts Univ Kiel, Inst Expt Med, Res Grp Med Syst Biol, Kiel, Germany.
   [von Bergen, Martin] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Leipzig, Germany.
C3 Helmholtz Association; Helmholtz Center for Environmental Research
   (UFZ); Swiss Federal Research Station Agroscope; Swiss Institute of
   Bioinformatics; University of Gottingen; University of Kiel; Leipzig
   University
RP von Bergen, M (corresponding author), Helmholtz Ctr Environm Res UFZ GmbH, Dept Mol Syst Biol, Leipzig, Germany.; Ahrens, CH (corresponding author), Agroscope Mol Diagnost Genom & Bioinformat, Wadenswil, Switzerland.; Ahrens, CH (corresponding author), SIB Swiss Inst Bioinformat, Wadenswil, Switzerland.; von Bergen, M (corresponding author), Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Leipzig, Germany.
EM christian.ahrens@agroscope.admin.ch; martin.vonbergen@ufz.de
RI von Bergen, Martin/D-7960-2011; Jehmlich, Nico/D-9041-2015; Daniel,
   Rolf/AAQ-5933-2021; Zimmermann, Johannes/HTP-7711-2023; Ahrens,
   Christian H./F-4656-2011; Canzler, Sebastian/AAT-8249-2020
OI von Bergen, Martin/0000-0003-2732-2977; Jehmlich,
   Nico/0000-0002-5638-6868; Daniel, Rolf/0000-0002-8646-7925; Zimmermann,
   Johannes/0000-0002-5041-1954; Ahrens, Christian H./0000-0002-8148-7257;
   Canzler, Sebastian/0000-0001-7935-9582; MARINOS,
   GEORGIOS/0000-0002-6443-7696; Petruschke, Hannes/0000-0002-7882-4179
FU DFG grant within the Priority Programme entitled "Small Proteins in
   Prokaryotes, an Unexplored World" [SPP 2002]; SNSF [156320, 197391]; DFG
   within the Excellence cluster "Precision Medicine in Chronic
   Inflammation" [EXC 22167]; DFG within collaborative research center
   "Metaorganisms" (CRC 1182); Projekt DEAL
FX This research project was funded by the DFG grant within the Priority
   Programme entitled "Small Proteins in Prokaryotes, an Unexplored World"
   (SPP 2002). CA acknowledges funding for CS from the SNSF (grants 156320
   and 197391). CK acknowledges support by the DFG within the Excellence
   cluster "Precision Medicine in Chronic Inflammation" (EXC 22167,
   sub-project RTF-VIII) and the collaborative research center
   "Metaorganisms" (CRC 1182, sub-project A1). Open Access funding enabled
   and organized by Projekt DEAL.
CR Aden K, 2019, GASTROENTEROLOGY, V157, P1279, DOI 10.1053/j.gastro.2019.07.025
   Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429
   Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   [Anonymous], 2017, LANG ENV STAT COMP
   Antipov D, 2016, BIOINFORMATICS, V32, P3380, DOI 10.1093/bioinformatics/btw493
   Barlow P, 2018, J BIOL CHEM, V293, P8691, DOI 10.1074/jbc.H118.002949
   Becker N, 2011, GUT MICROBES, V2, P25, DOI 10.4161/gmic.2.1.14651
   BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995
   Blakeley P, 2012, J PROTEOME RES, V11, P5221, DOI 10.1021/pr300411q
   Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191
   Cassidy L, 2016, J PROTEOME RES, V15, P3773, DOI 10.1021/acs.jproteome.6b00569
   Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377
   Chen J, 2020, SCIENCE, V367, P1140, DOI 10.1126/science.aay0262
   CLARKE DJ, 1976, J GEN MICROBIOL, V95, P67, DOI 10.1099/00221287-95-1-67
   Dahms NM., 1810, BIOCH BIOPHYS ACTA, V2011, P826
   de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124
   Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176
   Duval M, 2017, CURR OPIN MICROBIOL, V39, P81, DOI 10.1016/j.mib.2017.09.010
   Fernandez N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00924
   Garrison E., 2012, ARXIV E PRINTS ARXIV
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571
   Giansanti P, 2016, NAT PROTOC, V11, P993, DOI 10.1038/nprot.2016.057
   Gouveia D, 2020, NPJ BIOFILMS MICROBI, V6, DOI 10.1038/s41522-020-0133-2
   Haange SB, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-0788-1
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   Hassan M, 2012, J APPL MICROBIOL, V113, P723, DOI 10.1111/j.1365-2672.2012.05338.x
   Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449
   Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645
   Isaac NI, 2019, CLIN MASS SPECTROM, V14, P18, DOI 10.1016/j.clinms.2019.06.001
   Kampf C, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3219-1
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113
   Karpinski TM, 2013, POL J MICROBIOL, V62, P223
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kelly G, 1999, NAT STRUCT BIOL, V6, P313
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4
   Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277
   Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8
   Koo T, 2019, J ENVIRON MANAGE, V237, P247, DOI 10.1016/j.jenvman.2019.02.084
   Krause JL, 2020, GUT MICROBES, V11, DOI 10.1080/19490976.2019.1702431
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Ladha G, 2020, WORLD J MICROB BIOT, V36, DOI 10.1007/s11274-020-02847-w
   Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7
   Li H, 2013, 13033997V1 ARXIV, p1303.3997v1
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lohmann P, 2020, EXPERT REV PROTEOMIC, V17, P163, DOI 10.1080/14789450.2020.1738931
   MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442
   Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Mayjonade B, 2016, BIOTECHNIQUES, V61, P203, DOI 10.2144/000114460
   Melior H, 2020, MBIO, V11, DOI 10.1128/mBio.01027-20
   Moreno-Gamez S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00903-y
   Mortera SL, 2019, J PROTEOMICS, V203, DOI 10.1016/j.jprot.2019.103378
   Muller SA, 2013, J PROTEOMICS, V86, P27, DOI 10.1016/j.jprot.2013.04.036
   Muller SA, 2010, ANAL BIOANAL CHEM, V398, P2867, DOI 10.1007/s00216-010-4093-x
   Muth T, 2015, PROTEOMICS, V15, P3439, DOI 10.1002/pmic.201400560
   Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/nmeth.3144, 10.1038/NMETH.3144]
   Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009
   NissenMeyer J, 1997, ARCH MICROBIOL, V167, P67, DOI 10.1007/s002030050418
   Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566
   Omasits U, 2017, GENOME RES, V27, P2083, DOI 10.1101/gr.218255.116
   Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112
   Petruschke H, 2020, J PROTEOMICS, V213, DOI 10.1016/j.jprot.2019.103604
   Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647
   Raina M, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00130-17
   ROLFE RD, 1981, J INFECT DIS, V143, P470, DOI 10.1093/infdis/143.3.470
   Sberro H, 2019, CELL, V178, P1245, DOI 10.1016/j.cell.2019.07.016
   Schape SS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120641
   Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418
   Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7
   Singhal P, 2008, BIOPHYS J, V94, P4173, DOI 10.1529/biophysj.107.116392
   Soma Barman, 2018, Annals of Agrarian Science, V16, P286, DOI 10.1016/j.aasci.2018.05.004
   Sovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11307
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122
   Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400
   Stubbendieck RM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01234
   Stubbendieck RM, 2016, J BACTERIOL, V198, P2145, DOI 10.1128/JB.00275-16
   Su Mingming, 2013, Frontiers in Genetics, V4, P286, DOI 10.3389/fgene.2013.00286
   Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u
   Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   VanOrsdel CE, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700064
   Varadarajan AR, 2020, NPJ BIOFILMS MICROBI, V6, DOI 10.1038/s41522-020-00154-8
   Varadarajan AR, 2020, J PROTEOME RES, V19, P1647, DOI 10.1021/acs.jproteome.9b00842
   Veltri D, 2018, BIOINFORMATICS, V34, P2740, DOI 10.1093/bioinformatics/bty179
   Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131
   Weaver J, 2019, MBIO, V10, DOI 10.1128/mBio.02819-18
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4
   Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101
   Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618
   Zimmermann J, 2020, BIORXIV, DOI DOI 10.1101/2020.03.20.000737
   Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n
NR 95
TC 15
Z9 15
U1 4
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PD FEB 23
PY 2021
VL 9
IS 1
AR 55
DI 10.1186/s40168-020-00981-z
PG 19
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA QO6EL
UT WOS:000623233400003
PM 33622394
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Lawley, B
   Centanni, M
   Watanabe, J
   Sims, I
   Carnachan, S
   Broadbent, R
   Lee, PS
   Wong, KH
   Tannock, GW
AF Lawley, Blair
   Centanni, Manuela
   Watanabe, Jun
   Sims, Ian
   Carnachan, Susan
   Broadbent, Roland
   Lee, Pheng Soon
   Wong, Khai Hong
   Tannock, Gerald W.
TI tuf Gene Sequence Variation in Bifidobacterium longum subsp infantis
   Detected in the Fecal Microbiota of Chinese Infants
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE Bifidobacterium longum subsp infantis; microbiota; qPCR
ID DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN GUT MICROBIOME; HUMAN-MILK; PCR;
   OLIGOSACCHARIDES; IDENTIFICATION; FORMULA; LACTOBACILLUS; POPULATIONS;
   CYTOKINES
AB Members of the bacterial genus Bifidobacterium generally dominate the fecal microbiota of infants. The species Bifidobacterium longum is prevalent, but the B. longum subsp. longum and B. longum subsp. infantis strains that are known to colonize the infant bowel are not usually differentiated in microbiota investigations. These subspecies differ in their capacities to metabolize human milk oligosaccharides (HMO) and may have different ecological and symbiotic roles in humans. Quantitative PCR provides a quick analytical method by which to accurately ascertain the abundances of target species in microbiotas and microcosms. However, amplification targets in DNA extracted from samples need to be dependably differential. We evaluated the tuf gene sequence as a molecular target for quantitative PCR measurements of the abundances of B. longum subsp. infantis and B. longum subsp. longum in fecal microbiotas. This approach resulted in the detection of a tuf gene variant (operational taxonomic unit 49 [OTU49]) in Chinese infants that has sequence similarities to both B. longum subsp. infantis and B. longum subsp. longum. We compared the genome sequence and growth and transcriptional characteristics of an OTU49 isolate cultured in HMO medium to those of other B. longum subsp. infantis cultures. We concluded from these studies that OTU49 belongs to B. longum subsp. infantis, that dependable quantitative PCR (qPCR) differentiation between the B. longum subspecies cannot be achieved by targeting tuf gene sequences, and that functional genes involved in carbohydrate metabolism might be better targets because they delineate ecological functions.
   IMPORTANCE High-throughput DNA sequencing methods and advanced bioinformatics analysis have revealed the composition and biochemical capacities of microbial communities (microbiota and microbiome), including those that inhabit the gut of human infants. However, the microbiology and function of natural ecosystems have received little attention in recent decades, so an appreciation of the dynamics of gut microbiota interactions is lacking. With respect to infants, rapid methodologies, such as quantitative PCR, are needed to determine the prevalences and proportions of different bifidobacterial species in observational and microcosm studies in order to obtain a better understanding of the dynamics of bifidobacterial nutrition and syntrophy, knowledge that might be used to manipulate the microbiota and perhaps ensure the better health of infants.
C1 [Lawley, Blair; Centanni, Manuela; Tannock, Gerald W.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.
   [Watanabe, Jun] Natl Food Res Inst, Fond Funct Div, Tsukuba, Ibaraki, Japan.
   [Sims, Ian; Carnachan, Susan] Victoria Univ Wellington, Ferrier Res Inst, Lower Hutt, New Zealand.
   [Broadbent, Roland] Univ Otago, Dunedin Sch Med, Womens & Childrens Hlth, Dunedin, New Zealand.
   [Lee, Pheng Soon] Univ Otago, Dept Human Nutr, Dunedin, New Zealand.
   [Lee, Pheng Soon; Wong, Khai Hong] Mead Johnson Nutr, Marina Bay, Singapore.
   [Tannock, Gerald W.] Ctr Res Excellence, Riddet Inst, Palmerston North, New Zealand.
   [Sims, Ian; Tannock, Gerald W.] Univ Otago, Microbiome Otago, Dunedin, New Zealand.
C3 University of Otago; National Agriculture & Food Research Organization -
   Japan; National Food Research Institute - Japan; Victoria University
   Wellington; University of Otago; University of Otago; University of
   Otago
RP Tannock, GW (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.; Tannock, GW (corresponding author), Ctr Res Excellence, Riddet Inst, Palmerston North, New Zealand.; Tannock, GW (corresponding author), Univ Otago, Microbiome Otago, Dunedin, New Zealand.
EM gerald.tannock@otago.ac.nz
OI Carnachan, Susie/0000-0002-4728-2389
FU National Food Research Institute (Japan) fellowship; Riddet Centre of
   Research Excellence
FX Jun Watanabe was supported by a National Food Research Institute (Japan)
   fellowship. The OTU49 research was supported in part by funding from the
   Riddet Centre of Research Excellence.
CR Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Aronesty E., 2011, EXPR ANAL DURHAM
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]
   BIAVATI B, 1984, MICROBIOLOGICA, V7, P341
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485
   D'Aimmo MR, 2012, J APPL MICROBIOL, V112, P975, DOI 10.1111/j.1365-2672.2012.05261.x
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Edwards David J, 2013, Microb Inform Exp, V3, P2, DOI 10.1186/2042-5783-3-2
   Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002
   Frese SA, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00501-17, 10.1128/msphere.00501-17]
   Goehring KC, 2016, J NUTR, V146, P2559, DOI 10.3945/jn.116.236919
   Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347
   Gronlund MM, 2011, GUT MICROBES, V2, P227, DOI 10.4161/gmic.2.4.16799
   Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106
   Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937
   Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lawley B, 2017, PEERJ, V5, DOI 10.7717/peerj.3375
   LoCascio RG, 2009, MICROB BIOTECHNOL, V2, P333, DOI 10.1111/j.1751-7915.2008.00072.x
   Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331
   Martin R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158498
   Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004
   McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042
   McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444
   Mignard S, 2007, J MED MICROBIOL, V56, P1033, DOI 10.1099/jmm.0.47105-0
   Milani C, 2015, APPL ENVIRON MICROB, V81, P7078, DOI 10.1128/AEM.02037-15
   Palys T, 2000, INT J SYST EVOL MICR, V50, P1021, DOI 10.1099/00207713-50-3-1021
   Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0
   Roy D, 1996, INT J FOOD MICROBIOL, V29, P11, DOI 10.1016/0168-1605(95)00013-5
   Ruhaak LR, 2014, ANAL BIOANAL CHEM, V406, P5775, DOI 10.1007/s00216-014-8025-z
   Sakamoto M, 2010, J MED MICROBIOL, V59, P1293, DOI 10.1099/jmm.0.020420-0
   Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105
   Tannock GW, 2013, APPL ENVIRON MICROB, V79, P3040, DOI 10.1128/AEM.03910-12
   Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001
   Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957
   Ventura M, 2003, APPL ENVIRON MICROB, V69, P6908, DOI 10.1128/AEM.69.11.6908-6922.2003
   Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996
   Ward R. E., 2009, OPEN GLYCOSCIENCE, V2, P9, DOI DOI 10.2174/1875398100902010009
   Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150
   Youn SY, 2008, LETT APPL MICROBIOL, V46, P7, DOI 10.1111/j.1472-765X.2007.02263.x
   Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 47
TC 7
Z9 8
U1 3
U2 19
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUL
PY 2018
VL 84
IS 13
AR e00336-18
DI 10.1128/AEM.00336-18
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Microbiology
GA GJ6CS
UT WOS:000435471900011
PM 29703739
OA Green Published, Bronze
DA 2023-09-14
ER

PT J
AU Gupta, VK
   Bakshi, U
   Chang, DN
   Lee, AR
   Davis, JM
   Chandrasekaran, S
   Jin, YS
   Freeman, MF
   Sung, JY
AF Gupta, Vinod K.
   Bakshi, Utpal
   Chang, Daniel
   Lee, Aileen R.
   Davis III, John M. M.
   Chandrasekaran, Sriram
   Jin, Yong-Su
   Freeman, Michael F.
   Sung, Jaeyun
TI TaxiBGC: a Taxonomy-Guided Approach for Profiling Experimentally
   Characterized Microbial Biosynthetic Gene Clusters and Secondary
   Metabolite Production Potential in Metagenomes
SO MSYSTEMS
LA English
DT Article
DE biosynthetic gene cluster; natural product; secondary metabolite;
   metagenomics; microbiome; biomarkers; bacteriocin
ID NATURAL-PRODUCTS; IDENTIFICATION; BACTERIAL; GENOMES; HEALTH
AB Currently available bioinformatics tools to identify BGCs from metagenomic sequencing data are limited in their predictive capability or ease of use to even computationally oriented researchers. We present an automated computational pipeline called TaxiBGC, which predicts experimentally characterized BGCs (and infers their known SMs) in shotgun metagenomes by first considering the microbial species source.
   Biosynthetic gene clusters (BGCs) in microbial genomes encode bioactive secondary metabolites (SMs), which can play important roles in microbe-microbe and host-microbe interactions. Given the biological significance of SMs and the current profound interest in the metabolic functions of microbiomes, the unbiased identification of BGCs from high-throughput metagenomic data could offer novel insights into the complex chemical ecology of microbial communities. Currently available tools for predicting BGCs from shotgun metagenomes have several limitations, including the need for computationally demanding read assembly, predicting a narrow breadth of BGC classes, and not providing the SM product. To overcome these limitations, we developed taxonomy-guided identification of biosynthetic gene clusters (TaxiBGC), a command-line tool for predicting experimentally characterized BGCs (and inferring their known SMs) in metagenomes by first pinpointing the microbial species likely to harbor them. We benchmarked TaxiBGC on various simulated metagenomes, showing that our taxonomy-guided approach could predict BGCs with much-improved performance (mean F-1 score, 0.56; mean PPV score, 0.80) compared with directly identifying BGCs by mapping sequencing reads onto the BGC genes (mean F-1 score, 0.49; mean PPV score, 0.41). Next, by applying TaxiBGC on 2,650 metagenomes from the Human Microbiome Project and various case-control gut microbiome studies, we were able to associate BGCs (and their SMs) with different human body sites and with multiple diseases, including Crohn's disease and liver cirrhosis. In all, TaxiBGC provides an in silico platform to predict experimentally characterized BGCs and their SM production potential in metagenomic data while demonstrating important advantages over existing techniques.IMPORTANCE Currently available bioinformatics tools to identify BGCs from metagenomic sequencing data are limited in their predictive capability or ease of use to even computationally oriented researchers. We present an automated computational pipeline called TaxiBGC, which predicts experimentally characterized BGCs (and infers their known SMs) in shotgun metagenomes by first considering the microbial species source. Through rigorous benchmarking techniques on simulated metagenomes, we show that TaxiBGC provides a significant advantage over existing methods. When demonstrating TaxiBGC on thousands of human microbiome samples, we associate BGCs encoding bacteriocins with different human body sites and diseases, thereby elucidating a possible novel role of this antibiotic class in maintaining the stability of microbial ecosystems throughout the human body. Furthermore, we report for the first time gut microbial BGC associations shared among multiple pathologies. Ultimately, we expect our tool to facilitate future investigations into the chemical ecology of microbial communities across diverse niches and pathologies.
C1 [Gupta, Vinod K.; Sung, Jaeyun] Mayo Clin, Ctr Individualized Med, Microbiome Program, Rochester, MN 55902 USA.
   [Gupta, Vinod K.; Sung, Jaeyun] Mayo Clin, Dept Surg, Div Surg Res, Rochester, MN 55902 USA.
   [Bakshi, Utpal] Presidency Univ, Inst Hlth Sci, Kolkata, W Bengal, India.
   [Chang, Daniel] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA.
   [Lee, Aileen R.; Freeman, Michael F.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, St Paul, MN USA.
   [Davis III, John M. M.; Sung, Jaeyun] Mayo Clin, Dept Med, Div Rheumatol, Rochester, MN 55902 USA.
   [Chandrasekaran, Sriram] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI USA.
   [Chandrasekaran, Sriram] Univ Michigan, Program Chem Biol, Ann Arbor, MI USA.
   [Chandrasekaran, Sriram] Univ Michigan, Ctr Bioinformat & Computat Med, Ann Arbor, MI USA.
   [Jin, Yong-Su] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA.
   [Jin, Yong-Su] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA.
   [Lee, Aileen R.; Freeman, Michael F.] Univ Minnesota Twin Cities, BioTechnol Inst, St Paul, MN USA.
C3 Mayo Clinic; Mayo Clinic; Presidency University, Kolkata; University of
   Minnesota System; University of Minnesota Twin Cities; University of
   Minnesota System; University of Minnesota Twin Cities; Mayo Clinic;
   University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; University of Illinois System; University of
   Illinois Urbana-Champaign; University of Illinois System; University of
   Illinois Urbana-Champaign; University of Minnesota System; University of
   Minnesota Twin Cities
RP Sung, JY (corresponding author), Mayo Clin, Ctr Individualized Med, Microbiome Program, Rochester, MN 55902 USA.; Sung, JY (corresponding author), Mayo Clin, Dept Surg, Div Surg Res, Rochester, MN 55902 USA.; Sung, JY (corresponding author), Mayo Clin, Dept Med, Div Rheumatol, Rochester, MN 55902 USA.
EM Sung.Jaeyun@mayo.edu
RI Freeman, Michael/AIA-1555-2022; Gupta, Vinod K./AAR-9326-2021
OI Freeman, Michael/0000-0002-0491-9618; Gupta, Vinod
   K./0000-0003-1467-9993; Chandrasekaran, Sriram/0000-0002-8405-5708;
   Chang, Daniel/0000-0003-0076-2833
FU Mayo Clinic Center for Individualized Medicine; Mark E. and Mary A.
   Davis to Mayo Clinic Center for Individualized Medicine
FX We declare no conflict of interest. We thank David N. Rider and Ronald
   L. Neuharth for their help in downloading all metagenome samples used in
   our study. This work was supported in part by the Mayo Clinic Center for
   Individualized Medicine (J.S.) and Mark E. and Mary A. Davis to Mayo
   Clinic Center for Individualized Medicine (J.M.D. and J.S.). The funders
   had no role in the study design, data collection and interpretation, or
   the decision to submit the work for publication. J.S. conceived the
   problem. V.K.G., U.B., and J.S. designed all analytical methodologies.
   V.K.G., U.B., and D.C. built the TaxiBGC computational pipeline. V.K.G.
   performed all analyses. All authors analyzed the data. V.K.G., U.B., and
   J.S. wrote the manuscript, with editorial contributions from other
   authors.
CR Andreu VP, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00937-21
   Andreu VP, 2021, NUCLEIC ACIDS RES, V49, pW263, DOI 10.1093/nar/gkab353
   Baral B, 2018, SYN SYST BIOTECHNO, V3, P163, DOI 10.1016/j.synbio.2018.09.001
   Beghini F, 2021, ELIFE, V10, DOI 10.7554/eLife.65088
   Bessa LJ, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw150
   Brown JM, 2017, J BIOL CHEM, V292, P8560, DOI 10.1074/jbc.R116.765388
   Bushnell B., 2014, BBTOOLS SOFTWARE PAC
   Cech NB, 2021, NAT PROD REP, V38, P1947, DOI 10.1039/d1np00061f
   Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034
   Cobo-Lopez Sergio, 2022, PNAS Nexus, V1, ppgac055, DOI 10.1093/pnasnexus/pgac055
   Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273
   Culp EJ, 2019, NAT BIOTECHNOL, V37, P1149, DOI 10.1038/s41587-019-0241-9
   Davies J, 2013, J ANTIBIOT, V66, P361, DOI 10.1038/ja.2013.61
   Demain AL, 2011, MICROB BIOTECHNOL, V4, P687, DOI 10.1111/j.1751-7915.2010.00221.x
   Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11
   Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766
   Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4
   Glowacki RWP, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008370
   Gupta VK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18476-8
   Hannigan GD, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz654
   He Qing, 2017, Gigascience, V6, P1, DOI 10.1093/gigascience/gix050
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Jia B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075448
   Kalkreuter E, 2020, TRENDS PHARMACOL SCI, V41, P13, DOI 10.1016/j.tips.2019.11.002
   Kautsar SA, 2020, NUCLEIC ACIDS RES, V48, pD454, DOI 10.1093/nar/gkz882
   Kim M, 2022, METAB ENG, V70, P12, DOI 10.1016/j.ymben.2021.12.011
   Lee N, 2020, COMPUT STRUCT BIOTEC, V18, P1548, DOI 10.1016/j.csbj.2020.06.024
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Maldonado-Barragan A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0663-1
   Mann J, 2001, NAT PROD REP, V18, P417, DOI 10.1039/b001720p
   Marinelli F, 2009, METHOD ENZYMOL, V458, P29, DOI 10.1016/S0076-6879(09)04802-2
   Martinez KB, 2017, J BIOL CHEM, V292, P8553, DOI 10.1074/jbc.R116.752899
   McBurney MI, 2019, J NUTR, V149, P1880, DOI 10.1093/jn/nxz154
   Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890
   Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466
   Meleshko D, 2019, GENOME RES, V29, P1352, DOI 10.1101/gr.243477.118
   Navarro-Munoz JC, 2020, NAT CHEM BIOL, V16, P60, DOI 10.1038/s41589-019-0400-9
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Pham JV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01404
   Priya S, 2022, NAT MICROBIOL, V7, P780, DOI 10.1038/s41564-022-01121-z
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Schmidt R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00893-3
   Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106
   Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016
   Singh BP, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00914
   Skinnider MA, 2015, NUCLEIC ACIDS RES, V43, P9645, DOI 10.1093/nar/gkv1012
   Sugimoto Y, 2019, SCIENCE, V366, P1332, DOI 10.1126/science.aax9176
   Sung J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15393
   Sung J, 2016, APPL TRANSL GENOM, V10, P10, DOI 10.1016/j.atg.2016.02.001
   Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13
   Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004
   Watanabe A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92370-1
   Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
NR 60
TC 2
Z9 2
U1 9
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD DEC
PY 2022
VL 7
IS 6
DI 10.1128/msystems.00925-22
EA NOV 2022
PG 17
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 8M6WL
UT WOS:000885569100001
PM 36378489
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Szostak, N
   Handschuh, L
   Samelak-Czajka, A
   Tomela, K
   Schmidt, M
   Pruss, L
   Milanowska-Zabel, K
   Kozlowski, P
   Philips, A
AF Szostak, Natalia
   Handschuh, Luiza
   Samelak-Czajka, Anna
   Tomela, Katarzyna
   Schmidt, Marcin
   Pruss, Lukasz
   Milanowska-Zabel, Kaja
   Kozlowski, Piotr
   Philips, Anna
TI Host Factors Associated with Gut Mycobiome Structure
SO MSYSTEMS
LA English
DT Article
DE gut mycobiome; intestinal microbiota; high-throughput sequencing;
   taxonomy profiling; bioinformatics; next-generation sequencing
ID ASPERGILLUS-FUMIGATUS; FUNGAL MICROBIOTA; CANDIDA-ALBICANS; ANTIBIOTICS;
   PATHOGENESIS; INFLAMMATION; YEASTS; TOOLS; OBESE; DIET
AB The human gut is inhabited by many organisms, including bacteria and fungi, that may affect human health. However, research on human gut mycobiome is still rare.
   Recent studies revealed a significant role of the gut fungal community in human health. Here, we investigated the content and variation of gut mycobiota among subjects from the European population. We explored the interplay between gut fungi and various host-related sociodemographic, lifestyle, health, and dietary factors. The study included 923 participants. Fecal DNA samples were analyzed by whole-metagenome high-throughput sequencing. Subsequently, fungi taxonomic profiles were determined and accompanied by computational and statistical analyses of the association with 53 host-related factors. Fungal communities were characterized by a high prevalence of Saccharomyces, Candida, and Sporisorium. Ten factors were found to correlate significantly with the overall mycobiota variation. Most were diet related, including the consumption of chips, meat, sodas, sweetening, processed food, and alcohol, followed by age and marital status. Differences in alpha- and/or beta-diversity were also reported for other factors such as body mass index (BMI), job type, autoimmunological diseases, and probiotics. Differential abundance analysis revealed fungal species that exhibited different patterns of changes under specific conditions. The human gut mycobiota is dominated by yeast, including Saccharomyces, Malassezia, and Candida. Although intervolunteer variability was high, several fungal species persisted across most samples, which may be evidence that a core gut mycobiota exists. Moreover, we showed that host-related factors such as diet, age, and marital status influence the variability of gut mycobiota. To our knowledge, this is the first large and comprehensive study of the European cohort in terms of gut mycobiota associations with such an extensive and differentiated host-related set of factors.IMPORTANCE The human gut is inhabited by many organisms, including bacteria and fungi, that may affect human health. However, research on human gut mycobiome is still rare. Moreover, the large European-based cohort study is missing. Here, we analyzed the first large European cohort in terms of gut mycobiota associations with a differentiated host-related set of factors. Our results showed that chips, meat, sodas, sweetening, processed food, beer, alcohol consumption, age, and marital status were associated with the variability of gut mycobiota. Moreover, our analysis revealed changes in abundances at the fungal species level for many investigated factors. Our results can suggest potentially valuable paths for further, narrowly focused research on gut mycobiome and its impact on human health. In the coming era of gut microbiome-based precision medicine, further research into the relationship between different mycobial structures and host-related factors may result in new preventive approaches or therapeutic procedures.
C1 [Szostak, Natalia; Handschuh, Luiza; Samelak-Czajka, Anna; Tomela, Katarzyna; Schmidt, Marcin; Kozlowski, Piotr; Philips, Anna] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.
   [Handschuh, Luiza] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland.
   [Tomela, Katarzyna] Poznan Univ Med Sci, Chair Med Biotechnol, Dept Canc Immunol, Poznan, Poland.
   [Schmidt, Marcin] Poznan Univ Life Sci, Dept Food Biotechnol & Microbiol, Poznan, Poland.
   [Pruss, Lukasz; Milanowska-Zabel, Kaja] Ardigen SA, Krakow, Poland.
   [Pruss, Lukasz] Wroclaw Univ Sci & Technol, Fac Chem, Dept Biochem Mol Biol & Biotechnol, Wroclaw, Poland.
C3 Polish Academy of Sciences; Institute of Bioorganic Chemistry of the
   Polish Academy of Sciences; Poznan University of Technology; Poznan
   University of Medical Sciences; Poznan University of Life Sciences;
   Wroclaw University of Science & Technology
RP Philips, A (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.
EM aphilips@ibch.poznan.pl
RI Schmidt, Marcin/N-2740-2019; Szostak, Natalia/GPX-0551-2022; Schmidt,
   Marcin/A-6997-2008; Kozlowski, Piotr/I-1860-2019
OI Schmidt, Marcin/0000-0001-8417-2245; Szostak,
   Natalia/0000-0001-9933-0496; Schmidt, Marcin/0000-0001-8417-2245;
   Kozlowski, Piotr/0000-0003-3770-7715; Pruss, Lukasz/0000-0002-7223-9382;
   Samelak-Czajka, Anna/0000-0002-0167-8265
FU European Regional Development Fund under the Smart Growth Operational
   Program, Submeasure 4.1.2, Regional Research Agendas
   [POIR.04.01.02-00-0025/17-00]; Polish National Science Centre
   [UMO-2021/41/B/NZ9/03765]
FX This work was carried out under contract no. POIR.04.01.02-00-0025/17-00
   to A.P., as Polish Microbiome Map cofinanced by the European Regional
   Development Fund under the Smart Growth Operational Program, Submeasure
   4.1.2, Regional Research Agendas. This work was also supported by
   research grant from the Polish National Science Centre to A.P.
   (UMO-2021/41/B/NZ9/03765).
CR Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x
   Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500
   Borges FM, 2018, CURR MICROBIOL, V75, P726, DOI 10.1007/s00284-018-1438-8
   Cabral DJ, 2018, MICROB CELL, V5, P249, DOI 10.15698/mic2018.05.631
   Calderone R.A., 2011, CANDIDA CANDIDIASIS
   Cheema A, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010404
   Chiaro T, 2021, SCIENCE, V371, P1102, DOI 10.1126/science.abg6017
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Clancy C. J., 2012, Candida and candidiasis, P429
   CLARK JD, 1971, INFECT IMMUN, V4, P731, DOI 10.1128/IAI.4.6.731-737.1971
   DALTON HK, 1984, A VAN LEEUW J MICROB, V50, P227, DOI 10.1007/BF02342134
   Das A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79478-6
   de La Cuesta-Zuluag J, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00261-19
   Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107
   Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354
   Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503
   FLEET GH, 1990, J APPL BACTERIOL, V68, P199, DOI 10.1111/j.1365-2672.1990.tb02566.x
   Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11
   Gao WK, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1984122
   Garcia-Gonzalez A, 2009, REV INVEST CLIN, V61, P212
   Hallen-Adams HE, 2017, VIRULENCE, V8, P352, DOI 10.1080/21505594.2016.1247140
   He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x
   Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019
   Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07
   Hong GC, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13891
   Illumina, 2015, BCL2FASTQ BCL2FASTQ2
   Jiang HY, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1677
   Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013
   Kaplan GG, 2016, LANCET GASTROENTEROL, V1, P307, DOI 10.1016/S2468-1253(16)30077-2
   Kazemi A., 2021, NEUROSCIENCE DEPRESS, P463, DOI DOI 10.1016/B978-0-12-817935-2.00048-9
   Kim YS, 2020, WORLD J MENS HEALTH, V38, P48, DOI 10.5534/wjmh.190009
   Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010
   Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
   Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035
   Kong FL, 2016, CURR BIOL, V26, pR832, DOI 10.1016/j.cub.2016.08.015
   Krause R, 2005, CLIN MICROBIOL INFEC, V11, P1, DOI 10.1111/j.1469-0691.2004.00978.x
   Leonardi I, 2022, CELL, V185, P831, DOI 10.1016/j.cell.2022.01.017
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   LIN H, 2020, NAT COMMUN, V11
   Lou MX, 2022, GUT, V71, P1588, DOI 10.1136/gutjnl-2021-325115
   Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104
   Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521
   Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Morales P, 2010, REV MED CHILE, V138, P1020, DOI /S0034-98872010000800013
   Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4
   Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004
   ODDS FC, 1987, CRC CR REV MICROBIOL, V15, P1
   Palleja A, 2018, NAT MICROBIOL, V3, P1255, DOI 10.1038/s41564-018-0257-9
   Palma ML, 2015, APPL MICROBIOL BIOT, V99, P6563, DOI 10.1007/s00253-015-6776-x
   Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313
   Perez JC, 2021, INT J MED MICROBIOL, V311, DOI 10.1016/j.ijmm.2021.151490
   Philips A, 2017, GIGASCIENCE, V6
   Philips A, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06810-9
   R Core Team, 2017, PSYCH PROCEDURES PER
   R Core Team, 2020, VEG PACK COMM ECOL
   Richard ML, 2019, NAT REV GASTRO HEPAT, V16, P331, DOI 10.1038/s41575-019-0121-2
   SAMONIS G, 1993, ANTIMICROB AGENTS CH, V37, P51, DOI 10.1128/AAC.37.1.51
   Seelbinder B, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00899-6
   Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853
   Shuai ML, 2022, GUT, V71, P1810, DOI 10.1136/gutjnl-2021-326298
   Spellberg B., 2012, Candida and candidiasis, P1
   Stirling C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-122
   Strati F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01227
   Sun SS, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02753-3
   Sun SY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.777665
   Sun Y, 2021, GASTROENTEROLOGY, V160, P272, DOI 10.1053/j.gastro.2020.09.014
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   Szostak N, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-12037-3
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Valeri F, 2021, FRONT NEUROENDOCRIN, V61, DOI 10.1016/j.yfrne.2021.100912
   Wang ZK, 2014, ALIMENT PHARM THER, V39, P751, DOI 10.1111/apt.12665
   Wood Derrick E, 2019, Genome Biol, V20, P257, DOI 10.1186/s13059-019-1891-0
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Wu XY, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01024-x
   Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zeng SL, 2022, LIVER INT, V42, P729, DOI 10.1111/liv.15160
   Zhai B, 2020, NAT MED, V26, P59, DOI 10.1038/s41591-019-0709-7
   Zhang L, 2021, THER ADV GASTROENTER, V14, DOI 10.1177/17562848211047130
NR 84
TC 4
Z9 4
U1 12
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD APR 27
PY 2023
VL 8
IS 2
DI 10.1128/msystems.00986-22
EA FEB 2023
PG 23
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA E3EP8
UT WOS:000937364800001
PM 36786595
OA Green Published, gold
DA 2023-09-14
ER

PT J
AU Andreu-Sanchez, S
   Chen, LM
   Wang, DM
   Augustijn, HE
   Zhernakova, A
   Fu, JY
AF Andreu-Sanchez, Sergio
   Chen, Lianmin
   Wang, Daoming
   Augustijn, Hannah E.
   Zhernakova, Alexandra
   Fu, Jingyuan
TI A Benchmark of Genetic Variant Calling Pipelines Using Metagenomic
   Short-Read Sequencing
SO FRONTIERS IN GENETICS
LA English
DT Article
DE metagenomics; shotgun sequencing; short-reads; variant-calling;
   benchmark
ID DISCOVERY
AB Microbes live in complex communities that are of major importance for environmental ecology, public health, and animal physiology and pathology. Short-read metagenomic shotgun sequencing is currently the state-of-the-art technique for exploring these communities. With the aid of metagenomics, our understanding of the microbiome is moving from composition toward functionality, even down to the genetic variant level. While the exploration of single-nucleotide variation in a genome is a standard procedure in genomics, and many sophisticated tools exist to perform this task, identification of genetic variation in metagenomes remains challenging. Major factors that hamper the widespread application of variant-calling analysis include low-depth sequencing of individual genomes (which is especially significant for the microorganisms present in low abundance), the existence of large genomic variation even within the same species, the absence of comprehensive reference genomes, and the noise introduced by next-generation sequencing errors. Some bioinformatics tools, such as metaSNV or InStrain, have been created to identify genetic variants in metagenomes, but the performance of these tools has not been systematically assessed or compared with the variant callers commonly used on single or pooled genomes. In this study, we benchmark seven bioinformatic tools for genetic variant calling in metagenomics data and assess their performance. To do so, we simulated metagenomic reads to mimic human microbial composition, sequencing errors, and genetic variability. We also simulated different conditions, including low and high depth of coverage and unique or multiple strains per species. Our analysis of the simulated data shows that probabilistic method-based tools such as HaplotypeCaller and Mutect2 from the GATK toolset show the best performance. By applying these tools to longitudinal gut microbiome data from the Human Microbiome Project, we show that the genetic similarity between longitudinal samples from the same individuals is significantly greater than the similarity between samples from different individuals. Our benchmark shows that probabilistic tools can be used to call metagenomes, and we recommend the use of GATK's tools as reliable variant callers for metagenomic samples.
C1 [Andreu-Sanchez, Sergio; Chen, Lianmin; Wang, Daoming; Augustijn, Hannah E.; Zhernakova, Alexandra; Fu, Jingyuan] Univ Groningen, Dept Genet, Groningen, Netherlands.
   [Andreu-Sanchez, Sergio; Chen, Lianmin; Wang, Daoming; Augustijn, Hannah E.; Zhernakova, Alexandra; Fu, Jingyuan] Univ Med Ctr Groningen, Groningen, Netherlands.
   [Andreu-Sanchez, Sergio; Chen, Lianmin; Fu, Jingyuan] Univ Groningen, Dept Pediat, Groningen, Netherlands.
C3 University of Groningen; University of Groningen; University of
   Groningen
RP Fu, JY (corresponding author), Univ Groningen, Dept Genet, Groningen, Netherlands.; Fu, JY (corresponding author), Univ Med Ctr Groningen, Groningen, Netherlands.; Fu, JY (corresponding author), Univ Groningen, Dept Pediat, Groningen, Netherlands.
EM j.fu@umcg.nl
RI Fu, Jingyuan/ABE-6868-2020; Zhernakova, Alexandra/ABA-9372-2020; Wang,
   Daoming/CAI-2445-2022; Wang, Daoming/CAF-6851-2022; Chen,
   Lianmin/ABE-5876-2020
OI Fu, Jingyuan/0000-0001-5578-1236; Wang, Daoming/0000-0003-4623-8527;
   Chen, Lianmin/0000-0003-0660-3518; Augustijn,
   Hannah/0000-0002-1862-6699; Andreu-Sanchez, Sergio/0000-0002-3503-9971
FU Netherlands Heart Foundation (IN-CONTROL CVON grants) [2012-03,
   2018-27]; European Research Council (ERC) [715772, 101001678];
   Foundation De Cock-Hadders [20:20-13]; University Medical Centre
   Groningen [CSC201708320268]; China Scholarship Council [CSC201708320268,
   CSC201904910478]; Netherlands Organization for Scientific Research (NWO)
   [NWO-VICI VI.C.202.022, NWO-VIDI 016.178.056]; Netherlands Organization
   for Scientific Research (NWO) (NWO Gravitation Exposome) [NL
   024.004.017]; Netherlands Organization for Scientific Research (NWO)
   (NWO Gravitation Netherlands Organ-on-Chip Initiative) [024.003.001]
FX The researchers participating in this project were supported by the
   Netherlands Heart Foundation (IN-CONTROL CVON grants 2012-03 and 2018-27
   to AZ and JF), the Netherlands Organization for Scientific Research
   (NWO) (NWO-VICI VI.C.202.022 to JF, NWO-VIDI 016.178.056 to AZ, NWO
   Gravitation Exposome-NL 024.004.017 to JF and AZ, and NWO Gravitation
   Netherlands Organ-on-Chip Initiative 024.003.001 to JF), the European
   Research Council (ERC) (ERC Starting Grant 715772 to AZ and ERC
   Consolidator Grant 101001678 to JF), and the Foundation De Cock-Hadders
   (grant 20:20-13 to LC). LC also holds a joint fellowship from the
   University Medical Centre Groningen and China Scholarship Council
   (CSC201708320268). DW holds a fellowship from the China Scholarship
   Council (CSC201904910478).
CR Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Browne PD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa008
   Bush SJ, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa007
   Byrd AL, 2021, J EXP MED, V218, DOI 10.1084/jem.20200606
   Chen LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17840-y
   Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163
   Costea PI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182392
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116
   Gacesa R., 2020, BIORXIV PREPRINT
   Garrison E., HAPLOTYPE BASED VARI
   Gourle H, 2019, BIOINFORMATICS, V35, P521, DOI 10.1093/bioinformatics/bty630
   Gupta VK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18476-8
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480
   LANDER E S, 1988, Genomics, V2, P231
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Lou Y.C., 2021, INFANT GUT STRAIN PE, DOI [DOI 10.1101/2021.01.26.428340, 10.1101/ 2021.01.26.428340, DOI 10.2139/SSRN.3778932]
   Olm MR, 2021, NAT BIOTECHNOL, V39, P727, DOI 10.1038/s41587-020-00797-0
   Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x
   Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51
   Salosensaari A, 2020, AXONOMIC SIGNATURES, DOI [10.1101/2019.12.30.19015842, DOI 10.1101/2019.12.30.19015842]
   Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711
   Yoshimura D, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000261
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
NR 28
TC 9
Z9 9
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAY 10
PY 2021
VL 12
AR 648229
DI 10.3389/fgene.2021.648229
PG 15
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA SF9NQ
UT WOS:000653073500001
PM 34040632
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Li, WX
   Kari, L
   Yu, YL
   Hug, LA
AF Li, Wanxin
   Kari, Lila
   Yu, Yaoliang
   Hug, Laura A.
TI MT-MAG: Accurate and interpretable machine learning for complete or
   partial taxonomic assignments of metagenomeassembled genomes
SO PLOS ONE
LA English
DT Article
ID CLASSIFICATION
AB We propose MT-MAG, a novel machine learning-based software tool for the complete or partial hierarchically-structured taxonomic classification of metagenome-assembled genomes (MAGs). MT-MAG is alignment-free, with k-mer frequencies being the only feature used to distinguish a DNA sequence from another (herein k = 7). MT-MAG is capable of classifying large and diverse metagenomic datasets: a total of 245.68 Gbp in the training sets, and 9.6 Gbp in the test sets analyzed in this study. In addition to complete classifications, MT-MAG offers a "partial classification" option, whereby a classification at a higher taxonomic level is provided for MAGs that cannot be classified to the Species level. MT-MAG outputs complete or partial classification paths, and interpretable numerical classification confidences of its classifications, at all taxonomic ranks. To assess the performance of MT-MAG, we define a "weighted classification accuracy," with a weighting scheme reflecting the fact that partial classifications at different ranks are not equally informative. For the two benchmarking datasets analyzed (genomes from human gut microbiome species, and bacterial and archaeal genomes assembled from cow rumen metagenomic sequences), MT-MAG achieves an average of 87.32% in weighted classification accuracy. At the Species level, MT-MAG outperforms DeepMicrobes, the only other comparable software tool, by an average of 34.79% in weighted classification accuracy. In addition, MT-MAG is able to completely classify an average of 67.70% of the sequences at the Species level, compared with DeepMicrobes which only classifies 47.45%. Moreover, MT-MAG provides additional information for sequences that it could not classify at the Species level, resulting in the partial or complete classification of 95.13%, of the genomes in the datasets analyzed. Lastly, unlike other taxonomic assignment tools (e.g., GDTB-Tk), MT-MAG is an alignment-free and genetic marker-free tool, able to provide additional bioinformatics analysis to confirm existing or tentative taxonomic assignments.
C1 [Li, Wanxin; Kari, Lila; Yu, Yaoliang] Univ Waterloo, Sch Comp Sci, Waterloo, ON, Canada.
   [Hug, Laura A.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada.
C3 University of Waterloo; University of Waterloo
RP Li, WX (corresponding author), Univ Waterloo, Sch Comp Sci, Waterloo, ON, Canada.
EM wanxin.li@uwaterloo.ca
FU NSERC (Natural Sciences and Engineering Research Council of Canada)
   Discovery Grant NSERC (Natural Sciences and Engineering Research Council
   of Canada) [R2824A01 RGPIN-2017-05032]
FX We thank DeepMicrobes's co-author Qiaoxing Liang for the assistance with
   DeepMicrobes, Dr. Gurjit Randhawa for the guidance on MLDSP, Fatemeh
   Alipour and Pablo Millan Arias for replicating the results and
   proofreading the manuscript. Resources used in preparing this research
   were provided, in part, by the Province of Ontario, the Government of
   Canada through CIFAR, and the Vector Institute.
CR Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1
   Almeida JS, 2001, BIOINFORMATICS, V17, P429, DOI 10.1093/bioinformatics/17.5.429
   Arias PM, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0261531
   Babbar R, 2013, ANN C NEURAL INFORM, P1824
   Chaumeil PA, 2020, BIOINFORMATICS, V36, P1925, DOI 10.1093/bioinformatics/btz848
   Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048
   Eisenhofer R, 2019, PEERJ, V7, DOI 10.7717/peerj.6594
   Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178
   Frioux C, 2020, COMPUT STRUCT BIOTEC, V18, P1722, DOI 10.1016/j.csbj.2020.06.028
   Gao J, 2006, IEEE DATA MINING, P212
   Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708
   Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Liang QX, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa009
   Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257
   Mock F., 2021, BIORXIV
   Murali A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0521-5
   Murray AE, 2020, NAT MICROBIOL, V5, P987, DOI 10.1038/s41564-020-0733-x
   Ounit R, 2016, BIOINFORMATICS, V32, P3823, DOI 10.1093/bioinformatics/btw542
   Ounit R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1419-2
   Parks DH, 2020, NAT BIOTECHNOL, V38, P1079, DOI 10.1038/s41587-020-0501-8
   Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229
   Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7
   Perini L, 2020, JOINT EUROPEAN C MAC, P1824
   Platt JC, 2000, ADV NEUR IN, P61
   Ramaswamy HG, 2015, PR MACH LEARN RES, V37, P1852
   Randhawa GS, 2020, BIOINFORMATICS, V36, P2258, DOI 10.1093/bioinformatics/btz918
   Randhawa GS, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5571-y
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Sharon I, 2013, SCIENCE, V342, P1057, DOI 10.1126/science.1247023
   Stewart RD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03317-6
   Wang YW, 2005, GENE, V346, P173, DOI 10.1016/j.gene.2004.10.021
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546
   Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7
NR 35
TC 0
Z9 0
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 18
PY 2023
VL 18
IS 8
DI 10.1371/journal.pone.0283536
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA P6JI8
UT WOS:001051715300010
PM 37594964
OA gold
DA 2023-09-14
ER

PT J
AU Forsman, AM
   Savage, AE
   Hoenig, BD
   Gaither, MR
AF Forsman, Anna M.
   Savage, Anna E.
   Hoenig, Brandon D.
   Gaither, Michelle R.
TI DNA Metabarcoding Across Disciplines: Sequencing Our Way to Greater
   Understanding Across Scales of Biological Organization
SO INTEGRATIVE AND COMPARATIVE BIOLOGY
LA English
DT Article
ID ENVIRONMENTAL DNA; DIET
AB DNA metabarcoding describes the use of targeted DNA (i.e., amplicon) sequencing to identify community constituents from a complex sample containing genetic material from multiple organisms, such as water, soil, gut contents, microbiomes, or biofilms. This molecular approach for characterizing mixed DNA samples relies on the development of "universal primers" that allow for effective amplification of target sequences across a broad range of taxa. Armed with optimized lab protocols and rigorous bioinformatics tools, DNA metabarcoding can produce a wealth of information about the hidden biodiversity of various sample types by probing for organisms' molecular footprints. DNA metabarcoding has received considerable popular press over the last few years because of gut microbiome studies in humans and beyond. However, there are many other applications that are continually integrating molecular biology with other fields of study to address questions that have previously been unanswerable, for both prokaryotic and eukaryotic targets. For example, we can now sample mostly digested gut contents from virtually any organism to learn about ontogeny and foraging ecology. Water samples collected from different locations can be filtered to extract eDNA (i.e., environmental DNA), revealing the biodiversity of fish and other taxa targeted by carefully selected primer sets. This universal primer metabarcoding approach has even been extended to looking at diverse gene families within single species, which is particularly useful for complex immune system genetics. The purpose of this SICB symposium was to bring together researchers using DNA metabarcoding approaches to (a) showcase the diversity of applications of this technique for addressing questions spanning ecology, evolution, and physiology, and (b) to spark connections among investigators from different fields that are utilizing similar approaches to facilitate optimization and standardization of metabarcoding methods and analyses. The resulting manuscripts from this symposium represent a great diversity of metabarcoding applications and taxonomic groups of interest.
C1 [Forsman, Anna M.; Savage, Anna E.; Gaither, Michelle R.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.
   [Forsman, Anna M.; Gaither, Michelle R.] Univ Cent Florida, Genom & Bioinformat Cluster, Orlando, FL 32816 USA.
   [Hoenig, Brandon D.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15213 USA.
C3 State University System of Florida; University of Central Florida; State
   University System of Florida; University of Central Florida;
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Forsman, AM (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.; Forsman, AM (corresponding author), Univ Cent Florida, Genom & Bioinformat Cluster, Orlando, FL 32816 USA.
EM anna.forsman@ucf.edu
RI Forsman, Anna/S-9500-2017
OI Forsman, Anna/0000-0002-5942-4671
CR Bhadury P, 2006, AQUAT MICROB ECOL, V44, P97, DOI 10.3354/ame044097
   Biedrzycka A, 2020, EVOL APPL, V13, P752, DOI 10.1111/eva.12898
   Bonin M, 2020, ECOL EVOL, V10, P6664, DOI 10.1002/ece3.6397
   Burian A, 2021, MOL ECOL RESOUR, V21, P1422, DOI 10.1111/1755-0998.13367
   Campbell NR, 2015, MOL ECOL RESOUR, V15, P855, DOI 10.1111/1755-0998.12357
   Cindy B, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01760-8
   Corse E, 2019, ECOL EVOL, V9, P4603, DOI 10.1002/ece3.5063
   Cortazar-Chinarro M, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1022-z
   Czachur M. V., 2022, ENV DNA, V4, P181, DOI [10.1002/edn3.238, DOI 10.1002/EDN3.238]
   de Bruyn M., 2021, ENV DNA, V4, P157, DOI [10.1002/edn3.234, DOI 10.1002/EDN3.234]
   de Vere N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42838
   Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350
   DiBattista J, 2022, ENV DNA, V4, P206, DOI [DOI 10.1002/EDN3.252, 10.1002/edn3.252]
   Drinkwater R, 2021, MOL ECOL, V30, P3299, DOI 10.1111/mec.15724
   Eble JA, 2020, ADV MAR BIOL, V86, P141, DOI 10.1016/bs.amb.2020.01.001
   Elbrecht V, 2017, METHODS ECOL EVOL, V8, P622, DOI 10.1111/2041-210X.12687
   Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118
   Forsman AM, 2022, ORNITHOLOGY, V139, DOI 10.1093/ornithology/ukab075
   Francioli D, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9020361
   Gaither MR., 2022, ENV DNA, V4, P3, DOI [10.1002/EDN3.270, DOI 10.1002/EDN3.270, 10.1002/edn3.270]
   Gaithuma A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61817-2
   Genier CSV, 2021, CONSERV PHYSIOL, V9, DOI 10.1093/conphys/coaa140
   Gerwing TG, 2016, AUK, V133, P168, DOI 10.1642/AUK-15-176.1
   GILL RB, 1983, J WILDLIFE MANAGE, V47, P902, DOI 10.2307/3808149
   Hacker CE, 2021, BIODIVERS CONSERV, V30, P797, DOI 10.1007/s10531-021-02118-6
   Hoenig BD, 2022, ORNITHOLOGY, V139, DOI 10.1093/ornithology/ukab077
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x
   Jusino MA, 2019, MOL ECOL RESOUR, V19, P176, DOI 10.1111/1755-0998.12951
   Kumar G., 2022, ENV DNA, V4, P167, DOI [10.1002/edn3.235, DOI 10.1002/EDN3.235]
   Kumar G, 2020, MOL ECOL RESOUR, V20, P29, DOI 10.1111/1755-0998.13107
   Mariani S, 2019, CURR BIOL, V29, pR401, DOI 10.1016/j.cub.2019.04.031
   Martin KR, 2022, ROY SOC OPEN SCI, V9, DOI 10.1098/rsos.211190
   MCCARTER NH, 1986, NEW ZEAL J MAR FRESH, V20, P551, DOI 10.1080/00288330.1986.9516175
   McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18
   Meek MH, 2019, MOL ECOL RESOUR, V19, P795, DOI 10.1111/1755-0998.12998
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Minias P, 2019, GENOME BIOL EVOL, V11, P17, DOI 10.1093/gbe/evy253
   Mulder KP, 2017, DEV COMP IMMUNOL, V76, P177, DOI 10.1016/j.dci.2017.05.022
   O'Connor E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080848
   OGRAM A, 1987, J MICROBIOL METH, V7, P57, DOI 10.1016/0167-7012(87)90025-X
   Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1
   Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355
   Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x
   Poulin B, 1996, AUK, V113, P277, DOI 10.2307/4088894
   Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x
   Ruppert KM, 2019, GLOB ECOL CONSERV, V17, DOI 10.1016/j.gecco.2019.e00547
   Savage AE, 2018, CONSERV GENET, V19, P309, DOI 10.1007/s10592-017-1001-3
   Schabacker JC., 2020, ENV DNA, V2, P244, DOI DOI 10.1002/EDN3.63
   Soininen EM, 2014, ISOT ENVIRON HEALT S, V50, P361, DOI 10.1080/10256016.2014.915824
   STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541
   Sundaram AYM, 2020, IMMUNOGENETICS, V72, P89, DOI 10.1007/s00251-019-01143-8
   Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x
   Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621
   Timmers MA., 2022, ENV DNA, V4, P239, DOI [10.1002/edn3.163, DOI 10.1002/EDN3.163]
   TOFT CA, 1981, J HERPETOL, V15, P139, DOI 10.2307/1563372
   Trevelline BK, 2016, AUK, V133, P415, DOI 10.1642/AUK-15-222.1
   Trujillo AL, 2021, HEREDITY, V126, P640, DOI 10.1038/s41437-020-00402-9
   Verkuil Y., 2021, PREPRINT, DOI [10.22541/au.161645047.72057260, DOI 10.22541/AU.161645047.72057260]
   Wheeler SS, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04827-x
   Yamanaka H, 2018, ECOL RES, V33, P1075, DOI 10.1007/s11284-018-1612-2
NR 61
TC 0
Z9 0
U1 4
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1540-7063
EI 1557-7023
J9 INTEGR COMP BIOL
JI Integr. Comp. Biol.
PD AUG 25
PY 2022
VL 62
IS 2
BP 191
EP 198
DI 10.1093/icb/icac090
EA JUN 2022
PG 8
WC Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Zoology
GA 3Z2UO
UT WOS:000833465900001
PM 35687001
DA 2023-09-14
ER

PT J
AU Lin, Y
   Yan, GJ
   Feng, F
   Wang, MG
   Long, FL
AF Lin, Yong
   Yan, Gengjie
   Feng, Feng
   Wang, Minggang
   Long, Fuli
TI Characterization of intestinal microbiota and serum metabolites in
   patients with mild hepatic encephalopathy
SO OPEN LIFE SCIENCES
LA English
DT Article
DE micro-hepatic encephalopathy; intestinal microbiota; serum metabolites;
   variable characteristics; interactive relationship
ID HUMAN GUT MICROBIOME; CIRRHOSIS; MODULATION; PROFILE; SYSTEM
AB Mild micro-hepatic encephalopathy (MHE) is a severe complication of cirrhosis. At present, there are differences in the consistency of detection strategies and treatment directions for MHE. The characteristic changes in intestinal microbiota and serum metabolites in MHE patients and the possible relevant interaction mechanisms would inevitably affect the developmental direction of MHE. Therefore, the changes in the characteristics of intestinal microbiota and serum metabolites of MHE patients were determined, and the possible interactions between them were analyzed. Stool and serum tests were performed on both the MHE patients and healthy individuals. The 16S rRNA gene high-throughput sequencing and bioinformatics analyses were used to analyze the differences in intestinal microbiota in MHE patients. The serum metabolites were detected using liquid LC-MS/MS (liquid chromatography-mass spectrometry) technology, and the differences in the metabolic networks of blood metabolites in MHE patients were analyzed. A comprehensive bioinformatics analysis approach was adopted to identify the composition and characteristics of microbiota and serum metabolites and the possible correlation between them. The main characteristics of the structural imbalance in the intestinal microbiota of MHE patients included a decrease in the number of beneficial bacteria at the levels of phylum, class, order, family, and genus and an increase in the pathogenic bacteria, resulting in substantial changes in the relative abundances of bacteria in the intestinal microbiota. The main predicted functions that showed significant differences included chromosome, amino acid-related enzymes, methane metabolism, and arginine and proline metabolism. The detection of serum metabolites resulted in 10 different metabolites, including taurocholic acid, citrulline, d-phenyl-lactic acid, l-tyrosine, benzoate, phenylalanine, linoleic acid, eicosapedienic acid, alpha-dimorphecolic acid, and dehydroepiandrosterone. The subsequent metabolite pathways analysis showed differences in the metabolism of linoleic acid, phenyl-propane, caffeine, arginine, proline, glycine, serine, threonine, tyrosine, and pyrimidine compared to the control group. In summary, it seems that the changes in the microbiome that we have identified have resulted in corresponding changes to the serum metabolome. In turn, this may represent changes in the absorption of metabolites from the gut or reflect the changed metabolic capacity of the MHE liver or both. There were characteristic changes in the intestinal microbiota and serum metabolites in the MHE patients. There might be a related interaction mechanism between the two, which would provide evidence and direction for the detection and treatment strategies of MHE.
C1 [Lin, Yong; Yan, Gengjie; Feng, Feng; Wang, Minggang; Long, Fuli] Guangxi Univ Tradit Chinese Med, Dept Liver Dis, Affiliated Hosp 1, Nanning 530023, Guangxi, Peoples R China.
C3 Guangxi University of Chinese Medicine
RP Wang, MG; Long, FL (corresponding author), Guangxi Univ Tradit Chinese Med, Dept Liver Dis, Affiliated Hosp 1, Nanning 530023, Guangxi, Peoples R China.
EM wmgcb@163.com; longfuli005@163.com
FU Science and Technology Planning Project of Guangxi [2018GXNSFGA281002];
   National Natural Science Foundation of China [81704021, 817608448];
   National key S&T Special Projects [2018ZX10725505001-011]
FX This study was financially supported by the Science and Technology
   Planning Project of Guangxi (2018GXNSFGA281002), and the National
   Natural Science Foundation of China (No. 81704021, 817608448), the
   National key S&T Special Projects (2018ZX10725505001-011).
CR Acharya C, 2019, CLIN GASTROENTEROL H, V17, P307, DOI 10.1016/j.cgh.2018.08.008
   Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010
   Bajaj JS, 2019, CLIN GASTROENTEROL H, V17, P756, DOI 10.1016/j.cgh.2018.07.022
   Bajaj JS, 2015, NATURE, V525, pE1, DOI 10.1038/nature14851
   Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
   Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012
   Balzano T, 2020, J HEPATOL, V73, P582, DOI 10.1016/j.jhep.2019.01.008
   Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30
   Bo TB, 2020, ISME J, V14, P2625, DOI 10.1038/s41396-020-0711-6
   Chen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34055
   Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006
   Clavel T, 2017, IMMUNOL REV, V279, P8, DOI 10.1111/imr.12578
   Conde A, 2010, INT J BIOCHEM CELL B, V42, P857, DOI 10.1016/j.biocel.2009.12.012
   Cooper AJL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020016
   Danek PJ, 2020, TOXICOL APPL PHARM, V406, DOI 10.1016/j.taap.2020.115239
   DeMorrow S, 2019, J CLIN EXP HEPATOL, V9, P117, DOI 10.1016/j.jceh.2018.04.011
   Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250
   Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617
   Gillevet P, 2010, CHEM BIODIVERS, V7, P1065, DOI 10.1002/cbdv.200900322
   Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108
   Haussinger D, 2007, OXFORD TXB HEPATOLOG, P728
   Holzer P, 2016, INT REV NEUROBIOL, V131, P67, DOI 10.1016/bs.irn.2016.08.005
   Inoue T, 2018, CLIN INFECT DIS, V67, P869, DOI 10.1093/cid/ciy205
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Kruczek C, 2009, GLIA, V57, P79, DOI 10.1002/glia.20737
   Kwong E, 2015, ACTA PHARM SIN B, V5, P151, DOI 10.1016/j.apsb.2014.12.009
   Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32
   Ling ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep30673
   Liu WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep39576
   Mardini H, 2011, J HEPATOL, V54, P1154, DOI 10.1016/j.jhep.2010.09.030
   Menzel T, 2004, INFLAMM BOWEL DIS, V10, P122, DOI 10.1097/00054725-200403000-00010
   Patidar KR, 2014, AM J GASTROENTEROL, V109, P1757, DOI 10.1038/ajg.2014.264
   Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504
   Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011
   Schulz C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1205-8
   Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027
   Srivastava A, 2017, J HEPATOL, V66, P528, DOI 10.1016/j.jhep.2016.10.026
   Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000
   VanEldere J, 1996, APPL ENVIRON MICROB, V62, P656, DOI 10.1128/AEM.62.2.656-661.1996
   Wang K, 2019, CELL REP, V26, P222, DOI 10.1016/j.celrep.2018.12.028
   Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001
   Yamamoto K, 2019, HEPATOL INT, V13, P234, DOI 10.1007/s12072-019-09932-9
   Zhang ZG, 2013, AM J GASTROENTEROL, V108, P1601, DOI 10.1038/ajg.2013.221
NR 43
TC 1
Z9 1
U1 2
U2 6
PU DE GRUYTER POLAND SP Z O O
PI WARSAW
PA BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND
SN 2391-5412
J9 OPEN LIFE SCI
JI Open Life Sci.
PD MAR 10
PY 2022
VL 17
IS 1
BP 139
EP 154
DI 10.1515/biol-2021-0140
PG 16
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA ZQ4BY
UT WOS:000767053200001
PM 35350446
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Ammer-Herrmenau, C
   Pfisterer, N
   van den Berg, T
   Gavrilova, I
   Amanzada, A
   Singh, SK
   Khalil, A
   Alili, R
   Belda, E
   Clement, K
   El Wahed, AA
   Gady, EE
   Haubrock, M
   Beissbarth, T
   Ellenrieder, V
   Neesse, A
AF Ammer-Herrmenau, Christoph
   Pfisterer, Nina
   van den Berg, Tim
   Gavrilova, Ivana
   Amanzada, Ahmad
   Singh, Shiv K.
   Khalil, Alaa
   Alili, Rohia
   Belda, Eugeni
   Clement, Karine
   El Wahed, Ahmed Abd
   Gady, ElSagad Eltayeb
   Haubrock, Martin
   Beissbarth, Tim
   Ellenrieder, Volker
   Neesse, Albrecht
TI Comprehensive Wet-Bench and Bioinformatics Workflow for Complex
   Microbiota Using Oxford Nanopore Technologies
SO MSYSTEMS
LA English
DT Article
DE 16S rRNA; bioinformatic workflow; buccal swab; DNA extraction; eNAT;
   eSwab; Kaiju; Kraken2; metagenomics; MetaMaps; Metapont; microbiome;
   Oxford Nanopore Technologies; ONT; rectal swab; sampling; sequencing;
   storage
ID GUT MICROBIOME; ASSOCIATION; DIVERSITY; MUCOSAL; STORAGE; GENOME; SWAB
AB The advent of high-throughput sequencing techniques has recently provided an astonishing insight into the composition and function of the human microbiome. Next-generation sequencing (NGS) has become the gold standard for advanced microbiome analysis; however, 3rd generation real-time sequencing, such as Oxford Nanopore Technologies (ONT), enables rapid sequencing from several kilobases to >2Mb with high resolution. Despite the wide availability and the enormous potential for clinical and translational applications, ONT is poorly standardized in terms of sampling and storage conditions, DNA extraction, library creation, and bioinformatic classification. Here, we present a comprehensive analysis pipeline with sampling, storage, DNA extraction, library preparation, and bioinformatic evaluation for complex microbiomes sequenced with ONT. Our findings from buccal and rectal swabs and DNA extraction experiments indicate that methods that were approved for NGS microbiome analysis cannot be simply adapted to ONT. We recommend using swabs and DNA extractions protocols with extended washing steps. Both 16S rRNA and metagenomic sequencing achieved reliable and reproducible results. Our benchmarking experiments reveal thresholds for analysis parameters that achieved excellent precision, recall, and area under the precision recall values and is superior to existing classifiers (Kraken2, Kaiju, and MetaMaps). Hence, our workflow provides an experimental and bioinformatic pipeline to perform a highly accurate analysis of complex microbial structures from buccal and rectal swabs.
   IMPORTANCE Advanced microbiome analysis relies on sequencing of short DNA fragments from microorganisms like bacteria, fungi, and viruses. More recently, long fragment DNA sequencing of 3rd generation sequencing has gained increasing importance and can be rapidly conducted within a few hours due to its potential realtime sequencing. However, the analysis and correct identification of the microbiome relies on a multitude of factors, such as the method of sampling, DNA extraction, sequencing, and bioinformatic analysis. Scientists have used different protocols in the past that do not allow us to compare results across different studies and research fields. Here, we provide a comprehensive workflow from DNA extraction, sequencing, and bioinformatic workflow that allows rapid and accurate analysis of human buccal and rectal swabs with reproducible protocols. This workflow can be readily applied by many scientists from various research fields that aim to use long-fragment microbiome sequencing.
C1 [Ammer-Herrmenau, Christoph; Pfisterer, Nina; Gavrilova, Ivana; Amanzada, Ahmad; Singh, Shiv K.; Khalil, Alaa; Ellenrieder, Volker; Neesse, Albrecht] Univ Med Goettingen, Dept Gastroenterol Gastrointestinal Oncol & Endoc, Gottingen, Germany.
   [van den Berg, Tim; Haubrock, Martin; Beissbarth, Tim] Univ Med Goettingen, Dept Med Bioinformat, Gottingen, Germany.
   [Alili, Rohia; Belda, Eugeni; Clement, Karine] Sorbonne Univ, Fac Med, INSERM UMRS NutriOm, Paris, France.
   [El Wahed, Ahmed Abd] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany.
   [Gady, ElSagad Eltayeb] Al Neelain Univ, Fac Med, Ibn Sina Specialised Hosp, Khartoum, Sudan.
C3 UDICE-French Research Universities; Sorbonne Universite; Leipzig
   University
RP Neesse, A (corresponding author), Univ Med Goettingen, Dept Gastroenterol Gastrointestinal Oncol & Endoc, Gottingen, Germany.
EM albrecht.neesse@med.uni-goettingen.de
RI Ammer-Herrmenau, Christoph/GPK-8096-2022
OI mohamed, Elsagad/0000-0002-2120-9933; Haubrock,
   Martin/0000-0001-5292-4561; Abd El Wahed, Ahmed/0000-0003-3347-6075;
   Singh, Shiv K./0000-0002-5725-4058
FU Deutsche Forschungsgemeinschaft (DFG) [404935781, 404935781, 404935781]
   Funding Source: Medline
CR Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020
   Arango-Argoty GA, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0703-9
   Araujo-Perez F, 2012, GUT MICROBES, V3, P530, DOI 10.4161/gmic.22157
   Bassis CM, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0983-9
   Biehl LM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215428
   Bjerre RD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53599-z
   Budding AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101344
   Camelo-Castillo AJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00119
   Chen ZG, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00271-18
   Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960
   Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486
   Cusco Anna, 2018, F1000Res, V7, P1755, DOI 10.12688/f1000research.16817.2
   Cusco A, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0355-6
   Demuyser T, 2018, J MICROBIOL METH, V144, P73, DOI 10.1016/j.mimet.2017.11.009
   Dilthey AT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10934-2
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Fan XZ, 2018, GUT, V67, P120, DOI 10.1136/gutjnl-2016-312580
   GitHub, 2021, DILTHEYLAB METAMAPS
   GitHub, 2021, LIYU95 DEEPSIMULATO
   Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9
   Helmersen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59957-6
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   IHMS, 2020, STANDARD OPERATING P
   Jain M, 2018, NAT BIOTECHNOL, V36, P338, DOI 10.1038/nbt.4060
   Johnson JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13036-1
   Jones RB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22408-4
   Kai S, 2019, FEBS OPEN BIO, V9, P548, DOI 10.1002/2211-5463.12590
   Khan I, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030126
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Leidenfrost RM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61989-x
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li RS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10814
   Li Y, 2020, BIOINFORMATICS, V36, P2578, DOI 10.1093/bioinformatics/btz963
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   McIntyre ABR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1299-7
   Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257
   Moon J, 2018, EMERG INFECT DIS, V24, P1944, DOI 10.3201/eid2410.180234
   Moss EL, 2020, NAT BIOTECHNOL, V38, P701, DOI 10.1038/s41587-020-0422-6
   Nejman D, 2020, SCIENCE, V368, P973, DOI 10.1126/science.aay9189
   Nicholls SM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz043
   Nygaard AB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59771-0
   Oxford Nanopore Technologies, 2020, CREAT COMPL SAMPL TO
   Patel AL, 2016, J PEDIATR GASTR NUTR, V62, P292, DOI 10.1097/MPG.0000000000000913
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Reyman M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52549-z
   Ringel Y, 2015, GUT MICROBES, V6, P173, DOI 10.1080/19490976.2015.1044711
   Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037
   Sanderson ND, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5094-y
   Santos A, 2020, COMPUT STRUCT BIOTEC, V18, P296, DOI 10.1016/j.csbj.2020.01.005
   Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229
   Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486
   Shenwei356, 2020, US TAXONKIT NCBI TAX
   Shin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29681
   Si J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00516
   Sinha R, 2017, NAT BIOTECHNOL, V35, P1077, DOI 10.1038/nbt.3981
   Smirnova E, 2019, BIOSTATISTICS, V20, P615, DOI 10.1093/biostatistics/kxy020
   Teng F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34294-x
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Tyson JR, 2018, GENOME RES, V28, P266, DOI 10.1101/gr.221184.117
   Wei YP, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00053
   Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y
   Wick RR, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1727-y
   Woo JS, 2019, METHODS MOL BIOL, V1897, P99, DOI 10.1007/978-1-4939-8935-5_10
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Ye SH, 2019, CELL, V178, P779, DOI 10.1016/j.cell.2019.07.010
   Young RR, 2020, MICROBIOLOGYOPEN, V9, DOI 10.1002/mbo3.1046
   Zheng DP, 2020, CELL RES, V30, P492, DOI 10.1038/s41422-020-0332-7
   Zhu LD, 2020, VET RES, V51, DOI 10.1186/s13567-020-00755-3
NR 71
TC 9
Z9 9
U1 4
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD JUL
PY 2021
VL 6
IS 4
AR e00750-21
DI 10.1128/mSystems.00750-21
PG 19
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA WK6JW
UT WOS:000709832000019
PM 34427527
OA Green Published
DA 2023-09-14
ER

PT J
AU Han, SW
   Pan, YF
   Yang, X
   Da, M
   Wei, Q
   Gao, YH
   Qi, Q
   Ru, LX
AF Han, Shuwen
   Pan, Yuefen
   Yang, Xi
   Da, Miao
   Wei, Qiang
   Gao, Yuhai
   Qi, Quan
   Ru, Lixin
TI Intestinal microorganisms involved in colorectal cancer complicated with
   dyslipidosis
SO CANCER BIOLOGY & THERAPY
LA English
DT Article
DE colorectal cancer; lipid metabolism; microorganisms; hyperlipidaemia
ID HUMAN GUT MICROBIOME; LIPID-METABOLISM; RISK; ASSOCIATION; OBESITY; DIET
AB Background: Abnormal lipid metabolism is considered to be one of main promoters of colorectal cancer (CRC), and intestinal microorganisms may be involved in CRC in patients with abnormal lipid metabolism. Objective: To investigate lipid metabolism in CRC patients and explore the role of intestinal microorganisms in CRC complicated with abnormal lipid metabolism. Methods: Overall, 150 CRC patients in Huzhou Central Hospital from January 2016 to September 2017 were recruited in the present study. Basic patient information and clinical serological indicators were investigated and analyzed. Twenty-one stool samples were collected from patients after receiving informed consent. Next-generation sequencing technology was used to sequence bacterial 16S ribosomal RNA. Bioinformatics analysis was used to profile the microbial composition and screen distinctive bacteria in patients with CRC complicated with abnormal lipid metabolism. Results: Apo B and FFA levels were higher in patients with stage I disease than in patients with other stages. HDL, LDL, Apo B and FFA levels were higher in female patients than in male patients. FFA level was higher in rectal cancer patients than in colon cancer patients. These differences were statistically significant (p < 0.05). The proportion of Escherichia/Shigella was increased in CRC patients with hyperlipoidaemia and hypercholesteremia; the abundance of Streptococcus was increased in CRC patients with hyperlipoidaemia; the abundance of Clostridium XIVa was reduced in CRC patients with hyperlipoidaemia and hypercholesteremia; and the abundance of Ruminococcaceae was reduced in CRC patients with hypercholesteremia. Bilophila and Butyricicoccus were closely related to CRC patients without hyperlipoidaemia or hypercholesteremia, and Selenomonas, Clostridium, Bacteroidetes Slackia, Burkholderiales and Veillonellaceae were closely related to CRC patients with hyperlipoidaemia. Some pathways, including secretion system, chaperones and folding catalysts, amino sugar and nucleotide sugar metabolism, arginine and proline metabolism, glycine, serine and threonine metabolism, histidine metabolism, pores and ion channels, nitrogen metabolism and sporulation, may be involved in lipid metabolism abnormality in CRC patients. Conclusions: Many CRC patients have abnormal lipid metabolism, and the intestinal microbiota is altered in these CRC patients.
C1 [Han, Shuwen; Pan, Yuefen; Qi, Quan] Huzhou Cent Hosp, Dept Med Oncol, Huzhou, Zhejiang, Peoples R China.
   [Yang, Xi; Ru, Lixin] Huzhou Cent Hosp, Dept Intervent & Radiotherapy, 198 Hongqi Rd, Huzhou 313000, Zhejiang, Peoples R China.
   [Da, Miao] Huzhou Univ, Med Coll Nursing, Huzhou, Zhejiang, Peoples R China.
   [Wei, Qiang; Gao, Yuhai] Huzhou Cent Hosp, Dept Gastrointestinal Surg, Huzhou, Zhejiang, Peoples R China.
C3 Huzhou University; Huzhou University; Huzhou University; Huzhou
   University
RP Ru, LX (corresponding author), Huzhou Cent Hosp, Dept Intervent & Radiotherapy, 198 Hongqi Rd, Huzhou 313000, Zhejiang, Peoples R China.
EM rulixin2018@163.com
OI Han, Shuwen/0000-0001-6180-9565
FU Public Welfare Technology Application Research Program of Huzhou
   [2016GYB14]
FX This work was supported by the Public Welfare Technology Application
   Research Program of Huzhou (No. 2016GYB14).
CR Aguirre-Portoles C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101076
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Baxter NT, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0205-y
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chen DW, 2015, J MICROBIOL BIOTECHN, V25, P687, DOI 10.4014/jmb.1409.09085
   Chen TF, 2014, SURG LAPARO ENDO PER, V24, pE162, DOI 10.1097/SLE.0000000000000000
   Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gao YX, 2017, J DIABETES COMPLICAT, V31, P1641, DOI 10.1016/j.jdiacomp.2017.08.011
   Hale VL, 2017, CANCER EPIDEM BIOMAR, V26, P85, DOI 10.1158/1055-9965.EPI-16-0337
   Han SW, 2018, CANCER MANAG RES, V10, P199, DOI 10.2147/CMAR.S153482
   Joint Committee for Guideline Revision, 2016, CHIN CIRC J, V31, P937, DOI [10.3969/j.issn.1000-3614.2016.10.001, DOI 10.3969/J.ISSN.1000-3614.2016.10.001]
   Jung YS, 2015, DIGEST DIS SCI, V60, P2996, DOI 10.1007/s10620-015-3713-x
   Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713
   Kohoutova D, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0733-7
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee KJ, 2015, INTEST RES, V13, P306, DOI 10.5217/ir.2015.13.4.306
   Lg O, 2010, FINDINGS INT J MOL S, V11, P2499, DOI [10.3390/ijms11062499, DOI 10.3390/IJMS11062499]
   Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437
   Peng F, 2018, CANCER EPIDEMIOL, V52, P148, DOI 10.1016/j.canep.2018.01.001
   Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8
   Requena T, 2018, FOOD FUNCT, V9, P688, DOI [10.1039/c7fo01820g, 10.1039/C7FO01820G]
   Shen ZL, 2010, AM J SURG, V200, P59, DOI 10.1016/j.amjsurg.2009.05.005
   Si ZH, 2011, WORLD CHIN J DIGESTO, V34, P3542
   Siddiqui AA, 2011, AM J MED SCI, V341, P227, DOI 10.1097/MAJ.0b013e3181df9055
   Soleimani A, 2017, KIDNEY INT, V91, P435, DOI 10.1016/j.kint.2016.09.040
   Song Pengkun, 2016, Zhonghua Yu Fang Yi Xue Za Zhi, V50, P208, DOI 10.3760/cma.j.issn.0253-9624.2016.03.003
   Tuan J, 2016, GASTROINTEST TUMORS, V3, P17, DOI 10.1159/000442831
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wang X, 2018, TOXICOL LETT, V287, P10, DOI 10.1016/j.toxlet.2018.01.006
   Wu GD, 2013, CLIN GASTROENTEROL H, V11, P774, DOI 10.1016/j.cgh.2013.03.038
   Wu LY, 2014, METABOLISM, V63, P1469, DOI 10.1016/j.metabol.2014.08.010
   Wu T, 2018, LIFE SCI, V192, P173, DOI 10.1016/j.lfs.2017.11.049
   Yao X, 2015, CANCER CAUSE CONTROL, V26, P257, DOI 10.1007/s10552-014-0507-y
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 41
TC 31
Z9 31
U1 3
U2 28
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4047
EI 1555-8576
J9 CANCER BIOL THER
JI Cancer Biol. Ther.
PD JAN 2
PY 2019
VL 20
IS 1
BP 81
EP 89
DI 10.1080/15384047.2018.1507255
PG 9
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA HF9AI
UT WOS:000454533100011
PM 30239257
OA Green Published, Bronze
DA 2023-09-14
ER

PT J
AU Chao, XP
   Liu, Y
   Fan, QB
   Shi, HH
   Wang, S
   Lang, JH
AF Chao, Xiaopei
   Liu, Yang
   Fan, Qingbo
   Shi, Honghui
   Wang, Shu
   Lang, Jinghe
TI The role of the vaginal microbiome in distinguishing female chronic
   pelvic pain caused by endometriosis/adenomyosis
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Chronic pelvic pain (CPP); endometriosis; adenomyosis (EM; AM); 16S
   rRNA; function prediction; vaginal microbiome
ID GUT MICROBIOME; WOMEN; PREVALENCE; INFECTION
AB Background: This study aimed to investigate the specific vaginal microbiome in the differential diagnosis of endometriosis/adenomyosis (EM/AM)-associated chronic pelvic pain (CPP) from other types of CPP, and to explore the role of the vaginal microbiome in the mechanism of EM/AM-associated CPP.
   Methods: We recruited 37 women with EM/AM-associated CPP, 25 women with chronic pelvic pain syndrome (CPPS) without EM/AM, and 66 women without CPPS into our study. All of the participants were free from human papillomavirus (HPV) infection. Sequencing of barcoded 16S rRNA gene fragments (V4) was used to determine the vaginal microbiome composition on the Illumina HiSeq2500 System. Taxonomic and functional bioinformatics analyses were performed using t-test, linear discriminant analysis effect size (LEfSe), MetaStat, and PICRUSt algorithms.
   Results: At the species level, EM/AM-associated CPP was found to be associated with a predominance of Clostridium butyricum, Clostridium disporicum, Alloscardovia omnicolens, and Veillonella montpellierensis, and a concomitant paucity of Lactobacillus jensenii, Lactobacillus reuteri, and Lactobacillus iners. When the relative abundance of Clostridium disporicum was over 0.001105% and that of Lactobacillus reuteri was under 0.1911349%, the differential diagnostic sensitivity and specificity were 81.08% and 52.0%, respectively. When serum CA125 was combined, the sensitivity increased to 89.19%, but the specificity remained at 52.0%. The PICRUSt results identified 7 differentially regulated pathways within the 3 groups that may be of relevance.
   Conclusions: Compared to that of CPPS patients without EM/AM and women without CPPS, the vaginal microbiome of patients with EM/AM-associated CPP shows significantly higher alpha (phylogenetic) diversity, as well as higher counts of Clostridium butyricum, Clostridium disporicum, Alloscardovia omnicolens, and Veillonella montpellierensis. These differences in the vaginal microbiome may interfere with local functional pathways, which could provide a direction for innovative metabolite-specific targeted treatment. The combination of vaginal biomarkers and serum CA125 may provide an original method to differentiate EM/ AM-associated CPP.
C1 [Chao, Xiaopei; Liu, Yang; Fan, Qingbo; Shi, Honghui; Wang, Shu; Lang, Jinghe] Chinese Acad Med Sci CAMS & Peking Union Med Coll, Peking Union Med Coll Hosp PUMCH, Dept Obstet & Gynecol, Beijing, Peoples R China.
   [Chao, Xiaopei; Liu, Yang; Fan, Qingbo; Shi, Honghui; Wang, Shu; Lang, Jinghe] Natl Clin Res Ctr Obstetr & Gynecol Dis, Beijing, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Cancer Institute & Hospital - CAMS; Peking Union Medical College
RP Wang, S; Lang, JH (corresponding author), Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Shuaifuyuan 1, Beijing 100730, Peoples R China.
EM wangshu219@hotmail.com; langjh@hotmail.com
FU National Key R&D Program of China [2017YFC1001200]; CAMS Innovation Fund
   for Medical Sciences (CIFMS) [2016I2M1002]; Chinese Academy of Medical
   Sciences Initiative for Innovative Medicine [CAMS2017I2M1002]
FX This study was funded by National Key R&D Program of China
   (2017YFC1001200) , CAMS Innovation Fund for Medical Sciences (CIFMS)
   (2016I2M1002) , and Chinese Academy of Medical Sciences Initiative for
   Innovative Medicine (CAMS2017I2M1002) .
CR Ahangari A, 2014, PAIN PHYSICIAN, V17, pE141
   Akiyama K, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13147
   Allaire C, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.10.002
   Arora HC, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.32
   Chao MT, 2015, PAIN MED, V16, P328, DOI 10.1111/pme.12585
   Chen CY, 2017, ASIAN AUSTRAL J ANIM, V30, P211, DOI 10.5713/ajas.16.0203
   Chen C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00901-0
   Cheong Y, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-017-0509-5
   Gelbaya TA, 2001, OBSTET GYNECOL SURV, V56, P757, DOI 10.1097/00006254-200112000-00002
   Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065
   Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041
   Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10
   Govorov I, 2020, CURR MED CHEM, V27, P3611, DOI 10.2174/0929867326666190104124245
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Malykhina AP, 2007, NEUROSCIENCE, V149, P660, DOI 10.1016/j.neuroscience.2007.07.053
   Mathias SD, 1996, OBSTET GYNECOL, V87, P321, DOI 10.1016/0029-7844(95)00458-0
   No G G, 2012, ROYAL COLL OBSTETRIC, V41, P1
   Perry C P, 2001, JSLS, V5, P105
   Plassart C, 2013, ANAEROBE, V19, P77, DOI 10.1016/j.anaerobe.2012.12.002
   Rudick CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041273
   Schulberg J, 2016, INTERN MED J, V46, P266, DOI 10.1111/imj.13003
   Shoskes DA, 2016, UROLOGY, V92, P26, DOI 10.1016/j.urology.2016.02.043
   Smith SB, 2017, J PHYSIOL-LONDON, V595, P451, DOI 10.1113/JP271694
   Tai FW, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110379
   TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674
   Triolo Onofrio, 2013, J Clin Med Res, V5, P153, DOI 10.4021/jocmr1288w
   Walther-Antonio MRS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0368-y
   Woo PCY, 2001, J CLIN MICROBIOL, V39, P3147, DOI 10.1128/JCM.39.9.3147-3155.2001
   Xiao JQ, 2013, UROL INT, V91, P410, DOI 10.1159/000350934
NR 29
TC 9
Z9 9
U1 0
U2 5
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD MAY
PY 2021
VL 9
IS 9
AR 771
DI 10.21037/atm-20-4586
PG 16
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA SF9FV
UT WOS:000653053200013
PM 34268384
OA gold, Green Published
DA 2023-09-14
ER

PT J
AU Oliver, A
   Xue, ZY
   Villanueva, YT
   Durbin-Johnson, B
   Alkan, Z
   Taft, DH
   Liu, JX
   Korf, I
   Laugero, KD
   Stephensen, CB
   Mills, DA
   Kable, ME
   Lemay, DG
AF Oliver, Andrew
   Xue, Zhengyao
   Villanueva, Yirui T.
   Durbin-Johnson, Blythe
   Alkan, Zeynep
   Taft, Diana H.
   Liu, Jinxin
   Korf, Ian
   Laugero, Kevin D.
   Stephensen, Charles B.
   Mills, David A.
   Kable, Mary E.
   Lemay, Danielle G.
TI Association of Diet and Antimicrobial Resistance in Healthy US Adults
SO MBIO
LA English
DT Article
DE antibiotic resistance; bioinformatics; diet; diversity; fiber; food; gut
   microbes; human health; machine learning; metagenomes; microbiome;
   nutrition
ID INFANT GUT RESISTOME; FOOD-ANIMALS; CHRONIC STRESS; E.-COLI; MICROBIOTA;
   POPULATION; GAMMA; DHEA
AB Antimicrobial resistance (AMR) represents a significant source of morbidity and mortality worldwide, with expectations that AMR-associated consequences will continue to worsen throughout the coming decades. Since resistance to antibiotics is encoded in the microbiome, interventions aimed at altering the taxonomic composition of the gut might allow us to prophylactically engineer microbiomes that harbor fewer antibiotic resistant genes (ARGs). Diet is one method of intervention, and yet little is known about the association between diet and antimicrobial resistance. To address this knowledge gap, we examined diet using the food frequency questionnaire (FFQ; habitual diet) and 24-h dietary recalls (Automated Self-Administered 24-h [ASA24 (R)] tool) coupled with an analysis of the microbiome using shotgun metagenome sequencing in 290 healthy adult participants of the United States Department of Agriculture (USDA) Nutritional Phenotyping Study. We found that aminoglycosides were the most abundant and prevalent mechanism of AMR in these healthy adults and that aminoglycoside-O-phosphotransferases (aph3-dprime) correlated negatively with total calories and soluble fiber intake. Individuals in the lowest quartile of ARGs (low-ARG) consumed significantly more fiber in their diets than medium- and high-ARG individuals, which was concomitant with increased abundances of obligate anaerobes, especially from the family Clostridiaceae, in their gut microbiota. Finally, we applied machine learning to examine 387 dietary, physiological, and lifestyle features for associations with antimicrobial resistance, finding that increased phylogenetic diversity of diet was associated with low-ARG individuals. These data suggest diet may be a potential method for reducing the burden of AMR.
   IMPORTANCE Antimicrobial resistance (AMR) represents a considerable burden to health care systems, with the public health community largely in consensus that AMR will be a major cause of death worldwide in the coming decades. Humans carry antibiotic resistance in the microbes that live in and on us, collectively known as the human microbiome. Diet is a powerful method for shaping the human gut microbiome and may be a tractable method for lessening antibiotic resistance, and yet little is known about the relationship between diet and AMR. We examined this relationship in healthy individuals who contained various abundances of antibiotic resistance genes and found that individuals who consumed diverse diets that were high in fiber and low in animal protein had fewer antibiotic resistance genes. Dietary interventions may be useful for lessening the burden of antimicrobial resistance and might ultimately motivate dietary guidelines which will consider how nutrition can reduce the impact of infectious disease.
C1 [Oliver, Andrew; Xue, Zhengyao; Villanueva, Yirui T.; Alkan, Zeynep; Laugero, Kevin D.; Stephensen, Charles B.; Kable, Mary E.; Lemay, Danielle G.] USDA ARS Western Human Nutr Res Ctr, Davis, CA 28514 USA.
   [Xue, Zhengyao; Villanueva, Yirui T.; Taft, Diana H.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.
   [Durbin-Johnson, Blythe; Korf, Ian; Lemay, Danielle G.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.
   [Liu, Jinxin] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Gastrointestinal Microbiol, Nanjing, Peoples R China.
   [Laugero, Kevin D.; Stephensen, Charles B.; Kable, Mary E.; Lemay, Danielle G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
   [Mills, David A.] Univ Calif Davis, Robert Mondavi Inst Wine & Food Sci, Dept Viticulture & Enol, Davis, CA USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis; Nanjing
   Agricultural University; University of California System; University of
   California Davis; University of California System; University of
   California Davis
RP Lemay, DG (corresponding author), USDA ARS Western Human Nutr Res Ctr, Davis, CA 28514 USA.; Lemay, DG (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Lemay, DG (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
EM danielle.lemay@usda.gov
RI Mills, David Andrew/G-2282-2011; Mills, David/GXF-1821-2022
OI Mills, David Andrew/0000-0003-1913-9865; Taft,
   Diana/0000-0002-9306-9968; Kable, Mary/0000-0002-5485-6539
FU USDA Agricultural Research Service [2032-51530-026-00D,
   2032-51530-022-00-D]; 2019 USDA-ARS Antimicrobial Resistance Funding
   [0426572]; U.S. Department of Energy; ARS; SCINet project of the USDA
   Agricultural Research Service [0500-00093-001-00-D]
FX We thank Eduardo Cervantes, Ellen Bonnel, and the USDA Nutritional
   Phenotyping team for assisting in data collection, the USDA
   Bioanalytical Support Lab for sample management and stool processing and
   Sarah Spearman for assistance with fecal sample analysis. We thank Jules
   Larke and Elizabeth Chin for thoughtful discussions related to machine
   learning and Rachel Waymack for edits for clarity.; This research was
   primarily supported by USDA Agricultural Research Service grants
   2032-51530-026-00D and 2032-51530-022-00-D and by the 2019 USDA-ARS
   Antimicrobial Resistance Funding (number 0426572). A. O. was supported
   by an appointment to the Research Participation Program at the
   Agricultural Research Service, United States Department of Agriculture,
   administered by the Oak Ridge Institute for Science and Education
   through an interagency agreement between the U.S. Department of Energy
   and ARS. This research used resources provided by the SCINet project of
   the USDA Agricultural Research Service, ARS project number
   0500-00093-001-00-D.; The clinical trial is registered online at
   https://www.clinicaltrials.gov/(identifier NCT02367287).
CR [Anonymous], 2015, 2015 2020 DIET GUID
   [Anonymous], 2019, MEAS-INTERDISCIP RES, DOI [10.1080/15366367.2019.1565254, DOI 10.18637/JSS.V077.B02]
   [Anonymous], 2017, DUNN TEST DUNNS TEST
   Asnicar F, 2021, NAT MED, V27, P321, DOI 10.1038/s41591-020-01183-8
   Baldiviez Lacey M, 2017, BMC Nutr, V3, P79, DOI 10.1186/s40795-017-0197-4
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Boonyasiri A, 2014, PATHOG GLOB HEALTH, V108, P235, DOI 10.1179/2047773214Y.0000000148
   Bouzid YY, 2021, CURR DEV NUTR, V5, DOI 10.1093/cdn/nzab005
   Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927
   Bushnell B., 2015, BBMAP
   Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   Chin EL, 2021, J NUTR, V151, P3379, DOI 10.1093/jn/nxab266
   Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183
   de la Cuesta-Zuluaga J, 2020, BIOINFORMATICS, V36, P2314, DOI 10.1093/bioinformatics/btz899
   Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107
   Doster E, 2020, NUCLEIC ACIDS RES, V48, pD561, DOI 10.1093/nar/gkz1010
   Ellabaan MMH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22757-1
   Epidemiology and Genomics Research Program, 2016, AUT SELF ADM 24 HOUR
   Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503
   Fox J., 2019, R COMPANION APPL REG
   Genazzani AD, 2007, DRUG AGING, V24, P173, DOI 10.2165/00002512-200724030-00001
   Holmes ZC, 2020, MBIO, V11, DOI 10.1128/mBio.00914-20
   Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002
   Kable ME, 2022, J NUTR, V152, P779, DOI 10.1093/jn/nxab430
   Kajita K, 2003, ENDOCRINOLOGY, V144, P253, DOI 10.1210/en.2002-220039
   Karelis AD, 2010, BRIT J NUTR, V104, P222, DOI 10.1017/S0007114510000619
   Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005
   Kent AG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18164-7
   Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260
   Krysiak Robert, 2008, Pol Merkur Lekarski, V24, P66
   Lebeaux RM, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02129-x
   Lemay DG, 2021, J NUTR, V151, P1443, DOI 10.1093/jn/nxab019
   Li B, 2015, ISME J, V9, P2490, DOI 10.1038/ismej.2015.59
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Li XJ, 2021, CELL HOST MICROBE, V29, P975, DOI 10.1016/j.chom.2021.03.017
   Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076
   Liu JX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12111-x
   Liu Q, 2017, STAT MED, V36, P4316, DOI 10.1002/sim.7433
   Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109
   Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106
   Lundberg SM, 2017, ADV NEUR IN, V30
   MacFadden DR, 2018, NAT CLIM CHANGE, V8, P510, DOI 10.1038/s41558-018-0161-6
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578
   MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109
   McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001
   Muloi D, 2018, FOODBORNE PATHOG DIS, V15, P467, DOI 10.1089/fpd.2017.2411
   Murray CJL, 2022, LANCET, V399, P629, DOI 10.1016/S0140-6736(21)02724-0
   Nayfach S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0611-7
   Oliver A, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00115-21
   Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049
   Park J, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02215-0
   Parker CT, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10050529
   Parnanen K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06393-w
   Peterson RA, 2021, R J, V13, P310
   Plotkin BJ, 2017, STEROIDS, V128, P120, DOI 10.1016/j.steroids.2017.09.007
   Pouwels KB, 2018, J ANTIMICROB CHEMOTH, V73, P19, DOI 10.1093/jac/dkx502
   Qiu QW, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.590018
   Rahman SF, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00123
   Reese AT, 2018, ELIFE, V7, DOI 10.7554/eLife.35987
   Roope LSJ, 2019, SCIENCE, V364, P41, DOI 10.1126/science.aau4679
   Rotmistrovsky K., 2011, BMTAGGER BEST MATCH
   Salazar G., 2000, ECOLUTILS UTILITIES
   Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Sergio G, 2008, INFLAMM RES, V57, P558, DOI 10.1007/s00011-008-7243-2
   Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834
   Soltani H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111606
   Sonnenburg ED, 2019, NAT REV MICROBIOL, V17, P383, DOI 10.1038/s41579-019-0191-8
   Sonnenburg JL, 2019, SCIENCE, V366, P444, DOI 10.1126/science.aaw9255
   Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13
   Taft DH, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00441-18
   Thanner S, 2016, MBIO, V7, DOI 10.1128/mBio.02227-15
   Topcuoglu Begum D, 2021, J Open Source Softw, V6, DOI 10.21105/joss.03073
   Treiber ML, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3416-y
   Van Boeckel TP, 2019, SCIENCE, V365, P1266, DOI 10.1126/science.aaw1944
   Van Boeckel TP, 2017, SCIENCE, V357, P1350, DOI 10.1126/science.aao1495
   Van Rossum G., 2009, PYTHON 3 REFERENCE M
   Venables W.N., 2002, MODERN APPL STAT S
   Vikesland P, 2019, ACCOUNTS CHEM RES, V52, P916, DOI 10.1021/acs.accounts.8b00643
   von Meijenfeldt FAB, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1817-x
   Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026871
   Ward MJ, 2014, APPL ENVIRON MICROB, V80, P7275, DOI 10.1128/AEM.01777-14
   Wellcome Trust, 2016, TACKLING DRUG RESIST
   Wibowo MC, 2021, NATURE, V594, P234, DOI 10.1038/s41586-021-03532-0
   Wood Derrick E, 2019, Genome Biol, V20, P257, DOI 10.1186/s13059-019-1891-0
   Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083
   World Health Organization, 2019, ANTIBACTERIAL AGENTS
   Young DG, 1999, CLIN EXP IMMUNOL, V117, P476
   Zhang Z., 2014, R LANG ENV STAT COMP
NR 92
TC 16
Z9 16
U1 6
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUN 28
PY 2022
VL 13
IS 3
DI 10.1128/mbio.00101-22
EA MAY 2022
PG 18
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 2U3OC
UT WOS:000797908900006
PM 35536006
OA Green Published
DA 2023-09-14
ER

PT J
AU Suttner, B
   Johnston, ER
   Orellana, LH
   Rodriguez-R, LM
   Hatt, JK
   Carychao, D
   Carter, MQ
   Cooley, MB
   Konstantinidis, KT
AF Suttner, Brittany
   Johnston, Eric R.
   Orellana, Luis H.
   Rodriguez-R, Luis M.
   Hatt, Janet K.
   Carychao, Diana
   Carter, Michelle Q.
   Cooley, Michael B.
   Konstantinidis, Konstantinos T.
TI Metagenomics as a Public Health Risk Assessment Tool in a Study of
   Natural Creek Sediments Influenced by Agricultural and Livestock Runoff:
   Potential and Limitations
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE antibiotic resistance; metagenomics; microbial ecology; microbial source
   tracking; sediment microbial communities
ID ANTIBIOTIC-RESISTANCE GENES; ESCHERICHIA-COLI; NONPARAMETRIC-ESTIMATION;
   BACTERIA; WATER; DIVERSE; RIVER; COMMUNITIES; RESPONSES; ESTUARY
AB Little is known about the public health risks associated with natural creek sediments that are affected by runoff and fecal pollution from agricultural and livestock practices. For instance, the persistence of foodborne pathogens such as Shiga toxin-producing Escherichia coli (STEC) originating from these practices remains poorly quantified. Towards closing these knowledge gaps, the water-sediment interface of two creeks in the Salinas River Valley of California was sampled over a 9-month period using metagenomics and traditional culture-based tests for STEC. Our results revealed that these sediment communities are extremely diverse and have functional and taxonomic diversity comparable to that observed in soils. With our sequencing effort (similar to 4 Gbp per library), we were unable to detect any pathogenic E. coil in the metagenomes of 11 samples that had tested positive using culture-based methods, apparently due to relatively low abundance. Furthermore, there were no significant differences in the abundance of human- or cow-specific gut microbiome sequences in the downstream impacted sites compared to that in upstream more pristine (control) sites, indicating natural dilution of anthropogenic inputs. Notably, the high number of metagenomic reads carrying antibiotic resistance genes (ARGs) found in all samples was significantly higher than ARG reads in other available freshwater and soil metagenomes, suggesting that these communities may be natural reservoirs of ARGs. The work presented here should serve as a guide for sampling volumes, amount of sequencing to apply, and what bioinformatics analyses to perform when using metagenomics for public health risk studies of environmental samples such as sediments.
   IMPORTANCE Current agricultural and livestock practices contribute to fecal contamination in the environment and the spread of food- and waterborne disease and antibiotic resistance genes (ARGs). Traditionally, the level of pollution and risk to public health are assessed by culture-based tests for the intestinal bacterium Escherichia coil. However, the accuracy of these traditional methods (e.g., low accuracy in quantification, and false-positive signal when PCR based) and their suitability for sediments remain unclear. We collected sediments for a time series metagenomics study from one of the most highly productive agricultural regions in the United States in order to assess how agricultural runoff affects the native microbial communities and if the presence of Shiga toxin-producing Escherichia coil (STEC) in sediment samples can be detected directly by sequencing. Our study provided important information on the potential for using metagenomics as a tool for assessment of public health risk in natural environments.
C1 [Suttner, Brittany; Johnston, Eric R.; Orellana, Luis H.; Hatt, Janet K.; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.
   [Carychao, Diana; Carter, Michelle Q.; Cooley, Michael B.] USDA ARS, Prod Safety & Microbiol, Western Reg Res Ctr, Albany, CA USA.
   [Johnston, Eric R.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.
   [Rodriguez-R, Luis M.; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Ctr Bioinformat & Computat Genom, Sch Biol Sci, Atlanta, GA 30332 USA.
C3 University System of Georgia; Georgia Institute of Technology; United
   States Department of Agriculture (USDA); United States Department of
   Energy (DOE); Oak Ridge National Laboratory; University System of
   Georgia; Georgia Institute of Technology
RP Konstantinidis, KT (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.; Konstantinidis, KT (corresponding author), Georgia Inst Technol, Ctr Bioinformat & Computat Genom, Sch Biol Sci, Atlanta, GA 30332 USA.
EM kostas@ce.gatech.edu
RI Rodriguez-R, Luis M./S-6996-2018; Konstantinidis, Kostas/ABE-7113-2020;
   Hatt, Janet Kay/HME-2512-2023; Johnston, Eric R/J-1051-2019; Orellana,
   Luis/I-5621-2019
OI Rodriguez-R, Luis M./0000-0001-7603-3093; Konstantinidis,
   Kostas/0000-0002-0954-4755; Hatt, Janet Kay/0000-0002-5666-0994;
   Johnston, Eric R/0000-0002-3217-7711; Orellana,
   Luis/0000-0002-2766-5243; Suttner, Brittany/0000-0001-9004-4354; Carter,
   Michelle Qiu/0000-0002-0710-7420
FU USDA [2030-42000-050-10]; US National Science Foundation [1511825,
   1831582]; US National Science Foundation Graduate Research Fellowship
   [DGE-1650044]; Directorate For Engineering; Div Of Chem, Bioeng, Env, &
   Transp Sys [1511825] Funding Source: National Science Foundation;
   Division Of Environmental Biology; Direct For Biological Sciences
   [1831582] Funding Source: National Science Foundation
FX This work was supported by the USDA (award 2030-42000-050-10), the US
   National Science Foundation (award numbers 1511825 and 1831582 to
   K.T.K.), and the US National Science Foundation Graduate Research
   Fellowship under grant number DGE-1650044. The funding agencies had no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Abia ALK, 2018, SCI TOTAL ENVIRON, V616, P326, DOI 10.1016/j.scitotenv.2017.10.322
   Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI [10.1093/nar/gkh131, 10.1093/nar/gkw1099]
   Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08
   Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439
   Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Castro JC, 2018, PEERJ, V6, DOI 10.7717/peerj.5882
   CHAO A, 1984, SCAND J STAT, V11, P265
   Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727
   Chen BW, 2013, WATER RES, V47, P2811, DOI 10.1016/j.watres.2013.02.042
   Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159
   Cooley MB, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00448
   Cooley MB, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00030
   Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716
   Costa PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119465
   Cytryn E, 2013, SOIL BIOL BIOCHEM, V63, P18, DOI 10.1016/j.soilbio.2013.03.017
   D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Dorner SM, 2006, ENVIRON SCI TECHNOL, V40, P4746, DOI 10.1021/es060426z
   Durso LM, 2014, CURR OPIN MICROBIOL, V19, P37, DOI 10.1016/j.mib.2014.05.019
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Gibbons SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097435
   Graves CJ, 2016, APPL ENVIRON MICROB, V82, P2862, DOI 10.1128/AEM.03990-15
   Hausser J, 2009, J MACH LEARN RES, V10, P1469
   Huber DH, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00350-18
   Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763
   Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1704, DOI 10.1128/AEM.03172-12
   Johnston ER, 2019, SOIL BIOL BIOCHEM, V130, P43, DOI 10.1016/j.soilbio.2018.11.026
   Johnston ER, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00579
   Karkman A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07992-3
   Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3_13
   Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103
   Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Luo CW, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku169
   Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106
   Mantha S, 2017, SCI TOTAL ENVIRON, V598, P204, DOI 10.1016/j.scitotenv.2017.04.020
   MARTIN JF, 1989, ANNU REV MICROBIOL, V43, P173, DOI 10.1146/annurev.micro.43.1.173
   McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13
   Meziti A, 2016, ENVIRON MICROBIOL, V18, P4640, DOI 10.1111/1462-2920.13303
   Morlon H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130659
   Nayfach S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0611-7
   Negi Vivek, 2017, J Genomics, V5, P36, DOI 10.7150/jgen.16685
   Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x
   Orellana LH, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01646-17
   Orellana LH, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw900
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Petit F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00609
   Probert WS, 2017, EMERG INFECT DIS, V23, P1216, DOI 10.3201/eid2307.170226
   Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747
   Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034
   Rodriguez LM, 2015, ISME J, V9, P1928, DOI 10.1038/ismej.2015.5
   Rodriguez-R LM, 2014, BIOINFORMATICS, V30, P629, DOI 10.1093/bioinformatics/btt584
   SALYERS AA, 1995, MICROBIOL REV, V59, P579, DOI 10.1128/MMBR.59.4.579-590.1995
   Soller JA, 2010, WATER RES, V44, P4674, DOI 10.1016/j.watres.2010.06.049
   Su XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089323
   US-FDA, 2015, ANT SOLD DISTR US FO
   Van Rossum T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01405
   Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7
   WHO, 2014, ANT RES EM WAT SAN H
   Xu MY, 2014, ISME J, V8, P1932, DOI 10.1038/ismej.2014.42
   Yang J, 2013, MICROB ECOL, V65, P975, DOI 10.1007/s00248-013-0187-2
   Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209
   Zhang SY, 2019, ENVIRON MICROBIOL, V21, P182, DOI 10.1111/1462-2920.14439
   Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110
NR 71
TC 15
Z9 16
U1 7
U2 50
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD MAR
PY 2020
VL 86
IS 6
AR e02525-19
DI 10.1128/AEM.02525-19
PG 19
WC Biotechnology & Applied Microbiology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Microbiology
GA KZ0RF
UT WOS:000522978600013
PM 31924621
OA Green Published
DA 2023-09-14
ER

PT J
AU Lewis, JP
   Gui, Q
AF Lewis, Janina P.
   Gui, Qin
TI Iron Deficiency Modulates Metabolic Landscape of Bacteroidetes Promoting
   Its Resilience during Inflammation
SO MICROBIOLOGY SPECTRUM
LA English
DT Article; Early Access
DE Bacteroides thetaiotaomicron; Bacteroidetes; Porphyromonas gingivalis;
   Prevotella intermedia; host immune response; iron metabolism; iron
   regulation; iron uptake
ID FUNCTION SIGMA-FACTOR; PORPHYROMONAS-GINGIVALIS; FERREDOXIN ACTIVITY;
   FLAVODOXIN; THETAIOTAOMICRON; EXPRESSION; AVAILABILITY; SIDEROPHORES;
   MICROBIOME; PROTEINS
AB Bacteria have to persist under low iron conditions in order to adapt to the nutritional immunity of a host. Since the knowledge of iron stimulon of Bacteroidetes is sparse, we examined oral (Porphyromonas gingivalis and Prevotella intermedia) and gut (Bacteroides thataiotaomicron) representatives for their ability to adapt to iron deplete and iron replete conditions. Our transcriptomics and comparative genomics analysis show that many iron-regulated mechanisms are conserved within the phylum. They include genes upregulated in low iron, as follows: fldA (flavodoxin), hmu (hemin uptake operon), and loci encoding ABC transporters. Downregulated genes were frd (ferredoxin), rbr (rubrerythrin), sdh (succinate dehydrogenase/fumarate reductase), vor (oxoglutarate oxidoreductase/dehydrogenase), and pfor (pyruvate:ferredoxin/flavodoxin oxidoreductase). Some genus-specific mechanisms, such as the sus of B. thetaiotaomicron coding for carbohydrate metabolism and the xusABC coding for xenosiderophore utilization were also identified. While all bacteria tested in our study had the nrfAH operon coding for nitrite reduction and were able to reduce nitrite levels present in culture media, the expression of the operon was iron dependent only in B. thetaiotaomicron. It is noteworthy that we identified a significant overlap between regulated genes found in our study and the B. thetaiotaomicron colitis study (W. Zhu, M. G. Winter, L. Spiga, E. R. Hughes et al., Cell Host Microbe 27:376-388, 2020, ). Many of those commonly regulated genes were also iron regulated in the oral bacterial genera. Overall, this work points to iron being the master regulator enabling bacterial persistence in the host and paves the way for a more generalized investigation of the molecular mechanisms of iron homeostasis in Bacteroidetes.IMPORTANCE Bacteroidetes are an important group of anaerobic bacteria abundant both in the oral and gut microbiomes. Although iron is a required nutrient for most living organisms, the molecular mechanisms of adaptation to the changing levels of iron are not well known in this group of bacteria. We defined the iron stimulon of Bacteroidetes by examination of the transcriptomic response of Porphyromonas gingivalis and Prevotella intermedia (both belong to the oral microbiome) and Bacteroidetes thetaiotaomicron (belongs to the gut microbiome). Our results indicate that many of the iron-regulated operons are shared among the three genera. Furthermore, using bioinformatics analysis, we identified a significant overlap between our in vitro studies and transcriptomic data derived from a colitis study, thus underscoring the biological significance of our work. Defining the iron-dependent stimulon of Bacteroidetes can help to identify the molecular mechanisms of iron-dependent regulation as well as better understand the persistence of the anaerobes in the human host.
C1 [Lewis, Janina P.; Gui, Qin] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.
   [Lewis, Janina P.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23284 USA.
   [Lewis, Janina P.] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23284 USA.
C3 Virginia Commonwealth University; Virginia Commonwealth University;
   Virginia Commonwealth University
RP Lewis, JP (corresponding author), Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA 23284 USA.; Lewis, JP (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23284 USA.; Lewis, JP (corresponding author), Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23284 USA.
EM jplewis@vcu.edu
OI Lewis, Janina/0000-0002-0986-6201
FU NIH [1R01DE023304, NIHR21DE025555, K18 DE029865]; SRI International
FX This work was funded by NIH grants 1R01DE023304 (J.P.L.), NIHR21DE025555
   (J.P.L.) and K18 DE029865 (J.P.L.). Figures were generated using the
   BioCyc Pathways Tools version 26.0 (software by SRI International).
   J.P.L. performed experiments and analyzed all data. J.P.L. wrote the
   manuscript. Q.G. performed experiments. We have no conflicts of interest
   to declare.
CR Anaya-Bergman C, 2015, MOL ORAL MICROBIOL, V30, P39, DOI 10.1111/omi.12066
   Belvin BR, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00572-18
   Bielecki M, 2020, BIOCHEM J, V477, P381, DOI 10.1042/BCJ20190607
   Boyer E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33813-0
   Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401
   Butaite E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00509-4
   Carvalho RCC, 2016, ORAL DIS, V22, P75, DOI 10.1111/odi.12373
   Cavazza C, 2006, STRUCTURE, V14, P217, DOI 10.1016/j.str.2005.10.013
   Chabriere E, 2001, SCIENCE, V294, P2559, DOI 10.1126/science.1066198
   Chathoth K, 2020, FEMS MICROBIOL LETT, V367, DOI 10.1093/femsle/fnaa100
   Chawla A, 2010, MOL MICROBIOL, V78, P1510, DOI 10.1111/j.1365-2958.2010.07420.x
   Comstock LE, 2003, BIOESSAYS, V25, P926, DOI 10.1002/bies.10350
   Cremades N, 2009, ACS CHEM BIOL, V4, P928, DOI 10.1021/cb900166q
   Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552
   Ghosh S, 2021, ARCH MICROBIOL, V203, P5281, DOI 10.1007/s00203-021-02516-y
   Goff JL, 2023, ISME J, V17, P382, DOI 10.1038/s41396-022-01351-3
   Haigh RD, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01229-17
   Han Y, 2021, J PERIODONTAL RES, V56, P690, DOI 10.1111/jre.12865
   Hayase E, 2022, CELL, V185, P3705, DOI 10.1016/j.cell.2022.09.007
   Hezel MP, 2015, ORAL DIS, V21, P7, DOI 10.1111/odi.12157
   Holden VI, 2015, METALLOMICS, V7, P986, DOI 10.1039/c4mt00333k
   Hoover DM, 1997, PROTEIN SCI, V6, P2525
   Jiang YL, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.727732
   Karp PD, 2019, BRIEF BIOINFORM, V20, P1085, DOI 10.1093/bib/bbx085
   Kirst ME, 2015, APPL ENVIRON MICROB, V81, P783, DOI 10.1128/AEM.02712-14
   KNIGHT E, 1966, BIOCHIM BIOPHYS ACTA, V113, P626, DOI 10.1016/S0926-6593(66)80025-5
   Lapebie P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10068-5
   Lewin GR, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2116637119
   Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0
   Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929
   Mayneris-Perxachs J, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01052-7
   McKee LS, 2021, ENV MICROBIOL REP, V13, P559, DOI 10.1111/1758-2229.12980
   Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Nairz M, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100864
   Naito M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9030551
   Naito M, 2016, DNA RES, V23, P11, DOI 10.1093/dnares/dsv032
   Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003
   Nemeth E, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126493
   Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080
   O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k
   Ota K, 2017, ANAEROBE, V43, P82, DOI 10.1016/j.anaerobe.2016.12.006
   OTTO BR, 1988, MICROB PATHOGENESIS, V4, P279, DOI 10.1016/0882-4010(88)90088-5
   Phillips P, 2014, FEMS MICROBIOL LETT, V351, P202, DOI 10.1111/1574-6968.12320
   Karlusich JJP, 2014, J EXP BOT, V65, P5161, DOI 10.1093/jxb/eru273
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Salillas S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051881
   Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x
   Sieminska K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052237
   SIMONDSEN RP, 1980, MOL CELL BIOCHEM, V33, P13
   SMILLIE RM, 1965, BIOCHEM BIOPH RES CO, V20, P621, DOI 10.1016/0006-291X(65)90445-6
   Solbiati J, 2018, J DENT RES, V97, P492, DOI 10.1177/0022034518761644
   Velmurugan S, 2016, AM J CLIN NUTR, V103, P25, DOI 10.3945/ajcn.115.116244
   Wang RK, 2012, MICROB ECOL, V64, P152, DOI 10.1007/s00248-012-0013-2
   Welch JLM, 2019, ANNU REV MICROBIOL, V73, P335, DOI 10.1146/annurev-micro-090817-062503
   Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07
   Whitney LP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00234
   Wilson BR, 2016, TRENDS MOL MED, V22, P1077, DOI 10.1016/j.molmed.2016.10.005
   Wu DL, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01620
   Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029
   Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x
   Yost S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0153-3
   Yu F, 2007, PROTEOMICS, V7, P403, DOI 10.1002/pmic.200600441
   Zhu WH, 2020, CELL HOST MICROBE, V27, P376, DOI 10.1016/j.chom.2020.01.010
NR 64
TC 0
Z9 0
U1 6
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD 2023 JUN 14
PY 2023
DI 10.1128/spectrum.04733-22
EA JUN 2023
PG 39
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA J5EP4
UT WOS:001009851000001
PM 37314331
OA Green Submitted, gold
DA 2023-09-14
ER

PT J
AU Ye, S
   Li, SK
   Su, CJ
   Shi, ZQ
   Li, H
   Hong, JW
   Wang, SK
   Zhao, JY
   Zheng, WJ
   Dong, SX
   Ye, SH
   Lou, YL
   Zhou, ZM
   Du, JM
AF Ye, Sheng
   Li, Shengkai
   Su, Chenjun
   Shi, Zhuqing
   Li, Heng
   Hong, Jiawen
   Wang, Shengke
   Zhao, Jingyan
   Zheng, Weiji
   Dong, Shixuan
   Ye, Shuhan
   Lou, Yongliang
   Zhou, Zhemin
   Du, Jimei
TI Characterization of microbial community and antibiotic resistome in
   intra urban water, Wenzhou China
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE waterborne pathogen; antibiotic resistance; metagenomic analysis; public
   health; environment
ID BETA-LACTAMASE ESBL; RESISTANCE GENES; WASTE-WATER; BACTERIA;
   PREVALENCE; REMOVAL; SLUDGE; ARGS
AB The present study investigated the water quality index, microbial composition and antimicrobial resistance genes in urban water habitats. Combined chemicals testing, metagenomic analyses and qualitative PCR (qPCR) were conducted on 20 locations, including rivers from hospital surrounds (n = 7), community surrounds (n = 7), and natural wetlands (n = 6). Results showed that the indexes of total nitrogen, phosphorus, and ammonia nitrogen of hospital waters were 2-3 folds high than that of water from wetlands. Bioinformatics analysis revealed a total of 1,594 bacterial species from 479 genera from the three groups of water samples. The hospital-related samples had the greatest number of unique genera, followed by those from wetlands and communities. The hospital-related samples contained a large number of bacteria associated with the gut microbiome, including Alistipes, Prevotella, Klebsiella, Escherichia, Bacteroides, and Faecalibacterium, which were all significantly enriched compared to samples from the wetlands. Nevertheless, the wetland waters enriched bacteria from Nanopelagicus, Mycolicibacterium and Gemmatimonas, which are typically associated with aquatic environments. The presence of antimicrobial resistance genes (ARGs) that were associated with different species origins in each water sample was observed. The majority of ARGs from hospital-related samples were carried by bacteria from Acinetobacter, Aeromonas and various genera from Enterobacteriaceae, which each was associated with multiple ARGs. In contrast, the ARGs that were exclusively in samples from communities and wetlands were carried by species that encoded only 1 to 2 ARGs each and were not normally associated with human infections. The qPCR showed that water samples of hospital surrounds had higher concentrations of intI1 and antimicrobial resistance genes such as tetA, ermA, ermB, qnrB, sul1, sul2 and other beta-lactam genes. Further genes of functional metabolism reported that the enrichment of genes associated with the degradation/utilization of nitrate and organic phosphodiester were detected in water samples around hospitals and communities compared to those from wetlands. Finally, correlations between the water quality indicators and the number of ARGs were evaluated. The presence of total nitrogen, phosphorus, and ammonia nitrogen were significantly correlated with the presence of ermA and sul1. Furthermore, intI1 exhibited a significant correlation with ermB, sul1, and bla(SHV), indicating a prevalence of ARGs in urban water environments might be due to the integron intI1's diffusion-promoting effect. However, the high abundance of ARGs was limited to the waters around the hospital, and we did not observe the geographical transfer of ARGs along with the river flow. This may be related to water purifying capacity of natural riverine wetlands. Taken together, continued surveillance is required to assess the risk of bacterial horizontal transmission and its potential impact on public health in the current region.
C1 [Ye, Sheng; Li, Shengkai; Shi, Zhuqing; Hong, Jiawen; Wang, Shengke; Zhao, Jingyan; Zheng, Weiji; Dong, Shixuan; Ye, Shuhan; Lou, Yongliang; Du, Jimei] Wenzhou Med Univ, Sch Lab Med, Wenzhou Key Lab Sanit Microbiol, Dept Microbiol & Immunol, Wenzhou, Peoples R China.
   [Su, Chenjun; Li, Heng; Zhou, Zhemin] Soochow Univ, Pasteurien Coll, Suzhou Med Coll, Suzhou, Jiangsu, Peoples R China.
   [Hong, Jiawen] Taizhou Hosp Zhejiang Prov, Taizhou, Peoples R China.
C3 Wenzhou Medical University; Soochow University - China
RP Lou, YL; Du, JM (corresponding author), Wenzhou Med Univ, Sch Lab Med, Wenzhou Key Lab Sanit Microbiol, Dept Microbiol & Immunol, Wenzhou, Peoples R China.; Zhou, ZM (corresponding author), Soochow Univ, Pasteurien Coll, Suzhou Med Coll, Suzhou, Jiangsu, Peoples R China.
EM lyl@wmu.edu.cn; zmzhou@suda.edu.cn; djm@wmu.edu.cn
RI Shi, zhuqing/JAC-8650-2023; wang, jiahui/IXD-1197-2023; ZHAO,
   S/IWV-4219-2023; Zhang, Yun/JCN-7026-2023
CR An XL, 2023, MSYSTEMS, V8, DOI 10.1128/msystems.00576-22
   Che Y, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2008731118, 10.1073/pnas.2104557118]
   Choi S, 2020, SEP PURIF TECHNOL, V247, DOI 10.1016/j.seppur.2020.116946
   Dirar MH, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.2020.37.213.24988
   Duan X, 2021, WATER RES, V196, DOI 10.1016/j.watres.2021.117004
   Ejaz H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245126
   Gao YC, 2021, CHEMOSPHERE, V271, DOI 10.1016/j.chemosphere.2021.129566
   Gekenidis MT, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8070978
   Griebler C, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-6207-z
   Guo XP, 2017, CHEMOSPHERE, V175, P21, DOI 10.1016/j.chemosphere.2017.01.134
   Haberecht HB, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/3862949
   Hao H, 2019, J HAZARD MATER, V365, P340, DOI 10.1016/j.jhazmat.2018.11.004
   Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0
   Huang F, 2022, FRONT VET SCI, V9, DOI 10.3389/fvets.2022.1054316
   Jamborova I, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00519-18
   Johnson A, 2020, J WATER HEALTH, V18, P849, DOI 10.2166/wh.2020.065
   Kayali O, 2021, B ENVIRON CONTAM TOX, V106, P399, DOI 10.1007/s00128-020-03098-z
   Kim J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84974-4
   Li AL, 2018, ENVIRON SCI POLLUT R, V25, P26209, DOI 10.1007/s11356-018-2664-0
   Li H, 2021, WATER RES, V204, DOI 10.1016/j.watres.2021.117630
   Li W, 2021, ENVIRON INT, V156, DOI 10.1016/j.envint.2021.106620
   Liang CY, 2022, BIORESOURCE TECHNOL, V344, DOI 10.1016/j.biortech.2021.126272
   Liao JQ, 2018, REV ENVIRON SCI BIO, V17, P471, DOI 10.1007/s11157-018-9469-y
   Lu XM, 2016, APPL MICROBIOL BIOT, V100, P2817, DOI 10.1007/s00253-015-7103-2
   Lu Y, 2020, INFECT DRUG RESIST, V13, P3383, DOI 10.2147/IDR.S269766
   Maurya A., 2020, MICROORGANISMS SUSTA, V2020, P81, DOI [10.1016/B978-0-12-819001-2.00005-X, DOI 10.1016/B978-0-12-819001-2.00005-X]
   Messina M, 2020, INT J NEONAT SCREEN, V6, DOI 10.3390/ijns6030058
   Miyagi K, 2019, ENVIRON SCI POLLUT R, V26, P7697, DOI 10.1007/s11356-019-04189-z
   Nnadozie CE, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.113067
   Petersen TM, 2005, J ENVIRON ENG, V131, P1414, DOI 10.1061/(ASCE)0733-9372(2005)131:10(1414)
   Sileshi A, 2020, FRONT ENV SCI-SWITZ, V8, DOI 10.3389/fenvs.2020.00039
   Su ZG, 2020, MAR POLLUT BULL, V151, DOI 10.1016/j.marpolbul.2019.110856
   Wang RM, 2021, SCI TOTAL ENVIRON, V796, DOI 10.1016/j.scitotenv.2021.148919
   Wu ZQ, 2022, WATER RES, V226, DOI 10.1016/j.watres.2022.119282
   Yang YW, 2021, J HAZARD MATER, V404, DOI 10.1016/j.jhazmat.2020.124149
   Zainab SM, 2020, WATER RES, V187, DOI 10.1016/j.watres.2020.116455
NR 36
TC 0
Z9 0
U1 3
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 15
PY 2023
VL 14
AR 1169476
DI 10.3389/fmicb.2023.1169476
PG 13
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA K4UF3
UT WOS:001016399400001
PM 37396356
OA gold, Green Published
DA 2023-09-14
ER

EF